SB 895: California Science and Health Research Bond Act.
- Session Year: 2025-2026
- House: Senate
- Latest Version Date: 2026-09-30
Current Status:
Passed
(2026-09-30: Chaptered by Secretary of State. Chapter 1040, Statutes of 2026.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
(1)Existing law establishes various grant and loan programs for research, including, among others, the California Institute for Regenerative Medicine, California Firefighter Cancer Prevention and Research Program, and the Public Interest Research, Development, and Demonstration Program.
This bill would establish the California Foundation for Science and Health Research within the Government Operations Agency. The bill would require the Secretary of Government Operations to oversee the process of appointing the director of the foundation, and would authorize the Secretary of Government Operations to delegate the task of hiring and determining the salaries, bonuses, and benefits of additional personnel to the director, as specified. The bill would require the director and personnel of the foundation to be responsible for implementing the strategic objectives of the California Foundation for Science and Health Research Council, as described below, administering grants, loans, and contracts awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
This bill would create the California Foundation for Science and Health Research and Innovation Acceleration Fund and require the moneys in the fund to be used by the foundation to award grants and make loans to, and enter into contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development and for certain economic sectors, as specified, in specific areas of research, including, but not limited to, biomedical, behavioral health, and climate research. The bill would also create the California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund, to consist solely of private donations. The bill would make the moneys in the benefit fund available for the same purposes as the California Foundation for Science and Health Research and Innovation Acceleration Fund.
This bill would require that, prior to the first grant from the foundation and no later than one year from the date the bill takes effect, the council develop various provisions and requirements to facilitate the foundations goals of affordability and equitable access. The foundation shall impose various requirements on the grantees, loan recipients, and contractors, as specified, including, among other things, developing strategies to promote equitable access to the subject invention in various specified communities and making the data resulting from the bond-funded research available to the broader scientific community, except in cases involving national security interests. The council shall also establish standards requiring that all grants, awards, and contracts be subject to intellectual property agreements that balance the opportunity for the State of California to benefit from the inventions, technologies, patents, royalties, and licenses that result from research funded by certain public and private grants, as specified.
This bill would create the California Foundation for Science and Health Research Council, as specified, which shall be vested with full power, authority, and jurisdiction over the foundation. The bill would require the council to, among other things, develop the strategic objectives and priorities of the foundation and provide the opportunity for public comment on the foundations priorities, as specified, determine the research projects that will be funded by the California Foundation for Science and Health Research and Innovation Acceleration Fund, develop objectives and opportunities that offer support to early career researchers, and adopt certain regulations and standards, as specified. The bill would also require the council to consider how the foundations research priorities relate to or support various economic and industry considerations, as specified. The bill would provide that a majority of the members of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the council, except as otherwise provided. The bill would authorize the council to establish one or more scientific peer review panels consisting of experts in specified fields of research for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefit to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
This bill would require all research and development funded by the California Foundation for Science and Health Research and Innovation Acceleration Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight. The bill would require the funds and contracts to be awarded on the basis of the research priorities established for the foundation by the council and the scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $7,500,000,000, pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and operate and maintain facilities for research.
The bill would provide for the submission of the bond act to the voters at the March 7, 2028, statewide primary election.
(2)Existing law establishes prohibitions and penalties with respect to ethical obligations and conflicts of interest for public officials, including a prohibition on engaging in activities that are incompatible with their official duties and a prohibition on being financially interested in a contract made by them in their official capacity or the board of which they are a part.
This bill would authorize a council member to participate in a decision to approve or award a grant, loan, or contract for the purpose of research into a disease in which the member or their immediate family member has a personal interest, as specified. The bill would provide that service with specified educational institutions and organizations is not incompatible with a council members duties. The bill would provide that the prohibition on being financially interested in a contract, as specified, does not apply if the council member recuses themself from a decision to award or approve a grant, loan, or contract that would otherwise be subject to the prohibition. The bill would provide that council members are subject to certain disclosure requirements relating to personal investments and potential conflicts of interest, as specified.
(3)Existing law, the Bagley-Keene Open Meeting Act, requires that all meetings of a state body be open and public and all persons be permitted to attend any meeting of a state body, with specified exceptions for authorized closed sessions.
This bill would require the Bagley-Keene Open Meeting Act to apply to all meetings of the council and scientific peer review panels, except as specified for when the council or scientific peer review panels meet to consider or discuss specified matters in closed sessions, including matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(4)This bill would declare that it is to take effect immediately as an urgency statute.
(1)Existing law establishes various grant and loan programs for research, including, among others, the California Institute for Regenerative Medicine, California Firefighter Cancer Prevention and Research Program, and the Public Interest Research, Development, and Demonstration Program.
This bill would establish the California Foundation for Science and Health Research within the Government Operations Agency. The bill would require the Secretary of Government Operations to oversee the process of appointing the director of the foundation, and would authorize the Secretary of Government Operations to delegate the task of hiring and determining the salaries, bonuses, and benefits of additional personnel to the director, as specified. The bill would require the director and personnel of the foundation to be responsible for implementing the strategic objectives of the California Foundation for Science and Health Research Council, as described below, administering grants, loans, and contracts awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
This bill would create the California Foundation for Science and Health Research and Innovation Acceleration Fund and require the moneys in the fund to be used by the foundation to award grants and make loans to, and enter into contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development and for certain economic sectors, as specified, in specific areas of research, including, but not limited to, biomedical, behavioral health, and climate research. The bill would also create the California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund, to consist solely of private donations. The bill would make the moneys in the benefit fund available for the same purposes as the California Foundation for Science and Health Research and Innovation Acceleration Fund.
This bill would require that, prior to the first grant from the foundation and no later than one year from the date the bill takes effect, the council develop various provisions and requirements to facilitate the foundations goals of affordability and equitable access. The foundation shall impose various requirements on the grantees, loan recipients, and contractors, as specified, including, among other things, developing strategies to promote equitable access to the subject invention in various specified communities and making the data resulting from the bond-funded research available to the broader scientific community, except in cases involving national security interests. The council shall also establish standards requiring that all grants, awards, and contracts be subject to intellectual property agreements that balance the opportunity for the State of California to benefit from the inventions, technologies, patents, royalties, and licenses that result from research funded by certain public and private grants, as specified.
This bill would create the California Foundation for Science and Health Research Council, as specified, which shall be vested with full power, authority, and jurisdiction over the foundation. The bill would require the council to, among other things, develop the strategic objectives and priorities of the foundation and provide the opportunity for public comment on the foundations priorities, as specified, determine the research projects that will be funded by the California Foundation for Science and Health Research and Innovation Acceleration Fund, develop objectives and opportunities that offer support to early career researchers, and adopt certain regulations and standards, as specified. The bill would also require the council to consider how the foundations research priorities relate to or support various economic and industry considerations, as specified. The bill would provide that a majority of the members of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the council, except as otherwise provided. The bill would authorize the council to establish one or more scientific peer review panels consisting of experts in specified fields of research for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefit to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
This bill would require all research and development funded by the California Foundation for Science and Health Research and Innovation Acceleration Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight. The bill would require the funds and contracts to be awarded on the basis of the research priorities established for the foundation by the council and the scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $7,500,000,000, pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and operate and maintain facilities for research.
The bill would provide for the submission of the bond act to the voters at the March 7, 2028, statewide primary election.
(2)Existing law establishes prohibitions and penalties with respect to ethical obligations and conflicts of interest for public officials, including a prohibition on engaging in activities that are incompatible with their official duties and a prohibition on being financially interested in a contract made by them in their official capacity or the board of which they are a part.
This bill would authorize a council member to participate in a decision to approve or award a grant, loan, or contract for the purpose of research into a disease in which the member or their immediate family member has a personal interest, as specified. The bill would provide that service with specified educational institutions and organizations is not incompatible with a council members duties. The bill would provide that the prohibition on being financially interested in a contract, as specified, does not apply if the council member recuses themself from a decision to award or approve a grant, loan, or contract that would otherwise be subject to the prohibition. The bill would provide that council members are subject to certain disclosure requirements relating to personal investments and potential conflicts of interest, as specified.
(3)Existing law, the Bagley-Keene Open Meeting Act, requires that all meetings of a state body be open and public and all persons be permitted to attend any meeting of a state body, with specified exceptions for authorized closed sessions.
This bill would require the Bagley-Keene Open Meeting Act to apply to all meetings of the council and scientific peer review panels, except as specified for when the council or scientific peer review panels meet to consider or discuss specified matters in closed sessions, including matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(4)This bill would declare that it is to take effect immediately as an urgency statute.
(1)Existing law establishes various grant and loan programs for research, including, among others, the California Institute for Regenerative Medicine, California Firefighter Cancer Prevention and Research Program, and the Public Interest Research, Development, and Demonstration Program.
This bill would establish the California Foundation for Science and Health Research within the Government Operations Agency. The bill would require the Secretary of Government Operations to oversee the process of appointing the director of the foundation, and would authorize the Secretary of Government Operations to delegate the task of hiring and determining the salaries, bonuses, and benefits of additional personnel to the director, as specified. The bill would require the director and personnel of the foundation to be responsible for implementing the strategic objectives of the California Foundation for Science and Health Research Council, as described below, administering grants and loans grants, loans, and contracts awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
This bill would create the California Foundation for Science and Health Research and Innovation Acceleration Fund and require the moneys in the fund to be used by the foundation to award grants and make loans to to, and enter into contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development, development and for certain economic sectors, as specified, in specific areas of research, including, but not limited to, biomedical, behavioral health, and climate research. The bill would also create the California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund, to consist solely of private donations. The bill would make the moneys in the benefit fund available for the same purposes as the California Foundation for Science and Health Research and Innovation Acceleration Fund.
This bill would require that, prior to the first grant from the foundation and no later than one year from the date the bill takes effect, the council develop various provisions and requirements to facilitate the foundations goals of affordability and equitable access. The foundation shall impose various requirements on the grantees, loan recipients, and contractors, as specified, including, among other things, developing strategies to promote equitable access to the subject invention in various specified communities and making the data resulting from the bond-funded research available to the broader scientific community, except in cases involving national security interests. The council shall also establish standards requiring that all grants, awards, and contracts be subject to intellectual property agreements that balance the opportunity for the State of California to benefit from the inventions, technologies, patents, royalties, and licenses that result from research funded by certain public and private grants, as specified.
This bill would create the California Foundation for Science and Health Research Council, as specified. specified, which shall be vested with full power, authority, and jurisdiction over the foundation. The bill would require the council to, among other things, develop the strategic objectives and priorities of the foundation and provide the opportunity for public comment on the foundations priorities, as specified, determine the research projects that will be funded by the California Foundation for Science and Health Research and Innovation Acceleration Fund, develop objectives and opportunities that offer support to early career researchers, and adopt certain regulations and standards, as specified. The bill would also require the council to consider how the foundations research priorities relate to or support various economic and industry considerations, as specified. The bill would provide that a majority of the members of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the council, except as otherwise provided. The bill would authorize the council to establish one or more scientific peer review panels consisting of experts in specified fields of research for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefit to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
This bill would require all research and development funded by the California Foundation for Science and Health Research and Innovation Acceleration Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight. The bill would require the funds and contracts to be awarded on the basis of the research priorities established for the foundation by the council and the scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $5,000,000,000, $7,500,000,000, pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, operate and maintain facilities for research.
The bill would provide for the submission of the bond act to the voters at the next statewide general election. March 7, 2028, statewide primary election.
(2)Existing law establishes prohibitions and penalties with respect to ethical obligations and conflicts of interest for public officials, including a prohibition on engaging in activities that are incompatible with their official duties and a prohibition on being financially interested in a contract made by them in their official capacity or the board of which they are a part.
This bill would authorize a council member to participate in a decision to approve or award a grant or loan grant, loan, or contract for the purpose of research into a disease in which the member or their immediate family member has a personal interest, as specified. The bill would provide that service with specified educational institutions and organizations is not incompatible with a council members duties. The bill would provide that the prohibition on being financially interested in a contract, as specified, does not apply if the council member recuses themself from a decision to award or approve a grant or loan grant, loan, or contract that would otherwise be subject to the prohibition. The bill would provide that council members are subject to certain disclosure requirements relating to personal investments and potential conflicts of interest, as specified.
(3)Existing law, the Bagley-Keene Open Meeting Act, requires that all meetings of a state body be open and public and all persons be permitted to attend any meeting of a state body, with specified exceptions for authorized closed sessions.
This bill would require the Bagley-Keene Open Meeting Act to apply to all meetings of the council and scientific peer review panels, except as specified for when the council or scientific peer review panels meet to consider or discuss specified matters in closed sessions, including matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(4)This bill would declare that it is to take effect immediately as an urgency statute.
(1)Existing law establishes various grant and loan programs for research, including, among others, the California Institute for Regenerative Medicine, California Firefighter Cancer Prevention and Research Program, and the Public Interest Research, Development, and Demonstration Program.
This bill would establish the California Foundation for Science and Health Research within the Government Operations Agency. The bill would require the Secretary of Government Operations to oversee the process of appointing the director of the foundation, and would authorize the Secretary of Government Operations to delegate the task of hiring and determining the salaries, bonuses, and benefits of additional personnel to the director, as specified. The bill would require the director and personnel of the foundation to be responsible for implementing the strategic objectives of the California Foundation for Science and Health Research Council, as described below, administering grants and loans awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
This bill would create the California Foundation for Science and Health Research Fund and require the moneys in the fund to be used by the foundation to award grants and make loans to public or private research companies, universities, institutes, and organizations for scientific research and development, in specific areas of research, including, but not limited to, biomedical, behavioral health, and climate research. The bill would also create the California Foundation for Science and Health Research Benefit Fund, to consist solely of private donations. The bill would make the moneys in the benefit fund available for the same purposes as the California Foundation for Science and Health Research Fund.
This bill would create the California Foundation for Science and Health Research Council, as specified. The bill would require the council to, among other things, develop the strategic objectives and priorities of the foundation and determine the research projects that will be funded by the California Foundation for Science and Health Research Fund, as specified. The bill would provide that a majority of the members of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the council, except as otherwise provided. The bill would authorize the council to establish one or more scientific peer review panels consisting of experts in specified fields of research for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefit to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
This bill would require all research and development funded by the California Foundation for Science and Health Research Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight. The bill would require the funds to be awarded on the basis of the research priorities established for the foundation by the council and the scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $12,000,000,000, $5,000,000,000, pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research.
The bill would provide for the submission of the bond act to the voters at the next statewide general election.
(2)Existing law establishes prohibitions and penalties with respect to ethical obligations and conflicts of interest for public officials, including a prohibition on engaging in activities that are incompatible with their official duties and a prohibition on being financially interested in a contract made by them in their official capacity or the board of which they are a part.
This bill would authorize a council member to participate in a decision to approve or award a grant or loan for the purpose of research into a disease in which the member or their immediate family member has a personal interest, as specified. The bill would provide that service with specified educational institutions and organizations is not incompatible with a council members duties. The bill would provide that the prohibition on being financially interested in a contract, as specified, does not apply if the council member recuses themself from a decision to award or approve a grant or loan that would otherwise be subject to the prohibition.
(3)Existing law, the Bagley-Keene Open Meeting Act, requires that all meetings of a state body be open and public and all persons be permitted to attend any meeting of a state body, with specified exceptions for authorized closed sessions.
This bill would require the Bagley-Keene Open Meeting Act to apply to all meetings of the council and scientific peer review panels, except as specified for when the council or scientific peer review panels meet to consider or discuss specified matters in closed sessions, including matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(1)Existing law establishes various grant and loan programs for research, including, among others, the California Institute for Regenerative Medicine, California Firefighter Cancer Prevention and Research Program, and the Public Interest Research, Development, and Demonstration Program.
This bill would establish the California Foundation for Science and Health Research within the Government Operations Agency. The bill would require the Secretary of Government Operations to oversee the process of appointing the director of the foundation, and would authorize the Secretary of Government Operations to delegate the task of hiring and determining the salaries, bonuses, and benefits of additional personnel to the director, as specified. The bill would require the director and personnel of the foundation to be responsible for implementing the strategic objectives of the California Foundation for Science and Health Research Council, as described below, administering grants and loans awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
This bill would create the California Foundation for Science and Health Research Fund, upon appropriation by the Legislature, Fund and require the moneys in the fund to be used by the foundation to award grants and make loans to public or private research companies, universities, institutes, and organizations for scientific research and development, in specific areas of research, including, but not limited to, biomedical, behavioral health, and climate research. The bill would also create the California Foundation for Science and Health Research Benefit Fund, to consist solely of private donations. The bill would make the moneys in the benefit fund available for the same purposes as the California Foundation for Science and Health Research Fund.
This bill would create the California Foundation for Science and Health Research Council, as specified. The bill would require the council to, among other things, develop the strategic objectives and priorities of the foundation and determine the research projects that will be funded by the California Foundation for Science and Health Research Fund, as specified. The bill would provide that a majority of the members of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the council, except as otherwise provided. The bill would authorize the council to establish one or more scientific peer review panels consisting of experts in specified fields of research for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefit to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
This bill would require all research and development funded by the California Foundation for Science and Health Research Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight. The bill would require the funds to be awarded on the basis of the research priorities established for the foundation by the council and the scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $23,000,000,000, $12,000,000,000, pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research.
The bill would provide for the submission of the bond act to the voters at the next statewide general election.
(2)Existing law establishes prohibitions and penalties with respect to ethical obligations and conflicts of interest for public officials, including a prohibition on engaging in activities that are incompatible with their official duties and a prohibition on being financially interested in a contract made by them in their official capacity or the board of which they are a part.
This bill would authorize a council member to participate in a decision to approve or award a grant or loan for the purpose of research into a disease in which the member or their immediate family member has a personal interest, as specified. The bill would provide that service with specified educational institutions and organizations is not incompatible with a council members duties. The bill would provide that the prohibition on being financially interested in a contract, as specified, does not apply if the council member recuses themself from a decision to award or approve a grant or loan that would otherwise be subject to the prohibition.
(3)Existing law, the Bagley-Keene Open Meeting Act, requires that all meetings of a state body be open and public and all persons be permitted to attend any meeting of a state body, with specified exceptions for authorized closed sessions.
This bill would require the Bagley-Keene Open Meeting Act to apply to all meetings of the council and scientific peer review panels, except as specified for when the council or scientific peer review panels meet to consider or discuss specified matters in closed sessions, including matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
Existing
(1)Existing law establishes various grant and loan programs for research, including, among others, the California Institute for Regenerative Medicine, California Firefighter Cancer Prevention and Research Program, and the Public Interest Research, Development, and Demonstration Program.
This bill would establish the California Foundation for Science and Health Research within the Government Operations Agency. The bill would require the Secretary of Government Operations to oversee the process of appointing the director of the foundation, and would authorize the Secretary of Government Operations to delegate the task of hiring and determining the salaries, bonuses, and benefits of additional personnel to the director, as specified. The bill would require the director and personnel of the foundation to be responsible for implementing the strategic objectives of the California Foundation for Science and Health Research Council, as described below, administering grants and loans awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
This bill would create the California Foundation for Science and Health Research Fund, upon appropriation by the Legislature, and require the moneys in the fund to be used by the foundation to award grants and make loans to public or private research companies, universities, institutes, and organizations for scientific research and development, in specific areas of research, including, but not limited to, biomedical, behavioral health, and climate research.
This bill would create the California Foundation for Science and Health Research Council, as specified. The bill would require the council to, among other things, develop the strategic objectives and priorities of the foundation and determine the research projects that will be funded by the California Foundation for Science and Health Research Fund, as specified. The bill would require a majority vote by the appointed members of the council for the approval of funding for any research project or proposal presented for funding. provide that a majority of the members of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the council, except as otherwise provided. The bill would authorize the council to establish one or more scientific peer review panels consisting of experts in specified fields of research for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefit to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
This bill would require all research and development funded by the California Foundation for Science and Health Research Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight. The bill would require the funds to be awarded on the basis of the research priorities established for the foundation by the council and the scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $23,000,000,000, pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research.
The bill would provide for the submission of the bond act to the voters at the next statewide general election.
(2)Existing law establishes prohibitions and penalties with respect to ethical obligations and conflicts of interest for public officials, including a prohibition on engaging in activities that are incompatible with their official duties and a prohibition on being financially interested in a contract made by them in their official capacity or the board of which they are a part.
This bill would authorize a council member to participate in a decision to approve or award a grant or loan for the purpose of research into a disease in which the member or their immediate family member has a personal interest, as specified. The bill would provide that service with specified educational institutions and organizations is not incompatible with a council members duties. The bill would provide that the prohibition on being financially interested in a contract, as specified, does not apply if the council member recuses themself from a decision to award or approve a grant or loan that would otherwise be subject to the prohibition.
(3)Existing law, the Bagley-Keene Open Meeting Act, requires that all meetings of a state body be open and public and all persons be permitted to attend any meeting of a state body, with specified exceptions for authorized closed sessions.
This bill would require the Bagley-Keene Open Meeting Act to apply to all meetings of the council and scientific peer review panels, except as specified for when the council or scientific peer review panels meet to consider or discuss specified matters in closed sessions, including matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
Existing law establishes various grant and loan programs for research, including, among others, the California Institute for Regenerative Medicine, California Firefighter Cancer Prevention and Research Program, and the Public Interest Research, Development, and Demonstration Program.
This bill would establish the California Foundation for Science and Health Research within the Government Operations Agency. The bill would create require the Secretary of Government Operations to oversee the process of appointing the director of the foundation, and would authorize the Secretary of Government Operations to delegate the task of hiring and determining the salaries, bonuses, and benefits of additional personnel to the director, as specified. The bill would require the director and personnel of the foundation to be responsible for implementing the strategic objectives of the California Foundation for Science and Health Research Council, as described below, administering grants and loans awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
This bill would create the California Foundation for Science and Health Research Fund, upon appropriation by the Legislature, and require the moneys in the fund to be used by the foundation to award grants and make loans to public or private research companies, universities, institutes, and organizations for scientific research and development, in specific areas of research, including, but not limited to, biomedical, behavioral, behavioral health, and climate research.
This bill would create the California Foundation for Science and Health Research Council, as specified. The bill would require the council to, among other things, develop the strategic objectives and priorities of the foundation and determine the research projects that will be funded by the California Foundation for Science and Health Research Fund, as specified. The bill would require a majority vote by the appointed members for of the council for the approval of funding for any research project or proposal presented for funding. The bill would authorize the council to establish one or more scientific peer review panels consisting of experts in specified fields of research for the purposes of reviewing and prioritizing proposals on the basis of the track record of the investigators, scientific merit of the proposal, and proposal, the potential benefit to the health and well-being of the population, natural resources, and environment of the state. state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
This bill would require all research and development funded by the California Foundation for Science and Health Research Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight. The bill would require the funds to be awarded on the basis of the research priorities established for the foundation by the council and the scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $23,000,000,000, pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research.
The bill would provide for the submission of the bond act to the voters at the next statewide general election.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
Existing law establishes various grant and loan programs for research, including, among others, the California Institute for Regenerative Medicine, California Firefighter Cancer Prevention and Research Program, and the Public Interest Research, Development, and Demonstration Program.
This bill would establish the California Foundation for Science and Health Research within the Government Operations Agency. The bill would create the California Foundation for Science and Health Research Fund, upon appropriation by the Legislature, and require the moneys in the fund to be used by the foundation to award grants and make loans to public or private research companies, universities, institutes, and organizations for scientific research and development, in specific areas of research, including, but not limited to, biomedical, behavioral, and climate research.
This bill would create the California Foundation for Science and Health Research Council, as specified. The bill would require the council to, among other things, develop the strategic objectives and priorities of the foundation and determine the research projects that will be funded by the California Foundation for Science and Health Research Fund, as specified. The bill would require a majority vote by the appointed members for the council for the approval of funding for any research project or proposal presented for funding. The bill would authorize the council to establish one or more scientific peer review panels consisting of experts in specified fields of research for the purposes of reviewing and prioritizing proposals on the basis of the track record of the investigators, scientific merit of the proposal, and potential benefit to the health and well-being of the population, natural resources, and environment of the state.
This bill would require all research and development funded by the California Foundation for Science and Health Research Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight. The bill would require the funds to be awarded on the basis of the research priorities established for the foundation by the council and the scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $23,000,000,000, pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research.
The bill would provide for the submission of the bond act to the voters at the next statewide general election.
Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
The people of the State of California find and declare the following:
(a)Since World War II, the United States has been a global leader in scientific and health research and innovation. Through the financial support of governmental agencies including, but not limited to, the National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Food and Drug Administration (FDA), the federal Centers for Disease Control and Prevention (CDC), and the National Oceanic and Atmospheric Administration (NOAA), the scientific and health communities have been able to create life-enhancing scientific, biomedical, and public health discoveries.
(b)Americans have benefited enormously from that research with improved health, cures for diseases, vaccines, and improved air quality and environment. The United States economy has benefited greatly from that research as well.
(c)California produces an astonishing share of the top scientific research on the planet. It is estimated that $3 of every $10 in federal research investments are drawn to California. The state accounts for about 47 percent of United States biotechnology research and development spending and generates about 53 percent of the nations biotechnology revenues. Nearly one-half of all venture capital in the United States is invested in California. That success is driven in large part by the states world-class universities and research institutions. The University of California is the top research institution in the world for United States patent generation. Every dollar invested in science funding generates more than $2 in economic activity.
(d)Federal research funding has been integral in supporting the work of public and private research institutions in California. For example, federal funding supports a significant part of the University of Californias (UC) and California State Universitys (CSU) research operations. Federal grants pay for faculty research and the salaries of graduate and postdoctoral student researchers. Federal research grants totaled more than $5,000,000,000 to the University of California in the 202324 fiscal year. Public and private university research has led to the founding of thousands of startups, driving economic expansion and technological innovation. Federal funding reductions limit research opportunities and may impede Californias competitiveness and economic progress.
(e)Because the federal government has been one of the largest funders of scientific research in California, foundations, nonprofits, and corporations alone cannot make up the gap when cuts are made by the federal government. Unless the people of California rise up, much of this critical work may come to a halt. Federal cuts to scientific research pose a threat to the well-being of the people of California and will impair Californias ability to operate as a global leader in technology, innovation, and research across fields of study.
(f)The people of California propose this ballot measure to create the California Foundation for Science and Health Research (Foundation) to award grants and make loans to, and contract with, public and private universities, research companies, institutes, and health care organizations in California for scientific and health care research and development.
(g)Through the Foundation, funding would be distributed to UC, CSU, other California universities, and public and private entities engaged in critical science and health research. It would provide funding for staff, equipment, and facilities needed to carry out scientific research in fields including, but not limited to, public health, mental health, heart disease, cancer treatment, diabetes, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. Priority would be given to established research projects where the federal government has canceled funding. The measure would require annual audits.
(h)This measure will help preserve Californias position as a global leader in scientific innovation. This measure would allow important research to continue regardless of what happens at the federal level. This measure will ensure that California is not left behind.
(i)This measure will help sustain and grow the workforce of the state, with runoff economic benefits that will ensure a thriving future for Californians. This measure will support thousands of students and researchers at California universities in good-paying union jobs in growing industries. Supporting good-paying jobs in science, technology, engineering, and mathematics will help keep California economically competitive and generate billions of dollars each year in economic growth.
(j)There is some science that only public institutions will take on, for example cancer drug trials that combine drugs from different pharmaceutical companies, or as yet, unproven technologies in renewable energy. This measure would continue funding scientific research that looks for the greater good.
(k)Californias university and college system is a model for universities everywhere, involving students closely in practical, life-saving research. Cuts to federal funding threaten our students ability to learn the research skills they need to succeed. This measure will preserve Californias university and college system as a pathway to the middle class for California students.
(l)Too many Californians are driven into homelessness by drug abuse and mental health issues. This measure will help address this problem by continuing to fund critical research on promising mental health and addiction treatments.
(m)This measure contains strict fiscal accountability and transparency standards, including annual independent audits and public disclosure of all funding to ensure that Legislative allocations and bond funding is spent effectively, efficiently, and as promised.
(n)This measure will authorize the creation of regulations and standards that are intended to directly recoup part of the investment by the people of the State of California into scientific and health care research and development in the state by capturing a portion of the revenue from highly profitable inventions, such as blockbuster drugs, while not inhibiting startup companies or otherwise harming the technology transfer process.
SEC. 2.Chapter 12 (commencing with Section 11899) is added to Part 1 of Division 3 of Title 2 of the Government Code, to read:12.California Science and Health Research Bond Act1.California Foundation for Science and Health Research11899.As used in this chapter, the following terms have the following meaning:
(a)Act means the California Science and Health Research Bond Act constituting this chapter.
(b)Benefit fund means the California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund created pursuant to paragraph (2) of subdivision (a) of Section 11899.2.
(c)Committee means the California Foundation for Science and Health Research Finance Committee created pursuant to subdivision (a) of Section 11899.14.
(d)Council means the California Foundation for Science and Health Research Council created pursuant to Section 11899.3.
(e)Foundation means the California Foundation for Science and Health Research established pursuant to Section 11899.1.
(f)Fund means the California Foundation for Science and Health Research and Innovation Acceleration Fund created pursuant to paragraph (1) of subdivision (a) of Section 11899.2.
(g)Subject invention means any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement.
11899.1.(a)The California Foundation for Science and Health Research is established within the Government Operations Agency.
(b)(1)The foundations role is to facilitate scientific research by awarding grants and making loans to, and entering contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development and to construct facilities for research and development and for sectors identified as Bet and Accelerate sectors in the California Jobs First State Economic Blueprint, as published and updated by the Governors Office of Business and Economic Development, including, but not limited to, any of the following fields of research:
(A)Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, HIV/AIDS, and genetic and chronic diseases that affect children and infants.
(B)Public health, including, but not limited to, environmental health detecting and responding to new and emerging health threats.
(C)Disease prevention, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(D)Promoting healthy and safe behaviors, communities, and environment.
(E)Wildfire prevention.
(F)Behavioral health, including, but not limited to, addiction and substance use disorders.
(G)Climate, including climate change and its impact on human health.
(H)Weather.
(I)Ocean, including sea level rise.
(J)Coastal and marine ecosystems and resources.
(K)Agriculture and water.
(L)Emerging technologies.
(M)Safety, efficacy, and security of drugs, biological products, medical devices, our nations food supply, and cosmetics.
(N)Seismic and related geohazards.
(2)The foundation may enter into interagency agreements with state agencies to administer programs funded under this chapter.
(c)(1)The Governor shall appoint the director of the foundation. The salary for the director shall not exceed the base salary of the Provost and Executive Vice President of Academic Affairs of the University of California.
(2)The director and personnel of the foundation shall be responsible for implementing the strategic objectives of the council, administering the grants, loans, and contracts awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
11899.2.(a)(1)The California Foundation for Science and Health Research and Innovation Acceleration Fund is hereby created in the State Treasury. The proceeds of bonds issued and sold pursuant to this chapter shall be deposited in the fund pursuant to Section 11899.10.
(2)(A)The California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund is hereby created in the State Treasury.
(B)The benefit fund shall consist solely of private donations.
(C)All moneys in the benefit fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter. Moneys in the benefit fund shall be made available for the same purposes as the moneys in the California Foundation for Science and Health Research and Innovation Acceleration Fund.
(b)The proceeds of interim debt and bonds issued and sold pursuant to this chapter, excluding those issued in accordance with Section 11899.21, shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research and Innovation Acceleration Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
(c)Moneys in the fund shall be used by the foundation to award public and private grants to, make loans to, and enter into contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development, including, but not limited to, research in any of the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(d)(1)All research and development funded by the fund shall be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5), if applicable.
(2)All grants, loans, or contracts provided under this section shall be awarded or made available to researchers or projects located within this state, except that funding for research collaboratives between California and out-of-state researchers shall be permitted where the majority of the research is being conducted in California. For the purposes of this paragraph, the term majority of the research shall mean that 75 percent of the funds awarded by the foundation to a specific project are utilized by that project for research activities in California.
(3)No funds shall be awarded or made available to an entity that constitutes a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code and related regulations.
(4)All grants, loans, or contracts provided under this section shall be awarded based on the following:
(A)Consistency with the research priorities established for the foundation by the California Foundation for Science and Health Research Council as described in subdivision (a) of Section 11899.3.
(B)The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as described in Section 11899.4.
(C)Any funds allocated to a United States Department of Energy or National Aeronautics and Space Administration laboratory or field center pursuant to this section shall be conducted in accordance with the Federal Laboratory Contracting Act, as set forth in Chapter 7 (commencing with Section 12500) of Part 2 of Division 2 of the Public Contract Code. Only national laboratories and centers operating within California may be eligible for these funds.
(5)The foundation shall prioritize funding research impacted by discretionary programmatic funding cuts by the federal government and for research that supports or accelerates the development and deployment of research and innovations to grow Californias economy and that can lead to the creation of high-quality job opportunities.
(6)To be eligible for funding, all research projects involving human subjects shall be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5) and the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20 of the Health and Safety Code).
(7)The California State University and the University of California may submit proposed projects to the Department of Finance for approval for the construction and modernization of science, health care, technology, engineering, and other facilities that support research consistent with the priorities of the foundation. Upon approval, the Department of Finance may allocate funds through the budget for those projects from the fund. One billion dollars ($1,000,000,000) shall be utilized for this purpose. Two hundred fifty million dollars ($250,000,000) of this money shall be available to the University of California, and seven hundred fifty million dollars ($750,000,000) of this money shall be available to the California State University.
(e)(1)It is the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts that any biomedical inventions and technologies developed in whole or in part as a result of bond-funded research are affordable and available to Californians, and that the funding supports principles of open science where possible.
(2)Prior to the first grant from the foundation, and no later than one year from the date this legislation takes effect, the council shall develop such provisions to facilitate the foundations goals of affordability and equitable access that will include at least the following subjects, with requirements that the obligations of the provisions, when applicable, be passed through to further licensees, sublicensees, or assignees:
(A)The foundation shall require that grantees, loan recipients, and contractors submit, for the review and approval of the foundation, access plans specifying strategies and timelines for promoting equitable access to the subject invention in California, the United States, and in low- and middle-income countries (LMICs) on fair and reasonable conditions across criteria of affordability, availability, acceptability, sustainability, and transparency. The foundation shall create guidance for grantees, loan recipients, and contractors regarding these parameters and shall include nonlimiting examples of modalities for equitable access, such as, for example, nonexclusive licensing, technology transfer, and data sharing. The guidance shall further enumerate the timing for submission and updating of access plans, as well as the manner in which access plans will be evaluated by the foundation, and articulate at least (i) the manner in which the foundations expectations of equitable access should be flexible to reflect both public health needs and the uncertainties of product development and patient access, and proportional to the extent to which the foundations funding for the subject invention was responsible for the final commercializable product vis-a-vis private funding, and (ii) processes where the access plan, in whole or in part, may be waivable, such as for where the foundation funding does not yield a medical technology, or where aspects of the access plan are infeasible.
(B)The foundation shall require grantees, loan recipients, and contractors to manage, preserve, and make available any data resulting from bond-funded research to the broader scientific community for educational, academic, or research purposes, except where such requests are made by a foreign country of concern, as defined in Section 4651(7) of Title 15 of the United States Code, or an instrument thereof, or a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code, or if such disclosure could impair national security. Grantees, loan recipients, and contractors shall also be required to provide free public access to any publication that results from bond-funded research.
(C)The foundation shall require that subject inventions support Californian pandemic preparedness and health security by ensuring the inclusion of further provisions that may be triggered in the event of a declaration by the World Health Organization of a public health emergency of international concern (PHEIC) in relation to a pathogen or disease for which the subject invention is or may reasonably be expected to be relevant for prevention, diagnosis, or treatment, for the duration of the PHEIC, with additional access commitments designed to prioritize timely and equitable supply of the subject invention in LMICs, taking into account global health needs and available manufacturing capacity. Such access commitments may include, for example, either as independent measures or in combination, requirements to license the subject invention to a recognized licensing body or to facilitate technology transfer in order to facilitate the rapid development, manufacture, and distribution of the subject invention.
(D)The foundation may require grantees, loan recipients, and contractors to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant or applicants, upon terms that are reasonable under the circumstances, if the State of California determines either of the following:
(i)Such action is necessary because the grantee, loan recipient, or contractor licensee has not taken, or is not expected to take within a reasonable time, effective steps to achieve practical application of the foundation-funded invention in that field of use, as evidenced by a failure to timely complete specified development milestones contained in the license agreement.
(ii)Such action is necessary to alleviate health or safety needs that are not reasonably satisfied by the grantee, loan recipient, contractor, or their licensee as evidenced by a failure to timely complete specified development milestones contained in the license agreement.
(E)Before exercising authority under subparagraph (D), the foundation shall provide written notice of the grounds for the proposed action, a reasonable opportunity to cure any deficiency, and an opportunity for a hearing under procedures to be established by the foundation.
(3) (A)It is the intent of the Legislature that the foundation draw upon the greatest successes in American history in order to be equipped to solve the most pressing problems facing California and the nation.(B)In furtherance of subparagraph (A), it is the intent of the Legislature that the foundation accomplish all of the following:
(i)Learn from the most ambitious research models of the past century, including the DARPA/ARPA-E/ARPA-H model and Operation Warp Speed. At least 10 percent of the moneys in the fund shall be allocated consistent with the Advanced Research Projects Agency model that relies on collaboration between academic, industry, and government partners to pursue revolutionary breakthroughs focused on tangible, solutions-oriented aims. No more than 1.5 percent of total bond funds shall be allocated each year for this specific purpose. This model shall be referred to as California Advanced Research Project Activities or Cal-ARPA.
(ii)Support the commercialization of research by providing grants, loans, or contracts to entities that are focused on this purpose. Priority shall be provided to entities that can demonstrate job growth or future manufacturing opportunities in California or that can demonstrate additional funding mechanisms. No less than two hundred fifty million dollars ($250,000,000) shall be utilized for this purpose, and no more than 0.5 percent of total bond funds shall be allocated each year for this specific purpose. No funds shall be used to support manufacturing in a foreign country of concern, as defined in Section 4651(7) of Title 15 of the United States Code, or a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code, regardless of domicile.
(iii)Support a greater diversity of ideas by allocating funding for projects that are riskier than those typically funded by federal agencies and by ensuring that early career scientists, including scientists under 40 and scientists fewer than 10 years since completing their PhDs, are supported by the foundation.
(iv)Create award approval systems that are efficient and not overly reliant on paperwork, freeing up scientists to spend more time doing critical work.
(f)Not more than 3 percent of the moneys in the fund shall be used for administrative costs. Administrative costs include, but are not limited to, all of the following:
(1)Salaries and benefits paid or incurred with respect to the hiring or retention of a director of the foundation and other officers and administrative staff that shall work on behalf of the foundation under the supervision of the director.
(2)Legal and accounting fees and expenses.
(3)All costs associated with the establishment and operation of the foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the foundation.
(g)All intellectual property assets developed using funds authorized for, or made available to, the foundation shall be treated pursuant to state and federal law. Proceeds of intellectual property assets shall be deposited into the fund and shall be used consistent with this act.
(h)The foundation shall recommend to the council, and the council shall adopt, standards to ensure that if the grantee, loan recipient, or contracted entity purchases goods or services using funds authorized for, or made available to, the foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50 percent of purchases from California suppliers.
11899.3.(a)There is hereby established the California Foundation for Science and Health Research Council, which shall be vested with full power, authority, and jurisdiction over the foundation, including the authority to adopt regulations, and shall do all of the following:
(1)Develop the strategic objectives and research priorities of the foundation. The council shall provide opportunity for the public to provide comments on the priorities of the foundation in accordance with Section 11899.7. The council shall also consider how the research priorities relate to or support areas critical to Californias economy, as identified as Bet and Accelerate sectors in the California Jobs First State Economic Blueprint, as published and updated by the Governors Office of Business and Economic Development. The council shall further consider how the research priorities capitalize on and connect to regional research hubs, taking into account close proximity to relevant industry clusters, such as energy, life sciences, and other fields of research, as identified in paragraph (1) of subdivision (b) of Section 11899.1, with a focus on emerging industries.
(2)Actively participate in the overall management of the foundation.
(3)Determine which research projects will be funded by the fund based on the research priorities established for the foundation pursuant to paragraph (1) and the technical merits of the proposals, as determined by scientific peer review panels created pursuant to Section 11899.4.
(4)Develop objectives and opportunities that offer support to early career researchers at California universities and the private sector.
(5)Adopt regulations and standards to directly recoup or benefit from the investment by the people of the State of California into scientific and health care research and development in the state by capturing a portion of the revenue from highly profitable inventions, such as blockbuster drugs, while not inhibiting startup companies or otherwise harming the technology transfer process.
(b)(1)The council shall consist of all of the following:
(A)Nine members shall be appointed by the Governor.
(i)In making appointments to the council, the Governor shall consider appointees that bring scientific or research expertise, health or patient advocacy, economic expertise, or have demonstrated leadership in public entities, organizations, industries, or academic institutions aligned to the goals of the bond.
(ii)One member shall be a graduate-level researcher with current or past research experience in the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(iii)One member shall be a postdoctoral scholar with current or past research experience in the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(iv)One member shall have a background in research policy.
(B)One member shall be a health care provider appointed by the Senate Rules Committee.
(C)One member shall be an advocate in climate, environmental health, or environmental fields appointed by the Speaker of the Assembly.
(D)One member shall be the chief executive officer of the California Council on Science and Technology, or their designee.
(E)One member shall be a designee of the President of the University of California, if the president chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(F)One member shall be a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(G)One member shall be the President of the Association of Independent California Colleges and Universities, or the presidents designee, who shall be a scientist or hold a background in science or research.
(2)Any appointees to the council shall not be subject to confirmation by the Senate.
(c)(1)The members of the council shall serve four-year terms expiring June 30.
(2)The first terms for four of the appointments made by the Governor and the appointee of the Senate Committee on Rules shall be a two-year term.
(3)If the graduate-level researcher or postdoctoral scholar appointed pursuant to subparagraph (A) of paragraph (1) of subdivision (b) earns their degree or completes their placement before the conclusion of their four-year term, the graduate-level researcher or postdoctoral scholar may serve out the remainder of the academic year on the council. At the conclusion of the academic year, the Governor shall appoint a current graduate-level researcher or postdoctoral scholar who shall serve out the remainder of the term.
(4)If a vacancy occurs within a term, the appointing authority shall appoint a replacement member to serve the remainder of the term.
(5)When a term expires, the appointing authority shall appoint a member. A member shall serve until the appointment and qualification of their successor or until 365 days have elapsed since the expiration of the term, whichever occurs first.
(6)A grant, loan, or contract shall not be approved if there are more than six vacancies on the council.
(7)The first chair of the council shall be the Governors appointee with a background in research policy and shall serve as chair for two years. Each subsequent chair shall be elected by the members of the council for a term of two years.
(d)A majority of the membership of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the board. If a vacancy or recusal in the council occurs, then a majority of the remaining members of the council constitutes a quorum.
(e)Council members shall serve without compensation, but may receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
(f)(1)Unless prohibited by another law, including the Political Reform Act of 1974, a member may participate in a decision to approve or award a grant, loan, or contract to a person or entity for the purpose of research involving either a disease from which the member or their immediate family member suffers or a disease in which the member has an interest as a representative of a disease advocacy organization.
(2)Notwithstanding any other law:
(A)Service or employment as a trainee or member of the faculty or administration of the University of California, California State University, or the Association of Independent California Colleges and Universities, or as a member of the California Council on Science and Technology, is not, by itself, inconsistent, incompatible, in conflict with, or inimical to the duties of the council member and shall not result in the automatic forfeiture of either office or position.
(B)Service or employment as a representative or employee of a disease advocacy organization, a nonprofit academic and research institution, or a life science commercial entity is not inconsistent, incompatible, in conflict with, or inimical to the duties of the council member.
(3)For purposes of Section 1090, the council may approve or award a grant, loan, or contract in which a member of the council is financially interested as long as the interested member recuses themself from making, participating in making, or attempting to use their official position to influence a decision on the grant, loan, or contract. If this condition is satisfied, this transaction shall be deemed not to create a violation of Section 1090.
(4)Disclosure requirements under Article 2 (commencing with Section 87200) of Chapter 7 of Title 9 shall apply to council members.
(5)For purposes of this subdivision, decision does not include the adoption of standards.
11899.4.(a)The council may establish one or more scientific peer review panels consisting of experts in the fields described in paragraph (1) of subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
(b)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to subdivision (a).
11899.5.(a)The foundation shall issue an annual report that sets forth the foundations activities, grants awarded, loans made available, contracts entered, grants, loans, and contracts in progress, research accomplishments, and future program directions. The annual report shall be published on the foundations internet website.
(b)Each annual report shall include, but not be limited to, all of the following:
(1)The number and dollar amounts of research and facilities grants, loans, and contracts.
(2)The grantees, loan recipients, and contracted entities for the prior year.
(3)The foundations administrative expenses.
(4)An assessment of the availability of funding for research from sources other than the foundation.
(5)A summary of research findings, including promising new research areas.
(6)An assessment of the relationship between the foundations grants, loans, and contracts and the overall strategy of its research program.
(7)An assessment or summary of how the work funded by the foundation is having an impact on Californians or is supportive of Californias economy or job opportunities. The foundation shall consult with the Governors Office of Business and Economic Development in the preparation of this assessment or summary.
(8)A report of the foundations strategic research and financial plans.
11899.6.The foundation shall annually commission an independent financial audit of its activities from a certified public accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public report of that review. The Controller shall hold a public meeting with appropriate notice and a formal public comment period. The Controller shall evaluate public comments and shall include appropriate summaries in the annual report.
11899.7.(a)The Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) shall apply to all meetings of the council and a scientific peer review panel created pursuant to Section 11899.4, except as otherwise provided in this section. The council shall disclose all awarded grants and contracts entered into in public meetings, and shall award all grants, loans, and contracts in public meetings. The council and a scientific peer review panel created pursuant to Section 11899.4 shall adopt all governance, scientific, medical, and regulatory standards in public meetings.
(b)The council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) under Section 11126. In addition, the council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions when it meets to consider or discuss any of the following:
(1)Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
(2)Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it.
(3)Matters involving scientific data, analyses, or other research products not yet formally published in academic literature.
(4)Matters concerning the appointment, employment, performance, compensation, or dismissal of foundation officers and employees. Action on compensation of the foundations officers and employees shall only be taken in open session.
(5)Matters believed to pose a security risk to the people of California.
11899.8.(a)The council shall establish standards that require that all grants and loan awards be subject to intellectual property agreements that balance the opportunity of the State of California to benefit from the inventions, technologies, patents, royalties, and licenses that result from research funded by public and private grants to, and loans to, public and private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, research in any field described in paragraph (1) of subdivision (b) of Section 11899.1, with the need to ensure that such research is not unreasonably hindered by such intellectual property agreements.
(b)The council shall have the authority to adopt regulations to implement this section.
2.California Foundation for Science and Health Research Bonds11899.10.The proceeds of bonds, excluding those issued in accordance with Section 11899.21, issued and sold pursuant to this chapter shall be deposited into the California Foundation for Science and Health Research and Innovation Acceleration Fund. All moneys in the fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter.
11899.11.(a)Moneys in the fund shall be available for both of the following:
(1)Grants, loans, and contracts to fund research and operate and maintain facilities for research as provided in this chapter.
(2)Paying general administrative costs of the foundation, not to exceed 3 percent of the amount in the fund.
(b)Repayment of principal and interest on any loans made by the foundation pursuant to this chapter shall be deposited into the fund and used to make additional grants, loans, and contracts for the purposes of this act or for paying continuing costs of the annual administration of outstanding bonds.
11899.12.(a)Bonds in the total amount of seven billion five hundred million dollars ($7,500,000,000), not including the amount of any refunding bonds issued in accordance with Section 11899.21, may be issued and sold for the purposes expressed in this chapter and to reimburse the General Obligation Bond Expense Revolving Fund pursuant to Section 16724.5. The bonds, when sold, issued, and delivered, shall be and constitute a valid and binding obligation of the State of California, and the full faith and credit of the State of California is hereby pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
(b)The Treasurer shall issue and sell the bonds authorized in subdivision (a) in the amount determined by the committee to be necessary or desirable pursuant to Section 11899.15. The bonds shall be issued and sold upon the terms and conditions specified in a resolution to be adopted by the committee pursuant to Section 16731.
11899.13.(a)The bonds authorized by this chapter shall be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4), as amended from time to time, and all of the provisions of that law apply to the bonds and to this chapter and are hereby incorporated in this chapter as though set forth in full in this chapter, except that subdivisions (a) and (b) of Section 16727 shall not apply to restrict the use of bond proceeds to finance the operation and maintenance of facilities as provided in Section 11899.11.
(b)For purposes of this chapter, the references to committee in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research Finance Committee created in Section 11899.14, and the references to board in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research, established by Section 11899.1.
11899.14.(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this chapter, the California Foundation for Science and Health Research Finance Committee is hereby created.
(b)(1)The committee consists of all of the following:
(A)The Treasurer.
(B)The Controller.
(C)The Director of Finance.
(D)The Director of the California Foundation for Science and Health Research.
(E)Two members of the California Foundation for Science and Health Research Council, chosen by the Governor, or their designated representatives.
(2)The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.
(3)Notwithstanding any other law, any member may designate a representative to act as that member in the members place for all purposes, as though the member were personally present.
(c)The committee shall act independently of the foundation and council, but may request recommendations and relevant information so as to understand the financial needs of the foundation to accomplish the strategic objectives and research priorities established pursuant to Section 11899.3.
11899.15.The committee, by resolution, shall determine whether or not it is necessary or desirable to issue and sell bonds authorized pursuant to this chapter in order to carry out the actions specified in this chapter and, if so, the amount of bonds to be issued and sold. Successive issues of bonds may be authorized and sold to carry out those actions progressively, and it is not necessary that all of the bonds authorized to be issued be sold at any one time.
11899.16.There shall be collected each year and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state, a sum in an amount required to pay the principal of, and interest on, the bonds becoming due each year. It is the duty of all officers charged by law with any duty in regard to the collection of the revenue to do and perform each and every act that is necessary to collect that additional sum.
11899.17.Notwithstanding Section 13340, there is hereby continuously appropriated from the General Fund in the State Treasury, for the purposes of this chapter and without regard to fiscal years, an amount that equals the total of the sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this chapter, as the principal and interest become due and payable.
11899.18.For the purpose of carrying out this chapter, the Director of Finance may authorize the withdrawal from the General Fund of an amount, not to exceed the amount of the unsold bonds that have been authorized by the committee, to be sold for the purpose of carrying out this chapter, excluding any refunding bonds authorized pursuant to Section 11899.21 and any amount withdrawn from the General Fund pursuant to this section and not yet returned to the General Fund. Any amount withdrawn shall be deposited into the fund. Any moneys made available under this section shall be returned to the General Fund, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds for the purpose of carrying out this chapter.
11899.19.All moneys deposited into the fund that are derived from premium and accrued interest on bonds sold pursuant to this chapter shall be reserved in the fund and shall be available for transfer to the General Fund as a credit to expenditures for bond interest, except those amounts derived from premium may be reserved and used to pay the cost of bond issuance before any transfer to the General Fund.
11899.20.The bonds issued and sold pursuant to this chapter may be refunded in accordance with Article 6 (commencing with Section 16780) of Chapter 4 of Part 3 of Division 4, which is a part of the State General Obligation Bond Law. Approval by the voters of the state for the issuance of the bonds described in this chapter includes the approval of the issuance of any bonds issued to refund any bonds originally issued under this chapter or any previously issued refunding bonds. Any bond refunded with the proceeds of refunding bonds as authorized by this section may be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
11899.21.Notwithstanding any other provision of this chapter or the State General Obligation Bond Law, if the Treasurer sells bonds pursuant to this chapter that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, the Treasurer may maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. The Treasurer may use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
11899.22.The proceeds from the sale of bonds authorized by this chapter are not proceeds of taxes as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed by that article.
SEC. 3.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 4.Section 2 of this act shall take effect upon the approval by the voters of the California Science and Health Research Bond Act, as set forth in Section 2 of this act.
SEC. 5.(a)Notwithstanding Section 9040 of the Elections Code, or any other law, Section 2 of this act shall be submitted by the Secretary of State to the voters at the March 7, 2028, statewide primary election.
(b)The requirement of Section 9040 of the Elections Code that a measure submitted to the people by the Legislature appear on the ballot of the first statewide election occurring at least 131 days after the adoption of the proposal by the Legislature shall not apply to Section 2 of this act.
SEC. 6.This act shall be broadly construed to accomplish its purposes. The statutory provisions of the act may be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
SEC. 7.(a)This act shall be liberally construed to effectuate its purposes.
(b)If this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure shall be self-executing and given full force and effect.
SEC. 8.The Legislature finds and declares that Section 2 of this act, which adds Section 11899.7 to the Government Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the publics access to this information.
SEC. 9.This act is an urgency statute necessary for the immediate preservation of the public peace, health, or safety within the meaning of Article IV of the California Constitution and shall go into immediate effect. The facts constituting the necessity are:
Due to the uncertainty from the current federal administration relating to the availability and amount of federal funding for research and the instability this uncertainty causes in the California research sector, it is necessary for this act to take effect immediately to clearly demonstrate to Californians and the states research institutions the states investment and continued commitment to publicly funded research.
The people of the State of California find and declare the following:
(a)Since World War II, the United States has been a global leader in scientific and health research and innovation. Through the financial support of governmental agencies including, but not limited to, the National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Food and Drug Administration (FDA), the federal Centers for Disease Control and Prevention (CDC), and the National Oceanic and Atmospheric Administration (NOAA), the scientific and health communities have been able to create life-enhancing scientific, biomedical, and public health discoveries.
(b)Americans have benefited enormously from that research with improved health, cures for diseases, vaccines, and improved air quality and environment. The United States economy has benefited greatly from that research as well.
(c)California produces an astonishing share of the top scientific research on the planet. It is estimated that $3 of every $10 in federal research investments are drawn to California. The state accounts for about 47 percent of United States biotechnology research and development spending and generates about 53 percent of the nations biotechnology revenues. Nearly one-half of all venture capital in the United States is invested in California. That success is driven in large part by the states world-class universities and research institutions. The University of California is the top research institution in the world for United States patent generation. Every dollar invested in science funding generates more than $2 in economic activity.
(d)Federal research funding has been integral in supporting the work of public and private research institutions in California. For example, federal funding supports a significant part of the University of Californias (UC) and California State Universitys (CSU) research operations. Federal grants pay for faculty research and the salaries of graduate and postdoctoral student researchers. Federal research grants totaled more than $5,000,000,000 to the University of California in the 202324 fiscal year. Public and private university research has led to the founding of thousands of startups, driving economic expansion and technological innovation. Federal funding reductions limit research opportunities and may impede Californias competitiveness and economic progress.
(e)Because the federal government has been one of the largest funders of scientific research in California, foundations, nonprofits, and corporations alone cannot make up the gap when cuts are made by the federal government. Unless the people of California rise up, much of this critical work may come to a halt. Federal cuts to scientific research pose a threat to the well-being of the people of California and will impair Californias ability to operate as a global leader in technology, innovation, and research across fields of study.
(f)The people of California propose this ballot measure to create the California Foundation for Science and Health Research (Foundation) to award grants and make loans to, and contract with, public and private universities, research companies, institutes, and health care organizations in California for scientific and health care research and development.
(g)Through the Foundation, funding would be distributed to UC, CSU, other California universities, and public and private entities engaged in critical science and health research. It would provide funding for staff, equipment, and facilities needed to carry out scientific research in fields including, but not limited to, public health, mental health, heart disease, cancer treatment, diabetes, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. Priority would be given to established research projects where the federal government has canceled funding. The measure would require annual audits.
(h)This measure will help preserve Californias position as a global leader in scientific innovation. This measure would allow important research to continue regardless of what happens at the federal level. This measure will ensure that California is not left behind.
(i)This measure will help sustain and grow the workforce of the state, with runoff economic benefits that will ensure a thriving future for Californians. This measure will support thousands of students and researchers at California universities in good-paying union jobs in growing industries. Supporting good-paying jobs in science, technology, engineering, and mathematics will help keep California economically competitive and generate billions of dollars each year in economic growth.
(j)There is some science that only public institutions will take on, for example cancer drug trials that combine drugs from different pharmaceutical companies, or as yet, unproven technologies in renewable energy. This measure would continue funding scientific research that looks for the greater good.
(k)Californias university and college system is a model for universities everywhere, involving students closely in practical, life-saving research. Cuts to federal funding threaten our students ability to learn the research skills they need to succeed. This measure will preserve Californias university and college system as a pathway to the middle class for California students.
(l)Too many Californians are driven into homelessness by drug abuse and mental health issues. This measure will help address this problem by continuing to fund critical research on promising mental health and addiction treatments.
(m)This measure contains strict fiscal accountability and transparency standards, including annual independent audits and public disclosure of all funding to ensure that Legislative allocations and bond funding is spent effectively, efficiently, and as promised.
(n)This measure will authorize the creation of regulations and standards that are intended to directly recoup part of the investment by the people of the State of California into scientific and health care research and development in the state by capturing a portion of the revenue from highly profitable inventions, such as blockbuster drugs, while not inhibiting startup companies or otherwise harming the technology transfer process.
SEC. 2.Chapter 12 (commencing with Section 11899) is added to Part 1 of Division 3 of Title 2 of the Government Code, to read:12.California Science and Health Research Bond Act1.California Foundation for Science and Health Research11899.As used in this chapter, the following terms have the following meaning:
(a)Act means the California Science and Health Research Bond Act constituting this chapter.
(b)Benefit fund means the California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund created pursuant to paragraph (2) of subdivision (a) of Section 11899.2.
(c)Committee means the California Foundation for Science and Health Research Finance Committee created pursuant to subdivision (a) of Section 11899.14.
(d)Council means the California Foundation for Science and Health Research Council created pursuant to Section 11899.3.
(e)Foundation means the California Foundation for Science and Health Research established pursuant to Section 11899.1.
(f)Fund means the California Foundation for Science and Health Research and Innovation Acceleration Fund created pursuant to paragraph (1) of subdivision (a) of Section 11899.2.
(g)Subject invention means any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement.
11899.1.(a)The California Foundation for Science and Health Research is established within the Government Operations Agency.
(b)(1)The foundations role is to facilitate scientific research by awarding grants and making loans to, and entering contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development and to construct facilities for research and development and for sectors identified as Bet and Accelerate sectors in the California Jobs First State Economic Blueprint, as published and updated by the Governors Office of Business and Economic Development, including, but not limited to, any of the following fields of research:
(A)Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, HIV/AIDS, and genetic and chronic diseases that affect children and infants.
(B)Public health, including, but not limited to, environmental health detecting and responding to new and emerging health threats.
(C)Disease prevention, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(D)Promoting healthy and safe behaviors, communities, and environment.
(E)Wildfire prevention.
(F)Behavioral health, including, but not limited to, addiction and substance use disorders.
(G)Climate, including climate change and its impact on human health.
(H)Weather.
(I)Ocean, including sea level rise.
(J)Coastal and marine ecosystems and resources.
(K)Agriculture and water.
(L)Emerging technologies.
(M)Safety, efficacy, and security of drugs, biological products, medical devices, our nations food supply, and cosmetics.
(N)Seismic and related geohazards.
(2)The foundation may enter into interagency agreements with state agencies to administer programs funded under this chapter.
(c)(1)The Governor shall appoint the director of the foundation. The salary for the director shall not exceed the base salary of the Provost and Executive Vice President of Academic Affairs of the University of California.
(2)The director and personnel of the foundation shall be responsible for implementing the strategic objectives of the council, administering the grants, loans, and contracts awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
11899.2.(a)(1)The California Foundation for Science and Health Research and Innovation Acceleration Fund is hereby created in the State Treasury. The proceeds of bonds issued and sold pursuant to this chapter shall be deposited in the fund pursuant to Section 11899.10.
(2)(A)The California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund is hereby created in the State Treasury.
(B)The benefit fund shall consist solely of private donations.
(C)All moneys in the benefit fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter. Moneys in the benefit fund shall be made available for the same purposes as the moneys in the California Foundation for Science and Health Research and Innovation Acceleration Fund.
(b)The proceeds of interim debt and bonds issued and sold pursuant to this chapter, excluding those issued in accordance with Section 11899.21, shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research and Innovation Acceleration Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
(c)Moneys in the fund shall be used by the foundation to award public and private grants to, make loans to, and enter into contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development, including, but not limited to, research in any of the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(d)(1)All research and development funded by the fund shall be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5), if applicable.
(2)All grants, loans, or contracts provided under this section shall be awarded or made available to researchers or projects located within this state, except that funding for research collaboratives between California and out-of-state researchers shall be permitted where the majority of the research is being conducted in California. For the purposes of this paragraph, the term majority of the research shall mean that 75 percent of the funds awarded by the foundation to a specific project are utilized by that project for research activities in California.
(3)No funds shall be awarded or made available to an entity that constitutes a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code and related regulations.
(4)All grants, loans, or contracts provided under this section shall be awarded based on the following:
(A)Consistency with the research priorities established for the foundation by the California Foundation for Science and Health Research Council as described in subdivision (a) of Section 11899.3.
(B)The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as described in Section 11899.4.
(C)Any funds allocated to a United States Department of Energy or National Aeronautics and Space Administration laboratory or field center pursuant to this section shall be conducted in accordance with the Federal Laboratory Contracting Act, as set forth in Chapter 7 (commencing with Section 12500) of Part 2 of Division 2 of the Public Contract Code. Only national laboratories and centers operating within California may be eligible for these funds.
(5)The foundation shall prioritize funding research impacted by discretionary programmatic funding cuts by the federal government and for research that supports or accelerates the development and deployment of research and innovations to grow Californias economy and that can lead to the creation of high-quality job opportunities.
(6)To be eligible for funding, all research projects involving human subjects shall be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5) and the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20 of the Health and Safety Code).
(7)The California State University and the University of California may submit proposed projects to the Department of Finance for approval for the construction and modernization of science, health care, technology, engineering, and other facilities that support research consistent with the priorities of the foundation. Upon approval, the Department of Finance may allocate funds through the budget for those projects from the fund. One billion dollars ($1,000,000,000) shall be utilized for this purpose. Two hundred fifty million dollars ($250,000,000) of this money shall be available to the University of California, and seven hundred fifty million dollars ($750,000,000) of this money shall be available to the California State University.
(e)(1)It is the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts that any biomedical inventions and technologies developed in whole or in part as a result of bond-funded research are affordable and available to Californians, and that the funding supports principles of open science where possible.
(2)Prior to the first grant from the foundation, and no later than one year from the date this legislation takes effect, the council shall develop such provisions to facilitate the foundations goals of affordability and equitable access that will include at least the following subjects, with requirements that the obligations of the provisions, when applicable, be passed through to further licensees, sublicensees, or assignees:
(A)The foundation shall require that grantees, loan recipients, and contractors submit, for the review and approval of the foundation, access plans specifying strategies and timelines for promoting equitable access to the subject invention in California, the United States, and in low- and middle-income countries (LMICs) on fair and reasonable conditions across criteria of affordability, availability, acceptability, sustainability, and transparency. The foundation shall create guidance for grantees, loan recipients, and contractors regarding these parameters and shall include nonlimiting examples of modalities for equitable access, such as, for example, nonexclusive licensing, technology transfer, and data sharing. The guidance shall further enumerate the timing for submission and updating of access plans, as well as the manner in which access plans will be evaluated by the foundation, and articulate at least (i) the manner in which the foundations expectations of equitable access should be flexible to reflect both public health needs and the uncertainties of product development and patient access, and proportional to the extent to which the foundations funding for the subject invention was responsible for the final commercializable product vis-a-vis private funding, and (ii) processes where the access plan, in whole or in part, may be waivable, such as for where the foundation funding does not yield a medical technology, or where aspects of the access plan are infeasible.
(B)The foundation shall require grantees, loan recipients, and contractors to manage, preserve, and make available any data resulting from bond-funded research to the broader scientific community for educational, academic, or research purposes, except where such requests are made by a foreign country of concern, as defined in Section 4651(7) of Title 15 of the United States Code, or an instrument thereof, or a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code, or if such disclosure could impair national security. Grantees, loan recipients, and contractors shall also be required to provide free public access to any publication that results from bond-funded research.
(C)The foundation shall require that subject inventions support Californian pandemic preparedness and health security by ensuring the inclusion of further provisions that may be triggered in the event of a declaration by the World Health Organization of a public health emergency of international concern (PHEIC) in relation to a pathogen or disease for which the subject invention is or may reasonably be expected to be relevant for prevention, diagnosis, or treatment, for the duration of the PHEIC, with additional access commitments designed to prioritize timely and equitable supply of the subject invention in LMICs, taking into account global health needs and available manufacturing capacity. Such access commitments may include, for example, either as independent measures or in combination, requirements to license the subject invention to a recognized licensing body or to facilitate technology transfer in order to facilitate the rapid development, manufacture, and distribution of the subject invention.
(D)The foundation may require grantees, loan recipients, and contractors to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant or applicants, upon terms that are reasonable under the circumstances, if the State of California determines either of the following:
(i)Such action is necessary because the grantee, loan recipient, or contractor licensee has not taken, or is not expected to take within a reasonable time, effective steps to achieve practical application of the foundation-funded invention in that field of use, as evidenced by a failure to timely complete specified development milestones contained in the license agreement.
(ii)Such action is necessary to alleviate health or safety needs that are not reasonably satisfied by the grantee, loan recipient, contractor, or their licensee as evidenced by a failure to timely complete specified development milestones contained in the license agreement.
(E)Before exercising authority under subparagraph (D), the foundation shall provide written notice of the grounds for the proposed action, a reasonable opportunity to cure any deficiency, and an opportunity for a hearing under procedures to be established by the foundation.
(3) (A)It is the intent of the Legislature that the foundation draw upon the greatest successes in American history in order to be equipped to solve the most pressing problems facing California and the nation.(B)In furtherance of subparagraph (A), it is the intent of the Legislature that the foundation accomplish all of the following:
(i)Learn from the most ambitious research models of the past century, including the DARPA/ARPA-E/ARPA-H model and Operation Warp Speed. At least 10 percent of the moneys in the fund shall be allocated consistent with the Advanced Research Projects Agency model that relies on collaboration between academic, industry, and government partners to pursue revolutionary breakthroughs focused on tangible, solutions-oriented aims. No more than 1.5 percent of total bond funds shall be allocated each year for this specific purpose. This model shall be referred to as California Advanced Research Project Activities or Cal-ARPA.
(ii)Support the commercialization of research by providing grants, loans, or contracts to entities that are focused on this purpose. Priority shall be provided to entities that can demonstrate job growth or future manufacturing opportunities in California or that can demonstrate additional funding mechanisms. No less than two hundred fifty million dollars ($250,000,000) shall be utilized for this purpose, and no more than 0.5 percent of total bond funds shall be allocated each year for this specific purpose. No funds shall be used to support manufacturing in a foreign country of concern, as defined in Section 4651(7) of Title 15 of the United States Code, or a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code, regardless of domicile.
(iii)Support a greater diversity of ideas by allocating funding for projects that are riskier than those typically funded by federal agencies and by ensuring that early career scientists, including scientists under 40 and scientists fewer than 10 years since completing their PhDs, are supported by the foundation.
(iv)Create award approval systems that are efficient and not overly reliant on paperwork, freeing up scientists to spend more time doing critical work.
(f)Not more than 3 percent of the moneys in the fund shall be used for administrative costs. Administrative costs include, but are not limited to, all of the following:
(1)Salaries and benefits paid or incurred with respect to the hiring or retention of a director of the foundation and other officers and administrative staff that shall work on behalf of the foundation under the supervision of the director.
(2)Legal and accounting fees and expenses.
(3)All costs associated with the establishment and operation of the foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the foundation.
(g)All intellectual property assets developed using funds authorized for, or made available to, the foundation shall be treated pursuant to state and federal law. Proceeds of intellectual property assets shall be deposited into the fund and shall be used consistent with this act.
(h)The foundation shall recommend to the council, and the council shall adopt, standards to ensure that if the grantee, loan recipient, or contracted entity purchases goods or services using funds authorized for, or made available to, the foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50 percent of purchases from California suppliers.
11899.3.(a)There is hereby established the California Foundation for Science and Health Research Council, which shall be vested with full power, authority, and jurisdiction over the foundation, including the authority to adopt regulations, and shall do all of the following:
(1)Develop the strategic objectives and research priorities of the foundation. The council shall provide opportunity for the public to provide comments on the priorities of the foundation in accordance with Section 11899.7. The council shall also consider how the research priorities relate to or support areas critical to Californias economy, as identified as Bet and Accelerate sectors in the California Jobs First State Economic Blueprint, as published and updated by the Governors Office of Business and Economic Development. The council shall further consider how the research priorities capitalize on and connect to regional research hubs, taking into account close proximity to relevant industry clusters, such as energy, life sciences, and other fields of research, as identified in paragraph (1) of subdivision (b) of Section 11899.1, with a focus on emerging industries.
(2)Actively participate in the overall management of the foundation.
(3)Determine which research projects will be funded by the fund based on the research priorities established for the foundation pursuant to paragraph (1) and the technical merits of the proposals, as determined by scientific peer review panels created pursuant to Section 11899.4.
(4)Develop objectives and opportunities that offer support to early career researchers at California universities and the private sector.
(5)Adopt regulations and standards to directly recoup or benefit from the investment by the people of the State of California into scientific and health care research and development in the state by capturing a portion of the revenue from highly profitable inventions, such as blockbuster drugs, while not inhibiting startup companies or otherwise harming the technology transfer process.
(b)(1)The council shall consist of all of the following:
(A)Nine members shall be appointed by the Governor.
(i)In making appointments to the council, the Governor shall consider appointees that bring scientific or research expertise, health or patient advocacy, economic expertise, or have demonstrated leadership in public entities, organizations, industries, or academic institutions aligned to the goals of the bond.
(ii)One member shall be a graduate-level researcher with current or past research experience in the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(iii)One member shall be a postdoctoral scholar with current or past research experience in the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(iv)One member shall have a background in research policy.
(B)One member shall be a health care provider appointed by the Senate Rules Committee.
(C)One member shall be an advocate in climate, environmental health, or environmental fields appointed by the Speaker of the Assembly.
(D)One member shall be the chief executive officer of the California Council on Science and Technology, or their designee.
(E)One member shall be a designee of the President of the University of California, if the president chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(F)One member shall be a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(G)One member shall be the President of the Association of Independent California Colleges and Universities, or the presidents designee, who shall be a scientist or hold a background in science or research.
(2)Any appointees to the council shall not be subject to confirmation by the Senate.
(c)(1)The members of the council shall serve four-year terms expiring June 30.
(2)The first terms for four of the appointments made by the Governor and the appointee of the Senate Committee on Rules shall be a two-year term.
(3)If the graduate-level researcher or postdoctoral scholar appointed pursuant to subparagraph (A) of paragraph (1) of subdivision (b) earns their degree or completes their placement before the conclusion of their four-year term, the graduate-level researcher or postdoctoral scholar may serve out the remainder of the academic year on the council. At the conclusion of the academic year, the Governor shall appoint a current graduate-level researcher or postdoctoral scholar who shall serve out the remainder of the term.
(4)If a vacancy occurs within a term, the appointing authority shall appoint a replacement member to serve the remainder of the term.
(5)When a term expires, the appointing authority shall appoint a member. A member shall serve until the appointment and qualification of their successor or until 365 days have elapsed since the expiration of the term, whichever occurs first.
(6)A grant, loan, or contract shall not be approved if there are more than six vacancies on the council.
(7)The first chair of the council shall be the Governors appointee with a background in research policy and shall serve as chair for two years. Each subsequent chair shall be elected by the members of the council for a term of two years.
(d)A majority of the membership of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the board. If a vacancy or recusal in the council occurs, then a majority of the remaining members of the council constitutes a quorum.
(e)Council members shall serve without compensation, but may receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
(f)(1)Unless prohibited by another law, including the Political Reform Act of 1974, a member may participate in a decision to approve or award a grant, loan, or contract to a person or entity for the purpose of research involving either a disease from which the member or their immediate family member suffers or a disease in which the member has an interest as a representative of a disease advocacy organization.
(2)Notwithstanding any other law:
(A)Service or employment as a trainee or member of the faculty or administration of the University of California, California State University, or the Association of Independent California Colleges and Universities, or as a member of the California Council on Science and Technology, is not, by itself, inconsistent, incompatible, in conflict with, or inimical to the duties of the council member and shall not result in the automatic forfeiture of either office or position.
(B)Service or employment as a representative or employee of a disease advocacy organization, a nonprofit academic and research institution, or a life science commercial entity is not inconsistent, incompatible, in conflict with, or inimical to the duties of the council member.
(3)For purposes of Section 1090, the council may approve or award a grant, loan, or contract in which a member of the council is financially interested as long as the interested member recuses themself from making, participating in making, or attempting to use their official position to influence a decision on the grant, loan, or contract. If this condition is satisfied, this transaction shall be deemed not to create a violation of Section 1090.
(4)Disclosure requirements under Article 2 (commencing with Section 87200) of Chapter 7 of Title 9 shall apply to council members.
(5)For purposes of this subdivision, decision does not include the adoption of standards.
11899.4.(a)The council may establish one or more scientific peer review panels consisting of experts in the fields described in paragraph (1) of subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
(b)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to subdivision (a).
11899.5.(a)The foundation shall issue an annual report that sets forth the foundations activities, grants awarded, loans made available, contracts entered, grants, loans, and contracts in progress, research accomplishments, and future program directions. The annual report shall be published on the foundations internet website.
(b)Each annual report shall include, but not be limited to, all of the following:
(1)The number and dollar amounts of research and facilities grants, loans, and contracts.
(2)The grantees, loan recipients, and contracted entities for the prior year.
(3)The foundations administrative expenses.
(4)An assessment of the availability of funding for research from sources other than the foundation.
(5)A summary of research findings, including promising new research areas.
(6)An assessment of the relationship between the foundations grants, loans, and contracts and the overall strategy of its research program.
(7)An assessment or summary of how the work funded by the foundation is having an impact on Californians or is supportive of Californias economy or job opportunities. The foundation shall consult with the Governors Office of Business and Economic Development in the preparation of this assessment or summary.
(8)A report of the foundations strategic research and financial plans.
11899.6.The foundation shall annually commission an independent financial audit of its activities from a certified public accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public report of that review. The Controller shall hold a public meeting with appropriate notice and a formal public comment period. The Controller shall evaluate public comments and shall include appropriate summaries in the annual report.
11899.7.(a)The Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) shall apply to all meetings of the council and a scientific peer review panel created pursuant to Section 11899.4, except as otherwise provided in this section. The council shall disclose all awarded grants and contracts entered into in public meetings, and shall award all grants, loans, and contracts in public meetings. The council and a scientific peer review panel created pursuant to Section 11899.4 shall adopt all governance, scientific, medical, and regulatory standards in public meetings.
(b)The council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) under Section 11126. In addition, the council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions when it meets to consider or discuss any of the following:
(1)Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
(2)Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it.
(3)Matters involving scientific data, analyses, or other research products not yet formally published in academic literature.
(4)Matters concerning the appointment, employment, performance, compensation, or dismissal of foundation officers and employees. Action on compensation of the foundations officers and employees shall only be taken in open session.
(5)Matters believed to pose a security risk to the people of California.
11899.8.(a)The council shall establish standards that require that all grants and loan awards be subject to intellectual property agreements that balance the opportunity of the State of California to benefit from the inventions, technologies, patents, royalties, and licenses that result from research funded by public and private grants to, and loans to, public and private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, research in any field described in paragraph (1) of subdivision (b) of Section 11899.1, with the need to ensure that such research is not unreasonably hindered by such intellectual property agreements.
(b)The council shall have the authority to adopt regulations to implement this section.
2.California Foundation for Science and Health Research Bonds11899.10.The proceeds of bonds, excluding those issued in accordance with Section 11899.21, issued and sold pursuant to this chapter shall be deposited into the California Foundation for Science and Health Research and Innovation Acceleration Fund. All moneys in the fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter.
11899.11.(a)Moneys in the fund shall be available for both of the following:
(1)Grants, loans, and contracts to fund research and operate and maintain facilities for research as provided in this chapter.
(2)Paying general administrative costs of the foundation, not to exceed 3 percent of the amount in the fund.
(b)Repayment of principal and interest on any loans made by the foundation pursuant to this chapter shall be deposited into the fund and used to make additional grants, loans, and contracts for the purposes of this act or for paying continuing costs of the annual administration of outstanding bonds.
11899.12.(a)Bonds in the total amount of seven billion five hundred million dollars ($7,500,000,000), not including the amount of any refunding bonds issued in accordance with Section 11899.21, may be issued and sold for the purposes expressed in this chapter and to reimburse the General Obligation Bond Expense Revolving Fund pursuant to Section 16724.5. The bonds, when sold, issued, and delivered, shall be and constitute a valid and binding obligation of the State of California, and the full faith and credit of the State of California is hereby pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
(b)The Treasurer shall issue and sell the bonds authorized in subdivision (a) in the amount determined by the committee to be necessary or desirable pursuant to Section 11899.15. The bonds shall be issued and sold upon the terms and conditions specified in a resolution to be adopted by the committee pursuant to Section 16731.
11899.13.(a)The bonds authorized by this chapter shall be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4), as amended from time to time, and all of the provisions of that law apply to the bonds and to this chapter and are hereby incorporated in this chapter as though set forth in full in this chapter, except that subdivisions (a) and (b) of Section 16727 shall not apply to restrict the use of bond proceeds to finance the operation and maintenance of facilities as provided in Section 11899.11.
(b)For purposes of this chapter, the references to committee in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research Finance Committee created in Section 11899.14, and the references to board in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research, established by Section 11899.1.
11899.14.(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this chapter, the California Foundation for Science and Health Research Finance Committee is hereby created.
(b)(1)The committee consists of all of the following:
(A)The Treasurer.
(B)The Controller.
(C)The Director of Finance.
(D)The Director of the California Foundation for Science and Health Research.
(E)Two members of the California Foundation for Science and Health Research Council, chosen by the Governor, or their designated representatives.
(2)The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.
(3)Notwithstanding any other law, any member may designate a representative to act as that member in the members place for all purposes, as though the member were personally present.
(c)The committee shall act independently of the foundation and council, but may request recommendations and relevant information so as to understand the financial needs of the foundation to accomplish the strategic objectives and research priorities established pursuant to Section 11899.3.
11899.15.The committee, by resolution, shall determine whether or not it is necessary or desirable to issue and sell bonds authorized pursuant to this chapter in order to carry out the actions specified in this chapter and, if so, the amount of bonds to be issued and sold. Successive issues of bonds may be authorized and sold to carry out those actions progressively, and it is not necessary that all of the bonds authorized to be issued be sold at any one time.
11899.16.There shall be collected each year and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state, a sum in an amount required to pay the principal of, and interest on, the bonds becoming due each year. It is the duty of all officers charged by law with any duty in regard to the collection of the revenue to do and perform each and every act that is necessary to collect that additional sum.
11899.17.Notwithstanding Section 13340, there is hereby continuously appropriated from the General Fund in the State Treasury, for the purposes of this chapter and without regard to fiscal years, an amount that equals the total of the sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this chapter, as the principal and interest become due and payable.
11899.18.For the purpose of carrying out this chapter, the Director of Finance may authorize the withdrawal from the General Fund of an amount, not to exceed the amount of the unsold bonds that have been authorized by the committee, to be sold for the purpose of carrying out this chapter, excluding any refunding bonds authorized pursuant to Section 11899.21 and any amount withdrawn from the General Fund pursuant to this section and not yet returned to the General Fund. Any amount withdrawn shall be deposited into the fund. Any moneys made available under this section shall be returned to the General Fund, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds for the purpose of carrying out this chapter.
11899.19.All moneys deposited into the fund that are derived from premium and accrued interest on bonds sold pursuant to this chapter shall be reserved in the fund and shall be available for transfer to the General Fund as a credit to expenditures for bond interest, except those amounts derived from premium may be reserved and used to pay the cost of bond issuance before any transfer to the General Fund.
11899.20.The bonds issued and sold pursuant to this chapter may be refunded in accordance with Article 6 (commencing with Section 16780) of Chapter 4 of Part 3 of Division 4, which is a part of the State General Obligation Bond Law. Approval by the voters of the state for the issuance of the bonds described in this chapter includes the approval of the issuance of any bonds issued to refund any bonds originally issued under this chapter or any previously issued refunding bonds. Any bond refunded with the proceeds of refunding bonds as authorized by this section may be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
11899.21.Notwithstanding any other provision of this chapter or the State General Obligation Bond Law, if the Treasurer sells bonds pursuant to this chapter that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, the Treasurer may maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. The Treasurer may use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
11899.22.The proceeds from the sale of bonds authorized by this chapter are not proceeds of taxes as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed by that article.
SEC. 3.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 4.Section 2 of this act shall take effect upon the approval by the voters of the California Science and Health Research Bond Act, as set forth in Section 2 of this act.
SEC. 5.(a)Notwithstanding Section 9040 of the Elections Code, or any other law, Section 2 of this act shall be submitted by the Secretary of State to the voters at the March 7, 2028, statewide primary election.
(b)The requirement of Section 9040 of the Elections Code that a measure submitted to the people by the Legislature appear on the ballot of the first statewide election occurring at least 131 days after the adoption of the proposal by the Legislature shall not apply to Section 2 of this act.
SEC. 6.This act shall be broadly construed to accomplish its purposes. The statutory provisions of the act may be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
SEC. 7.(a)This act shall be liberally construed to effectuate its purposes.
(b)If this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure shall be self-executing and given full force and effect.
SEC. 8.The Legislature finds and declares that Section 2 of this act, which adds Section 11899.7 to the Government Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the publics access to this information.
SEC. 9.This act is an urgency statute necessary for the immediate preservation of the public peace, health, or safety within the meaning of Article IV of the California Constitution and shall go into immediate effect. The facts constituting the necessity are:
Due to the uncertainty from the current federal administration relating to the availability and amount of federal funding for research and the instability this uncertainty causes in the California research sector, it is necessary for this act to take effect immediately to clearly demonstrate to Californians and the states research institutions the states investment and continued commitment to publicly funded research.
The People people of the State of California find and declare the following:
(a)Since World War II, the United States has been a global leader in scientific and health research and innovation. Through the financial support of governmental agencies including, but not limited to, the National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Food and Drug Administration (FDA), the federal Centers for Disease Control and Prevention (CDC), and the National Oceanic and Atmospheric Administration (NOAA), the scientific and health communities have been able to create life-enhancing scientific, biomedical, and public health discoveries.
(b)Americans have benefited enormously from that research with improved health, cures for diseases, vaccines, and improved air quality and environment. The United States economy has benefited greatly from that research as well.
(c)California produces an astonishing share of the top scientific research on the planet. It is estimated that $3 of every $10 in federal research investments are drawn to California. The state accounts for about 47 percent of United States biotechnology research and development spending and generates about 53 percent of the nations biotechnology revenues. Nearly one-half of all venture capital in the United States is invested in California. That success is driven in large part by the states world-class universities and research institutions. The University of California is the top research institution in the world for United States patent generation. Every dollar invested in science funding generates more than $2 in economic activity.
(d)Federal research funding has been integral in supporting the work of public and private research institutions in California. For example, federal funding supports a significant part of the University of Californias (UC) and California State Universitys (CSU) research operations. Federal grants pay for faculty research and the salaries of graduate and postdoctoral student researchers. Federal research grants totaled more than $5,000,000,000 to the University of California in the 202324 fiscal year. Public and private university research has led to the founding of thousands of startups, driving economic expansion and technological innovation. Federal funding reductions limit research opportunities and may impede Californias competitiveness and economic progress.
(e)Because the federal government has been one of the largest funders of scientific research in California, foundations, nonprofits, and corporations alone cannot make up the gap when cuts are made by the federal government. Unless the people of California rise up, much of this critical work may come to a halt. Federal cuts to scientific research pose a threat to the well-being of the people of California and will impair Californias ability to operate as a global leader in technology, innovation, and research across fields of study.
(f)The people of California propose this ballot measure to create the California Foundation for Science and Health Research (Foundation) to award grants and make loans to to, and contract with, public and private universities, research companies, institutes, and health care organizations in California for scientific and health care research and development.
(g)Through the Foundation, funding would be distributed to UC, CSU, other California universities, and public and private entities engaged in critical science and health research. It would provide funding for staff, equipment, and facilities needed to carry out scientific research in fields including, but not limited to, public health, mental health, heart disease, cancer treatment, diabetes, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. Priority would be given to established research projects where the federal government has canceled funding. The measure would require annual audits.
(h)This measure will help preserve Californias position as a global leader in scientific innovation. This measure would allow important research to continue regardless of what happens at the federal level. This measure will ensure that California is not left behind.
(i)This measure will help sustain and grow the workforce of the state, with runoff economic benefits that will ensure a thriving future for Californians. This measure will support thousands of students and researchers at California universities in good-paying union jobs in growing industries. Supporting good-paying jobs in science, technology, engineering, and mathematics will help keep California economically competitive and generate billions of dollars each year in economic growth.
(j)There is some science that only public institutions will take on, for example cancer drug trials that combine drugs from different pharmaceutical companies, or as yet, unproven technologies in renewable energy. This measure would continue funding scientific research that looks beyond the profit motive for the greater good.
(k)Californias university and college system is a model for universities everywhere, involving students closely in practical, life-saving research. Cuts to federal funding threaten our students ability to learn the research skills they need to succeed. This measure will preserve Californias university and college system as a pathway to the middle class for California students.
(l)Too many Californians are driven into homelessness by drug abuse and mental health issues. This measure will help address this problem by continuing to fund critical research on promising mental health and addiction treatments.
(m)This measure contains strict fiscal accountability and transparency standards, including annual independent audits and public disclosure of all funding to ensure that Legislative allocations and bond funding is spent effectively, efficiently, and as promised.
(n)This measure will authorize the creation of regulations and standards that are intended to directly recoup part of the investment by the people of the State of California into scientific and health care research and development in the state by capturing a portion of the revenue from highly profitable inventions, such as blockbuster drugs, while not inhibiting startup companies or otherwise harming the technology transfer process.
SEC. 2.Chapter 12 (commencing with Section 11899) is added to Part 1 of Division 3 of Title 2 of the Government Code, to read:12.California Science and Health Research Bond Act1.California Foundation for Science and Health Research11899.As used in this chapter, the following terms have the following meaning:
(a)Act means the California Science and Health Research Bond Act constituting this chapter.
(b)Benefit fund means the California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund created pursuant to paragraph (2) of subdivision (a) of Section 11899.2.
(c)Committee means the California Foundation for Science and Health Research Finance Committee created pursuant to subdivision (a) of Section 11899.15. 11899.14.
(d)Council means the California Foundation for Science and Health Research Council created pursuant to Section 11899.3.
(e)Foundation means the California Foundation for Science and Health Research established pursuant to Section 11899.1.
(f)Fund means the California Foundation for Science and Health Research and Innovation Acceleration Fund created pursuant to paragraph (1) of subdivision (a) of Section 11899.2.
(g)Subject invention means any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement.
11899.1.(a)The California Foundation for Science and Health Research is established within the Government Operations Agency.
(b)(1)The foundations role is to facilitate scientific research by awarding grants and making loans to to, and entering contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development and to construct facilities for research and development, development and for sectors identified as Bet and Accelerate sectors in the California Jobs First State Economic Blueprint, as published and updated by the Governors Office of Business and Economic Development, including, but not limited to, any of the following fields: fields of research:
(1)(A)Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, HIV/AIDS, and genetic and chronic diseases that affect children and infants.
(2)(B)Public health, including, but not limited to, environmental health detecting and responding to new and emerging health threats.
(3)(C)Disease prevention, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(4)(D)Promoting healthy and safe behaviors, communities, and environment.
(5)(E)Wildfire prevention.
(6)(F)Behavioral health, including, but not limited to, addiction and substance use disorders.
(7)(G)Climate, including climate change and its impact on human health.
(8)(H)Weather.
(9)Ocean.(I)Ocean, including sea level rise.
(10)(J)Coastal and marine ecosystems and resources.
(11)(K)Agriculture and water.
(12)(L)Emerging technologies.
(13)(M)Safety, efficacy, and security of drugs, biological products, medical devices, our nations food supply, and cosmetics.
(N)Seismic and related geohazards.
(2)The foundation may enter into interagency agreements with state agencies to administer programs funded under this chapter.
(c)(1)The Secretary of Government Operations Governor shall oversee the process of appointing appoint the director of the foundation and shall set the level of salaries, bonuses, and benefits for the director. The task of hiring and determining the salaries, bonuses, and benefits of additional personnel may be delegated by the secretary to the director, subject to approval and oversight by the secretary. foundation. The salary for the director shall not exceed the base salary of the Provost and Executive Vice President of Academic Affairs of the University of California.
(2)The director and personnel of the foundation shall be responsible for implementing the strategic objectives of the council, administering the grants and loans grants, loans, and contracts awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
11899.2.(a)(1)The California Foundation for Science and Health Research and Innovation Acceleration Fund is hereby created in the State Treasury. The proceeds of bonds issued and sold pursuant to this chapter shall be deposited in the fund pursuant to Section 11899.10.
(2)(A)The California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund is hereby created in the State Treasury.
(B)The benefit fund shall consist solely of private donations.
(C)All moneys in the benefit fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter. Moneys in the benefit fund shall be made available for the same purposes as the moneys in the California Foundation for Science and Health Research and Innovation Acceleration Fund.
(b)The proceeds of interim debt and bonds issued and sold pursuant to this chapter chapter, excluding those issued in accordance with Section 11899.21, shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund. and Innovation Acceleration Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
(c)Moneys in the fund shall be used by the foundation to award public and private grants to, and make loans to, and enter into contracts with, public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development, including, but not limited to, research in any of the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(d)(1)All research and development funded by the fund shall be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5), if applicable.
(2)All grants or loans grants, loans, or contracts provided under this section shall be awarded or made available to researchers or projects located within this state, except that funding for research collaboratives between California and out-of-state researchers shall be permitted. permitted where the majority of the research is being conducted in California. For the purposes of this paragraph, the term majority of the research shall mean that 75 percent of the funds awarded by the foundation to a specific project are utilized by that project for research activities in California.
(3)No funds shall be awarded or made available to an entity that constitutes a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code and related regulations.
(3)(4)All grants or loans grants, loans, or contracts provided under this section shall be awarded based on both of the following:
(A)Consistency with the research priorities established for the foundation by the California Foundation for Science and Health Research Council as described in subdivision (a) of Section 11899.3.
(B)The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as described in Section 11899.4.
(C)Any funds allocated to a United States Department of Energy or National Aeronautics and Space Administration laboratory or field center pursuant to this section shall be conducted in accordance with the Federal Laboratory Contracting Act, as set forth in Chapter 7 (commencing with Section 12500) of Part 2 of Division 2 of the Public Contract Code. Only national laboratories and centers operating within California may be eligible for these funds.
(4)(5)The foundation shall prioritize funding research that replaces impacted by discretionary programmatic funding cuts by the federal government. government and for research that supports or accelerates the development and deployment of research and innovations to grow Californias economy and that can lead to the creation of high-quality job opportunities.
(5)(6)To be eligible for funding, all research projects submitted for potential funding involving human subjects shall be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5) and the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20 of the Health and Safety Code).
(7)The California State University and the University of California may submit proposed projects to the Department of Finance for approval for the construction and modernization of science, health care, technology, engineering, and other facilities that support research consistent with the priorities of the foundation. Upon approval, the Department of Finance may allocate funds through the budget for those projects from the fund. One billion dollars ($1,000,000,000) shall be utilized for this purpose. Two hundred fifty million dollars ($250,000,000) of this money shall be available to the University of California, and seven hundred fifty million dollars ($750,000,000) of this money shall be available to the California State University.
(e)(1)It is the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount. that any biomedical inventions and technologies developed in whole or in part as a result of bond-funded research are affordable and available to Californians, and that the funding supports principles of open science where possible.
(2)It is the intent of the Legislature that under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at a discount to Californians and for profit to other states.(2)Prior to the first grant from the foundation, and no later than one year from the date this legislation takes effect, the council shall develop such provisions to facilitate the foundations goals of affordability and equitable access that will include at least the following subjects, with requirements that the obligations of the provisions, when applicable, be passed through to further licensees, sublicensees, or assignees:
(A)The foundation shall require that grantees, loan recipients, and contractors submit, for the review and approval of the foundation, access plans specifying strategies and timelines for promoting equitable access to the subject invention in California, the United States, and in low- and middle-income countries (LMICs) on fair and reasonable conditions across criteria of affordability, availability, acceptability, sustainability, and transparency. The foundation shall create guidance for grantees, loan recipients, and contractors regarding these parameters and shall include nonlimiting examples of modalities for equitable access, such as, for example, nonexclusive licensing, technology transfer, and data sharing. The guidance shall further enumerate the timing for submission and updating of access plans, as well as the manner in which access plans will be evaluated by the foundation, and articulate at least (i) the manner in which the foundations expectations of equitable access should be flexible to reflect both public health needs and the uncertainties of product development and patient access, and proportional to the extent to which the foundations funding for the subject invention was responsible for the final commercializable product vis-a-vis private funding, and (ii) processes where the access plan, in whole or in part, may be waivable, such as for where the foundation funding does not yield a medical technology, or where aspects of the access plan are infeasible.
(B)The foundation shall require grantees, loan recipients, and contractors to manage, preserve, and make available any data resulting from bond-funded research to the broader scientific community for educational, academic, or research purposes, except where such requests are made by a foreign country of concern, as defined in Section 4651(7) of Title 15 of the United States Code, or an instrument thereof, or a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code, or if such disclosure could impair national security. Grantees, loan recipients, and contractors shall also be required to provide free public access to any publication that results from bond-funded research.
(C)The foundation shall require that subject inventions support Californian pandemic preparedness and health security by ensuring the inclusion of further provisions that may be triggered in the event of a declaration by the World Health Organization of a public health emergency of international concern (PHEIC) in relation to a pathogen or disease for which the subject invention is or may reasonably be expected to be relevant for prevention, diagnosis, or treatment, for the duration of the PHEIC, with additional access commitments designed to prioritize timely and equitable supply of the subject invention in LMICs, taking into account global health needs and available manufacturing capacity. Such access commitments may include, for example, either as independent measures or in combination, requirements to license the subject invention to a recognized licensing body or to facilitate technology transfer in order to facilitate the rapid development, manufacture, and distribution of the subject invention.
(D)The foundation may require grantees, loan recipients, and contractors to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant or applicants, upon terms that are reasonable under the circumstances, if the State of California determines either of the following:
(i)Such action is necessary because the grantee, loan recipient, or contractor licensee has not taken, or is not expected to take within a reasonable time, effective steps to achieve practical application of the foundation-funded invention in that field of use, as evidenced by a failure to timely complete specified development milestones contained in the license agreement.
(ii)Such action is necessary to alleviate health or safety needs that are not reasonably satisfied by the grantee, loan recipient, contractor, or their licensee as evidenced by a failure to timely complete specified development milestones contained in the license agreement.
(E)Before exercising authority under subparagraph (D), the foundation shall provide written notice of the grounds for the proposed action, a reasonable opportunity to cure any deficiency, and an opportunity for a hearing under procedures to be established by the foundation.
(3) (A)It is the intent of the Legislature that the foundation draw upon the greatest successes in American history in order to be equipped to solve the most pressing problems facing California and the nation.(B)In furtherance of subparagraph (A), it is the intent of the Legislature that the foundation accomplish all of the following:
(i)Learn from the most ambitious research models of the past century, including the DARPA/ARPA DARPA/ARPA-E/ARPA-H model and Operation Warp Speed. At least 10 percent of the moneys in the fund shall be allocated consistent with the Advanced Research Projects Agency model that relies on collaboration between academic, industry, and government partners to pursue revolutionary breakthroughs focused on tangible, solutions-oriented aims. No more than 1.5 percent of total bond funds shall be allocated each year for this specific purpose. This model shall be referred to as California Advanced Research Project Activities or Cal-ARPA.
(ii)Support the commercialization of research by providing grants, loans, or contracts to entities that are focused on this purpose. Priority shall be provided to entities that can demonstrate job growth or future manufacturing opportunities in California or that can demonstrate additional funding mechanisms. No less than two hundred fifty million dollars ($250,000,000) shall be utilized for this purpose, and no more than 0.5 percent of total bond funds shall be allocated each year for this specific purpose. No funds shall be used to support manufacturing in a foreign country of concern, as defined in Section 4651(7) of Title 15 of the United States Code, or a foreign entity of concern, as defined in Section 4651(8) of Title 15 of the United States Code, regardless of domicile.
(ii)(iii)Support a greater diversity of ideas by allocating funding for projects that are riskier than those typically funded by federal agencies and by ensuring that early career scientists, including scientists under 40 and scientists fewer than 10 years since completing their PhDs, are supported by the foundation.
(iii)(iv)Create award approval systems that are efficient and not overly reliant on paperwork, freeing up scientists to spend more time doing critical work.
(f)Not more than 3 percent of the moneys in the fund shall be used for administrative costs. Administrative costs include, but are not limited to, all of the following:
(1)Salaries, bonuses, Salaries and benefits paid or incurred with respect to the hiring or retention of a director of the foundation and other officers and administrative staff that shall work on behalf of the foundation under the supervision of the director.
(2)Legal and accounting fees and expenses.
(3)All costs associated with the establishment and operation of the foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the foundation.
(g)All intellectual property assets developed using funds authorized for, or made available to, the foundation shall be treated pursuant to state and federal law. Proceeds of intellectual property assets shall be deposited into the fund and shall be used consistent with this act.
(h)The foundation shall recommend to the council, and the council shall adopt, standards to ensure that if the grantee or loan recipient grantee, loan recipient, or contracted entity purchases goods or services using funds authorized for, or made available to, the foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50 percent of purchases from California suppliers.
11899.3.(a)There is hereby established the California Foundation for Science and Health Research Council that Council, which shall be vested with full power, authority, and jurisdiction over the foundation, including the authority to adopt regulations, and shall do all of the following:
(1)Develop the strategic objectives and research priorities of the foundation. The council shall provide opportunity for the public to provide comments on the priorities of the foundation in accordance with Section 11899.7. The council shall also consider how the research priorities relate to or support areas critical to Californias economy, as identified as Bet and Accelerate sectors in the California Jobs First State Economic Blueprint, as published and updated by the Governors Office of Business and Economic Development. The council shall further consider how the research priorities capitalize on and connect to regional research hubs, taking into account close proximity to relevant industry clusters, such as energy, life sciences, and other fields of research, as identified in paragraph (1) of subdivision (b) of Section 11899.1, with a focus on emerging industries.
(2)Actively participate in the overall management of the foundation.
(3)Determine which research projects will be funded by the fund based on the research priorities established for the foundation pursuant to paragraph (1) and the technical merits of the proposals, as determined by scientific peer review panels created pursuant to subdivision (e). Section 11899.4.
(4)Develop objectives and opportunities that offer support to early career researchers at California universities and the private sector.
(5)Adopt regulations and standards to directly recoup or benefit from the investment by the people of the State of California into scientific and health care research and development in the state by capturing a portion of the revenue from highly profitable inventions, such as blockbuster drugs, while not inhibiting startup companies or otherwise harming the technology transfer process.
(b)(1)The council shall consist of 11 to 13 members. of all of the following:
(A)Seven Nine members shall be appointed by the Secretary of Government Operations. Governor.
(i)Five members shall be scientists or hold backgrounds in science or research, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the fields described in subdivision (b) of Section 11899.1.(i)In making appointments to the council, the Governor shall consider appointees that bring scientific or research expertise, health or patient advocacy, economic expertise, or have demonstrated leadership in public entities, organizations, industries, or academic institutions aligned to the goals of the bond.
(ii)One member shall hold a background in economics. be a graduate-level researcher with current or past research experience in the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(iii)One member shall be a patient advocate. postdoctoral scholar with current or past research experience in the fields described in paragraph (1) of subdivision (b) of Section 11899.1.
(iv)One member shall have a background in research policy.
(B)One member shall be a health care provider appointed by the Senate Rules Committee.
(C)One member shall be an advocate in climate climate, environmental health, or environmental fields appointed by the Speaker of the Assembly.
(D)One member shall be the chief executive officer of the California Council on Science and Technology, or their designee.
(E)One member shall be a designee of the President of the University of California, if the president chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(F)One member shall be a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(G)One member shall be the President of the Association of Independent California Colleges and Universities, or the presidents designee, who shall be a scientist or hold a background in science or research.
(2)(A)Individuals and organizations may submit nominations for membership to the Secretary of Government Operations.(B)The Secretary of Government Operations may solicit nominations from relevant organizations and individuals.(3)(2)Any appointees to the council shall not be subject to confirmation by the Senate.
(c)(1)The members of the council shall serve four-year terms. A member shall serve a maximum of two terms. terms expiring June 30.
(2)The first terms for four of the appointments made by the Governor and the appointee of the Senate Committee on Rules shall be a two-year term.
(2)(3)If the graduate-level researcher or postdoctoral scholar appointed pursuant to subparagraph (A) of paragraph (1) of subdivision (b) earns their degree or completes their placement before the conclusion of their four-year term, the graduate-level researcher or postdoctoral scholar may serve out the remainder of the academic year on the council. At the conclusion of the academic year, the Secretary of Government Operations Governor shall appoint a current graduate-level researcher or postdoctoral scholar who may serve a four-year term or until they earn their degree or complete their placement. shall serve out the remainder of the term.
(3)(4)If a vacancy occurs within a term, the Secretary of Government Operations appointing authority shall appoint a replacement member within 45 days to serve the remainder of the term.
(4)(5)When a term expires, the Secretary of Government Operations appointing authority shall appoint a member within 30 days. A member shall serve until their replacement is appointed. member. A member shall serve until the appointment and qualification of their successor or until 365 days have elapsed since the expiration of the term, whichever occurs first.
(5)(6)A grant or a loan grant, loan, or contract shall not be approved if there are more than six vacancies on the council.
(7)The first chair of the council shall be the Governors appointee with a background in research policy and shall serve as chair for two years. Each subsequent chair shall be elected by the members of the council for a term of two years.
(d)A majority of the membership of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the board. If a vacancy or recusal in the council occurs, then a majority of the remaining members of the council constitutes a quorum.
(e)Council members shall serve without compensation, but may receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
(f)(1)Unless prohibited by another law, including the Political Reform Act of 1974, a member may participate in a decision to approve or award a grant or loan grant, loan, or contract to a person or entity for the purpose of research involving either a disease from which the member or their immediate family member suffers or a disease in which the member has an interest as a representative of a disease advocacy organization.
(2)Notwithstanding any other law:
(A)Service or employment as a trainee or member of the faculty or administration of the University of California, California State University, or the Association of Independent California Colleges and Universities, or as a member of the California Council on Science and Technology, is not, by itself, inconsistent, incompatible, in conflict with, or inimical to the duties of the council member and shall not result in the automatic forfeiture of either office or position.
(B)Service or employment as a representative or employee of a disease advocacy organization, a nonprofit academic and research institution, or a life science commercial entity is not inconsistent, incompatible, in conflict with, or inimical to the duties of the council member.
(3)For purposes of Section 1090, the council may approve or award a grant or loan grant, loan, or contract in which a member of the council is financially interested as long as the interested member recuses themself from making, participating in making, or attempting to use their official position to influence a decision on the grant or loan. grant, loan, or contract. If this condition is satisfied, this transaction shall be deemed not to create a violation of Section 1090.
(4)Disclosure requirements under Article 2 (commencing with Section 87200) of Chapter 7 of Title 9 shall apply to council members.
(4)(5)For purposes of this subdivision, decision does not include the adoption of standards.
11899.4.(a)The council may establish one or more scientific peer review panels consisting of experts in the fields described in paragraph (1) of subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
(b)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to subdivision (a).
11899.5.(a)The foundation shall issue an annual report that sets forth the foundations activities, grants awarded, loans made available, grants and loans contracts entered, grants, loans, and contracts in progress, research accomplishments, and future program directions. The annual report shall be published on the foundations internet website.
(b)Each annual report shall include, but not be limited to, all of the following:
(1)The number and dollar amounts of research and facilities grants and loans. grants, loans, and contracts.
(2)The grantees and loan recipients grantees, loan recipients, and contracted entities for the prior year.
(3)The foundations administrative expenses.
(4)An assessment of the availability of funding for research from sources other than the foundation.
(5)A summary of research findings, including promising new research areas.
(6)An assessment of the relationship between the foundations grants and loans grants, loans, and contracts and the overall strategy of its research program.
(7)An assessment or summary of how the work funded by the foundation is having an impact on Californians or is supportive of Californias economy or job opportunities. The foundation shall consult with the Governors Office of Business and Economic Development in the preparation of this assessment or summary.
(7)(8)A report of the foundations strategic research and financial plans.
11899.6.The foundation shall annually commission an independent financial audit of its activities from a certified public accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public report of that review. The Controller shall hold a public meeting with appropriate notice and a formal public comment period. The Controller shall evaluate public comments and shall include appropriate summaries in the annual report.
11899.7.(a)The Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) shall apply to all meetings of the council and a scientific peer review panel created pursuant to Section 11899.4, except as otherwise provided in this section. The council shall disclose all awarded grants and contracts entered into in public meetings, and shall award all grants, loans, and contracts in public meetings. The council and a scientific peer review panel created pursuant to Section 11899.4 shall adopt all governance, scientific, medical, and regulatory standards in public meetings.
(b)The council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) under Section 11126. In addition, the council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions when it meets to consider or discuss any of the following:
(1)Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
(2)Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it.
(3)Matters involving scientific data, analyses, or other research products not yet formally published in academic literature.
(4)Matters concerning the appointment, employment, performance, compensation, or dismissal of foundation officers and employees. Action on compensation of the foundations officers and employees shall only be taken in open session.
(5)Matters believed to pose a security risk to the people of California.
11899.8.(a)The council shall establish standards that require that all grants and loan awards be subject to intellectual property agreements that balance the opportunity of the State of California to benefit from the inventions, technologies, patents, royalties, and licenses that result from research funded by public and private grants to, and loans to, public and private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, research in any field described in paragraph (1) of subdivision (b) of Section 11899.1, with the need to ensure that such research is not unreasonably hindered by such intellectual property agreements.
(b)The council shall have the authority to adopt regulations to implement this section.
2.California Foundation for Science and Health Research Bonds11899.10.The proceeds of bonds, excluding those issued in accordance with Section 11899.21, issued and sold pursuant to this chapter shall be deposited into the California Foundation for Science and Health Research and Innovation Acceleration Fund. All moneys in the fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter.
11899.11.(a)Moneys in the fund shall be available for both of the following:
(1)Grants and loans Grants, loans, and contracts to fund research and operate and maintain facilities for research as provided in this chapter.
(2)Paying general administrative costs of the foundation, not to exceed 3 percent of the amount in the fund.
(b)Repayment of principal and interest on any loans made by the foundation pursuant to this chapter shall be deposited into the fund and used to make additional grants and loans grants, loans, and contracts for the purposes of this act or for paying continuing costs of the annual administration of outstanding bonds.
11899.12.The proceeds of interim debt and bonds issued and sold pursuant to this article shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund.11899.13.11899.12.(a)Bonds in the total amount of five billion dollars ($5,000,000,000), seven billion five hundred million dollars ($7,500,000,000), not including the amount of any refunding bonds issued in accordance with Section 11899.21, may be issued and sold for the purposes expressed in this chapter and to reimburse the General Obligation Bond Expense Revolving Fund pursuant to Section 16724.5. The bonds, when sold, issued, and delivered, shall be and constitute a valid and binding obligation of the State of California, and the full faith and credit of the State of California is hereby pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
(b)The Treasurer shall issue and sell the bonds authorized in subdivision (a) in the amount determined by the committee to be necessary or desirable pursuant to Section 11899.16. 11899.15. The bonds shall be issued and sold upon the terms and conditions specified in a resolution to be adopted by the committee pursuant to Section 16731.
11899.14.11899.13.(a)The bonds authorized by this chapter shall be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4), as amended from time to time, and all of the provisions of that law apply to the bonds and to this chapter and are hereby incorporated in this chapter as though set forth in full in this chapter, except that subdivisions (a) and (b) of Section 16727 shall not apply to restrict the use of bond proceeds to finance the operation and maintenance of facilities as provided in Section 11899.11.
(b)For purposes of this chapter, the references to committee in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research Finance Committee created in Section 11899.15, 11899.14, and the references to board in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research, established by Section 11899.1.
11899.15.11899.14.(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this chapter, the California Foundation for Science and Health Research Finance Committee is hereby created.
(b)(1)The committee consists of all of the following:
(A)The Treasurer.
(B)The Controller.
(C)The Director of Finance.
(D)The Director of the California Foundation for Science and Health Research.
(E)Two members of the California Foundation for Science and Health Research Council, chosen by the Secretary of Government Operations, Governor, or their designated representatives.
(2)The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.
(3)Notwithstanding any other law, any member may designate a representative to act as that member in the members place for all purposes, as though the member were personally present.
(c)The committee shall act independently of the foundation and council, but may request recommendations and relevant information so as to understand the financial needs of the foundation to accomplish the strategic objectives and research priorities established pursuant to Section 11899.3.
11899.16.11899.15.The committee, by resolution, shall determine whether or not it is necessary or desirable to issue and sell bonds authorized pursuant to this chapter in order to carry out the actions specified in this chapter and, if so, the amount of bonds to be issued and sold. Successive issues of bonds may be authorized and sold to carry out those actions progressively, and it is not necessary that all of the bonds authorized to be issued be sold at any one time.
11899.17.11899.16.There shall be collected each year and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state, a sum in an amount required to pay the principal of, and interest on, the bonds becoming due each year. It is the duty of all officers charged by law with any duty in regard to the collection of the revenue to do and perform each and every act that is necessary to collect that additional sum.
11899.18.11899.17.Notwithstanding Section 13340, there is hereby continuously appropriated from the General Fund in the State Treasury, for the purposes of this chapter and without regard to fiscal years, an amount that equals the total of the sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this chapter, as the principal and interest become due and payable.
11899.19.11899.18.For the purpose of carrying out this chapter, the Director of Finance may authorize the withdrawal from the General Fund of an amount, not to exceed the amount of the unsold bonds that have been authorized by the committee, to be sold for the purpose of carrying out this chapter, excluding any refunding bonds authorized pursuant to Section 11899.21 and any amount withdrawn from the General Fund pursuant to this section and not yet returned to the General Fund. Any amount withdrawn shall be deposited into the fund. Any moneys made available under this section shall be returned to the General Fund, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds for the purpose of carrying out this chapter.
11899.20.11899.19.All moneys deposited into the fund that are derived from premium and accrued interest on bonds sold pursuant to this chapter shall be reserved in the fund and shall be available for transfer to the General Fund as a credit to expenditures for bond interest, except those amounts derived from premium may be reserved and used to pay the cost of bond issuance before any transfer to the General Fund.
11899.21.11899.20.The bonds issued and sold pursuant to this chapter may be refunded in accordance with Article 6 (commencing with Section 16780) of Chapter 4 of Part 3 of Division 4, which is a part of the State General Obligation Bond Law. Approval by the voters of the state for the issuance of the bonds described in this chapter includes the approval of the issuance of any bonds issued to refund any bonds originally issued under this chapter or any previously issued refunding bonds. Any bond refunded with the proceeds of refunding bonds as authorized by this section may be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
11899.22.11899.21.Notwithstanding any other provision of this chapter or the State General Obligation Bond Law, if the Treasurer sells bonds pursuant to this chapter that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, the Treasurer may maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. The Treasurer may use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
11899.23.11899.22.The proceeds from the sale of bonds authorized by this chapter are not proceeds of taxes as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed by that article.
SEC. 3.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 4.Section 2 of this act shall take effect upon the approval by the voters of the California Science and Health Research Bond Act, as set forth in Section 2 of this act.
SEC. 5.Section 2 of this act shall be submitted to the voters at the next statewide election in accordance with provisions of the Government Code and the Elections Code governing the submission of a statewide measure to the voters.SEC. 5.(a)Notwithstanding Section 9040 of the Elections Code, or any other law, Section 2 of this act shall be submitted by the Secretary of State to the voters at the March 7, 2028, statewide primary election.
(b)The requirement of Section 9040 of the Elections Code that a measure submitted to the people by the Legislature appear on the ballot of the first statewide election occurring at least 131 days after the adoption of the proposal by the Legislature shall not apply to Section 2 of this act.
SEC. 6.This act shall be broadly construed to accomplish its purposes. The statutory provisions of the act may be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
SEC. 7.(a)This act shall be liberally construed to effectuate its purposes.
(b)If this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure shall be self-executing and given full force and effect.
SEC. 8.The Legislature finds and declares that Section 2 of this act, which adds Section 11899.7 to the Government Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the publics access to this information.
SEC. 9.This act is an urgency statute necessary for the immediate preservation of the public peace, health, or safety within the meaning of Article IV of the California Constitution and shall go into immediate effect. The facts constituting the necessity are:
Due to the uncertainty from the current federal administration relating to the availability and amount of federal funding for research and the instability this uncertainty causes in the California research sector, it is necessary for this act to take effect immediately to clearly demonstrate to Californians and the states research institutions the states investment and continued commitment to publicly funded research.
The People of the State of California find and declare the following:
(a)Since World War II, the United States has been a global leader in scientific and health research and innovation. Through the financial support of governmental agencies including, but not limited to, the National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Food and Drug Administration (FDA), the federal Centers for Disease Control and Prevention (CDC), and the National Oceanic and Atmospheric Administration (NOAA), the scientific and health communities have been able to create life-enhancing scientific, biomedical, and public health discoveries.
(b)Americans have benefited enormously from that research with improved health, cures for diseases, vaccines, and improved air quality and environment. The United States economy has benefited greatly from that research as well.
(c)California produces an astonishing share of the top scientific research on the planet. It is estimated that $3 of every $10 in federal research investments are drawn to California. The state accounts for about 47 percent of United States biotechnology research and development spending and generates about 53 percent of the nations biotechnology revenues. Nearly one-half of all venture capital in the United States is invested in California. That success is driven in large part by the states world-class universities and research institutions. The University of California is the top research institution in the world for United States patent generation. Every dollar invested in science funding generates more than $2 in economic activity.
(d)Federal research funding has been integral in supporting the work of public and private research institutions in California. For example, federal funding supports a significant part of the University of Californias (UC) and California State Universitys (CSU) research operations. Federal grants pay for faculty research and the salaries of graduate and postdoctoral student researchers. Federal research grants totaled more than $5,000,000,000 to the University of California in the 202324 fiscal year. Public and private university research has led to the founding of thousands of startups, driving economic expansion and technological innovation. Federal funding reductions limit research opportunities and may impede Californias competitiveness and economic progress.
(e)Because the federal government has been one of the largest funders of scientific research in California, foundations, nonprofits, and corporations alone cannot make up the gap when cuts are made by the federal government. Unless the people of California rise up, much of this critical work may come to a halt. Federal cuts to scientific research pose a threat to the well-being of the people of California and will impair Californias ability to operate as a global leader in technology, innovation, and research across fields of study.
(f)The people of California propose this ballot measure to create the California Foundation for Science and Health Research (Foundation) to award grants and make loans to public and private universities, research companies, institutes, and health care organizations in California for scientific and health care research and development.
(g)Through the Foundation, funding would be distributed to UC, CSU, other California universities, and public and private entities engaged in critical science and health research. It would provide funding for staff, equipment, and facilities needed to carry out scientific research in fields including, but not limited to, public health, mental health, heart disease, cancer treatment, diabetes, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. Priority would be given to established research projects where the federal government has canceled funding. The measure would require annual audits.
(h)This measure will help preserve Californias position as a global leader in scientific innovation. This measure would allow important research to continue regardless of what happens at the federal level. This measure will ensure that California is not left behind.
(i)This measure will help sustain and grow the workforce of the state, with runoff economic benefits that will ensure a thriving future for Californians. This measure will support thousands of students and researchers at California universities in good-paying union jobs in growing industries. Supporting good-paying jobs in science, technology, engineering, and mathematics will help keep California economically competitive and generate billions of dollars each year in economic growth.
(j)There is some science that only public institutions will take on, for example cancer drug trials that combine drugs from different pharmaceutical companies, or as yet, unproven technologies in renewable energy. This measure would continue funding scientific research that looks beyond the profit motive for the greater good.
(k)Californias university and college system is a model for universities everywhere, involving students closely in practical, life-saving research. Cuts to federal funding threaten our students ability to learn the research skills they need to succeed. This measure will preserve Californias university and college system as a pathway to the middle class for California students.
(l)Too many Californians are driven into homelessness by drug abuse and mental health issues. This measure will help address this problem by continuing to fund critical research on promising mental health and addiction treatments.
(m)This measure contains strict fiscal accountability and transparency standards, including annual independent audits and public disclosure of all funding to ensure that Legislative allocations and bond funding is spent effectively, efficiently, and as promised.
SEC. 2.Chapter 12 (commencing with Section 11899) is added to Part 1 of Division 3 of Title 2 of the Government Code, to read:12.California Science and Health Research Bond Act1.California Foundation for Science and Health Research11899.As used in this chapter, the following terms have the following meaning:
(a)Act means the California Science and Health Research Bond Act constituting this chapter.
(b)Benefit fund means the California Foundation for Science and Health Research Benefit Fund created pursuant to paragraph (2) of subdivision (a) of Section 11899.2.
(c)Committee means the California Foundation for Science and Health Research Finance Committee created pursuant to subdivision (a) of Section 11899.15.
(d)Council means the California Foundation for Science and Health Research Council created pursuant to Section 11899.3.
(e)Foundation means the California Foundation for Science and Health Research established pursuant to Section 11899.1.
(f)Fund means the California Foundation for Science and Health Research Fund created pursuant to paragraph (1) of subdivision (a) of Section 11899.2.
11899.1.(a)The California Foundation for Science and Health Research is established within the Government Operations Agency.
(b)The foundations role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development, including, but not limited to, any of the following fields:
(1)Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, HIV/AIDS, and genetic and chronic diseases that affect children and infants.
(2)Public health, including, but not limited to, detecting and responding to new and emerging health threats.
(3)Disease prevention, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(4)Promoting healthy and safe behaviors, communities, and environment.
(5)Wildfire prevention.
(6)Behavioral health, including, but not limited to, addiction and substance use disorders.
(7)Climate, including climate change and its impact on human health.
(8)Weather.
(9)Ocean.
(10)Coastal and marine ecosystems and resources.
(11)Agriculture and water.
(12)Emerging technologies.
(13)Safety, efficacy, and security of drugs, biological products, medical devices, our nations food supply, and cosmetics.
(c)(1)The Secretary of Government Operations shall oversee the process of appointing the director of the foundation and shall set the level of salaries, bonuses, and benefits for the director. The task of hiring and determining the salaries, bonuses, and benefits of additional personnel may be delegated by the secretary to the director, subject to approval and oversight by the secretary.
(2)The director and personnel of the foundation shall be responsible for implementing the strategic objectives of the council, administering the grants and loans awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
11899.2.(a)(1)The California Foundation for Science and Health Research Fund is hereby created in the State Treasury. The proceeds of bonds issued and sold pursuant to this chapter shall be deposited in the fund pursuant to Section 11899.10.
(2)(A)The California Foundation for Science and Health Research Benefit Fund is hereby created in the State Treasury.
(B)The benefit fund shall consist solely of private donations.
(C)All moneys in the benefit fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter. Moneys in the benefit fund shall be made available for the same purposes as the moneys in the California Foundation for Science and Health Research Fund.
(b)The proceeds of interim debt and bonds issued and sold pursuant to this chapter shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund.
(c)Moneys in the fund shall be used by the foundation to award public and private grants to, and make loans to, public or private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, research in any of the fields described in subdivision (b) of Section 11899.1.
(d)(1)All research and development funded by the fund shall be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5), if applicable.
(2)All grants or loans provided under this section shall be awarded or made available to researchers or projects located within this state, except that funding for research collaboratives between California and out-of-state researchers shall be permitted.
(3)All grants or loans provided under this section shall be awarded based on both of the following:
(A)Consistency with the research priorities established for the foundation by the California Foundation for Science and Health Research Council as described in subdivision (a) of Section 11899.3.
(B)The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as described in Section 11899.4.
(4)The foundation shall prioritize funding research that replaces funding cuts by the federal government.
(5)To be eligible for funding, all research projects submitted for potential funding shall be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5) and the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20 of the Health and Safety Code).
(e)(1)It is the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount.
(2)It is the intent of the Legislature that under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at a discount to Californians and for profit to other states.
(3)(A)It is the intent of the Legislature that the foundation draw upon the greatest successes in American history in order to be equipped to solve the most pressing problems facing California and the nation.
(B)In furtherance of subparagraph (A), it is the intent of the Legislature that the foundation accomplish all of the following:
(i)Learn from the most ambitious research models of the past century, including the DARPA/ARPA model and Operation Warp Speed.
(ii)Support a greater diversity of ideas by allocating funding for projects that are riskier than those typically funded by federal agencies and by ensuring that early career scientists, including scientists under 40 and scientists fewer than 10 years since completing their PhDs, are supported by the foundation.
(iii)Create award approval systems that are efficient and not overly reliant on paperwork, freeing up scientists to spend more time doing critical work.
(f)Not more than 3 percent of the moneys in the fund shall be used for administrative costs. Administrative costs include, but are not limited to, all of the following:
(1)Salaries, bonuses, and benefits paid or incurred with respect to the hiring or retention of a director of the foundation and other officers and administrative staff that shall work on behalf of the foundation under the supervision of the director.
(2)Legal and accounting fees and expenses.
(3)All costs associated with the establishment and operation of the foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the foundation.
(g)All intellectual property assets developed using funds authorized for, or made available to, the foundation shall be treated pursuant to state and federal law.
(h)The foundation shall recommend to the council, and the council shall adopt, standards to ensure that if the grantee or loan recipient purchases goods or services using funds authorized for, or made available to, the foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50 percent of purchases from California suppliers.
11899.3.(a)There is hereby established the California Foundation for Science and Health Research Council that shall do all of the following:
(1)Develop the strategic objectives and research priorities of the foundation.
(2)Actively participate in the overall management of the foundation.
(3)Determine which research projects will be funded by the fund based on the research priorities established for the foundation pursuant to paragraph (1) and the technical merits of the proposals, as determined by scientific peer review panels created pursuant to subdivision (e).
(b)(1)The council shall consist of 11 to 13 members.
(A)Seven members shall be appointed by the Secretary of Government Operations.
(i)Five members shall be scientists or hold backgrounds in science or research, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the fields described in subdivision (b) of Section 11899.1.
(ii)One member shall hold a background in economics.
(iii)One member shall be a patient advocate.
(B)One member shall be a health care provider appointed by the Senate Rules Committee.
(C)One member shall be an advocate in climate or environmental fields appointed by the Speaker of the Assembly.
(D)One member shall be the chief executive officer of the California Council on Science and Technology, or their designee.
(E)One member shall be a designee of the President of the University of California, if the president chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(F)One member shall be a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(G)One member shall be the President of the Association of Independent California Colleges and Universities, or the presidents designee, who shall be a scientist or hold a background in science or research.
(2)(A)Individuals and organizations may submit nominations for membership to the Secretary of Government Operations.
(B)The Secretary of Government Operations may solicit nominations from relevant organizations and individuals.
(3)Any appointees to the council shall not be subject to confirmation by the Senate.
(c)(1)The members of the council shall serve four-year terms. A member shall serve a maximum of two terms.
(2)If the graduate-level researcher or postdoctoral scholar appointed pursuant to subparagraph (A) of paragraph (1) of subdivision (b) earns their degree or completes their placement before the conclusion of their four-year term, the graduate-level researcher or postdoctoral scholar may serve out the remainder of the academic year on the council. At the conclusion of the academic year, the Secretary of Government Operations shall appoint a current graduate-level researcher or postdoctoral scholar who may serve a four-year term or until they earn their degree or complete their placement.
(3)If a vacancy occurs within a term, the Secretary of Government Operations shall appoint a replacement member within 45 days to serve the remainder of the term.
(4)When a term expires, the Secretary of Government Operations shall appoint a member within 30 days. A member shall serve until their replacement is appointed.
(5)A grant or a loan shall not be approved if there are more than six vacancies on the council.
(d)A majority of the membership of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the board. If a vacancy or recusal in the council occurs, then a majority of the remaining members of the council constitutes a quorum.
(e)Council members shall serve without compensation, but may receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
(f)(1)Unless prohibited by another law, including the Political Reform Act of 1974, a member may participate in a decision to approve or award a grant or loan to a person or entity for the purpose of research involving either a disease from which the member or their immediate family member suffers or a disease in which the member has an interest as a representative of a disease advocacy organization.
(2)Notwithstanding any other law:
(A)Service or employment as a trainee or member of the faculty or administration of the University of California, California State University, or the Association of Independent California Colleges and Universities, or as a member of the California Council on Science and Technology, is not, by itself, inconsistent, incompatible, in conflict with, or inimical to the duties of the council member and shall not result in the automatic forfeiture of either office or position.
(B)Service or employment as a representative or employee of a disease advocacy organization, a nonprofit academic and research institution, or a life science commercial entity is not inconsistent, incompatible, in conflict with, or inimical to the duties of the council member.
(3)For purposes of Section 1090, the council may approve or award a grant or loan in which a member of the council is financially interested as long as the interested member recuses themself from making, participating in making, or attempting to use their official position to influence a decision on the grant or loan. If this condition is satisfied, this transaction shall be deemed not to create a violation of Section 1090.
(4)For purposes of this subdivision, decision does not include the adoption of standards.
11899.4.(a)The council may establish one or more scientific peer review panels consisting of experts in the fields described in subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
(b)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to subdivision (a).
11899.5.(a)The foundation shall issue an annual report that sets forth the foundations activities, grants awarded, loans made available, grants and loans in progress, research accomplishments, and future program directions. The annual report shall be published on the foundations internet website.
(b)Each annual report shall include, but not be limited to, all of the following:
(1)The number and dollar amounts of research and facilities grants and loans.
(2)The grantees and loan recipients for the prior year.
(3)The foundations administrative expenses.
(4)An assessment of the availability of funding for research from sources other than the foundation.
(5)A summary of research findings, including promising new research areas.
(6)An assessment of the relationship between the foundations grants and loans and the overall strategy of its research program.
(7)A report of the foundations strategic research and financial plans.
11899.6.The foundation shall annually commission an independent financial audit of its activities from a certified public accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public report of that review. The Controller shall hold a public meeting with appropriate notice and a formal public comment period. The Controller shall evaluate public comments and shall include appropriate summaries in the annual report.
11899.7.(a)The Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) shall apply to all meetings of the council and a scientific peer review panel created pursuant to Section 11899.4, except as otherwise provided in this section. The council shall disclose all awarded grants in public meetings, shall award all grants, loans, and contracts in public meetings. The council and a scientific peer review panel created pursuant to Section 11899.4 shall adopt all governance, scientific, medical, and regulatory standards in public meetings.
(b)The council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) under Section 11126. In addition, the council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions when it meets to consider or discuss any of the following:
(1)Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
(2)Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it.
(3)Matters involving scientific data, analyses, or other research products not yet formally published in academic literature.
(4)Matters concerning the appointment, employment, performance, compensation, or dismissal of foundation officers and employees. Action on compensation of the foundations officers and employees shall only be taken in open session.
(5)Matters believed to pose a security risk to the people of California.
2.California Foundation for Science and Health Research Bonds11899.10.The proceeds of bonds, excluding those issued in accordance with Section 11899.21, issued and sold pursuant to this chapter shall be deposited into the California Foundation for Science and Health Research Fund. All moneys in the fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter.
11899.11.(a)Moneys in the fund shall be available for both of the following:
(1)Grants and loans to fund research and operate and maintain facilities for research as provided in this chapter.
(2)Paying general administrative costs of the foundation, not to exceed 3 percent of the amount in the fund.
(b)Repayment of principal and interest on any loans made by the foundation pursuant to this chapter shall be deposited into the fund and used to make additional grants and loans for the purposes of this act or for paying continuing costs of the annual administration of outstanding bonds.
11899.12.The proceeds of interim debt and bonds issued and sold pursuant to this article shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund.
11899.13.(a)Bonds in the total amount of twelve five billion dollars ($12,000,000,000), ($5,000,000,000), not including the amount of any refunding bonds issued in accordance with Section 11899.21, may be issued and sold for the purposes expressed in this chapter and to reimburse the General Obligation Bond Expense Revolving Fund pursuant to Section 16724.5. The bonds, when sold, issued, and delivered, shall be and constitute a valid and binding obligation of the State of California, and the full faith and credit of the State of California is hereby pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
(b)The Treasurer shall issue and sell the bonds authorized in subdivision (a) in the amount determined by the committee to be necessary or desirable pursuant to Section 11899.16. The bonds shall be issued and sold upon the terms and conditions specified in a resolution to be adopted by the committee pursuant to Section 16731.
11899.14.(a)The bonds authorized by this chapter shall be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4), as amended from time to time, and all of the provisions of that law apply to the bonds and to this chapter and are hereby incorporated in this chapter as though set forth in full in this chapter, except that subdivisions (a) and (b) of Section 16727 shall not apply to restrict the use of bond proceeds to finance the operation and maintenance of facilities as provided in Section 11899.11.
(b)For purposes of this chapter, the references to committee in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research Finance Committee created in Section 11899.15, and the references to board in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research, established by Section 11899.1.
11899.15.(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this chapter, the California Foundation for Science and Health Research Finance Committee is hereby created.
(b)(1)The committee consists of all of the following:
(A)The Treasurer.
(B)The Controller.
(C)The Director of Finance.
(D)The Director of the California Foundation for Science and Health Research.
(E)Two members of the California Foundation for Science and Health Research Council, chosen by the Secretary of Government Operations, or their designated representatives.
(2)The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.
(3)Notwithstanding any other law, any member may designate a representative to act as that member in the members place for all purposes, as though the member were personally present.
(c)The committee shall act independently of the foundation and council, but may request recommendations and relevant information so as to understand the financial needs of the foundation to accomplish the strategic objectives and research priorities established pursuant to Section 11899.3.
11899.16.The committee, by resolution, shall determine whether or not it is necessary or desirable to issue and sell bonds authorized pursuant to this chapter in order to carry out the actions specified in this chapter and, if so, the amount of bonds to be issued and sold. Successive issues of bonds may be authorized and sold to carry out those actions progressively, and it is not necessary that all of the bonds authorized to be issued be sold at any one time.
11899.17.There shall be collected each year and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state, a sum in an amount required to pay the principal of, and interest on, the bonds becoming due each year. It is the duty of all officers charged by law with any duty in regard to the collection of the revenue to do and perform each and every act that is necessary to collect that additional sum.
11899.18.Notwithstanding Section 13340, there is hereby continuously appropriated from the General Fund in the State Treasury, for the purposes of this chapter and without regard to fiscal years, an amount that equals the total of the sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this chapter, as the principal and interest become due and payable.
11899.19.For the purpose of carrying out this chapter, the Director of Finance may authorize the withdrawal from the General Fund of an amount, not to exceed the amount of the unsold bonds that have been authorized by the committee, to be sold for the purpose of carrying out this chapter, excluding any refunding bonds authorized pursuant to Section 11899.21 and any amount withdrawn from the General Fund pursuant to this section and not yet returned to the General Fund. Any amount withdrawn shall be deposited into the fund. Any moneys made available under this section shall be returned to the General Fund, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds for the purpose of carrying out this chapter.
11899.20.All moneys deposited into the fund that are derived from premium and accrued interest on bonds sold pursuant to this chapter shall be reserved in the fund and shall be available for transfer to the General Fund as a credit to expenditures for bond interest, except those amounts derived from premium may be reserved and used to pay the cost of bond issuance before any transfer to the General Fund.
11899.21.The bonds issued and sold pursuant to this chapter may be refunded in accordance with Article 6 (commencing with Section 16780) of Chapter 4 of Part 3 of Division 4, which is a part of the State General Obligation Bond Law. Approval by the voters of the state for the issuance of the bonds described in this chapter includes the approval of the issuance of any bonds issued to refund any bonds originally issued under this chapter or any previously issued refunding bonds. Any bond refunded with the proceeds of refunding bonds as authorized by this section may be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
11899.22.Notwithstanding any other provision of this chapter or the State General Obligation Bond Law, if the Treasurer sells bonds pursuant to this chapter that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, the Treasurer may maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. The Treasurer may use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
11899.23.The proceeds from the sale of bonds authorized by this chapter are not proceeds of taxes as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed by that article.
SEC. 3.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 4.Section 2 of this act shall take effect upon the approval by the voters of the California Science and Health Research Bond Act, as set forth in Section 2 of this act.
SEC. 5.Section 2 of this act shall be submitted to the voters at the next statewide election in accordance with provisions of the Government Code and the Elections Code governing the submission of a statewide measure to the voters.
SEC. 6.This act shall be broadly construed to accomplish its purposes. The statutory provisions of the act may be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
SEC. 7.(a)This act shall be liberally construed to effectuate its purposes.
(b)If this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure shall be self-executing and given full force and effect.
SEC. 8.The Legislature finds and declares that Section 2 of this act, which adds Section 11899.7 to the Government Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the publics access to this information.
The People of the State of California find and declare the following:
(a)Since World War II, the United States has been a global leader in scientific and health research and innovation. Through the financial support of governmental agencies including, but not limited to, the National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Food and Drug Administration (FDA), the federal Centers for Disease Control and Prevention (CDC), and the National Oceanic and Atmospheric Administration (NOAA), the scientific and health communities have been able to create life-enhancing scientific, biomedical, and public health discoveries.
(b)Americans have benefited enormously from that research with improved health, cures for diseases, vaccines, and improved air quality and environment. The United States economy has benefited greatly from that research as well.
(c)California produces an astonishing share of the top scientific research on the planet. It is estimated that $3 of every $10 in federal research investments are drawn to California. The state accounts for about 47 percent of United States biotechnology research and development spending and generates about 53 percent of the nations biotechnology revenues. Nearly one-half of all venture capital in the United States is invested in California. That success is driven in large part by the states world-class universities and research institutions. The University of California is the top research institution in the world for United States patent generation. Every dollar invested in science funding generates more than $2 in economic activity.
(d)Federal research funding has been integral in supporting the work of public and private research institutions in California. For example, federal funding supports a significant part of the University of Californias (UC) and California State Universitys (CSU) research operations. Federal grants pay for faculty research and the salaries of graduate and postdoctoral student researchers. Federal research grants totaled more than $5,000,000,000 to the University of California in the 202324 fiscal year. Public and private university research has led to the founding of thousands of startups, driving economic expansion and technological innovation. Federal funding reductions limit research opportunities and may impede Californias competitiveness and economic progress.
(e)Because the federal government has been one of the largest funders of scientific research in California, foundations, nonprofits, and corporations alone cannot make up the gap when cuts are made by the federal government. Unless the people of California rise up, much of this critical work may come to a halt. Federal cuts to scientific research pose a threat to the well-being of the people of California and will impair Californias ability to operate as a global leader in technology, innovation, and research across fields of study.
(f)The people of California propose this ballot measure to create the California Foundation for Science and Health Research (Foundation) to award grants and make loans to public and private universities, research companies, institutes, and health care organizations in California for scientific and health care research and development.
(g)Through the Foundation, funding would be distributed to UC, CSU, other California universities, and public and private entities engaged in critical science and health research. It would provide funding for staff, equipment, and facilities needed to carry out scientific research in fields including, but not limited to, public health, mental health, heart disease, cancer treatment, diabetes, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. Priority would be given to established research projects where the federal government has canceled funding. The measure would require annual audits.
(h)This measure will help preserve Californias position as a global leader in scientific innovation. This measure would allow important research to continue regardless of what happens at the federal level. This measure will ensure that California is not left behind.
(i)This measure will help sustain and grow the workforce of the state, with runoff economic benefits that will ensure a thriving future for Californians. This measure will support thousands of students and researchers at California universities in good-paying union jobs in growing industries. Supporting good-paying jobs in science, technology, engineering, and mathematics will help keep California economically competitive and generate billions of dollars each year in economic growth.
(j)There is some science that only public institutions will take on, for example cancer drug trials that combine drugs from different pharmaceutical companies, or as yet, unproven technologies in renewable energy. This measure would continue funding scientific research that looks beyond the profit motive for the greater good.
(k)Californias university and college system is a model for universities everywhere, involving students closely in practical, life-saving research. Cuts to federal funding threaten our students ability to learn the research skills they need to succeed. This measure will preserve Californias university and college system as a pathway to the middle class for California students.
(l)Too many Californians are driven into homelessness by drug abuse and mental health issues. This measure will help address this problem by continuing to fund critical research on promising mental health and addiction treatments.
(m)This measure contains strict fiscal accountability and transparency standards, including annual independent audits and public disclosure of all funding to ensure that Legislative allocations and bond funding is spent effectively, efficiently, and as promised.
SEC. 2.Chapter 12 (commencing with Section 11899) is added to Part 1 of Division 3 of Title 2 of the Government Code, to read:12.California Science and Health Research Bond Act1.California Foundation for Science and Health Research11899.As used in this chapter, the following terms have the following meaning:
(a)Act means the California Science and Health Research Bond Act constituting this chapter.
(b)Benefit fund means the California Foundation for Science and Health Research Benefit Fund created pursuant to paragraph (2) of subdivision (a) of Section 11899.2.
(b)(c)Committee means the California Foundation for Science and Health Research Finance Committee created pursuant to subdivision (a) of Section 11899.16. 11899.15.
(c)(d)Council means the California Foundation for Science and Health Research Council created pursuant to Section 11899.3.
(d)(e)Foundation means the California Foundation for Science and Health Research established pursuant to Section 11899.1.
(e)(f)Fund means the California Foundation for Science and Health Research Fund created pursuant to paragraph (1) of subdivision (a) of Section 11899.2.
(f)Interim debt means any interim loans pursuant to Sections 11899.20 and 11899.21, bond anticipation notes or commercial paper notes issued to make deposits into the fund, and which will be paid from the proceeds of bonds issued pursuant to Article 2 (commencing with Section 11899.10).11899.1.(a)The California Foundation for Science and Health Research is established within the Government Operations Agency.
(b)The foundations role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development, including, but not limited to, any of the following fields:
(1)Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. HIV/AIDS, and genetic and chronic diseases that affect children and infants.
(2)Detecting Public health, including, but not limited to, detecting and responding to new and emerging health threats.
(3)Disease prevention, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(4)Promoting healthy and safe behaviors, communities, and environment.
(5)Wildfire prevention.
(6)Behavioral health, including, but not limited to, addiction and substance use disorders.
(7)Climate, including climate change and its impact on human health.
(8)Weather.
(9)Ocean.
(10)Coastal and marine ecosystems and resources.
(11)Agriculture and water.
(12)Emerging technologies.
(13)Safety, efficacy, and security of drugs, biological products, medical devices, our nations food supply, and cosmetics.
(c)(1)The Secretary of Government Operations shall oversee the process of appointing the director of the foundation and shall set the level of salaries, bonuses, and benefits for the director. The task of hiring and determining the salaries, bonuses, and benefits of additional personnel may be delegated by the secretary to the director, subject to approval and oversight by the secretary.
(2)The director and personnel of the foundation shall be responsible for implementing the strategic objectives of the council, administering the grants and loans awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
11899.2.(a)(1)Upon appropriation by the Legislature, funds shall be deposited into the California Foundation for Science and Health Research Fund, which is hereby created in the State Treasury.(2)The California Foundation for Science and Health Research Fund may be funded by both private and public funds, including private donations.11899.2.(a)(1)The California Foundation for Science and Health Research Fund is hereby created in the State Treasury. The proceeds of bonds issued and sold pursuant to this chapter shall be deposited in the fund pursuant to Section 11899.10.
(2)(A)The California Foundation for Science and Health Research Benefit Fund is hereby created in the State Treasury.
(B)The benefit fund shall consist solely of private donations.
(C)All moneys in the benefit fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter. Moneys in the benefit fund shall be made available for the same purposes as the moneys in the California Foundation for Science and Health Research Fund.
(b)The proceeds of interim debt and bonds issued and sold pursuant to Article 2 (commencing with Section 11899.10) this chapter shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund, except as stated in Section 11899.13. Fund.
(c)Moneys in the fund shall be used by the foundation to award public and private grants to, and make loans to, public or private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, research in any of the fields described in subdivision (b) of Section 11899.1.
(d)(1)All research and development funded by the fund shall be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5), if applicable.
(2)All grants or loans provided under this section shall be awarded or made available to researchers or projects located within this state, except that funding for research collaboratives between California and out-of-state researchers shall be permitted.
(3)All grants or loans provided under this section shall be awarded based on both of the following:
(A)Consistency with the research priorities established for the foundation by the California Foundation for Science and Health Research Council as described in subdivision (a) of Section 11899.3.
(B)The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as described in Section 11899.4.
(4)The foundation shall prioritize funding research that replaces funding cuts by the federal government.
(5)To be eligible for funding, all research projects submitted for potential funding shall be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5) and the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20 of the Health and Safety Code).
(e)(1)It is the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount.
(2)It is the intent of the Legislature that under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at a discount to Californians and for profit to other states.
(3)(A)It is the intent of the Legislature that the foundation draw upon the greatest successes in American history in order to be equipped to solve the most pressing problems facing California and the nation.
(B)In furtherance of subparagraph (A), it is the intent of the Legislature that the foundation accomplish all of the following:
(i)Learn from the most ambitious research models of the past century, including the DARPA/ARPA model and Operation Warp Speed.
(ii)Support a greater diversity of ideas by allocating funding for projects that are riskier than those typically funded by federal agencies and by ensuring that early career scientists, including scientists under 40 and scientists fewer than 10 years since completing their PhDs, are supported by the foundation.
(iii)Create award approval systems that are efficient and not overly reliant on paperwork, freeing up scientists to spend more time doing critical work.
(f)Not more than three 3 percent of the moneys in the fund shall be used for administrative costs. Administrative costs include, but are not limited to, all of the following:
(1)Salaries, bonuses, and benefits paid or incurred with respect to the hiring or retention of a director of the foundation and other officers and administrative staff that shall work on behalf of the foundation under the supervision of the director.
(2)Legal and accounting fees and expenses.
(3)All costs associated with the establishment and operation of the foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the foundation.
(g)All intellectual property assets developed using funds authorized for, or made available to, the foundation shall be treated pursuant to state and federal law.
(h)The foundation shall recommend to the council, and the council shall adopt, standards to ensure that if the grantee or loan recipient purchases goods or services using funds authorized for, or made available to, the foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50 percent of purchases from California suppliers.
11899.3.(a)There is hereby established the California Foundation for Science and Health Research Council that shall do all of the following:
(1)Develop the strategic objectives and research priorities of the foundation.
(2)Actively participate in the overall management of the foundation.
(3)Determine which research projects will be funded by the fund based on the research priorities established for the foundation pursuant to paragraph (1) and the technical merits of the proposals, as determined by scientific peer review panels created pursuant to subdivision (e).
(b)(1)The council shall consist of 11 to 13 members.
(A)Seven members shall be appointed by the Secretary of Government Operations.
(i)Five members shall be scientists or hold backgrounds in science or research, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the fields described in subdivision (b) of Section 11899.1.
(ii)One member shall hold a background in economics.
(iii)One member shall be a patient advocate.
(B)One member shall be a health care provider appointed by the Senate Rules Committee.
(C)One member shall be an advocate in climate or environmental fields appointed by the Speaker of the Assembly.
(D)One member shall be the chief executive officer of the California Council on Science and Technology, or their designee.
(E)One member shall be a designee of the President of the University of California, if the president chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(F)One member shall be a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(G)One member shall be the President of the Association of Independent California Colleges and Universities, or the presidents designee, who shall be a scientist or hold a background in science or research.
(2)(A)Individuals and organizations may submit nominations for membership to the Secretary of Government Operations.
(B)The Secretary of Government Operations may solicit nominations from relevant organizations and individuals.
(3)Any appointees to the council shall not be subject to confirmation by the Senate.
(c)(1)The members of the council shall serve four-year terms. A member shall serve a maximum of two terms.
(2)If the graduate-level researcher or postdoctoral scholar appointed pursuant to subparagraph (A) of paragraph (1) of subdivision (b) earns their degree or completes their placement before the conclusion of their four-year term, the graduate-level researcher or postdoctoral scholar may serve out the remainder of the academic year on the council. At the conclusion of the academic year, the Secretary of Government Operations shall appoint a current graduate-level researcher or postdoctoral scholar who may serve a four-year term or until they earn their degree or complete their placement.
(3)If a vacancy occurs within a term, the Secretary of Government Operations shall appoint a replacement member within 45 days to serve the remainder of the term.
(4)When a term expires, the Secretary of Government Operations shall appoint a member within 30 days. A member shall serve until their replacement is appointed.
(5)A grant or a loan shall not be approved if there are more than six vacancies on the council.
(d)A majority of the membership of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the board. If a vacancy or recusal in the council occurs, then a majority of the remaining members of the council constitutes a quorum.
(e)Council members shall serve without compensation, but may receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
(f)(1)Unless prohibited by another law, including the Political Reform Act of 1974, a member may participate in a decision to approve or award a grant or loan to a person or entity for the purpose of research involving either a disease from which the member or their immediate family member suffers or a disease in which the member has an interest as a representative of a disease advocacy organization.
(2)Notwithstanding any other law:
(A)Service or employment as a trainee or member of the faculty or administration of the University of California, California State University, or the Association of Independent California Colleges and Universities, or as a member of the California Council on Science and Technology, is not, by itself, inconsistent, incompatible, in conflict with, or inimical to the duties of the council member and shall not result in the automatic forfeiture of either office or position.
(B)Service or employment as a representative or employee of a disease advocacy organization, a nonprofit academic and research institution, or a life science commercial entity is not inconsistent, incompatible, in conflict with, or inimical to the duties of the council member.
(3)For purposes of Section 1090, the council may approve or award a grant or loan in which a member of the council is financially interested as long as the interested member recuses themself from making, participating in making, or attempting to use their official position to influence a decision on the grant or loan. If this condition is satisfied, this transaction shall be deemed not to create a violation of Section 1090.
(4)For purposes of this subdivision, decision does not include the adoption of standards.
11899.4.(a)The council may establish one or more scientific peer review panels consisting of experts in the fields described in subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
(b)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to subdivision (a).
11899.5.(a)The foundation shall issue an annual report that sets forth the foundations activities, grants awarded, loans made available, grants and loans in progress, research accomplishments, and future program directions. The annual report shall be published on the foundations internet website.
(b)Each annual report shall include, but not be limited to, all of the following:
(1)The number and dollar amounts of research and facilities grants and loans.
(2)The grantees and loan recipients for the prior year.
(3)The foundations administrative expenses.
(4)An assessment of the availability of funding for research from sources other than the foundation.
(5)A summary of research findings, including promising new research areas.
(6)An assessment of the relationship between the foundations grants and loans and the overall strategy of its research program.
(7)A report of the foundations strategic research and financial plans.
11899.6.The foundation shall annually commission an independent financial audit of its activities from a certified public accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public report of that review. The Controller shall hold a public meeting with appropriate notice and a formal public comment period. The Controller shall evaluate public comments and shall include appropriate summaries in the annual report.
11899.7.(a)The Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) shall apply to all meetings of the council and a scientific peer review panel created pursuant to Section 11899.4, except as otherwise provided in this section. The council shall disclose all awarded grants in public meetings, shall award all grants, loans, and contracts in public meetings. The council and a scientific peer review panel created pursuant to Section 11899.4 shall adopt all governance, scientific, medical, and regulatory standards in public meetings.
(b)The council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) under Section 11126. In addition, the council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions when it meets to consider or discuss any of the following:
(1)Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
(2)Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it.
(3)Matters involving scientific data, analyses, or other research products not yet formally published in academic literature.
(4)Matters concerning the appointment, employment, performance, compensation, or dismissal of foundation officers and employees. Action on compensation of the foundations officers and employees shall only be taken in open session.
(5)Matters believed to pose a security risk to the people of California.
2.California Foundation for Science and Health Research Bonds11899.10.The proceeds of bonds, excluding those issued in accordance with Section 11899.23, 11899.21, issued and sold pursuant to this article chapter shall be deposited into the California Foundation for Science and Health Research Fund. All moneys in the fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter.
11899.11.The sum of ____ dollars ($____) shall be available for grants and loans to fund the construction and acquisition of facilities for research as provided in this chapter.11899.12.11899.11.(a)The sum of ____ dollars ($____) Moneys in the fund shall be available for all both of the following:
(1)Grants and loans to fund research and operate and maintain facilities for research as provided in this chapter.
(2)Paying general administrative costs of the foundation, not to exceed 3 percent of the amount in the fund.
(3)Paying the annual administration costs of the interim debt or bonds after December 31 of the fifth full calendar year after this article takes effect.(4)Paying the costs of issuing interim debt, paying the annual administration costs of the interim debt until and including December 31 of the fifth full calendar year after this article takes effect, and paying interest on interim debt, if that interim debt is incurred or issued on or before December 31 of the fifth full calendar year after this article takes effect.(5)Paying the costs of issuing bonds, paying the annual administration costs of the bonds until and including December 31 of the fifth full calendar year after this article takes effect, and paying interest on bonds that accrues on or before December 31 of the fifth full calendar year after this article takes effect, except that this limitation does not apply to premium and accrued interest as provided in Section 11899.22.(6)Moneys in the fund or other proceeds of the sale of bonds authorized by this article may be used to pay principal of or redemption premium on any interim debt issued before the issuance of bonds authorized by this article. Moneys deposited into the fund from the proceeds of interim debt may be used to pay general administrative costs of the foundation without regard to the 3-percent limit set forth in paragraph (2), so long as the 3-percent limit is satisfied for each issue of bonds.(b)Repayment of principal and interest on any loans made by the foundation pursuant to this article chapter shall be deposited into the fund and used to make additional grants and loans for the purposes of this act or for paying continuing costs of the annual administration of outstanding bonds.
(c)Costs allowable under this section include costs incidentally but directly related to construction or acquisition, including, but not limited to, planning, engineering, construction management, architectural, and other design work, environmental impact reports and assessments, required mitigation expenses, appraisals, legal expenses, site acquisitions, and necessary easements.11899.13.11899.12.The proceeds of interim debt and bonds issued and sold pursuant to this article shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt. Fund.
11899.14.11899.13.(a)Bonds in the total amount of twenty-three twelve billion dollars ($23,000,000,000), ($12,000,000,000), not including the amount of any refunding bonds issued in accordance with Section 11899.23, 11899.21, may be issued and sold for the purposes expressed in this article chapter and to reimburse the General Obligation Bond Expense Revolving Fund pursuant to Section 16724.5. The bonds, when sold, issued, and delivered, shall be and constitute a valid and binding obligation of the State of California, and the full faith and credit of the State of California is hereby pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
(b)The Treasurer shall issue and sell the bonds authorized in subdivision (a) in the amount determined by the committee to be necessary or desirable pursuant to Section 11899.15. 11899.16. The bonds shall be issued and sold upon the terms and conditions specified in a resolution to be adopted by the committee pursuant to Section 16731.
11899.15.11899.14.(a)The bonds authorized by this article chapter shall be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4), as amended from time to time, and all of the provisions of that law apply to the bonds and to this article chapter and are hereby incorporated in this article chapter as though set forth in full in this article, chapter, except that subdivisions (a) and (b) of Section 16727 shall not apply. apply to restrict the use of bond proceeds to finance the operation and maintenance of facilities as provided in Section 11899.11.
(b)For purposes of this article, chapter, the references to committee in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research Finance Committee created in Section 11899.16, 11899.15, and the references to board in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research. Research, established by Section 11899.1.
11899.16.11899.15.(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this article, chapter, the California Foundation for Science and Health Research Finance Committee is hereby created.
(b)(1)The committee consists of all of the following:
(A)The Treasurer.
(B)The Controller.
(C)The Director of Finance.
(D)The Director of the California Foundation for Science and Health Research.
(E)Two members of the California Foundation for Science and Health Research Council, chosen by the Secretary of Government Operations, or their designated representatives.
(2)The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.
(3)Notwithstanding any other law, any member may designate a representative to act as that member in the members place for all purposes, as though the member were personally present.
(c)The committee shall act independently of the foundation and council, but may request recommendations and relevant information so as to understand the financial needs of the foundation to accomplish the strategic objectives and research priorities established pursuant to Section 11899.3.
11899.17.(a)11899.16.The committee, by resolution, shall determine whether or not it is necessary or desirable to issue and sell bonds authorized pursuant to this article chapter in order to carry out the actions specified in this article chapter and, if so, the amount of bonds to be issued and sold. Successive issues of bonds may be authorized and sold to carry out those actions progressively, and it is not necessary that all of the bonds authorized to be issued be sold at any one time. The bonds may bear interest, which is includable in gross income for federal income tax purposes if the committee determines that the treatment is necessary in order to provide funds for the purposes of the act.
(b)An interest-only floating rate bond structure will be implemented for interim debt and bonds until at least December 31 of the fifth full calendar year after this article takes effect, with all interest to be paid from proceeds from the sale of interim debt or bonds, to minimize debt service payable from the General Fund during the initial period of basic research and development, if the committee determines, with the advice of the Treasurer, that this structure will result in the lowest achievable borrowing costs for the state during that five-year period considering the objective of avoiding any bond debt service payments, by the General Fund, during that period. Upon the initial determination, the committee may delegate, by resolution, to the Treasurer the authority in connection with issuance of bonds as it may determine, including, but not limited to, the authority to do both of the following:(1)Implement and continue the bond financing structure established by this article, including during any time following the initial five-year period.(2)Determine that an alternative financing plan would result in significant lower borrowing costs for the state consistent with the objectives related to the General Fund and to implement that alternative financing plan.11899.18.11899.17.There shall be collected each year and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state, a sum in an amount required to pay the principal of, and interest on, the bonds becoming due each year. It is the duty of all officers charged by law with any duty in regard to the collection of the revenue to do and perform each and every act that is necessary to collect that additional sum.
11899.19.11899.18.Notwithstanding Section 13340, there is hereby continuously appropriated from the General Fund in the State Treasury, for the purposes of this article chapter and without regard to fiscal years, an amount that equals the total of both of the following: the sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this chapter, as the principal and interest become due and payable.
(a)The sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this article, as the principal and interest become due and payable.(b)The sum necessary to carry out Section 11899.20.11899.20.The foundation may request the Pooled Money Investment Board to make a loan from the Pooled Money Investment Account, in accordance with Section 16312, for the purposes of carrying out this article less any amount withdrawn pursuant to Section 11899.21 and not yet returned to the General Fund. The amount of the request shall not exceed the amount of the unsold bonds that the committee, by resolution, has authorized to be sold for the purpose of carrying out this article, excluding any refunding bonds authorized pursuant to Section 11899.23, less any amount loaned pursuant to this section and not yet repaid and any amount withdrawn from the General Fund pursuant to Section 11899.21 and not yet returned to the General Fund. The foundation shall execute any documents required by the Pooled Money Investment Board to obtain and repay the loan. Any amounts loaned shall be deposited into the fund to be allocated by the foundation in accordance with this article.11899.21.11899.19.For the purposes purpose of carrying out this article, chapter, the Director of Finance may authorize the withdrawal from the General Fund of an amount, not to exceed the amount of the unsold bonds that have been authorized by the committee, to be sold for the purpose of carrying out this article, chapter, excluding any refunding bonds authorized pursuant to Section 11899.23, less any amount loaned pursuant to Section 11899.20 and not yet repaid, 11899.21 and any amount withdrawn from the General Fund pursuant to this section and not yet returned to the General Fund. Any amount withdrawn shall be deposited into the fund. Any moneys made available under this section shall be returned to the General Fund, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds for the purpose of carrying out this article. chapter.
11899.22.11899.20.All moneys deposited into the fund that are derived from premium and accrued interest on bonds sold pursuant to this article chapter shall be reserved in the fund and shall be available for transfer to the General Fund as a credit to expenditures for bond interest, except those amounts derived from premium may be reserved and used to pay the cost of bond issuance before any transfer to the General Fund.
11899.23.11899.21.The bonds issued and sold pursuant to this article chapter may be refunded in accordance with Article 6 (commencing with Section 16780) of Chapter 4 of Part 3 of Division 4, which is a part of the State General Obligation Bond Law. Approval by the voters of the state for the issuance of the bonds described in this article chapter includes the approval of the issuance of any bonds issued to refund any bonds originally issued under this article chapter or any previously issued refunding bonds. Any bond refunded with the proceeds of refunding bonds as authorized by this section may be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
11899.24.11899.22.Notwithstanding any other provision of this article chapter or the State General Obligation Bond Law, if the Treasurer sells bonds pursuant to this article chapter that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, the Treasurer may maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. The Treasurer may use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
11899.25.11899.23.The proceeds from the sale of bonds authorized by this article chapter are not proceeds of taxes as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed by that article.
SEC. 3.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 4.Section 2 of this act shall take effect upon the approval by the voters of the California Science and Health Research Bond Act, as set forth in Section 2 of this act.
SEC. 5.Section 2 of this act shall be submitted to the voters at the next statewide election in accordance with provisions of the Government Code and the Elections Code governing the submission of a statewide measure to the voters.
SEC. 6.This act shall be broadly construed to accomplish its purposes. The statutory provisions of the act may be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
SEC. 7.(a)This act shall be liberally construed to effectuate its purposes.
(b)If this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure shall be self-executing and given full force and effect.
SEC. 8.The Legislature finds and declares that Section 2 of this act, which adds Section 11899.7 to the Government Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the publics access to this information.
REVISIONS: HeadingLine 10.The People of the State of California find and declare the following:
(a)Since World War II, the United States has been a global leader in scientific and health research and innovation. Through the financial support of governmental agencies including, but not limited to, the National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Food and Drug Administration (FDA), the federal Centers for Disease Control and Prevention (CDC), and the National Oceanic and Atmospheric Administration (NOAA), the scientific and health communities have been able to create life-enhancing scientific, biomedical, and public health discoveries.
(b)Americans have benefited enormously from that research with improved health, cures for diseases, vaccines, and improved air quality and environment. The United States economy has benefited greatly from that research as well.
(c)California produces an astonishing share of the top scientific research on the planet. It is estimated that $3 of every $10 in federal research investments are drawn to California. The state accounts for about 47 percent of United States biotechnology research and development spending and generates about 53 percent of the nations biotechnology revenues. Nearly one-half of all venture capital in the United States is invested in California. That success is driven in large part by the states world-class universities and research institutions. The University of California is the top research institution in the world for United States patent generation. Every dollar invested in science funding generates more than $2 in economic activity.
(d)Federal research funding has been integral in supporting the work of public and private research institutions in California. For example, federal funding supports a significant part of the University of Californias (UC) and California State Universitys (CSU) research operations. Federal grants pay for faculty research and the salaries of graduate and postdoctoral student researchers. Federal research grants totaled more than $5,000,000,000 to the University of California in the 202324 fiscal year. Public and private university research has led to the founding of thousands of startups, driving economic expansion and technological innovation. Federal funding reductions limit research opportunities and may impede Californias competitiveness and economic progress.
(e)Because the federal government has been one of the largest funders of scientific research in California, foundations, nonprofits, and corporations alone cannot make up the gap when cuts are made by the federal government. Unless the people of California rise up, much of this critical work may come to a halt. Federal cuts to scientific research pose a threat to the well-being of the people of California and will impair Californias ability to operate as a global leader in technology, innovation, and research across fields of study.
(f)The people of California propose this ballot measure to create the California Foundation for Science and Health Research (Foundation) to award grants and make loans to public and private universities, research companies, institutes, and health care organizations in California for scientific and health care research and development.
(g)Through the Foundation, funding would be distributed to UC, CSU, other California universities, and public and private entities engaged in critical science and health research. It would provide funding for staff, equipment, and facilities needed to carry out scientific research in fields including, but not limited to, public health, mental health, heart disease, cancer treatment, diabetes, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. Priority would be given to established research projects where the federal government has canceled funding. The measure would require annual audits.
(h)This measure will help preserve Californias position as a global leader in scientific innovation. This measure would allow important research to continue regardless of what happens at the federal level. This measure will ensure that California is not left behind.
(i)This measure will help sustain and grow the workforce of the state, with runoff economic benefits that will ensure a thriving future for Californians. This measure will support thousands of students and researchers at California universities in good-paying union jobs in growing industries. Supporting good-paying jobs in science, technology, engineering, and mathematics will help keep California economically competitive and generate billions of dollars each year in economic growth.
(j)There is some science that only public institutions will take on, for example cancer drug trials that combine drugs from different pharmaceutical companies, or as yet, unproven technologies in renewable energy. This measure would continue funding scientific research that looks beyond the profit motive for the greater good.
(k)Californias university and college system is a model for universities everywhere, involving students closely in practical, life-saving research. Cuts to federal funding threaten our students ability to learn the research skills they need to succeed. This measure will preserve Californias university and college system as a pathway to the middle class for California students.
(l)Too many Californians are driven into homelessness by drug abuse and mental health issues. This measure will help address this problem by continuing to fund critical research on promising mental health and addiction treatments.
(m)This measure contains strict fiscal accountability and transparency standards, including annual independent audits and public disclosure of all funding to ensure that Legislative allocations and bond funding is spent effectively, efficiently, and as promised.
SEC. 2.Chapter 12 (commencing with Section 11899) is added to Part 1 of Division 3 of Title 2 of the Government Code, to read:12.California Science and Health Research Bond Act1.California Foundation for Science and Health Research11899.As used in this chapter, the following terms have the following meaning:
(a)Act means the California Science and Health Research Bond Act constituting this chapter.
(b)Committee means the California Foundation for Science and Health Research Finance Committee created pursuant to subdivision (a) of Section 11899.16.
(c)Council means the California Foundation for Science and Health Research Finance Council created pursuant to subdivision (a) of Section 11899.3.
(d)Foundation means the California Foundation for Science and Health Research established pursuant to subdivision (a) of Section 11899.1.
(e)Fund means the California Foundation for Science and Health Research Fund created pursuant to Section 11899.2.
(f)Interim debt means any interim loans pursuant to Sections 11899.20 and 11899.21, bond anticipation notes or commercial paper notes issued to make deposits into the fund, and which will be paid from the proceeds of bonds issued pursuant to Article 2 (commencing with Section 11899.10).
11899.1.(a)The California Foundation for Science and Health Research is established within the Government Operations Agency.
(b)The foundations role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development, including, but not limited to, any of the following fields:
(1)Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(2)Detecting and responding to new and emerging health threats.
(3)Disease prevention, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(4)Promoting healthy and safe behaviors, communities, and environment.
(5)Wildfire prevention.
(6)Behavioral health, including, but not limited to, addiction and substance use disorders.
(7)Climate, including climate change and its impact on human health.
(8)Weather.
(9)Ocean.
(10)Coastal and marine ecosystems and resources.
(11)Agriculture and water.
(12)Emerging technologies.
(13)Safety, efficacy, and security of drugs, biological products, medical devices, our nations food supply, and cosmetics.
(c)(1)The Secretary of Government Operations shall oversee the process of appointing the director of the foundation and shall set the level of salaries, bonuses, and benefits for the director. The task of hiring and determining the salaries, bonuses, and benefits of additional personnel may be delegated by the secretary to the director, subject to approval and oversight by the secretary.
(2)The director and personnel of the foundation shall be responsible for implementing the strategic objectives of the council, administering the grants and loans awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
11899.2.(a)(1)Upon appropriation by the Legislature, funds shall be deposited into the California Foundation for Science and Health Research Fund, which is hereby created in the State Treasury.
(2)The California Foundation for Science and Health Research Fund may be funded by both private and public funds, including private donations.
(b)The proceeds of interim debt and bonds issued and sold pursuant to Article 2 (commencing with Section 11899.10) shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund, except as stated in Section 11899.13.
(c)Moneys in the fund shall be used by the foundation to award public and private grants to, and make loans to, public or private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, research in any of the fields described in subdivision (b) of Section 11899.1.
(d)(1)All research and development funded by the fund shall be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5), if applicable.
(2)All grants or loans provided under this section shall be awarded or made available to researchers or projects located within this state, except that funding for research collaboratives between California and out-of-state researchers shall be permitted.
(3)All grants or loans provided under this section shall be awarded based on both of the following:
(A)Consistency with the research priorities established for the foundation by the California Foundation for Science and Health Research Council as described in subdivision (a) of Section 11899.3.
(B)The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as described in subdivision (e) of Section 11899.3. Section 11899.4.
(4)The foundation shall prioritize funding research that replaces funding cuts by the federal government.
(5)To be eligible for funding, all research projects submitted for potential funding shall be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5) and the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20 of the Health and Safety Code).
(e)(1)It is the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount.
(2)It is the intent of the Legislature that under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at a discount to Californians and for profit to other states.
(f)Not more than three percent of the moneys in the fund shall be used for administrative costs. Administrative costs include, but are not limited to, all of the following:
(1)Salaries, bonuses, and benefits paid or incurred with respect to the hiring or retention of a director of the foundation and other officers and administrative staff that shall work on behalf of the foundation under the supervision of the director.
(2)Legal and accounting fees and expenses.
(3)All costs associated with the establishment and operation of the foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the foundation.
(g)All intellectual property assets developed using funds authorized for, or made available to, the foundation shall be treated pursuant to state and federal law.
(h)The foundation shall recommend to the council, and the council shall adopt, standards to ensure that if the grantee or loan recipient purchases goods or services using funds authorized for, or made available to, the foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50 percent of purchases from California suppliers.
11899.3.(a)There is hereby established the California Foundation for Science and Health Research Council that shall do all of the following:
(1)Develop the strategic objectives and research priorities of the foundation.
(2)Actively participate in the overall management of the foundation.
(3)Determine which research projects will be funded by the fund based on the research priorities established for the foundation pursuant to paragraph (1) and the technical merits of the proposals, as determined by scientific peer review panels created pursuant to subdivision (e).
(4)Determine which state agency will oversee a research project funded by the fund, including, but not limited to:(A)Office of Emergency Services.(B)Natural Resources Agency.(C)California Health and Human Services Agency.(b)(1)The council shall consist of 11 to 13 members.
(A)Five Seven members shall be appointed by the Secretary of Government Operations and Operations.
(i)Five members shall be scientists or hold backgrounds in science or research, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the fields described in subdivision (b) of Section 11899.1.
(B)Three members shall be members of the public appointed by the Secretary of Government Operations.(ii)One member shall hold a background in economics.
(iii)One member shall be a patient advocate.
(C)(B)One member shall be a member of the public health care provider appointed by the Senate Rules Committee.
(D)(C)One member shall be a member of the public an advocate in climate or environmental fields appointed by the Speaker of the Assembly.
(D)One member shall be the chief executive officer of the California Council on Science and Technology, or their designee.
(E)One member shall be a designee of the President of the University of California, if the president chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(F)One member shall be a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative, who shall be a scientist or hold a background in science or research.
(G)One member shall be the President of the Association of Independent California Colleges and Universities, or the presidents designee, who shall be a scientist or hold a background in science or research.
(2)(A)Individuals and organizations may submit nominations for membership to the Secretary of Government Operations.
(B)The Secretary of Government Operations may solicit nominations from relevant organizations and individuals.
(3)Any appointees to the council shall not be subject to confirmation by the Senate.
(c)(1)The members of the council shall serve four-year terms. A member shall serve a maximum of two terms.
(2)If the graduate-level researcher or postdoctoral scholar appointed pursuant to subparagraph (A) of paragraph (1) of subdivision (b) earns their degree or completes their placement before the conclusion of their four-year term, the graduate-level researcher or postdoctoral scholar may serve out the remainder of the academic year on the council. At the conclusion of the academic year, the Secretary of Government Operations shall appoint a current graduate-level researcher or postdoctoral scholar who may serve a four-year term or until they earn their degree or complete their placement.
(3)If a vacancy occurs within a term, the Secretary of Government Operations shall appoint a replacement member within 45 days to serve the remainder of the term.
(4)When a term expires, the Secretary of Government Operations shall appoint a member within 30 days. A member shall serve until their replacement is appointed.
(5)A grant or a loan shall not be approved if there are more than three six vacancies on the council.
(d)A vote of a majority of the members of the council shall be required for the approval of funding of any research project or proposal presented for funding.(e)(1)The council may establish one or more scientific peer review panels consisting of experts in the fields described in subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.(2)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to paragraph (1).(d)A majority of the membership of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the board. If a vacancy or recusal in the council occurs, then a majority of the remaining members of the council constitutes a quorum.
(f)(e)Council members shall serve without compensation, but may receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
(f)(1)Unless prohibited by another law, including the Political Reform Act of 1974, a member may participate in a decision to approve or award a grant or loan to a person or entity for the purpose of research involving either a disease from which the member or their immediate family member suffers or a disease in which the member has an interest as a representative of a disease advocacy organization.
(2)Notwithstanding any other law:
(A)Service or employment as a trainee or member of the faculty or administration of the University of California, California State University, or the Association of Independent California Colleges and Universities, or as a member of the California Council on Science and Technology, is not, by itself, inconsistent, incompatible, in conflict with, or inimical to the duties of the council member and shall not result in the automatic forfeiture of either office or position.
(B)Service or employment as a representative or employee of a disease advocacy organization, a nonprofit academic and research institution, or a life science commercial entity is not inconsistent, incompatible, in conflict with, or inimical to the duties of the council member.
(3)For purposes of Section 1090, the council may approve or award a grant or loan in which a member of the council is financially interested as long as the interested member recuses themself from making, participating in making, or attempting to use their official position to influence a decision on the grant or loan. If this condition is satisfied, this transaction shall be deemed not to create a violation of Section 1090.
(4)For purposes of this subdivision, decision does not include the adoption of standards.
11899.4.(a)The council may establish one or more scientific peer review panels consisting of experts in the fields described in subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
(b)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to subdivision (a).
11899.4.11899.5.(a)The foundation shall issue an annual report that sets forth the foundations activities, grants awarded, loans made available, grants and loans in progress, research accomplishments, and future program directions. The annual report shall be published on the foundations internet website.
(b)Each annual report shall include, but not be limited to, all of the following:
(1)The number and dollar amounts of research and facilities grants and loans.
(2)The grantees and loan recipients for the prior year.
(3)The foundations administrative expenses.
(4)An assessment of the availability of funding for research from sources other than the foundation.
(5)A summary of research findings, including promising new research areas.
(6)An assessment of the relationship between the foundations grants and loans and the overall strategy of its research program.
(7)A report of the foundations strategic research and financial plans.
11899.5.11899.6.The foundation shall annually commission an independent financial audit of its activities from a certified public accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public report of that review. The Controller shall hold a public meeting with appropriate notice and a formal public comment period. The Controller shall evaluate public comments and shall include appropriate summaries in the annual report.
11899.6.11899.7.(a)The Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) shall apply to all meetings of the council, council and a scientific peer review panel created pursuant to Section 11899.4, except as otherwise provided in this section. The council shall disclose all awarded grants in public meetings, shall award all grants, loans, and contracts in public meetings, and meetings. The council and a scientific peer review panel created pursuant to Section 11899.4 shall adopt all governance, scientific, medical, and regulatory standards in public meetings.
(b)The council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) under Section 11126. In addition, the council and a scientific peer review panel created pursuant to Section 11899.4 may conduct closed sessions when it meets to consider or discuss any of the following:
(1)Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
(2)Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it.
(3)Matters involving scientific data, analyses, or other research products not yet formally published in academic literature.
(4)Matters concerning the appointment, employment, performance, compensation, or dismissal of foundation officers and employees. Action on compensation of the foundations officers and employees shall only be taken in open session.
(5)Matters believed to pose a security risk to the people of California.
2.California Foundation for Science and Health Research Bonds11899.10.The proceeds of bonds, excluding those issued in accordance with Section 11899.23, issued and sold pursuant to this article shall be deposited into the California Foundation for Science and Health Research Fund. All moneys in the fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter.
11899.11.The sum of ____ dollars ($____) shall be available for grants and loans to fund the construction and acquisition of facilities for research as provided in this chapter.
11899.12.(a)The sum of ____ dollars ($____) shall be available for all of the following:
(1)Grants and loans to fund research and operate and maintain facilities for research as provided in this chapter.
(2)Paying general administrative costs of the foundation, not to exceed 3 percent of the amount in the fund.
(3)Paying the annual administration costs of the interim debt or bonds after December 31 of the fifth full calendar year after this article takes effect.
(4)Paying the costs of issuing interim debt, paying the annual administration costs of the interim debt until and including December 31 of the fifth full calendar year after this article takes effect, and paying interest on interim debt, if that interim debt is incurred or issued on or before December 31 of the fifth full calendar year after this article takes effect.
(5)Paying the costs of issuing bonds, paying the annual administration costs of the bonds until and including December 31 of the fifth full calendar year after this article takes effect, and paying interest on bonds that accrues on or before December 31 of the fifth full calendar year after this article takes effect, except that this limitation does not apply to premium and accrued interest as provided in Section 11899.22.
(6)Moneys in the fund or other proceeds of the sale of bonds authorized by this article may be used to pay principal of or redemption premium on any interim debt issued before the issuance of bonds authorized by this article. Moneys deposited into the fund from the proceeds of interim debt may be used to pay general administrative costs of the foundation without regard to the 3-percent limit set forth in paragraph (2), so long as the 3-percent limit is satisfied for each issue of bonds.
(b)Repayment of principal and interest on any loans made by the foundation pursuant to this article shall be deposited into the fund and used to make additional grants and loans for the purposes of this act or for paying continuing costs of the annual administration of outstanding bonds.
(c)Costs allowable under this section include costs incidentally but directly related to construction or acquisition, including, but not limited to, planning, engineering, construction management, architectural, and other design work, environmental impact reports and assessments, required mitigation expenses, appraisals, legal expenses, site acquisitions, and necessary easements.
11899.13.The proceeds of interim debt and bonds issued and sold pursuant to this article shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
11899.14.(a)Bonds in the total amount of twenty-three billion dollars ($23,000,000,000), not including the amount of any refunding bonds issued in accordance with Section 11899.23, may be issued and sold for the purposes expressed in this article and to reimburse the General Obligation Bond Expense Revolving Fund pursuant to Section 16724.5. The bonds, when sold, issued, and delivered, shall be and constitute a valid and binding obligation of the State of California, and the full faith and credit of the State of California is hereby pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
(b)The Treasurer shall issue and sell the bonds authorized in subdivision (a) in the amount determined by the committee to be necessary or desirable pursuant to Section 11899.15. The bonds shall be issued and sold upon the terms and conditions specified in a resolution to be adopted by the committee pursuant to Section 16731.
11899.15.(a)The bonds authorized by this article shall be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4), as amended from time to time, and all of the provisions of that law apply to the bonds and to this article and are hereby incorporated in this article as though set forth in full in this article, except that subdivisions (a) and (b) of Section 16727 shall not apply.
(b)For purposes of this article, the references to committee in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research Finance Committee created in Section 11899.16, and the references to board in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research.
11899.16.(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this article, the California Foundation for Science and Health Research Finance Committee is hereby created.
(b)(1)The committee consists of all of the following:
(A)The Treasurer.
(B)The Controller.
(C)The Director of Finance.
(D)The Director of the California Foundation for Science and Health Research.
(E)Two members of the California Foundation for Science and Health Research Council, chosen by the Secretary of Government Operations, or their designated representatives.
(2)The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.
(c)The committee shall act independently of the foundation and council, but may request recommendations and relevant information so as to understand the financial needs of the foundation to accomplish the strategic objectives and research priorities established pursuant to Section 11899.3.
11899.17.(a)The committee, by resolution, shall determine whether or not it is necessary or desirable to issue and sell bonds authorized pursuant to this article in order to carry out the actions specified in this article and, if so, the amount of bonds to be issued and sold. Successive issues of bonds may be authorized and sold to carry out those actions progressively, and it is not necessary that all of the bonds authorized to be issued be sold at any one time. The bonds may bear interest, which is includable in gross income for federal income tax purposes if the committee determines that the treatment is necessary in order to provide funds for the purposes of the act.
(b)An interest-only floating rate bond structure will be implemented for interim debt and bonds until at least December 31 of the fifth full calendar year after this article takes effect, with all interest to be paid from proceeds from the sale of interim debt or bonds, to minimize debt service payable from the General Fund during the initial period of basic research and development, if the committee determines, with the advice of the Treasurer, that this structure will result in the lowest achievable borrowing costs for the state during that five-year period considering the objective of avoiding any bond debt service payments, by the General Fund, during that period. Upon the initial determination, the committee may delegate, by resolution, to the Treasurer the authority in connection with issuance of bonds as it may determine, including, but not limited to, the authority to do both of the following:
(1)Implement and continue the bond financing structure established by this article, including during any time following the initial five-year period.
(2)Determine that an alternative financing plan would result in significant lower borrowing costs for the state consistent with the objectives related to the General Fund and to implement that alternative financing plan.
11899.18.There shall be collected each year and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state, a sum in an amount required to pay the principal of, and interest on, the bonds becoming due each year. It is the duty of all officers charged by law with any duty in regard to the collection of the revenue to do and perform each and every act that is necessary to collect that additional sum.
11899.19.Notwithstanding Section 13340, there is hereby continuously appropriated from the General Fund in the State Treasury, for the purposes of this article and without regard to fiscal years, an amount that equals the total of both of the following:
(a)The sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this article, as the principal and interest become due and payable.
(b)The sum necessary to carry out Section 11899.20.
11899.20.The foundation may request the Pooled Money Investment Board to make a loan from the Pooled Money Investment Account, in accordance with Section 16312, for the purposes of carrying out this article less any amount withdrawn pursuant to Section 11899.21 and not yet returned to the General Fund. The amount of the request shall not exceed the amount of the unsold bonds that the committee, by resolution, has authorized to be sold for the purpose of carrying out this article, excluding any refunding bonds authorized pursuant to Section 11899.23, less any amount loaned pursuant to this section and not yet repaid and any amount withdrawn from the General Fund pursuant to Section 11899.21 and not yet returned to the General Fund. The foundation shall execute any documents required by the Pooled Money Investment Board to obtain and repay the loan. Any amounts loaned shall be deposited into the fund to be allocated by the foundation in accordance with this article.
11899.21.For the purposes of carrying out this article, the Director of Finance may authorize the withdrawal from the General Fund of an amount, not to exceed the amount of the unsold bonds that have been authorized by the committee, to be sold for the purpose of carrying out this article, excluding any refunding bonds authorized pursuant to Section 11899.23, less any amount loaned pursuant to Section 11899.20 and not yet repaid, and any amount withdrawn from the General Fund pursuant to this section and not yet returned to the General Fund. Any amount withdrawn shall be deposited into the fund. Any moneys made available under this section shall be returned to the General Fund, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds for the purpose of carrying out this article.
11899.22.All moneys deposited into the fund that are derived from premium and accrued interest on bonds sold pursuant to this article shall be reserved in the fund and shall be available for transfer to the General Fund as a credit to expenditures for bond interest, except those amounts derived from premium may be reserved and used to pay the cost of bond issuance before any transfer to the General Fund.
11899.23.The bonds issued and sold pursuant to this article may be refunded in accordance with Article 6 (commencing with Section 16780) of Chapter 4 of Part 3 of Division 4, which is a part of the State General Obligation Bond Law. Approval by the voters of the state for the issuance of the bonds described in this article includes the approval of the issuance of any bonds issued to refund any bonds originally issued under this article or any previously issued refunding bonds. Any bond refunded with the proceeds of refunding bonds as authorized by this section may be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
11899.24.Notwithstanding any provision of this article or the State General Obligation Bond Law, if the Treasurer sells bonds pursuant to this article that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, the Treasurer may maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. The Treasurer may use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
11899.25.The proceeds from the sale of bonds authorized by this article are not proceeds of taxes as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed by that article.
SEC. 3.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 4.Section 2 of this act shall take effect upon the approval by the voters of the California Science and Health Research Bond Act, as set forth in Section 2 of this act.
SEC. 5.Section 2 of this act shall be submitted to the voters at the next statewide election in accordance with provisions of the Government Code and the Elections Code governing the submission of a statewide measure to the voters.
SEC. 6.This act shall be broadly construed to accomplish its purposes. The statutory provisions of the act may be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
SEC. 7.(a)This act shall be liberally construed to effectuate its purposes.
(b)If this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure shall be self-executing and given full force and effect.
SEC. 8.The Legislature finds and declares that Section 2 of this act, which adds Section 11899.6 11899.7 to the Government Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the publics access to this information.
The People of the State of California find and declare the following:
(a)Since World War II, the United States has been a global leader in scientific and health research and innovation. Through the financial support of governmental agencies including, but not limited to, the National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Food and Drug Administration (FDA), the federal Centers for Disease Control and Prevention (CDC), and the National Oceanic and Atmospheric Administration (NOAA), the scientific and health communities have been able to create life-enhancing scientific, biomedical, and public health discoveries.
(b)Americans have benefited enormously from that research with improved health, cures for diseases, vaccines, and improved air quality and environment. The United States economy has benefited greatly from that research as well.
(c)California produces an astonishing share of the top scientific research on the planet. It is estimated that $3 of every $10 in federal research investments are drawn to California. The state accounts for about 47 percent of United States biotechnology research and development spending and generates about 53 percent of the nations biotechnology revenues. Nearly one-half of all venture capital in the United States is invested in California. That success is driven in large part by the states world-class universities and research institutions. The University of California is the top research institution in the world for United States patent generation. Every dollar invested in science funding generates more than $2 in economic activity.
(d)Federal research funding has been integral in supporting the work of public and private research institutions in California. For example, federal funding supports a significant part of the University of Californias (UC) and California State Universitys (CSU) research operations. Federal grants pay for faculty research and the salaries of graduate and postdoctoral student researchers. Federal research grants totaled more than $5,000,000,000 to the University of California in the 202324 fiscal year. Public and private university research has led to the founding of thousands of startups, driving economic expansion and technological innovation. Federal funding reductions limit research opportunities and may impede Californias competitiveness and economic progress.
(e)Because the federal government has been one of the largest funders of scientific research in California, foundations, nonprofits, and corporations alone cannot make up the gap when cuts are made by the federal government. Unless the people of California rise up, much of this critical work may come to a halt. Federal cuts to scientific research pose a threat to the well-being of the people of California and will impair Californias ability to operate as a global leader in technology, innovation, and research across fields of study.
(f)The people of California propose this ballot measure to create the California Foundation for Science and Health Research (Foundation) to award grants and make loans to public and private universities, research companies, institutes, and health care organizations in California for scientific and health care research and development.
(g)Through the Foundation, funding would be distributed to UC, CSU, other California universities, and public and private entities engaged in critical science and health research. It would provide funding for staff, equipment, and facilities needed to carry out scientific research in fields including, but not limited to, public health, mental health, heart disease, cancer treatment, diabetes, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. Priority would be given to established research projects where the federal government has canceled funding. The measure would require annual audits.
(h)This measure will help preserve Californias position as a global leader in scientific innovation. This measure would allow important research to continue regardless of what happens at the federal level. This measure will ensure that California is not left behind.
(i)This measure will help sustain and grow the workforce of the state, with runoff economic benefits that will ensure a thriving future for Californians. This measure will support thousands of students and researchers at California universities in good-paying union jobs in growing industries. Supporting good-paying jobs in science, technology, engineering, and mathematics will help keep California economically competitive and generate billions of dollars each year in economic growth.
(j)There is some science that only public institutions will take on, for example cancer drug trials that combine drugs from different pharmaceutical companies, or as yet, unproven technologies in renewable energy. This measure would continue funding scientific research that looks beyond the profit motive for the greater good.
(k)Californias university and college system is a model for universities everywhere, involving students closely in practical, life-saving research. Cuts to federal funding threaten our students ability to learn the research skills they need to succeed. This measure will preserve Californias university and college system as a pathway to the middle class for California students.
(l)Too many Californians are driven into homelessness by drug abuse and mental health issues. This measure will help address this problem by continuing to fund critical research on promising mental health and addiction treatments.
(m)This measure contains strict fiscal accountability and transparency standards, including annual independent audits and public disclosure of all funding to ensure that Legislative allocations and bond funding is spent effectively, efficiently, and as promised.
SEC. 2.Chapter 12 (commencing with Section 11899) is added to Part 1 of Division 3 of Title 2 of the Government Code, to read:12.California Science and Health Research Bond Act1.California Foundation for Science and Health Research11899.As used in this chapter, the following terms have the following meaning:
(a)Act means the California Science and Health Research Bond Act constituting this chapter.
(b)Committee means the California Foundation for Science and Health Research Finance Committee created pursuant to subdivision (a) of Section 11899.16.
(c)Council means the California Foundation for Science and Health Research Finance Council created pursuant to subdivision (a) of Section 11899.3.
(d)Foundation means the California Foundation for Science and Health Research established pursuant to subdivision (a) of Section 11899.1.
(e)Fund means the California Foundation for Science and Health Research Fund created pursuant to Section 11899.2.
(f)Interim debt means any interim loans pursuant to Sections 11899.20 and 11899.21, bond anticipation notes or commercial paper notes issued to make deposits into the fund, and which will be paid from the proceeds of bonds issued pursuant to Article 2 (commencing with Section 11899.10).
11899.1.(a)The California Foundation for Science and Health Research is established within the Government Operations Agency.
(b)The foundations role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development, including, but not limited to, any of the following fields:
(1)Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(2)Detecting and responding to new and emerging health threats.
(3)Disease prevention, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(4)Promoting healthy and safe behaviors, communities, and environment.
(5)Wildfire prevention.
(6)Addiction and substance use.(7)Behavioral.(6)Behavioral health, including, but not limited to, addiction and substance use disorders.
(8)(7)Climate, including climate change and its impact on human health.
(9)(8)Weather.
(10)(9)Ocean.
(11)(10)Coastal and marine ecosystems and resources.
(12)(11)Agriculture and water.
(13)(12)Emerging technologies.
(14)(13)Safety, efficacy, and security of drugs, biological products, medical devices, our nations food supply, and cosmetics.
(c)(1)The Secretary of Government Operations shall oversee the process of appointing the director of the foundation and shall set the level of salaries, bonuses, and benefits for the director. The task of hiring and determining the salaries, bonuses, and benefits of additional personnel may be delegated by the secretary to the director, subject to approval and oversight by the secretary.
(2)The director and personnel of the foundation shall be responsible for implementing the strategic objectives of the council, administering the grants and loans awarded by the council, and all other duties as deemed necessary for the operation of the foundation.
11899.2.(a)(1)Upon appropriation by the Legislature, funds shall be deposited into the California Foundation for Science and Health Research Fund, which is hereby created in the State Treasury.
(2)The California Foundation for Science and Health Research Fund may be funded by both private and public funds, including private donations.
(b)The proceeds of interim debt and bonds issued and sold pursuant to Article 2 (commencing with Section 11899.10) shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund, except as stated in Section 11899.13.
(c)Moneys in the fund shall be used by the foundation to award public and private grants to, and make loans to to, public or private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, research in any of the fields described in subdivision (b) of Section 11899.1.
(d)(1)All research and development funded by the fund shall be conducted under established standards of open scientific exchange, peer review, and public oversight. oversight, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5), if applicable.
(2)All grants or loans provided under this section shall be awarded or made available to researchers or projects located within this state, except that funding for research collaboratives between California and out-of-state researchers shall be permitted.
(3)All grants or loans provided under this section shall be awarded based on both of the following:
(A)Consistency with the research priorities established for the foundation by the California Foundation for Science and Health Research Council as described in subdivision (a) of Section 11899.3.
(B)The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as described in subdivision (e) of Section 11899.3.
(4)The foundation shall prioritize funding research that replaces funding cuts by the federal government.
(5)To be eligible for funding, all research projects submitted for potential funding shall be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations. regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act (Chapter 2.5 (commencing with Section 13989) of Part 4.5) and the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20 of the Health and Safety Code).
(e)(1)It is the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount.
(2)It is the intent of the Legislature that under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at a discount to Californians and for profit to other states.
(f)The Secretary of Government Operations shall oversee the process of appointing the director of the foundation and shall set the level of salaries, bonuses, and benefits for the director. The task of hiring and determining the salaries, bonuses, and benefits of additional personnel may be delegated by the Secretary to the director, subject to approval and oversight by the Secretary.(g)(f)Not more than three percent of the moneys in the fund shall be used for administrative costs. Administrative costs include, but are not limited to, all of the following:
(1)Salaries, bonuses, and benefits paid or incurred with respect to the hiring or retention of a director of the foundation and other officers and administrative staff that shall work on behalf of the foundation under the supervision of the director.
(2)Legal and accounting fees and expenses.
(3)All costs associated with the establishment and operation of the foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the foundation.
(h)(g)All intellectual property assets developed using funds authorized for, or made available to, the foundation shall be treated pursuant to state and federal law.
(h)The foundation shall recommend to the council, and the council shall adopt, standards to ensure that if the grantee or loan recipient purchases goods or services using funds authorized for, or made available to, the foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50 percent of purchases from California suppliers.
11899.3.(a)There is hereby established the California Foundation for Science and Health Research Council that shall do all of the following:
(1)Develop the strategic objectives and research priorities of the foundation.
(2)Actively participate in the overall management of the foundation.
(3)Determine which research projects will be funded by the fund based on the research priorities established for the foundation pursuant to paragraph (1) and the technical merits of the proposals, as determined by scientific peer review panels created pursuant to subdivision (e).
(4)Determine which state agency will oversee a research project funded by the fund, including, but not limited to:
(A)Office of Emergency Services.
(B)Natural Resources Agency.
(C)California Health and Human Services Agency.
(b)(1)The council shall consist of 10 11 to 13 members appointed by the Secretary of Government Operations. members.
(A)A majority of Five members of the council shall be scientists, appointed by the Secretary of Government Operations and shall be scientists or hold backgrounds in science or research, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the fields described in subdivision (b) of Section 11899.1.
(B)At least two Three members of the council shall be members of the public. public appointed by the Secretary of Government Operations.
(C)One member shall be a member of the public appointed by the Senate Rules Committee.
(D)One member shall be a member of the public appointed by the Speaker of the Assembly.
(C)(E)One member shall be a designee of the President of the University of California, if the president chooses to designate a representative. representative, who shall be a scientist or hold a background in science or research.
(D)(F)One member shall be a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative. representative, who shall be a scientist or hold a background in science or research.
(E)(G)One member shall be the President of the Association of Independent California Colleges and Universities, or the presidents designee. designee, who shall be a scientist or hold a background in science or research.
(2)(A)Individuals and organizations may submit nominations for membership to the Secretary of Government Operations.
(B)The Secretary of Government Operations may solicit nominations from relevant organizations and individuals.
(c)(1)The members of the council shall serve four-year terms. A member shall serve a maximum of two terms.
(2)If the graduate-level researcher or postdoctoral scholar appointed pursuant to subparagraph (A) of paragraph (1) of subdivision (b) earns their degree or completes their placement before the conclusion of their four-year term, the graduate-level researcher or postdoctoral scholar may serve out the remainder of the academic year on the council. At the conclusion of the academic year, the Secretary of Government Operations shall appoint a current graduate-level researcher or postdoctoral scholar who may serve a four-year term or until they earn their degree or complete their placement.
(2)(3)If a vacancy occurs within a term, the Secretary of Government Operations shall appoint a replacement member within 45 days to serve the remainder of the term.
(3)A vacancy affecting the proportional representation shall be filled before grants are approved.(4)When a term expires, the Secretary of Government Operations shall appoint a member within 30 days. A member shall serve until their replacement is appointed.
(5)A grant or a loan shall not be approved if there are more than three vacancies on the council.
(d)(1)A vote of a majority of the members of the council shall be required for the approval of funding of any research project or proposal presented for funding.
(2)The council shall contain the proportional representation of appointees described in paragraph (1) of subdivision (b) when the council approves the funding of research grants.(e)(1)The council may establish one or more scientific peer review panels consisting of experts in the fields described in subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the track record of the researchers and investigators, scientific merit of the proposal, and the potential benefits to the health and well-being of the population, natural resources, and environment of the state. state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
(2)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to paragraph (1).
(f)Council members shall serve without compensation, but may receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
11899.4.(a)The foundation shall issue an annual report that sets forth the foundations activities, grants awarded, loans made available, grants and loans in progress, research accomplishments, and future program directions. The annual report shall be published on the foundations internet website.
(b)Each annual report shall include, but not be limited to, all of the following:
(1)The number and dollar amounts of research and facilities grants. grants and loans.
(2)The grantees and loan recipients for the prior year.
(3)The foundations administrative expenses.
(4)An assessment of the availability of funding for research from sources other than the foundation.
(5)A summary of research findings, including promising new research areas.
(6)An assessment of the relationship between the foundations grants and loans and the overall strategy of its research program.
(7)A report of the foundations strategic research and financial plans.
11899.5.The foundation shall annually commission an independent financial audit of its activities from a certified public accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public report of that review. The Controller shall hold a public meeting with appropriate notice and a formal public comment period. The Controller shall evaluate public comments and shall include appropriate summaries in the annual report.
11899.6.(a)The Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) shall apply to all meetings of the foundation, council, except as otherwise provided in this section. The foundation council shall disclose all awarded grants in public meetings, shall award all grants, loans, and contracts in public meetings, and shall adopt all governance, scientific, medical, and regulatory standards in public meetings.
(b)The foundation council may conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) under Section 11126. In addition, the foundation council may conduct closed sessions when it meets to consider or discuss any of the following:
(1)Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
(2)Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it.
(3)Matters involving scientific data, analyses, or other research products not yet formally published in academic literature.
(4)Matters concerning the appointment, employment, performance, compensation, or dismissal of foundation officers and employees. Action on compensation of the foundations officers and employees shall only be taken in open session.
(5)Matters believed to pose a security risk to the people of California.
2.California Foundation for Science and Health Research Bonds11899.10.The proceeds of bonds, excluding those issued in accordance with Section 11899.23, issued and sold pursuant to this article shall be deposited into the California Foundation for Science and Health Research Fund. All moneys in the fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter.
11899.11.The sum of ____ dollars ($____) shall be available for grants and loans to fund the construction and acquisition of facilities for research as provided in this chapter.
11899.12.(a)The sum of ____ dollars ($____) shall be available for all of the following:
(1)Grants and loans to fund research and operate and maintain facilities for research as provided in this chapter.
(2)Paying general administrative costs of the foundation, not to exceed 3 percent of the net proceeds of each sale of bonds. amount in the fund.
(3)Paying the annual administration costs of the interim debt or bonds after December 31 of the fifth full calendar year after this article takes effect.
(4)Paying the costs of issuing interim debt, paying the annual administration costs of the interim debt until and including December 31 of the fifth full calendar year after this article takes effect, and paying interest on interim debt, if that interim debt is incurred or issued on or before December 31 of the fifth full calendar year after this article takes effect.
(5)Paying the costs of issuing bonds, paying the annual administration costs of the bonds until and including December 31 of the fifth full calendar year after this article takes effect, and paying interest on bonds that accrues on or before December 31 of the fifth full calendar year after this article takes effect, except that this limitation does not apply to premium and accrued interest as provided in Section 11899.22.
(6)Moneys in the fund or other proceeds of the sale of bonds authorized by this article may be used to pay principal of or redemption premium on any interim debt issued before the issuance of bonds authorized by this article. Moneys deposited into the fund from the proceeds of interim debt may be used to pay general administrative costs of the foundation without regard to the 3-percent limit set forth in paragraph (2), so long as the 3-percent limit is satisfied for each issue of bonds.
(b)Repayment of principal and interest on any loans made by the foundation pursuant to this article shall be deposited into the fund and used to make additional grants and loans for the purposes of this act or for paying continuing costs of the annual administration of outstanding bonds.
(c)Costs allowable under this section include costs incidentally but directly related to construction or acquisition, including, but not limited to, planning, engineering, construction management, architectural, and other design work, environmental impact reports and assessments, required mitigation expenses, appraisals, legal expenses, site acquisitions, and necessary easements.
11899.13.The proceeds of interim debt and bonds issued and sold pursuant to this article shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
11899.14.(a)Bonds in the total amount of twenty-three billion dollars ($23,000,000,000), not including the amount of any refunding bonds issued in accordance with Section 11899.23, may be issued and sold for the purposes expressed in this article and to reimburse the General Obligation Bond Expense Revolving Fund pursuant to Section 16724.5. The bonds, when sold, issued, and delivered, shall be and constitute a valid and binding obligation of the State of California, and the full faith and credit of the State of California is hereby pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
(b)The Treasurer shall issue and sell the bonds authorized in subdivision (a) in the amount determined by the committee to be necessary or desirable pursuant to Section 11899.15. The bonds shall be issued and sold upon the terms and conditions specified in a resolution to be adopted by the committee pursuant to Section 16731.
11899.15.(a)The bonds authorized by this article shall be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4), as amended from time to time, and all of the provisions of that law apply to the bonds and to this article and are hereby incorporated in this article as though set forth in full in this article, except that subdivisions (a) and (b) of Section 16727 shall not apply.
(b)For purposes of this article, the references to committee in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research Finance Committee created in Section 11899.16, and the references to board in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research.
11899.16.(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this article, the California Foundation for Science and Health Research Finance Committee is hereby created.
(b)(1)The committee consists of all of the following:
(A)The Treasurer.
(B)The Controller.
(C)The Director of Finance.
(D)The Director of the California Foundation for Science and Health Research.
(E)Two members of the California Foundation for Science and Health Research Council, chosen by the Secretary of Government Operations, or their designated representatives.
(2)The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.
(c)The committee shall act independently of the foundation and council, but may request recommendations and relevant information so as to understand the financial needs of the foundation to accomplish the strategic objectives and research priorities established pursuant to Section 11899.3.
11899.17.(a)The committee, by resolution, shall determine whether or not it is necessary or desirable to issue and sell bonds authorized pursuant to this article in order to carry out the actions specified in this article and, if so, the amount of bonds to be issued and sold. Successive issues of bonds may be authorized and sold to carry out those actions progressively, and it is not necessary that all of the bonds authorized to be issued be sold at any one time. The bonds may bear interest, which is includable in gross income for federal income tax purposes if the committee determines that the treatment is necessary in order to provide funds for the purposes of the act.
(b)An interest-only floating rate bond structure will be implemented for interim debt and bonds until at least December 31 of the fifth full calendar year after this article takes effect, with all interest to be paid from proceeds from the sale of interim debt or bonds, to minimize debt service payable from the General Fund during the initial period of basic research and development, if the committee determines, with the advice of the Treasurer, that this structure will result in the lowest achievable borrowing costs for the state during that five-year period considering the objective of avoiding any bond debt service payments, by the General Fund, during that period. Upon the initial determination, the committee may delegate, by resolution, to the Treasurer the authority in connection with issuance of bonds as it may determine, including, but not limited to, the authority to do both of the following:
(1)Implement and continue the bond financing structure established by this article, including during any time following the initial five-year period.
(2)Determine that an alternative financing plan would result in significant lower borrowing costs for the state consistent with the objectives related to the General Fund and to implement that alternative financing plan.
11899.18.There shall be collected each year and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state, a sum in an amount required to pay the principal of, and interest on, the bonds becoming due each year. It is the duty of all officers charged by law with any duty in regard to the collection of the revenue to do and perform each and every act that is necessary to collect that additional sum.
11899.19.Notwithstanding Section 13340, there is hereby continuously appropriated from the General Fund in the State Treasury, for the purposes of this article and without regard to fiscal years, an amount that equals the total of both of the following:
(a)The sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this article, as the principal and interest become due and payable.
(b)The sum necessary to carry out Section 11899.20.
11899.20.The foundation may request the Pooled Money Investment Board to make a loan from the Pooled Money Investment Account, in accordance with Section 16312, for the purposes of carrying out this article less any amount withdrawn pursuant to Section 11899.21 and not yet returned to the General Fund. The amount of the request shall not exceed the amount of the unsold bonds that the committee, by resolution, has authorized to be sold for the purpose of carrying out this article, excluding any refunding bonds authorized pursuant to Section 11899.23, less any amount loaned pursuant to this section and not yet repaid and any amount withdrawn from the General Fund pursuant to Section 11899.21 and not yet returned to the General Fund. The foundation shall execute any documents required by the Pooled Money Investment Board to obtain and repay the loan. Any amounts loaned shall be deposited into the fund to be allocated by the foundation in accordance with this article.
11899.21.For the purposes of carrying out this article, the Director of Finance may authorize the withdrawal from the General Fund of an amount, not to exceed the amount of the unsold bonds that have been authorized by the committee, to be sold for the purpose of carrying out this article, excluding any refunding bonds authorized pursuant to Section 11899.23, less any amount loaned pursuant to Section 11899.20 and not yet repaid, and any amount withdrawn from the General Fund pursuant to this section and not yet returned to the General Fund. Any amount withdrawn shall be deposited into the fund. Any moneys made available under this section shall be returned to the General Fund, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds for the purpose of carrying out this article.
11899.22.All moneys deposited into the fund that are derived from premium and accrued interest on bonds sold pursuant to this article shall be reserved in the fund and shall be available for transfer to the General Fund as a credit to expenditures for bond interest, except those amounts derived from premium may be reserved and used to pay the cost of bond issuance before any transfer to the General Fund.
11899.23.The bonds issued and sold pursuant to this article may be refunded in accordance with Article 6 (commencing with Section 16780) of Chapter 4 of Part 3 of Division 4, which is a part of the State General Obligation Bond Law. Approval by the voters of the state for the issuance of the bonds described in this article includes the approval of the issuance of any bonds issued to refund any bonds originally issued under this article or any previously issued refunding bonds. Any bond refunded with the proceeds of refunding bonds as authorized by this section may be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
11899.24.Notwithstanding any provision of this article or the State General Obligation Bond Law, if the Treasurer sells bonds pursuant to this article that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, the Treasurer may maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. The Treasurer may use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
11899.25.The proceeds from the sale of bonds authorized by this article are not proceeds of taxes as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed by that article.
SEC. 3.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 3.SEC. 4.Section 2 of this act shall take effect upon the approval by the voters of the California Science and Health Research Bond Act, as set forth in Section 2 of this act.
SEC. 4.SEC. 5.Section 2 of this act shall be submitted to the voters at the next statewide election in accordance with provisions of the Government Code and the Elections Code governing the submission of a statewide measure to the voters.
SEC. 5.SEC. 6.This act shall be broadly construed to accomplish its purposes. The statutory provisions of the act may be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
SEC. 6.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 7.(a)This act shall be liberally construed to effectuate its purposes.
(b)If this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure shall be self-executing and given full force and effect.
SEC. 8.The Legislature finds and declares that Section 2 of this act, which adds Section 11899.6 to the Government Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the publics access to this information.
The People of California find and declare the following:
(a)Since World War II, the United States has been a global leader in scientific and health research and innovation. Through the financial support of governmental agencies including, but not limited to, the National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Food and Drug Administration (FDA), the federal Centers for Disease Control and Prevention (CDC), and the National Oceanic and Atmospheric Administration (NOAA), the scientific and health communities have been able to create life-enhancing scientific, biomedical, and public health discoveries.
(b)Americans have benefited enormously from that research with improved health, cures for diseases, vaccines, and improved air quality and environment. The United States economy has benefited greatly from that research as well.
(c)California produces an astonishing share of the top scientific research on the planet. It is estimated that $3 of every $10 in federal research investments are drawn to California. The state accounts for about 47 percent of United States biotechnology research and development spending and generates about 53 percent of the nations biotechnology revenues. Nearly one-half of all venture capital in the United States is invested in California. That success is driven in large part by the states world-class universities and research institutions. The University of California is the top research institution in the world for United States patent generation. Every dollar invested in science funding generates more than $2 in economic activity.
(d)Federal research funding has been integral in supporting the work of public and private research institutions in California. For example, federal funding supports a significant part of the University of Californias (UC) and California State Universitys (CSU) research operations. Federal grants pay for faculty research and the salaries of graduate and postdoctoral student researchers. Federal research grants totaled more than $5,000,000,000 to the University of California in the 202324 fiscal year. Public and private university research has led to the founding of thousands of startups, driving economic expansion and technological innovation. Federal funding reductions limit research opportunities and may impede Californias competitiveness and economic progress.
(e)Because the federal government has been one of the largest funders of scientific research in California, foundations, nonprofits, and corporations alone cannot make up the gap when cuts are made by the federal government. Unless the people of California rise up, much of this critical work may come to a halt. Federal cuts to scientific research pose a threat to the well-being of the people of California and will impair Californias ability to operate as a global leader in technology, innovation, and research across fields of study.
(f)The people of California propose this ballot measure to create the California Foundation for Science and Health Research (Foundation) to award grants and make loans to public and private universities, research companies, institutes, and health care organizations in California for scientific and health care research and development.
(g)Through the Foundation, funding would be distributed to UC, CSU, other California universities, and public and private entities engaged in critical science and health research. It would provide funding for staff, equipment, and facilities needed to carry out scientific research in fields including, but not limited to, public health, mental health, heart disease, cancer treatment, diabetes, Alzheimers disease, Parkinsons disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS. Priority would be given to established research projects where the federal government has canceled funding. The measure would require annual audits.
(h)This measure will help preserve Californias position as a global leader in scientific innovation. This measure would allow important research to continue regardless of what happens at the federal level. This measure will ensure that California is not left behind.
(i)This measure will help sustain and grow the workforce of the state, with runoff economic benefits that will ensure a thriving future for Californians. This measure will support thousands of students and researchers at California universities in good-paying union jobs in growing industries. Supporting good-paying jobs in science, technology, engineering, and mathematics will help keep California economically competitive and generate billions of dollars each year in economic growth.
(j)There is some science that only public institutions will take on, for example cancer drug trials that combine drugs from different pharmaceutical companies, or as yet, unproven technologies in renewable energy. This measure would continue funding scientific research that looks beyond the profit motive for the greater good.
(k)Californias university and college system is a model for universities everywhere, involving students closely in practical, life-saving research. Cuts to federal funding threaten our students ability to learn the research skills they need to succeed. This measure will preserve Californias university and college system as a pathway to the middle class for California students.
(l)Too many Californians are driven into homelessness by drug abuse and mental health issues. This measure will help address this problem by continuing to fund critical research on promising mental health and addiction treatments.
(m)This measure contains strict fiscal accountability and transparency standards, including annual independent audits and public disclosure of all funding to ensure that Legislative allocations and bond funding is spent effectively, efficiently, and as promised.
SEC. 2.Chapter 12 (commencing with Section 11899) is added to Part 1 of Division 3 of Title 2 of the Government Code, to read:12.California Science and Health Research Bond Act1.California Foundation for Science and Health Research11899.As used in this chapter, the following terms have the following meaning:
(a)Act means the California Science and Health Research Bond Act constituting this chapter.
(b)Committee means the California Foundation for Science and Health Research Finance Committee created pursuant to subdivision (a) of Section 11899.16.
(c)Council means the California Foundation for Science and Health Research Finance Council created pursuant to subdivision (a) of Section 11899.3.
(d)Foundation means the California Foundation for Science and Health Research established pursuant to subdivision (a) of Section 11899.1.
(e)Fund means the California Foundation for Science and Health Research Fund created pursuant to Section 11899.2.
(f)Interim debt means any interim loans pursuant to Sections 11899.20 and 11899.21, bond anticipation notes or commercial paper notes issued to make deposits into the fund, and which will be paid from the proceeds of bonds issued pursuant to Article 2 (commencing with Section 11899.10).
11899.1.(a)The California Foundation for Science and Health Research is established within the Government Operations Agency.
(b)The foundations role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development, including, but not limited to, any of the following fields:
(1)Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(2)Detecting and responding to new and emerging health threats.
(3)Disease prevention, including, but not limited to, cancer, Alzheimers disease, Parkinsons disease, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS.
(4)Promoting healthy and safe behaviors, communities, and environment.
(5)Wildfire prevention.
(6)Addiction and substance use.
(7)Behavioral.
(8)Climate, including climate change and its impact on human health.
(9)Weather.
(10)Ocean.
(11)Coastal and marine ecosystems and resources.
(12)Agriculture and water.
(13)Emerging technologies.
(14)Safety, efficacy, and security of drugs, biological products, medical devices, our nations food supply, and cosmetics.
11899.2.(a)(1)Upon appropriation by the Legislature, funds shall be deposited into the California Foundation for Science and Health Research Fund, which is hereby created in the State Treasury.
(2)The California Foundation for Science and Health Research Fund may be funded by both private and public funds, including private donations.
(b)The proceeds of interim debt and bonds issued and sold pursuant to Article 2 (commencing with Section 11899.10) shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund, except as stated in Section 11899.13.
(c)Moneys in the fund shall be used by the foundation to award public and private grants and make loans to public or private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, research in any of the fields described in subdivision (b) of Section 11899.1.
(d)(1)All research and development funded by the fund shall be conducted under established standards of open scientific exchange, peer review, and public oversight.
(2)All grants or loans provided under this section shall be awarded or made available to researchers or projects located within this state, except that funding for research collaboratives between California and out-of-state researchers shall be permitted.
(3)All grants or loans provided under this section shall be awarded based on both of the following:
(A)Consistency with the research priorities established for the foundation by the California Foundation for Science and Health Research Council as described in subdivision (a) of Section 11899.3.
(B)The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as described in subdivision (e) of Section 11899.3.
(4)The foundation shall prioritize funding research that replaces funding cuts by the federal government.
(5)To be eligible for funding, all research projects submitted for potential funding shall be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations.
(e)(1)It is the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount.
(2)It is the intent of the Legislature that under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at a discount to Californians and for profit to other states.
(f)The Secretary of Government Operations shall oversee the process of appointing the director of the foundation and shall set the level of salaries, bonuses, and benefits for the director. The task of hiring and determining the salaries, bonuses, and benefits of additional personnel may be delegated by the Secretary to the director, subject to approval and oversight by the Secretary.
(g)Not more than three percent of the moneys in the fund shall be used for administrative costs. Administrative costs include, but are not limited to, all of the following:
(1)Salaries, bonuses, and benefits paid or incurred with respect to the hiring or retention of a director of the foundation and other officers and administrative staff that shall work on behalf of the foundation under the supervision of the director.
(2)Legal and accounting fees and expenses.
(3)All costs associated with the establishment and operation of the foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the foundation.
(h)All intellectual property assets developed using funds authorized for, or made available to, the foundation shall be treated pursuant to state and federal law.
11899.3.(a)There is hereby established the California Foundation for Science and Health Research Council that shall do all of the following:
(1)Develop the strategic objectives and research priorities of the foundation.
(2)Actively participate in the overall management of the foundation.
(3)Determine which research projects will be funded by the fund based on the research priorities established for the foundation pursuant to paragraph (1) and the technical merits of the proposals, as determined by scientific peer review panels created pursuant to subdivision (e).
(4)Determine which state agency will oversee a research project funded by the fund, including, but not limited to:
(A)Office of Emergency Services.
(B)Natural Resources Agency.
(C)California Health and Human Services Agency.
(b)(1)The council shall consist of 10 to 13 members appointed by the Secretary of Government Operations.
(A)A majority of members of the council shall be scientists, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the fields described in subdivision (b) of Section 11899.1.
(B)At least two members of the council shall be members of the public.
(C)One member shall be a designee of the President of the University of California, if the president chooses to designate a representative.
(D)One member shall be a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative.
(E)One member shall be the President of the Association of Independent California Colleges and Universities, or the presidents designee.
(2)(A)Individuals and organizations may submit nominations for membership to the Secretary of Government Operations.
(B)The Secretary of Government Operations may solicit nominations from relevant organizations and individuals.
(c)(1)The members of the council shall serve four-year terms. A member shall serve a maximum of two terms.
(2)If a vacancy occurs within a term, the Secretary of Government Operations shall appoint a replacement member within 45 days to serve the remainder of the term.
(3)A vacancy affecting the proportional representation shall be filled before grants are approved.
(4)When a term expires, the Secretary of Government Operations shall appoint a member within 30 days. A member shall serve until their replacement is appointed.
(d)(1)A vote of a majority of the members of the council shall be required for the approval of funding of any research project or proposal presented for funding.
(2)The council shall contain the proportional representation of appointees described in paragraph (1) of subdivision (b) when the council approves the funding of research grants.
(e)(1)The council may establish one or more scientific peer review panels consisting of experts in the fields described in subdivision (b) of Section 11899.1 for the purposes of reviewing and prioritizing proposals on the basis of the track record of the researchers and investigators, scientific merit of the proposal, and potential benefits to the health and well-being of the population, natural resources, and environment of the state.
(2)An expert on a scientific review panel shall not have a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing pursuant to paragraph (1).
(f)Council members shall serve without compensation, but may receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
11899.4.(a)The foundation shall issue an annual report that sets forth the foundations activities, grants awarded, grants in progress, research accomplishments, and future program directions. The annual report shall be published on the foundations internet website.
(b)Each annual report shall include, but not be limited to, all of the following:
(1)The number and dollar amounts of research and facilities grants.
(2)The grantees for the prior year.
(3)The foundations administrative expenses.
(4)An assessment of the availability of funding for research from sources other than the foundation.
(5)A summary of research findings, including promising new research areas.
(6)An assessment of the relationship between the foundations grants and the overall strategy of its research program.
(7)A report of the foundations strategic research and financial plans.
11899.5.The foundation shall annually commission an independent financial audit of its activities from a certified public accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public report of that review. The Controller shall hold a public meeting with appropriate notice and a formal public comment period. The Controller shall evaluate public comments and shall include appropriate summaries in the annual report.
11899.6.(a)The Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) shall apply to all meetings of the foundation, except as otherwise provided in this section. The foundation shall disclose all awarded grants in public meetings, shall award all grants, loans, and contracts in public meetings, and shall adopt all governance, scientific, medical, and regulatory standards in public meetings.
(b)The foundation may conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act (Article 9 (commencing with Section 11120) of Chapter 1) under Section 11126. In addition, the foundation may conduct closed sessions when it meets to consider or discuss any of the following:
(1)Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy.
(2)Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it.
(3)Matters involving scientific data, analyses, or other research products not yet formally published in academic literature.
(4)Matters concerning the appointment, employment, performance, compensation, or dismissal of foundation officers and employees. Action on compensation of the foundations officers and employees shall only be taken in open session.
(5)Matters believed to pose a security risk to the people of California.
2.California Foundation for Science and Health Research Bonds11899.10.The proceeds of bonds, excluding those issued in accordance with Section 11899.23, issued and sold pursuant to this article shall be deposited into the California Foundation for Science and Health Research Fund. All moneys in the fund, notwithstanding Section 13340, are hereby continuously appropriated without respect to fiscal years for the purposes of this chapter.
11899.11.The sum of ____ dollars ($____) shall be available for grants and loans to fund the construction and acquisition of facilities for research as provided in this chapter.
11899.12.(a)The sum of ____ dollars ($____) shall be available for all of the following:
(1)Grants and loans to fund research and operate and maintain facilities for research as provided in this chapter.
(2)Paying general administrative costs of the foundation, not to exceed 3 percent of the net proceeds of each sale of bonds.
(3)Paying the annual administration costs of the interim debt or bonds after December 31 of the fifth full calendar year after this article takes effect.
(4)Paying the costs of issuing interim debt, paying the annual administration costs of the interim debt until and including December 31 of the fifth full calendar year after this article takes effect, and paying interest on interim debt, if that interim debt is incurred or issued on or before December 31 of the fifth full calendar year after this article takes effect.
(5)Paying the costs of issuing bonds, paying the annual administration costs of the bonds until and including December 31 of the fifth full calendar year after this article takes effect, and paying interest on bonds that accrues on or before December 31 of the fifth full calendar year after this article takes effect, except that this limitation does not apply to premium and accrued interest as provided in Section 11899.22.
(6)Moneys in the fund or other proceeds of the sale of bonds authorized by this article may be used to pay principal of or redemption premium on any interim debt issued before the issuance of bonds authorized by this article. Moneys deposited into the fund from the proceeds of interim debt may be used to pay general administrative costs of the foundation without regard to the 3-percent limit set forth in paragraph (2), so long as the 3-percent limit is satisfied for each issue of bonds.
(b)Repayment of principal and interest on any loans made by the foundation pursuant to this article shall be deposited into the fund and used to make additional grants and loans for the purposes of this act or for paying continuing costs of the annual administration of outstanding bonds.
(c)Costs allowable under this section include costs incidentally but directly related to construction or acquisition, including, but not limited to, planning, engineering, construction management, architectural, and other design work, environmental impact reports and assessments, required mitigation expenses, appraisals, legal expenses, site acquisitions, and necessary easements.
11899.13.The proceeds of interim debt and bonds issued and sold pursuant to this article shall be deposited into the State Treasury to the credit of the California Foundation for Science and Health Research Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
11899.14.(a)Bonds in the total amount of twenty-three billion dollars ($23,000,000,000), not including the amount of any refunding bonds issued in accordance with Section 11899.23, may be issued and sold for the purposes expressed in this article and to reimburse the General Obligation Bond Expense Revolving Fund pursuant to Section 16724.5. The bonds, when sold, issued, and delivered, shall be and constitute a valid and binding obligation of the State of California, and the full faith and credit of the State of California is hereby pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
(b)The Treasurer shall issue and sell the bonds authorized in subdivision (a) in the amount determined by the committee to be necessary or desirable pursuant to Section 11899.15. The bonds shall be issued and sold upon the terms and conditions specified in a resolution to be adopted by the committee pursuant to Section 16731.
11899.15.(a)The bonds authorized by this article shall be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4), as amended from time to time, and all of the provisions of that law apply to the bonds and to this article and are hereby incorporated in this article as though set forth in full in this article, except that subdivisions (a) and (b) of Section 16727 shall not apply.
(b)For purposes of this article, the references to committee in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research Finance Committee created in Section 11899.16, and the references to board in the State General Obligation Bond Law shall mean the California Foundation for Science and Health Research.
11899.16.(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this article, the California Foundation for Science and Health Research Finance Committee is hereby created.
(b)(1)The committee consists of all of the following:
(A)The Treasurer.
(B)The Controller.
(C)The Director of Finance.
(D)The Director of the California Foundation for Science and Health Research.
(E)Two members of the California Foundation for Science and Health Research Council, chosen by the Secretary of Government Operations, or their designated representatives.
(2)The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.
11899.17.(a)The committee, by resolution, shall determine whether or not it is necessary or desirable to issue and sell bonds authorized pursuant to this article in order to carry out the actions specified in this article and, if so, the amount of bonds to be issued and sold. Successive issues of bonds may be authorized and sold to carry out those actions progressively, and it is not necessary that all of the bonds authorized to be issued be sold at any one time. The bonds may bear interest, which is includable in gross income for federal income tax purposes if the committee determines that the treatment is necessary in order to provide funds for the purposes of the act.
(b)An interest-only floating rate bond structure will be implemented for interim debt and bonds until at least December 31 of the fifth full calendar year after this article takes effect, with all interest to be paid from proceeds from the sale of interim debt or bonds, to minimize debt service payable from the General Fund during the initial period of basic research and development, if the committee determines, with the advice of the Treasurer, that this structure will result in the lowest achievable borrowing costs for the state during that five-year period considering the objective of avoiding any bond debt service payments, by the General Fund, during that period. Upon the initial determination, the committee may delegate, by resolution, to the Treasurer the authority in connection with issuance of bonds as it may determine, including, but not limited to, the authority to do both of the following:
(1)Implement and continue the bond financing structure established by this article, including during any time following the initial five-year period.
(2)Determine that an alternative financing plan would result in significant lower borrowing costs for the state consistent with the objectives related to the General Fund and to implement that alternative financing plan.
11899.18.There shall be collected each year and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state, a sum in an amount required to pay the principal of, and interest on, the bonds becoming due each year. It is the duty of all officers charged by law with any duty in regard to the collection of the revenue to do and perform each and every act that is necessary to collect that additional sum.
11899.19.Notwithstanding Section 13340, there is hereby continuously appropriated from the General Fund in the State Treasury, for the purposes of this article and without regard to fiscal years, an amount that equals the total of both of the following:
(a)The sum annually necessary to pay the principal of, and interest on, bonds issued and sold pursuant to this article, as the principal and interest become due and payable.
(b)The sum necessary to carry out Section 11899.20.
11899.20.The foundation may request the Pooled Money Investment Board to make a loan from the Pooled Money Investment Account, in accordance with Section 16312, for the purposes of carrying out this article less any amount withdrawn pursuant to Section 11899.21 and not yet returned to the General Fund. The amount of the request shall not exceed the amount of the unsold bonds that the committee, by resolution, has authorized to be sold for the purpose of carrying out this article, excluding any refunding bonds authorized pursuant to Section 11899.23, less any amount loaned pursuant to this section and not yet repaid and any amount withdrawn from the General Fund pursuant to Section 11899.21 and not yet returned to the General Fund. The foundation shall execute any documents required by the Pooled Money Investment Board to obtain and repay the loan. Any amounts loaned shall be deposited into the fund to be allocated by the foundation in accordance with this article.
11899.21.For the purposes of carrying out this article, the Director of Finance may authorize the withdrawal from the General Fund of an amount, not to exceed the amount of the unsold bonds that have been authorized by the committee, to be sold for the purpose of carrying out this article, excluding any refunding bonds authorized pursuant to Section 11899.23, less any amount loaned pursuant to Section 11899.20 and not yet repaid, and any amount withdrawn from the General Fund pursuant to this section and not yet returned to the General Fund. Any amount withdrawn shall be deposited into the fund. Any moneys made available under this section shall be returned to the General Fund, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds for the purpose of carrying out this article.
11899.22.All moneys deposited into the fund that are derived from premium and accrued interest on bonds sold pursuant to this article shall be reserved in the fund and shall be available for transfer to the General Fund as a credit to expenditures for bond interest, except those amounts derived from premium may be reserved and used to pay the cost of bond issuance before any transfer to the General Fund.
11899.23.The bonds issued and sold pursuant to this article may be refunded in accordance with Article 6 (commencing with Section 16780) of Chapter 4 of Part 3 of Division 4, which is a part of the State General Obligation Bond Law. Approval by the voters of the state for the issuance of the bonds described in this article includes the approval of the issuance of any bonds issued to refund any bonds originally issued under this article or any previously issued refunding bonds. Any bond refunded with the proceeds of refunding bonds as authorized by this section may be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
11899.24.Notwithstanding any provision of this article or the State General Obligation Bond Law, if the Treasurer sells bonds pursuant to this article that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, the Treasurer may maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. The Treasurer may use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
11899.25.The proceeds from the sale of bonds authorized by this article are not proceeds of taxes as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed by that article.
SEC. 3.Section 2 of this act shall take effect upon the approval by the voters of the California Science and Health Research Bond Act, as set forth in Section 2 of this act.
SEC. 4.Section 2 of this act shall be submitted to the voters at the next statewide election in accordance with provisions of the Government Code and the Elections Code governing the submission of a statewide measure to the voters.
SEC. 5.This act shall be broadly construed to accomplish its purposes. The statutory provisions of the act may be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
SEC. 6.The provisions of this act are severable. If any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision shall not affect the validity of the remaining portions of this act. The people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
SEC. 7.(a)This act shall be liberally construed to effectuate its purposes.
(b)If this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure shall be self-executing and given full force and effect.
SEC. 8.The Legislature finds and declares that Section 2 of this act, which adds Section 11899.6 to the Government Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the publics access to this information.
|
Date
|
Status
|
|---|---|
| Sep 30, 2026 | Chaptered by Secretary of State. Chapter 1040, Statutes of 2026. |
| Sep 30, 2026 | Approved by the Governor. |
| Sep 10, 2026 | Enrolled and presented to the Governor at 4 p.m. |
| Aug 31, 2026 | Assembly amendments concurred in. (Ayes 28. Noes 9.) Ordered to engrossing and enrolling. |
| Aug 31, 2026 | Urgency clause adopted. |
| Aug 31, 2026 | In Senate. Concurrence in Assembly amendments pending. |
| Aug 31, 2026 | Read third time. Urgency clause adopted. Passed. (Ayes 67. Noes 6. Page 7010.) Ordered to the Senate. |
| Aug 31, 2026 | Read third time. Urgency clause adopted. Passed. Ordered to the Senate. |
| Aug 27, 2026 | Joint Rule 61(b)(16) suspended. (Ayes 58. Noes 1. Page 6727.) |
| Aug 27, 2026 | Ordered to third reading. |
| Aug 27, 2026 | Read third time and amended. |
| Aug 27, 2026 | Joint Rule 61(b)(16) suspended. |
| Aug 17, 2026 | Read second time. Ordered to third reading. |
| Aug 13, 2026 | Read second time and amended. Ordered to second reading. |
| Aug 13, 2026 | From committee: Do pass as amended. (Ayes 12. Noes 1.) (August 13). |
| Aug 13, 2026 | Assembly Rule 63 suspended. |
| Jun 24, 2026 | June 24 set for first hearing. Placed on suspense file. |
| Jun 10, 2026 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 2.) (June 9). Re-referred to Com. on APPR. |
| Jun 10, 2026 | Coauthors revised. |
| Jun 4, 2026 | Referred to Com. on HEALTH. |
| May 27, 2026 | In Assembly. Read first time. Held at Desk. |
| May 27, 2026 | Read third time. Passed. (Ayes 29. Noes 9. Page 4496.) Ordered to the Assembly. |
| May 27, 2026 | Read third time. Passed. (Ayes 29. Noes 9.) Ordered to the Assembly. |
| May 18, 2026 | Read second time. Ordered to third reading. |
| May 14, 2026 | From committee: Do pass as amended. (Ayes 5. Noes 2. Page 4256.) (May 14). |
| May 14, 2026 | Read second time and amended. Ordered to second reading. |
| May 14, 2026 | From committee: Do pass as amended. (Ayes 5. Noes 2.) (May 14). |
| May 8, 2026 | Set for hearing May 14. |
| Apr 27, 2026 | April 27 hearing: Placed on APPR. suspense file. |
| Apr 17, 2026 | Set for hearing April 27. |
| Apr 14, 2026 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 5. Noes 2. Page 3869.) (April 14). Re-referred to Com. on APPR. |
| Apr 14, 2026 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 5. Noes 2.) (April 14). Re-referred to Com. on APPR. |
| Apr 9, 2026 | Set for hearing April 14. |
| Apr 6, 2026 | Read second time and amended. Re-referred to Com. on N.R. & W. |
| Mar 26, 2026 | From committee: Do pass as amended and re-refer to Com. on N.R. & W. (Ayes 9. Noes 2. Page 3689.) (March 25). |
| Mar 26, 2026 | From committee: Do pass as amended and re-refer to Com. on N.R. & W. (Ayes 9. Noes 2.) (March 25). |
| Mar 16, 2026 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH. |
| Mar 11, 2026 | Set for hearing March 25. |
| Feb 11, 2026 | Referred to Coms. on HEALTH and N.R. & W. |
| Jan 16, 2026 | From printer. May be acted upon on or after February 15. |
| Jan 15, 2026 | Introduced. Read first time. To Com. on RLS. for assignment. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 31, 2026 | Unfinished Business SB895 Wiener et al. Urgency Clause Concurrence | Senate Floor |
Passed |
|
| Aug 31, 2026 | SB 895 Wiener Third Reading Urgency By Solache | Assembly Floor |
Passed |
|
| Aug 13, 2026 | Do pass as amended. | Assembly Standing Committee on Appropriations |
Passed |
|
| Jun 9, 2026 | Do pass and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Health |
Passed |
|
| May 27, 2026 | Senate 3rd Reading SB895 Wiener et al. | Senate Floor |
Passed |
|
| May 14, 2026 | Do pass as amended | Senate Standing Committee on Appropriations |
Passed |
|
| Apr 27, 2026 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Apr 14, 2026 | Do pass, but first be re-referred to the Committee on [Appropriations] | Senate Standing Committee on Natural Resources and Water |
Passed |
|
| Mar 25, 2026 | Do pass as amended, but first amend, and re-refer to the Committee on [Natural Resources and Water] | Senate Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| 350 Bay Area Action | ** Support | |
| Access Reproductive Justice | ** Support | |
| Alameda Labor Council | ** Support | |
| ALS Association | ** Support | |
| ALS Network | ** Support | |
| alzheimer's greater los angeles | ** Support | |
| alzheimer's orange county | ** Support | |
| Alzheimer'S San Diego | ** Support | |
| American Academy of Neurology | ** Support | |
| American Anthropological Association | ** Support | |
| American Brain Coalition | ** Support | |
| American College Of Physicians - California Chapter | ** Support | |
| American Federation of State, County, and Municipal Employees | ** Support | |
| American Parkinson Disease Association | ** Support | |
| American Parkison Disease Association | ** Support | |
| Association for Frontotemporal Degeneration | ** Support | |
| Association of California Caregiver Resource Centers | ** Support | |
| Association of Independent California Colleges & Universities | ** Support | |
| Association Of Northern California Oncologists | ** Support | |
| Berkeley Faculty Association | ** Support | |
| Blood Cancer United | ** Support | |
| California Academy of Preventive Medicine | ** Support | |
| California Academy Of Sciences | ** Support | |
| California Association of Professional Scientists, UAW Local 1115 | ** Support | |
| California Association of Professional Scientists UAW Local 115 | ** Support | |
| California Association Of Public Hospitals And Health Systems | ** Support | |
| California Chronic Care Coalition | ** Support | |
| California Consortium of Addiction Programs and Professionals | ** Support | |
| California Environmental Voters | ** Support | |
| California Faculty Association | ** Support | |
| California Federation of Labor Unions | ** Support | |
| California Institute of Technology | ** Support | |
| California Nurses Association | ** Support | |
| California Physicians Alliance | ** Support | |
| California Psychological Association | ** Support | |
| California State University | ** Support | |
| California State University, Office Of The Chancellor | ** Support | |
| California Working Families Party | ** Support | |
| Chamber San Mateo County | ** Support | |
| Children’s Specialty Care Coalition | ** Support | |
| Children'S Specialty Care Coalition | ** Support | |
| City of Eureka | ** Support | |
| cleanearth4kids.org | ** Support | |
| Council of University of California Faculty Associations | ** Support | |
| County Of San Diego | ** Support | |
| Courage California | ** Support | |
| Culver City Democratic Club | ** Support | |
| Equality California | ** Support | |
| Greater Fresno Parkinson's Support Group | ** Support | |
| Greater Fresno Parkinson’s Support Group | ** Support | |
| Humane World for Animals | ** Support | |
| imperial Valley Equity and Justice Coalition | ** Support | |
| Indivisible Ca: Statestrong | ** Support | |
| International Union, United Automobile, Aerospace, and Agricultural Implement Workers of America | ** Support | |
| Lieutenant Governor Eleni Kounalakis | ** Support | |
| Loma Linda University Adventist Health Sciences Center | ** Support | |
| Medical Oncology Association Of Southern California | ** Support | |
| Michael J. Fox Foundation for Parkinson’s Research | ** Support | |
| Natera, Inc. | ** Support | |
| National Union Of Healthcare Workers | ** Support | |
| Northeastern University | ** Support | |
| Palo Alto Chamber of Commerce | ** Support | |
| Parkinson Association of Northern California | ** Support | |
| Parkinson Network of Mt. Diablo | ** Support | |
| Parkinson’s Association of Northern California | ** Support | |
| Parkinson's Association of San Diego | ** Support | |
| Parkinson’s Association of San Diego | ** Support | |
| Parkinson's Community Los Angeles | ** Support | |
| Parkinson’s Community Los Angeles | ** Support | |
| Parkinson's Foundation | ** Support | |
| Parkinson’s Foundation | ** Support | |
| Parkinson's Resource Organization | ** Support | |
| Parkinson’s Resource Organization | ** Support | |
| Point Blue Conservation Science | ** Support | |
| Public Health Institute | ** Support | |
| San Diego Faculty Association | ** Support | |
| San Diego Natural History Museum | ** Support | |
| San Diego Zoo Wildlife Alliance | ** Support | |
| San Francisco Chamber of Commerce | ** Support | |
| san francisco marin medical society | ** Support | |
| San Mateo County Economic Development Association | ** Support | |
| Santa Monica Democratic Club | ** Support | |
| Seven Individuals | ** Support | |
| Silicon Valley Leadership Group | ** Support | |
| Solano County Democratic Central Committee | ** Support | |
| Stanford University | ** Support | |
| Teamsters California | ** Support | |
| The Children's Partnership | ** Support | |
| The Children’s Partnership | ** Support | |
| The Climate Center | ** Support | |
| The Los Angeles Trust for Children’s Health | ** Support | |
| Two individuals | ** Support | |
| Union of American Physicians and Dentists (Co-source) | ** Support | |
| Union Of Concerned Scientists | ** Support | |
| United Auto Workers Local 1115 | ** Support | |
| United Auto Workers Local 230 | ** Support | |
| United Auto Workers Local 4123 | ** Support | |
| United Auto Workers Local 4811 | ** Support | |
| United Auto Workers Local 509 | ** Support | |
| United Auto Workers Local 872 | ** Support | |
| United Auto Workers Region 6 (co-source) | ** Support | |
| United Auto Workers (UAW) 4811 | ** Support | |
| Universities Allied for Essential Medicines | ** Support | |
| University of California Chicanx Latinx Alumni Association | ** Support | |
| University of California (co-source) | ** Support | |
| University of California Graduate and Professional Council | ** Support | |
| University of California Irvine Faculty Association | ** Support | |
| University of California Los Angeles Faculty Association | ** Support | |
| University of California Los Angeles Graduate Students Association | ** Support | |
| University of California Office of the President | ** Support | |
| University of California Riverside Faculty Association | ** Support | |
| University of California San Francisco Faculty Association | ** Support | |
| University Of California Student Association | ** Support | |
| U.S. Pain Foundation | ** Support | |
| western center on law & poverty | ** Support |
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-4171 | SB 895 |
UNFINISHED BUSINESS
Bill No: SB 895
Author: Wiener (D), Pérez (D) and Wahab (D), et al.
Amended: 8/27/26
Vote: 27- Urgency
SENATE HEALTH COMMITTEE: 9-2, 3/25/26
AYES: Weber Pierson, Caballero, Durazo, Gonzalez, Menjivar, Padilla, Pérez, Rubio, Smallwood-Cuevas
NOES: Valladares, Grove
SENATE NATURAL RES. & WATER COMMITTEE: 5-2, 4/14/26
AYES: Becker, Allen, Cabaldon, Cortese, Stern
NOES: Seyarto, Grove
SENATE APPROPRIATIONS COMMITTEE: 5-2, 5/14/26
AYES: Cervantes, Cabaldon, Grayson, Richardson, Wahab
NOES: Seyarto, Dahle
SENATE FLOOR: 29-9, 5/27/26
AYES: Allen, Archuleta, Arreguín, Ashby, Becker, Blakespear, Cabaldon, Caballero, Cervantes, Cortese, Durazo, Gonzalez, Grayson, Laird, Limón, McGuire, McNerney, Menjivar, Padilla, Pérez, Reyes, Richardson, Rubio, Smallwood-Cuevas, Stern, Umberg, Wahab, Weber Pierson, Wiener
NOES: Alvarado-Gil, Choi, Grove, Jones, Niello, Ochoa Bogh, Seyarto, Strickland, Valladares
NO VOTE RECORDED: Dahle, Hurtado
ASSEMBLY FLOOR: 67-6, 8/31/26 - See last page for vote
SUBJECT: California Science and Health Research Bond Act
SOURCE: United Auto Workers Region 6
Union of American Physicians and Dentists
University of California
DIGEST:
- This bill creates the California Foundation for Science and Health Research (CFSHR), housed in the Government Operations Agency, to award grants, loans, and contracts to public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development from a California Foundation for Science and Health Research and Innovation Acceleration (CFSHRIA) Fund and CFSHRIA Benefit Fund. Establishes the CFSHR Council to establish and develop the strategic objectives and priorities of the Foundation and determine which projects will be awarded grants, loans, or contracts. Funds the CFSHRIA Fund through the issuance and sale of $7.5 billion in bonds, pending voter approval on the March 7, 2028 primary election ballot. Establishes the CFSHR Finance Committee to authorize the issuance and sale of bonds. Contains an urgency clause that will make this bill effective upon enactment.
Assembly Amendments
:
- Reduce the amount authorized for bond issuance and sale to $7.5 billion.
- Require at least 10% of fund money (no more than 1.5% of total bond funds annually) to be allocated consistent with the Advanced Research Projects Agency model.
- Require at least $250 million (no more than 0.5% of total bond funds annually) to be allocated to entities focused on the commercialization of research.
- Permits the University of California (UC) and California State University (CSU) to submit construction and modernization proposals to the Department of Finance (DOF) for facilities that support research consistent with CFSHR priorities. Requires the DOF, upon approval, to allocate $250 million to UC and $750 million to CSU from the CHSHRIA Fund for this purpose.
- Allow the CFSHR to award contracts, expand awardees to include academic medical centers, and restrict awardees to those where the majority of research is being conducted in California, and prohibit awards to, or collaborations with, specified foreign entities of concern.
- Include seismic and related geohazards in the list of research fields eligible for awards.
- Require the CFSHR to prioritize funding research that, beyond being subject to discretionary programmatic federal funding cuts, supports or accelerates the development and deployment of research that grows California’s economy and can lead to high-quality jobs.
- Permit the CFSHR to adopt regulations to achieve the goals of the CFSHR, and allow the CFSHR to enter into interagency agreements to administer programs funded by the CFSHR.
- Restrict the salary of the CFSHR director to the base salary of the Provost and Executive Vice President of Academic Affairs of the University of California.
- Require nine of the CFSHR Council members to be appointed by the Governor, instead of the Secretary of the Government Operations Agency (GovOps), including one with a background in research policy, establish a chair and staggered terms, remove term limits, and make Council members subject to disclosure requirements relating to personal investments and conflicts of interest.
- Require the CFSHR Council to provide the opportunity for public comment when developing the strategic objectives and priorities of the CFSHR, consider how the research priorities relate to or support the state’s economies and industries, and develop objectives and opportunities that support early-career researchers.
- Require the CFSHR Council to develop provisions and requirements to increase promote equitable access to subject inventions, make data resulting from bond-funded research available to the scientific community, and establish standards for intellectual property agreements that allow the state to benefit from the research it funds.
- Require the CFSHR to adopt regulations and standards to directly recoup or benefit from the research and development it funds and require proceeds of intellectual property assets to be deposited into the CFSHRIA Fund.
- Require the CFHSR to include in their annual report, in consultation with the Governor’s Office of Business and Economic Development, an assessment of how the work funded by the CFHSR impacts Californians or is supportive of California’s economy or job opportunities.
- Add an urgency clause that will make this bill effective upon enactment.
- Make various technical and conforming changes.
ANALYSIS:
Existing law:
- Establishes GovOps, which includes the Department of Technology, the Department of General Services, and the Office of Data and Innovation, among other departments, offices, and boards. [GOV §12803.2]
- Establishes the California Taxpayer Access to Publicly Funded Research Act, which requires a grantee that receives funding, in whole or in part, in the form of a research grant from a state agency to provide for free public access to any publication of a peer-reviewed manuscript describing state-agency-funded knowledge, a state-agency-funded invention, or state-agency-funded technology. [GOV §13989, et seq.]
- Establishes, within the California Constitution, the California Institute for Regenerative Medicine (CIRM) to make grants and loans for stem cell research, for research facilities, and for other vital research opportunities to realize therapies, protocols, and/or medical procedures that will result in, as speedily as possible, the cure for, and/or substantial mitigation of, major diseases, injuries, and orphan diseases. [California Constitution, Article XXXV, §2]
This bill:
CFSHR.
- Establishes the CFSHR in GovOps, and states that its role is to facilitate scientific research by awarding grants, loans, and contracts to companies, universities, academic medical centers, institutes, and organizations for scientific research and development, to construct facilities for research and development, and for sectors identified as “Bet” and “Accelerate” in the February 2025 California Jobs First State Economic Blueprint, including, but not limited to the following fields of research:
- Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), heart disease, strokes, child and adult leukemia, infectious diseases, HIV/AIDS, and genetic and chronic diseases affecting children and infants;
- Public health, including, but not limited to, environmental health detecting and responding to new and emerging health threats;
- Disease prevention, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS;
- Promoting healthy and safe behaviors, communities, and environment;
- Wildfire prevention;
- Behavioral health, including, but not limited to, addiction and substance use disorders;
- Climate, including climate change and its impact on human health and weather;
- Ocean, including sea level rise, and coastal and marine ecosystems and resources;
- Agriculture and water;
- Seismic and related geohazards;
- Emerging technologies; and,
- Safety, efficacy, and security of drugs, biological products, medical devices, our nation’s food supply, and cosmetics.
CFSHRIA Fund.
- Establishes the CFSHRIA Fund in the State Treasury, into which the proceeds of bonds issued/sold pursuant to this bill are required to be deposited. Establishes the CFSHRIA Benefit Fund in the State Treasury, consisting solely of donations. Requires the CFSHRIA Fund and CFSHRIA Benefit Fund to fund the CFSHR’s awarded grants, loans, and contracts.
- Requires research and development funded to be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to the California Taxpayer Access to Publicly Funded Research Act.
- Requires grants, loans, or contracts to be awarded or made available to researchers or projects located within this state. Permits funding for research collaboratives between California and out-of-state researchers if 75% of the funds awarded by the CFSHR to a specific project are used for research activities in California, and prohibits funding for entities that constitute a foreign entity of concern. Requires grants or loans to be awarded based on:
- Consistency with the research priorities established for CFSHR by the CFSHR Council established under this bill; and,
- The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as specified.
- The Federal Laboratory Contracting Act, if the funds are allocated to a U.S. Department of Energy or National Aeronautics and Space Administration laboratory operating within California.
- Requires CFSHR to prioritize funding research impacted by discretionary programmatic cuts by the federal government or research that supports or accelerates the development and deployment of research and innovations to grow California’s economy and that can lead to the creation of high-quality jobs.
- Requires research projects involving human subjects, to be eligible for funding, to be reviewed and approved by an institutional review board that meets specified requirements.
- Permits the UC and CSU to submit construction and modernization proposals to the DOF for facilities that support research consistent with CFSHR priorities. Requires the DOF, upon approval, to allocate $250 million to UC and $750 million to CSU from the CHSHRIA Fund through the budget for this purpose.
- Requires at least 10% of the money in the CFSHRIA Fund to be allocated consistent with the Advanced Research Projects Agency model that relies on collaboration between academic, industry, and government partners to pursue revolutionary breakthroughs focused on tangible, solutions-oriented aims. Restricts the finding to 1.5% of total bond funds to be allocated annually for this specific purpose.
- Requires at least $250 million and no more than 0.5% of total bond funds annually, to be used for commercialization of research by providing grants, loans, or contracts to entities focused on this purpose, with priority given to those that can demonstrate job growth or future manufacturing opportunities in California or can demonstrate additional funding mechanisms. Prohibits supporting manufacturing in foreign countries or foreign entities of concern.
- Requires proceeds of intellectual property assets to be deposited into CFSHRIA Fund and requires all intellectual property assets developed using funds authorized for, or made available to, the CFSHR be treated pursuant to state and federal law.
CFSHR administration.
- Requires the Governor to appoint the CFSHR director. Restricts the salary for the CFSHR director to the base salary of the UC Provost and Executive Vice President of Academic Affairs. Requires the CFSHR director and personnel to be responsible for implementing the strategic objectives of the CFSHR Council, administering the grants, loans, and contracts awarded by the CFSHR Council, and all other duties as deemed necessary.
- Prohibits more than 3% of CFSHRIA Fund money from being used for administrative costs.
- Requires CFSHR to recommend to the CFSHR Council, and requires the Council to adopt, standards to ensure that if a grantee, loan recipient, or contracted entity purchases goods or services using CFSHRIA funds, they are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50% of purchases from California suppliers.
CFSHR Council.
- Establishes the CFSHR Council, vested with full power, authority, and jurisdiction over the CFSHR, including the authority to adopt regulations to:
- Develop strategic objectives and research priorities, with a requirement to provide opportunity for public comment, and a requirement to consider how research priorities support areas critical to California’s economy and capitalize on and connect regional research hubs;
- Actively participate in the overall management of CFSHR; and,
- Determine which research projects will be funded based on the established research priorities and the technical merits of the proposals, as determined by scientific peer review panels.
- Develop objectives and opportunities that offer support to early career researchers.
- Requires the CFSHR Council to adopt regulations and standards to directly recoup or benefit from the investment by capturing a portion of the revenue from highly profitable inventions while not inhibiting the technology transfer process.
- Requires the CFSHR Council to consist of members, not subject to Senate confirmation, as follows:
- Nine members, appointed by the Governor, including one graduate-level researcher and at least one postdoctoral scholar, with current or past research experience in specified fields, and one member with a background in research policy;
- One member who is a health care provider appointed by the Senate Rules Committee;
- One member who is a climate, environmental, or environmental health advocate appointed by the Speaker of the Assembly;
- One member who is the CEO of the California Council on Science and Technology or their designee;
- One member designated by the President of the UC and one member designated by the Chancellor of the CSU, if the president and/or chancellor chooses to designate a representative, both of whom are required to be scientists or hold a background in science or research; and,
- One member designated by the President of the Association of Independent California Colleges and Universities, or the president’s designee, who is required to be a scientist or hold a background in science or research.
- Requires CFSHR Council members to serve four-year terms expiring June 30. Stipulates exceptions for graduate-level researchers and postdoctoral scholars. Requires the first terms for four of the appointments to be two-year terms.
- Establishes the member with a background in research policy as the first chair of the CFSHR Council, serving as chair for two years. Requires each subsequent chair to be elected by the members of the council for a term of two years.
- Requires the appointing authority, if a vacancy occurs within a term, to appoint a replacement member to serve the remainder of the term. Requires the appointing authority, when a term expires, to appoint a member to serve until the appointment of their successor or until a year has elapsed since the expiration of the term, whichever occurs first.
- Requires CFSHR Council members to serve without compensation but permits reimbursement for travel and necessary expenses actually incurred in the performance of duties.
- Specifies that a majority of the membership of the CFSHR Council (excluding recused or vacant seats) specifies a quorum for the transaction of any business, performance of any duty, or exercise of any power of the board. Requires a vote of a majority of the CFSHR Council members for the approval of funding of any research project or proposal presented for funding. Prohibits a grant or a loan from being approved if there are more than six vacancies on the CFSHR Council.
- Requires the CFSHR Council, prior to the first grant, and no later than one year from the date of enactment, to develop provisions to facilitate goals of affordability and equitable access that include guidance on the following topics:
- Access plans specifying strategies and timelines for promoting equitable access to the subject invention in California, the U.S., and low- and middle-income countries, addressing affordability, availability, acceptability, sustainability, and transparency.
- Data management, preservation, and availability resulting from bond-funded research to the broader scientific community, excepting requests from foreign countries or entities of concern. Requires grantees, loan recipients, and contractors to provide free public access to any publication that results from the bond-funded research.
- Provisions that may be triggered in the event of a declaration by the World Health Organization of a public health emergency of international concern related to a pathogen or disease for which the subject invention may be expected to be relevant for the prevention, diagnosis, or treatment of the emergency, with access commitments designed to prioritize timely and equitable supply of the invention in low- and middle-income countries, taking into account global health needs and manufacturing capacity.
- Requirements for grantees, loan recipients, or contractors to grant a license in any field of use to a responsible applicant or applicants, if, after written notice, a reasonable opportunity to cure any deficiency, and an opportunity for a hearing:
- The State of California determines that the grantee, loan recipient, or contractor licensee has not taken, or is not expected to take, steps to achieve practical application of the invention in that field of use; or,
- The State of California determines that such action is necessary to alleviate health and safety needs that the grantee, loan recipient, or contractor, or their licensee, is unlikely to satisfy.
- Permits the CFSHR Council to establish one or more scientific peer review panels consisting of experts in specified fields for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, potential benefits to the health and well-being of the population, natural resources, environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
- Prohibits an expert on a scientific review panel from having a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing.
- Authorizes a Council member to participate in decisions regarding research into a disease from which the member or their immediate family suffers. Provides that employment or service with specified institutions or organizations is not inimical to the Council member’s duties and provides that the Political Reform Act of 1974 does not apply to the council member if they recuse themselves from the decision to award or approve the grant or loan. Requires CFSHR Council members to disclose potential conflicts of interest.
- Applies the Bagley-Keene Open Meeting Act to all meetings of the CFSHR Council and any scientific peer review panels, except when discussing specified matters in closed sessions, including matters involving information relating to medical or scientific research subjects, confidential intellectual property, unpublished research products, personnel issues, and information believed to pose a security risk.
CFSHR annual reporting.
- Requires CFSHR to issue an annual report that sets forth its activities, grants, loans, or contracts awarded or in progress, research accomplishments, and future program directions, as specified. Requires the report to be published on the CFSHR website.
- Requires CFSHR to annually commission an independent financial audit of its activities from a certified public accounting firm, and provide that audit to the State Controller, who is required to review it annually and issue a public report. Requires the Controller to hold a public meeting with appropriate notice and a formal public comment period. Requires the Controller to evaluate public comments and include appropriate summaries in the annual report.
CFSHR bonds.
- Permits $7.5 billion in bonds to be issued and sold, not including the amount of any refunding bonds issued, as specified. Requires the bonds to be a valid and binding obligation of the State of California, and the full faith and credit of the State of California is pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
- Requires authorized bonds to be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law, the provisions of which apply to the bonds and to this bill, as specified.
- Requires the proceeds of bonds issued and sold to be deposited into the CFSHRIA Fund, and makes all money in the Fund continuously appropriated without respect to fiscal years for the purposes of this bill. Requires the Fund to be available for:
- Grants, loans, and contracts to fund research and operate and maintain facilities for research under this bill; and,
- Paying general administrative costs of CFSHR, not to exceed 3% of the CFSHRIA Fund amount.
- Requires repayment of principal and interest on any loans made by CFHSR to be deposited into the CFSHRIA Fund and used to make additional grants and loans or for paying continuing costs of the annual administration of outstanding bonds.
- Requires proceeds of interim debt and bonds to be deposited into the State Treasury to the credit of the CFSHRIA Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
CFSHR Finance Committee.
- Creates the CFSHR Finance Committee solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this bill. Requires the Finance Committee to consist of: the Treasurer; the Controller; the Director of Finance; the CFSHR Director; and, two members of the CFSHR Council, chosen by the Governor or their designated representatives. Requires the Treasurer to serve as chairperson of the Finance Committee.
- Requires the Finance Committee, by resolution, to determine whether or not it is necessary or desirable to issue and sell bonds in order to carry out the actions specified in this bill and, if so, the amount of bonds to be issued and sold. Permits successive issues of bonds to be authorized and sold to carry out those actions progressively, and specifies that it is not necessary that all of the bonds authorized to be issued be sold at any one time. Requires the Treasurer to issue and sell bonds in the amount determined by the Finance Committee to be necessary or desirable. Requires the bonds to be issued and sold upon the terms and conditions specified in a resolution adopted by the Finance Committee, as specified.
Revenue and principal/interest payments.
- Requires a sum to be collected each year in an amount required to pay the principal of, and interest on, the bonds becoming due each year, and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state. Makes it the duty of all officers charged by law with any duty in regard to the collection of the revenue to perform each and every act that is necessary to collect that additional sum.
- Requires continuous appropriation from the GF, for the purposes of this bill and without regard to fiscal years, the sum annually necessary to pay the principal of, and interest on, bonds issued and sold, as the principal and interest become due and payable.
- Permits the Director of Finance to authorize the withdrawal from the GF of an amount, not to exceed the amount of the unsold bonds that have been authorized by the Finance Committee, to be sold for the purpose of carrying out this bill, excluding any refunding bonds authorized and any amount withdrawn from the GF pursuant to this section and not yet returned. Requires any amount withdrawn to be deposited into the CFSHRIA Fund. Requires moneys made available to be returned to the GF, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds.
- Requires money in the CFSHRIA Fund derived from premium and accrued interest on bonds sold to be reserved and available for transfer to the GF as a credit to expenditures for bond interest. Permits those amounts derived from premium to be reserved and used to pay the cost of bond issuance before any transfer to the GF.
Miscellaneous.
- Permits bonds issued and sold to be refunded in accordance with the State General Obligation Bond Law. States that approval by the voters of the state for the issuance of the bonds includes the approval of the issuance of any bonds issued to refund any bonds originally issued or any previously issued refunding bonds. Permits any bond refunded with the proceeds of refunding bonds to be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
- Permits the Treasurer, if they sell bonds that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, to maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. Permits the Treasurer to use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
- Requires this bill to be submitted to the voters at the March 7, 2028 statewide primary election, to take effect upon approval voter approval. Exempts this bill from the requirement that a measure submitted to the people by the Legislature appear on the ballot of the first statewide election occurring at least 131 days after the adoption of the proposal by the Legislature.
- Makes the provisions of this bill severable.
- Makes a legislative finding and declaration that this bill imposes a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies to protect the privacy rights and the intellectual property interests of individuals and the security of the public.
- Contains an urgency clause that will make this bill effective upon enactment.
Comments
According to the author of this bill:
This bill will place on the March 2028 ballot a $7.5 billion bond to fund health and science research. The bill will additionally establish CFSHR, require affordability and recoupment provisions, and devote resources to a Cal-ARPA approach and commercialization efforts. Over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California’s health and economic wellbeing. Scientific research and innovation have driven California’s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state’s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health (NIH) research there is a return of approximately $2.50 in economic activity. Without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, this bill is a critical step.
Background: Please see the Senate Health Committee analysis for background information.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
This bill was amended after the Assembly Appropriations Committee analysis to increase the bond amount to $7.5 billion. According to the Assembly Appropriations Committee:
- Assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale), the total principal and interest costs to pay off the bonds would be approximately $9 billion ($5 billion in principal and $4 billion in interest), with average annual debt service payments of around $300 million (General Fund) when all bonds are sold.
- Administrative costs: GovOps estimates costs between $7.5 million to $15 million to implement this measure. GovOps states this bill requires a new function that GovOps has never done. GovOps estimates it would need between 15 and 23 staff of various classifications and significant funding for operating expenses and equipment to begin implementing the provisions of this bill. GovOps staff would need to support the Foundation and the Council, manage grants and loans made pursuant to this measure, issue reports, conduct bond compliance activities, bond accounting activities, develop the Foundation′s strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc. GovOps would likely need a General Fund loan to establish the Foundation and the Council, and to hire staff prior to the issuance of bonds. The General Fund could be paid back from bond proceeds in the future.
- Ballot costs: The Secretary of State (SOS) estimates this bill will require approximately 12 to 15 additional pages in the State Voter Information Guide and Text of Proposed Laws. Based on current printing rates of $123,359 per page, SOS estimates the cost to add the Bond Act to the ballot between $1.48 million and $1.85 million in fiscal year (FY) 2026-27 (General Fund).
SUPPORT: (Verified 8/30/26)
United Auto Workers Region 6 (co-source)
Union of American Physicians and Dentists (co-source)
University of California (co-source)
Lieutenant Governor Eleni Kounalakis
350 Bay Area Action
Access Reproductive Justice
Alameda Labor Council
ALS Association
ALS Network
American Academy of Neurology
American College of Physicians - California Chapter
American Federation of State, County, and Municipal Employees
American Parkison Disease Association
Association of California Caregiver Resource Centers
Association of Independent California Colleges & Universities
Association of Northern California Oncologists
Berkeley Faculty Association
Blood Cancer United
California Academy of Preventive Medicine
California Academy of Sciences
California Association of Professional Scientists, UAW Local 1115
California Chronic Care Coalition
California Consortium of Addiction Programs and Professionals
California Environmental Voters
California Faculty Association
California Federation of Labor Unions
California Institute of Technology
California Nurses Association
California Physicians Alliance
California Psychological Association
California State University
Chamber San Mateo County
Children’s Specialty Care Coalition
City of Eureka
CleanEarth4Kids.org
Council of University of California Faculty Associations
County of San Diego
Courage California
Culver City Democratic Club
Equality California
Greater Fresno Parkinson’s Support Group
Humane World for Animals
Indivisible CA: StateStrong
International Union, United Automobile, Aerospace, and Agricultural Implement
Workers of America
Loma Linda University Adventist Health Sciences Center
Medical Oncology Association of Southern California
Michael J. Fox Foundation for Parkinson’s Research
Natera, Inc.
National Union of Healthcare Workers
Northeastern University
Palo Alto Chamber of Commerce
Parkinson Network of Mt. Diablo
Parkinson’s Association of Northern California
Parkinson’s Association of San Diego
Parkinson’s Community Los Angeles
Parkinson’s Foundation
Parkinson’s Resource Organization
Point Blue Conservation Science
Public Health Institute
San Diego Faculty Association
San Diego Natural History Museum
San Diego Zoo Wildlife Alliance
San Francisco Chamber of Commerce
San Francisco Marin Medical Society
San Mateo County Economic Development Association
Santa Monica Democratic Club
Silicon Valley Leadership Group
Solano County Democratic Central Committee
Stanford University
Teamsters California
The Children's Partnership
U.S. Pain Foundation
The Climate Center
United Auto Workers Local 230
United Auto Workers Local 509
United Auto Workers Local 872
United Auto Workers Local 1115
United Auto Workers Local 4123
United Auto Workers Local 4811
Universities Allied for Essential Medicines
University of California Irvine Faculty Association
University of California Los Angeles Faculty Association
University of California Los Angeles Graduate Students Association
University of California Graduate and Professional Council
University of California Riverside Faculty Association
University of California San Francisco Faculty Association
University of California Student Association
Western Center on Law & Poverty
Seven individuals
OPPOSITION: (Verified 8/30/26)
None received
ARGUMENTS IN SUPPORT: The United Auto Workers (UAW) Region 6, UAW Local 4811, and the Union of American Physicians and Dentists, co-sponsors of the bill, call for action to counteract federal cuts and suspensions to NIH grants, and state that the CFSHR will safeguard California’s role as a global leader in innovation, boost tax revenue, drive middle class job growth, and provide hope and healing to millions of Californians facing deadly and debilitating diseases. The University of California, another co-sponsor, asserts that they currently receive $5.7 billion annually in federal support for research, and that a sustained loss in federal funding would cause enormous harm to the institution and their students, causing tens of thousands of jobs lost and an exodus of research talent from the state. Other supporters, including groups representing business, labor, patients, physicians, and academics echo that this bill preserves and strengthens California’s global leadership position in science, innovation, and public health, creates hundreds of thousands of high-wage jobs, and ensures that lifesaving and economically vital scientific research continues in the state, even if the federal government cuts or withholds federal funds. University student associations highlight the role of graduate students in driving academic research and the importance of this bill for the scientific and healthcare workforce pipeline in an uncertain federal funding environment. These groups emphasize that reliable funding is important for timely degree completion, access to laboratory resources, and the hands-on experience required for careers in science, medicine, and engineering.
Support if amended. The Association for Frontotemporal Degeneration writes that amending all references of Alzheimer’s disease to “Alzheimer’s and other dementias” would better reflect the full scope of dementias affecting Californians, strengthening the bill’s public health impact by addressing an often-overshadowed need.
Beyond an amendment to include academic medical centers as eligible recipients of CFSHR funding, which was included in recent amendments, Cedars-Sinai requests that the bill include dedicated representation for academic medical centers on the CFSHR Council, ensuring that health system and patient-care perspectives inform funding priorities and decision-making.
ASSEMBLY FLOOR: 67-6, 8/31/26
AYES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Castillo, Connolly, Davies, Elhawary, Ellis, Flora, Fong, Gabriel, Garcia, Gipson, Jeff Gonzalez, Mark González, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Kalra, Krell, Lee, Lowenthal, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Pellerin, Petrie-Norris, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Blanca Rubio, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NOES: DeMaio, Dixon, Johnson, Macedo, Sanchez, Tangipa
NO VOTE RECORDED: Chen, Hadwick, Lackey, Patterson, Quirk-Silva, Ta
Prepared by: Natalie Gehred / HEALTH / (916) 651-4111
9/22/26 15:42:32
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-4171 | SB 895 |
UNFINISHED BUSINESS
Bill No: SB 895
Author: Wiener (D), Pérez (D) and Wahab (D), et al.
Amended: 8/27/26
Vote: 27
SENATE HEALTH COMMITTEE: 9-2, 3/25/26
AYES: Weber Pierson, Caballero, Durazo, Gonzalez, Menjivar, Padilla, Pérez, Rubio, Smallwood-Cuevas
NOES: Valladares, Grove
SENATE NATURAL RES. & WATER COMMITTEE: 5-2, 4/14/26
AYES: Becker, Allen, Cabaldon, Cortese, Stern
NOES: Seyarto, Grove
SENATE APPROPRIATIONS COMMITTEE: 5-2, 5/14/26
AYES: Cervantes, Cabaldon, Grayson, Richardson, Wahab
NOES: Seyarto, Dahle
SENATE FLOOR: 29-9, 5/27/26
AYES: Allen, Archuleta, Arreguín, Ashby, Becker, Blakespear, Cabaldon, Caballero, Cervantes, Cortese, Durazo, Gonzalez, Grayson, Laird, Limón, McGuire, McNerney, Menjivar, Padilla, Pérez, Reyes, Richardson, Rubio, Smallwood-Cuevas, Stern, Umberg, Wahab, Weber Pierson, Wiener
NOES: Alvarado-Gil, Choi, Grove, Jones, Niello, Ochoa Bogh, Seyarto, Strickland, Valladares
NO VOTE RECORDED: Dahle, Hurtado
ASSEMBLY FLOOR: Passed, 8/31/26
SUBJECT: California Science and Health Research Bond Act
SOURCE: United Auto Workers Region 6
Union of American Physicians and Dentists
University of California
DIGEST:
- This bill creates the California Foundation for Science and Health Research (CFSHR), housed in the Government Operations Agency, to award grants, loans, and contracts to public or private research companies, universities, academic medical centers, institutes, and organizations for scientific research and development from a California Foundation for Science and Health Research and Innovation Acceleration (CFSHRIA) Fund and CFSHRIA Benefit Fund. Establishes the CFSHR Council to establish and develop the strategic objectives and priorities of the Foundation and determine which projects will be awarded grants, loans, or contracts. Funds the CFSHRIA Fund through the issuance and sale of $7.5 billion in bonds, pending voter approval on the March 7, 2028 primary election ballot. Establishes the CFSHR Finance Committee to authorize the issuance and sale of bonds. Contains an urgency clause that will make this bill effective upon enactment.
Assembly Amendments
:
- Reduce the amount authorized for bond issuance and sale to $7.5 billion.
- Require at least 10% of fund money (no more than 1.5% of total bond funds annually) to be allocated consistent with the Advanced Research Projects Agency model.
- Require at least $250 million (no more than 0.5% of total bond funds annually) to be allocated to entities focused on the commercialization of research.
- Permits the University of California (UC) and California State University (CSU) to submit construction and modernization proposals to the Department of Finance (DOF) for facilities that support research consistent with CFSHR priorities. Requires the DOF, upon approval, to allocate $250 million to UC and $750 million to CSU from the CHSHRIA Fund for this purpose.
- Allow the CFSHR to award contracts, expand awardees to include academic medical centers, and restrict awardees to those where the majority of research is being conducted in California, and prohibit awards to, or collaborations with, specified foreign entities of concern.
- Include seismic and related geohazards in the list of research fields eligible for awards.
- Require the CFSHR to prioritize funding research that, beyond being subject to discretionary programmatic federal funding cuts, supports or accelerates the development and deployment of research that grows California’s economy and can lead to high-quality jobs.
- Permit the CFSHR to adopt regulations to achieve the goals of the CFSHR, and allow the CFSHR to enter into interagency agreements to administer programs funded by the CFSHR.
- Restrict the salary of the CFSHR director to the base salary of the Provost and Executive Vice President of Academic Affairs of the University of California.
- Require nine of the CFSHR Council members to be appointed by the Governor, instead of the Secretary of the Government Operations Agency (GovOps), including one with a background in research policy, establish a chair and staggered terms, remove term limits, and make Council members subject to disclosure requirements relating to personal investments and conflicts of interest.
- Require the CFSHR Council to provide the opportunity for public comment when developing the strategic objectives and priorities of the CFSHR, consider how the research priorities relate to or support the state’s economies and industries, and develop objectives and opportunities that support early-career researchers.
- Require the CFSHR Council to develop provisions and requirements to increase promote equitable access to subject inventions, make data resulting from bond-funded research available to the scientific community, and establish standards for intellectual property agreements that allow the state to benefit from the research it funds.
- Require the CFSHR to adopt regulations and standards to directly recoup or benefit from the research and development it funds and require proceeds of intellectual property assets to be deposited into the CFSHRIA Fund.
- Require the CFHSR to include in their annual report, in consultation with the Governor’s Office of Business and Economic Development, an assessment of how the work funded by the CFHSR impacts Californians or is supportive of California’s economy or job opportunities.
- Add an urgency clause that will make this bill effective upon enactment.
- Make various technical and conforming changes.
ANALYSIS:
Existing law:
- Establishes GovOps, which includes the Department of Technology, the Department of General Services, and the Office of Data and Innovation, among other departments, offices, and boards. [GOV §12803.2]
- Establishes the California Taxpayer Access to Publicly Funded Research Act, which requires a grantee that receives funding, in whole or in part, in the form of a research grant from a state agency to provide for free public access to any publication of a peer-reviewed manuscript describing state-agency-funded knowledge, a state-agency-funded invention, or state-agency-funded technology. [GOV §13989, et seq.]
- Establishes, within the California Constitution, the California Institute for Regenerative Medicine (CIRM) to make grants and loans for stem cell research, for research facilities, and for other vital research opportunities to realize therapies, protocols, and/or medical procedures that will result in, as speedily as possible, the cure for, and/or substantial mitigation of, major diseases, injuries, and orphan diseases. [California Constitution, Article XXXV, §2]
This bill:
CFSHR.
- Establishes the CFSHR in GovOps, and states that its role is to facilitate scientific research by awarding grants, loans, and contracts to companies, universities, academic medical centers, institutes, and organizations for scientific research and development, to construct facilities for research and development, and for sectors identified as “Bet” and “Accelerate” in the February 2025 California Jobs First State Economic Blueprint, including, but not limited to the following fields of research:
- Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), heart disease, strokes, child and adult leukemia, infectious diseases, HIV/AIDS, and genetic and chronic diseases affecting children and infants;
- Public health, including, but not limited to, environmental health detecting and responding to new and emerging health threats;
- Disease prevention, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS;
- Promoting healthy and safe behaviors, communities, and environment;
- Wildfire prevention;
- Behavioral health, including, but not limited to, addiction and substance use disorders;
- Climate, including climate change and its impact on human health and weather;
- Ocean, including sea level rise, and coastal and marine ecosystems and resources;
- Agriculture and water;
- Seismic and related geohazards;
- Emerging technologies; and,
- Safety, efficacy, and security of drugs, biological products, medical devices, our nation’s food supply, and cosmetics.
CFSHRIA Fund.
- Establishes the CFSHRIA Fund in the State Treasury, into which the proceeds of bonds issued/sold pursuant to this bill are required to be deposited. Establishes the CFSHRIA Benefit Fund in the State Treasury, consisting solely of donations. Requires the CFSHRIA Fund and CFSHRIA Benefit Fund to fund the CFSHR’s awarded grants, loans, and contracts.
- Requires research and development funded to be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to the California Taxpayer Access to Publicly Funded Research Act.
- Requires grants, loans, or contracts to be awarded or made available to researchers or projects located within this state. Permits funding for research collaboratives between California and out-of-state researchers if 75% of the funds awarded by the CFSHR to a specific project are used for research activities in California, and prohibits funding for entities that constitute a foreign entity of concern. Requires grants or loans to be awarded based on:
- Consistency with the research priorities established for CFSHR by the CFSHR Council established under this bill; and,
- The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as specified.
- The Federal Laboratory Contracting Act, if the funds are allocated to a U.S. Department of Energy or National Aeronautics and Space Administration laboratory operating within California.
- Requires CFSHR to prioritize funding research impacted by discretionary programmatic cuts by the federal government or research that supports or accelerates the development and deployment of research and innovations to grow California’s economy and that can lead to the creation of high-quality jobs.
- Requires research projects involving human subjects, to be eligible for funding, to be reviewed and approved by an institutional review board that meets specified requirements.
- Permits the UC and CSU to submit construction and modernization proposals to the DOF for facilities that support research consistent with CFSHR priorities. Requires the DOF, upon approval, to allocate $250 million to UC and $750 million to CSU from the CHSHRIA Fund through the budget for this purpose.
- Requires at least 10% of the money in the CFSHRIA Fund to be allocated consistent with the Advanced Research Projects Agency model that relies on collaboration between academic, industry, and government partners to pursue revolutionary breakthroughs focused on tangible, solutions-oriented aims. Restricts the finding to 1.5% of total bond funds to be allocated annually for this specific purpose.
- Requires at least $250 million and no more than 0.5% of total bond funds annually, to be used for commercialization of research by providing grants, loans, or contracts to entities focused on this purpose, with priority given to those that can demonstrate job growth or future manufacturing opportunities in California or can demonstrate additional funding mechanisms. Prohibits supporting manufacturing in foreign countries or foreign entities of concern.
- Requires proceeds of intellectual property assets to be deposited into CFSHRIA Fund and requires all intellectual property assets developed using funds authorized for, or made available to, the CFSHR be treated pursuant to state and federal law.
CFSHR administration.
- Requires the Governor to appoint the CFSHR director. Restricts the salary for the CFSHR director to the base salary of the UC Provost and Executive Vice President of Academic Affairs. Requires the CFSHR director and personnel to be responsible for implementing the strategic objectives of the CFSHR Council, administering the grants, loans, and contracts awarded by the CFSHR Council, and all other duties as deemed necessary.
- Prohibits more than 3% of CFSHRIA Fund money from being used for administrative costs.
- Requires CFSHR to recommend to the CFSHR Council, and requires the Council to adopt, standards to ensure that if a grantee, loan recipient, or contracted entity purchases goods or services using CFSHRIA funds, they are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50% of purchases from California suppliers.
CFSHR Council.
- Establishes the CFSHR Council, vested with full power, authority, and jurisdiction over the CFSHR, including the authority to adopt regulations to:
- Develop strategic objectives and research priorities, with a requirement to provide opportunity for public comment, and a requirement to consider how research priorities support areas critical to California’s economy and capitalize on and connect regional research hubs;
- Actively participate in the overall management of CFSHR; and,
- Determine which research projects will be funded based on the established research priorities and the technical merits of the proposals, as determined by scientific peer review panels.
- Develop objectives and opportunities that offer support to early career researchers.
- Requires the CFSHR Council to adopt regulations and standards to directly recoup or benefit from the investment by capturing a portion of the revenue from highly profitable inventions while not inhibiting the technology transfer process.
- Requires the CFSHR Council to consist of members, not subject to Senate confirmation, as follows:
- Nine members, appointed by the Governor, including one graduate-level researcher and at least one postdoctoral scholar, with current or past research experience in specified fields, and one member with a background in research policy;
- One member who is a health care provider appointed by the Senate Rules Committee;
- One member who is a climate, environmental, or environmental health advocate appointed by the Speaker of the Assembly;
- One member who is the CEO of the California Council on Science and Technology or their designee;
- One member designated by the President of the UC and one member designated by the Chancellor of the CSU, if the president and/or chancellor chooses to designate a representative, both of whom are required to be scientists or hold a background in science or research; and,
- One member designated by the President of the Association of Independent California Colleges and Universities, or the president’s designee, who is required to be a scientist or hold a background in science or research.
- Requires CFSHR Council members to serve four-year terms expiring June 30. Stipulates exceptions for graduate-level researchers and postdoctoral scholars. Requires the first terms for four of the appointments to be two-year terms.
- Establishes the member with a background in research policy as the first chair of the CFSHR Council, serving as chair for two years. Requires each subsequent chair to be elected by the members of the council for a term of two years.
- Requires the appointing authority, if a vacancy occurs within a term, to appoint a replacement member to serve the remainder of the term. Requires the appointing authority, when a term expires, to appoint a member to serve until the appointment of their successor or until a year has elapsed since the expiration of the term, whichever occurs first.
- Requires CFSHR Council members to serve without compensation but permits reimbursement for travel and necessary expenses actually incurred in the performance of duties.
- Specifies that a majority of the membership of the CFSHR Council (excluding recused or vacant seats) specifies a quorum for the transaction of any business, performance of any duty, or exercise of any power of the board. Requires a vote of a majority of the CFSHR Council members for the approval of funding of any research project or proposal presented for funding. Prohibits a grant or a loan from being approved if there are more than six vacancies on the CFSHR Council.
- Requires the CFSHR Council, prior to the first grant, and no later than one year from the date of enactment, to develop provisions to facilitate goals of affordability and equitable access that include guidance on the following topics:
- Access plans specifying strategies and timelines for promoting equitable access to the subject invention in California, the U.S., and low- and middle-income countries, addressing affordability, availability, acceptability, sustainability, and transparency.
- Data management, preservation, and availability resulting from bond-funded research to the broader scientific community, excepting requests from foreign countries or entities of concern. Requires grantees, loan recipients, and contractors to provide free public access to any publication that results from the bond-funded research.
- Provisions that may be triggered in the event of a declaration by the World Health Organization of a public health emergency of international concern related to a pathogen or disease for which the subject invention may be expected to be relevant for the prevention, diagnosis, or treatment of the emergency, with access commitments designed to prioritize timely and equitable supply of the invention in low- and middle-income countries, taking into account global health needs and manufacturing capacity.
- Requirements for grantees, loan recipients, or contractors to grant a license in any field of use to a responsible applicant or applicants, if, after written notice, a reasonable opportunity to cure any deficiency, and an opportunity for a hearing:
- The State of California determines that the grantee, loan recipient, or contractor licensee has not taken, or is not expected to take, steps to achieve practical application of the invention in that field of use; or,
- The State of California determines that such action is necessary to alleviate health and safety needs that the grantee, loan recipient, or contractor, or their licensee, is unlikely to satisfy.
- Permits the CFSHR Council to establish one or more scientific peer review panels consisting of experts in specified fields for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, potential benefits to the health and well-being of the population, natural resources, environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
- Prohibits an expert on a scientific review panel from having a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing.
- Authorizes a Council member to participate in decisions regarding research into a disease from which the member or their immediate family suffers. Provides that employment or service with specified institutions or organizations is not inimical to the Council member’s duties and provides that the Political Reform Act of 1974 does not apply to the council member if they recuse themselves from the decision to award or approve the grant or loan. Requires CFSHR Council members to disclose potential conflicts of interest.
- Applies the Bagley-Keene Open Meeting Act to all meetings of the CFSHR Council and any scientific peer review panels, except when discussing specified matters in closed sessions, including matters involving information relating to medical or scientific research subjects, confidential intellectual property, unpublished research products, personnel issues, and information believed to pose a security risk.
CFSHR annual reporting.
- Requires CFSHR to issue an annual report that sets forth its activities, grants, loans, or contracts awarded or in progress, research accomplishments, and future program directions, as specified. Requires the report to be published on the CFSHR website.
- Requires CFSHR to annually commission an independent financial audit of its activities from a certified public accounting firm, and provide that audit to the State Controller, who is required to review it annually and issue a public report. Requires the Controller to hold a public meeting with appropriate notice and a formal public comment period. Requires the Controller to evaluate public comments and include appropriate summaries in the annual report.
CFSHR bonds.
- Permits $7.5 billion in bonds to be issued and sold, not including the amount of any refunding bonds issued, as specified. Requires the bonds to be a valid and binding obligation of the State of California, and the full faith and credit of the State of California is pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
- Requires authorized bonds to be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law, the provisions of which apply to the bonds and to this bill, as specified.
- Requires the proceeds of bonds issued and sold to be deposited into the CFSHRIA Fund, and makes all money in the Fund continuously appropriated without respect to fiscal years for the purposes of this bill. Requires the Fund to be available for:
- Grants, loans, and contracts to fund research and operate and maintain facilities for research under this bill; and,
- Paying general administrative costs of CFSHR, not to exceed 3% of the CFSHRIA Fund amount.
- Requires repayment of principal and interest on any loans made by CFHSR to be deposited into the CFSHRIA Fund and used to make additional grants and loans or for paying continuing costs of the annual administration of outstanding bonds.
- Requires proceeds of interim debt and bonds to be deposited into the State Treasury to the credit of the CFSHRIA Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
CFSHR Finance Committee.
- Creates the CFSHR Finance Committee solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this bill. Requires the Finance Committee to consist of: the Treasurer; the Controller; the Director of Finance; the CFSHR Director; and, two members of the CFSHR Council, chosen by the Governor or their designated representatives. Requires the Treasurer to serve as chairperson of the Finance Committee.
- Requires the Finance Committee, by resolution, to determine whether or not it is necessary or desirable to issue and sell bonds in order to carry out the actions specified in this bill and, if so, the amount of bonds to be issued and sold. Permits successive issues of bonds to be authorized and sold to carry out those actions progressively, and specifies that it is not necessary that all of the bonds authorized to be issued be sold at any one time. Requires the Treasurer to issue and sell bonds in the amount determined by the Finance Committee to be necessary or desirable. Requires the bonds to be issued and sold upon the terms and conditions specified in a resolution adopted by the Finance Committee, as specified.
Revenue and principal/interest payments.
- Requires a sum to be collected each year in an amount required to pay the principal of, and interest on, the bonds becoming due each year, and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state. Makes it the duty of all officers charged by law with any duty in regard to the collection of the revenue to perform each and every act that is necessary to collect that additional sum.
- Requires continuous appropriation from the GF, for the purposes of this bill and without regard to fiscal years, the sum annually necessary to pay the principal of, and interest on, bonds issued and sold, as the principal and interest become due and payable.
- Permits the Director of Finance to authorize the withdrawal from the GF of an amount, not to exceed the amount of the unsold bonds that have been authorized by the Finance Committee, to be sold for the purpose of carrying out this bill, excluding any refunding bonds authorized and any amount withdrawn from the GF pursuant to this section and not yet returned. Requires any amount withdrawn to be deposited into the CFSHRIA Fund. Requires moneys made available to be returned to the GF, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds.
- Requires money in the CFSHRIA Fund derived from premium and accrued interest on bonds sold to be reserved and available for transfer to the GF as a credit to expenditures for bond interest. Permits those amounts derived from premium to be reserved and used to pay the cost of bond issuance before any transfer to the GF.
Miscellaneous.
- Permits bonds issued and sold to be refunded in accordance with the State General Obligation Bond Law. States that approval by the voters of the state for the issuance of the bonds includes the approval of the issuance of any bonds issued to refund any bonds originally issued or any previously issued refunding bonds. Permits any bond refunded with the proceeds of refunding bonds to be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
- Permits the Treasurer, if they sell bonds that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, to maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. Permits the Treasurer to use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
- Requires this bill to be submitted to the voters at the March 7, 2028 statewide primary election, to take effect upon approval voter approval. Exempts this bill from the requirement that a measure submitted to the people by the Legislature appear on the ballot of the first statewide election occurring at least 131 days after the adoption of the proposal by the Legislature.
- Makes the provisions of this bill severable.
- Makes a legislative finding and declaration that this bill imposes a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies to protect the privacy rights and the intellectual property interests of individuals and the security of the public.
- Contains an urgency clause that will make this bill effective upon enactment.
Comments
According to the author of this bill:
This bill will place on the March 2028 ballot a $7.5 billion bond to fund health and science research. The bill will additionally establish CFSHR, require affordability and recoupment provisions, and devote resources to a Cal-ARPA approach and commercialization efforts. Over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California’s health and economic wellbeing. Scientific research and innovation have driven California’s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state’s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health (NIH) research there is a return of approximately $2.50 in economic activity. Without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, this bill is a critical step.
Background: Please see the Senate Health Committee analysis for background information.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
This bill was amended after the Assembly Appropriations Committee analysis to increase the bond amount to $7.5 billion. According to the Assembly Appropriations Committee:
- Assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale), the total principal and interest costs to pay off the bonds would be approximately $9 billion ($5 billion in principal and $4 billion in interest), with average annual debt service payments of around $300 million (General Fund) when all bonds are sold.
- Administrative costs: GovOps estimates costs between $7.5 million to $15 million to implement this measure. GovOps states this bill requires a new function that GovOps has never done. GovOps estimates it would need between 15 and 23 staff of various classifications and significant funding for operating expenses and equipment to begin implementing the provisions of this bill. GovOps staff would need to support the Foundation and the Council, manage grants and loans made pursuant to this measure, issue reports, conduct bond compliance activities, bond accounting activities, develop the Foundation′s strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc. GovOps would likely need a General Fund loan to establish the Foundation and the Council, and to hire staff prior to the issuance of bonds. The General Fund could be paid back from bond proceeds in the future.
- Ballot costs: The Secretary of State (SOS) estimates this bill will require approximately 12 to 15 additional pages in the State Voter Information Guide and Text of Proposed Laws. Based on current printing rates of $123,359 per page, SOS estimates the cost to add the Bond Act to the ballot between $1.48 million and $1.85 million in fiscal year (FY) 2026-27 (General Fund).
SUPPORT: (Verified 8/30/26)
United Auto Workers Region 6 (co-source)
Union of American Physicians and Dentists (co-source)
University of California (co-source)
Lieutenant Governor Eleni Kounalakis
350 Bay Area Action
Access Reproductive Justice
Alameda Labor Council
ALS Association
ALS Network
American Academy of Neurology
American College of Physicians - California Chapter
American Federation of State, County, and Municipal Employees
American Parkison Disease Association
Association of California Caregiver Resource Centers
Association of Independent California Colleges & Universities
Association of Northern California Oncologists
Berkeley Faculty Association
Blood Cancer United
California Academy of Preventive Medicine
California Academy of Sciences
California Association of Professional Scientists, UAW Local 1115
California Chronic Care Coalition
California Consortium of Addiction Programs and Professionals
California Environmental Voters
California Faculty Association
California Federation of Labor Unions
California Institute of Technology
California Nurses Association
California Physicians Alliance
California Psychological Association
California State University
Chamber San Mateo County
Children’s Specialty Care Coalition
City of Eureka
CleanEarth4Kids.org
Council of University of California Faculty Associations
County of San Diego
Courage California
Culver City Democratic Club
Equality California
Greater Fresno Parkinson’s Support Group
Humane World for Animals
Indivisible CA: StateStrong
International Union, United Automobile, Aerospace, and Agricultural Implement
Workers of America
Loma Linda University Adventist Health Sciences Center
Medical Oncology Association of Southern California
Michael J. Fox Foundation for Parkinson’s Research
Natera, Inc.
National Union of Healthcare Workers
Northeastern University
Palo Alto Chamber of Commerce
Parkinson Network of Mt. Diablo
Parkinson’s Association of Northern California
Parkinson’s Association of San Diego
Parkinson’s Community Los Angeles
Parkinson’s Foundation
Parkinson’s Resource Organization
Point Blue Conservation Science
Public Health Institute
San Diego Faculty Association
San Diego Natural History Museum
San Diego Zoo Wildlife Alliance
San Francisco Chamber of Commerce
San Francisco Marin Medical Society
San Mateo County Economic Development Association
Santa Monica Democratic Club
Silicon Valley Leadership Group
Solano County Democratic Central Committee
Stanford University
Teamsters California
The Children's Partnership
U.S. Pain Foundation
The Climate Center
United Auto Workers Local 230
United Auto Workers Local 509
United Auto Workers Local 872
United Auto Workers Local 1115
United Auto Workers Local 4123
United Auto Workers Local 4811
Universities Allied for Essential Medicines
University of California Irvine Faculty Association
University of California Los Angeles Faculty Association
University of California Los Angeles Graduate Students Association
University of California Graduate and Professional Council
University of California Riverside Faculty Association
University of California San Francisco Faculty Association
University of California Student Association
Western Center on Law & Poverty
Seven individuals
OPPOSITION: (Verified 8/30/26)
None received
ARGUMENTS IN SUPPORT: The United Auto Workers (UAW) Region 6, UAW Local 4811, and the Union of American Physicians and Dentists, co-sponsors of the bill, call for action to counteract federal cuts and suspensions to NIH grants, and state that the CFSHR will safeguard California’s role as a global leader in innovation, boost tax revenue, drive middle class job growth, and provide hope and healing to millions of Californians facing deadly and debilitating diseases. The University of California, another co-sponsor, asserts that they currently receive $5.7 billion annually in federal support for research, and that a sustained loss in federal funding would cause enormous harm to the institution and their students, causing tens of thousands of jobs lost and an exodus of research talent from the state. Other supporters, including groups representing business, labor, patients, physicians, and academics echo that this bill preserves and strengthens California’s global leadership position in science, innovation, and public health, creates hundreds of thousands of high-wage jobs, and ensures that lifesaving and economically vital scientific research continues in the state, even if the federal government cuts or withholds federal funds. University student associations highlight the role of graduate students in driving academic research and the importance of this bill for the scientific and healthcare workforce pipeline in an uncertain federal funding environment. These groups emphasize that reliable funding is important for timely degree completion, access to laboratory resources, and the hands-on experience required for careers in science, medicine, and engineering.
Support if amended. The Association for Frontotemporal Degeneration writes that amending all references of Alzheimer’s disease to “Alzheimer’s and other dementias” would better reflect the full scope of dementias affecting Californians, strengthening the bill’s public health impact by addressing an often-overshadowed need. Beyond an amendment to include academic medical centers as eligible recipients of CFSHR funding, which was included in recent amendments, Cedars-Sinai requests that the bill include dedicated representation for academic medical centers on the CFSHR Council, ensuring that health system and patient-care perspectives inform funding priorities and decision-making.
Prepared by: Natalie Gehred / HEALTH / (916) 651-4111
8/31/26 15:44:00
SENATE THIRD READING
STR Bill Id:SB 895
Author:(Wiener, et al.)
As Amended Ver:August 27, 2026
2/3 vote. Urgency
SUMMARY
Enacts the California Science and Health Research Bond Act, which, if approved by the voters at the March 7, 2028 statewide primary election, would authorize the issuance of bonds in the amount of $7.5 billion pursuant to the State General Obligation Bond Law, to finance grants, loans, or contracts to fund research and operate and maintain facilities for research. Establishes the California Foundation for Science and Health Research (Foundation) to award such grants, loans, and contracts to public or private research companies, universities, academic medical centers, institutes, and organizations in the fields of biomedical, disease prevention, wildfire prevention, climate, weather, ocean, and coastal and marine ecosystems, among others. Creates the California Foundation for Science and Health Research and Innovation Acceleration Fund (Fund) and requires the proceeds from the bonds to be deposited into the Fund. Creates the California Foundation for Science and Health Research and Innovation Acceleration Benefit Fund (Benefit Fund), to consist solely of private donations and available for the same purposes as the Fund. Permits the California State University (CSU) and the University of California (UC) to submit proposed projects to the Department of Finance (DOF) for approval for the construction and modernization of science, health care, technology, engineering, and other facilities that support research consistent with the priorities of the Foundation. Permits DOF, upon approval, to allocate funds through the budget for those projects from the Fund, with $250,000,000 available to the UC, and $750,000,000 available to the CSU.
Requires that, prior to the first grant from the Foundation and no later than one year from the date this bill takes effect, the California Foundation for Science and Health Research Council (Council) develop various provisions and requirements to facilitate the Foundation's goals of affordability and equitable access. Requires the Foundation to impose various requirements on the grantees, loan recipients, and contractors, including, among other things, developing strategies to promote equitable access to the subject invention in various specified communities and making the data resulting from the bond-funded research available to the broader scientific community. Establishes the Council and requires the Council to establish and develop the strategic objectives and priorities of the Foundation. Requires the Council to establish regulations and standards requiring that all grants, awards, and contracts be subject to intellectual property agreements that balance the opportunity for the State to benefit from the inventions, technologies, patents, royalties, and licenses that result from research funded by certain public and private grants. Contains an urgency clause to ensure that the provisions of this bill go into immediate effect upon enactment.
Major Provisions
COMMENTS
Science and California′s economy. The Public Policy Institute of California reports that California′s professional services and information sectors have grown substantially since 1998, due largely to technological innovation. As a result, the state outpaces the nation in technology-driven growth. Technology sectors contribute more than $620 billion to the state economy, the largest output of any state. California is also home to the largest life sciences industry in the U.S. According to Biocom California′s Life Science Economic Impact Report, California-produced goods account for roughly 10% of annual U.S. pharmaceutical exports and more than 15% of U.S. exports of medical equipment and supplies. In 2024, the state′s life sciences industry employed approximately 450,000 workers across 17,220 companies and generated $395.7 billion in total economic output.
According to the U.S. Bureau of Economic Analysis, California accounts for nearly one-third of research and development (R&D) contributions to national gross domestic product (GDP), with research activities generating over $226 billion annually within the state—about 6% of the state′s GDP—and directly employing approximately 688,000 workers. A large share of R&D investment is directed to California universities: the National Center for Science and Engineering Statistics Higher Education Research and Development Survey found that California led the nation in higher education R&D spending, exceeding $14 billion in fiscal year 2024. These investments support a robust innovation ecosystem, enabling California to maintain the largest share of U.S. patent applications—nearly 30% each year. California is a hotspot for emerging technology startups like those in the artificial intelligence industry: two-thirds of Forbes′s 2025 list of the top 50 artificial intelligence companies are headquartered in California.
Impact of federal science funding cuts to California. Federal investment fuels research and development in California. California leads the nation in funding from agencies like the National Institutes of Health (NIH) and National Science Foundation (NSF). California also captures a large share of funding from the National Aeronautics and Space Administration (NASA) and the Department of Energy (DOE), given the concentration of national laboratories and technology industries in the state. In federal fiscal year 2024, California institutions received $5.2 billion from the NIH and over $1 billion from the NSF to support research at the state′s universities, hospitals, and companies. A large share of this funding is funneled to the University of California (UC) system, which receives more NIH and NSF grants than any other institution in the nation. Across all federal agencies, the UCs were awarded $5 billion for nearly 17,000 projects in 2024, accounting for more than half of all UC research awards.
The Trump Administration′s fiscal year 2026 budget proposal included 40% to 55% cuts to scientific funding agencies like the NIH, NSF, and NASA. Additionally, some federal agencies announced policies to cap facilities and administrative (F&A) cost reimbursements, used by the grantee′s institution to support scientific infrastructure, at 15%, a significant cut for many institutions. Although Congress rejected these budget cuts and incorporated language barring the 15% F&A cap in the 2026 budget, science research is still experiencing a challenging federal environment. According to a January 2026 article in Nature, 5,844 NIH grants and 1,996 NSF grants were cancelled or suspended for not aligning with the Trump Administration′s priorities, affecting research on topics like vaccine uptake, infectious diseases, and people from underrepresented groups. Federal agencies are also awarding fewer new grants; for example, the NIH awarded 21% fewer new research project grants in fiscal year 2025. In fiscal year 2026, STAT has reported that the number of competitive NIH awards issued to date is 74% lower than the average recorded by February over fiscal years 2021–2024, and the total value of those awards is 62% below the average at this point over those same years.
Disruptions to the stability and predictability of federal science funding have already impacted California research groups. According to the grant tracking website Grant Witness, 775 California grants were disrupted from the NIH and 467 from the NSF since January 2025. Although many have since been restored due to intervention by the courts, the state is experiencing an estimated loss of $26 million from the NIH, $46 million from the NSF, $835 million from the Environmental Protection Agency (EPA), and $95 million from the Centers for Disease Control and Prevention (CDC). Last July, the federal government froze nearly $600 million in NIH and NSF funding to UC Los Angeles (UCLA) alone over claims of antisemitism on campus. Although these funds were eventually restored by court order, hundreds of research projects were halted for two months with no guarantee of being restored, disrupting experiments, wasting resources, and placing financial strain on graduate and postdoctoral researchers living paycheck to paycheck on federally funded stipends.
Further federal control of research. National Public Radio (NPR) reports that the Trump administration is pursuing a bureaucratic rule change that could allow for greater political influence over billions of dollars in federal research grants. The new rule would have a broad impact on research fields, including housing and transportation. Health and science funding would be most significantly affected. The new proposed rule, published May 29, 2026, would both codify the administration′s strategies to dismantle certain fields of study in the U.S. and lend it new authority to advance the President′s policy priorities, according to NPR. Under the new rule, peer review would not be eliminated, but political appointees would be required to review grants before awards are made. In addition to giving the administration increased authority, the proposed rule officially bans research on diversity, equity and inclusion or gender as grant conditions, and places broad prohibition on international scientific collaborations.
California Institute for Regenerative Medicine (CIRM). California has previously used voter-approved bonds to fund scientific research and infrastructure through CIRM. Following the Bush Administration′s 2001 Executive Order to ban the use of federal funds for embryonic stem cell research, Proposition 71 was placed on the 2004 ballot through the citizen′s initiative process, funded largely by stem-cell research advocate Robert Klein II. Proposition 71 authorized $3 billion in general obligation bonds to establish CIRM in order to fund stem cell research in California over a ten-year period. Proposition 71 also included language requiring that all grants and loan awards be subject to intellectual property agreements that balance the opportunity of the State to benefit from the patents, royalties, and licenses that result from the funded research, with the need to ensure that essential medical research is not unreasonably hindered by the intellectual property agreements. Proposition 71 required, at a minimum, that CIRM grantees share a fraction of the revenue they receive from licensing or self-commercializing an invention or technology that arises from research funded by CIRM pursuant to a specified formula. The Obama Administration rescinded the ban on federal stem cell research in 2009. In 2020, Robert Klein helped to fund another initiative, known as Proposition 14, to authorize an additional $5.5 billion in state general obligation bonds to fund research grants. Proposition 14, which passed with 51% of the vote, dedicated $1.5 billion to research and therapy for Alzheimer′s disease, Parkinson′s disease, stroke, dementia, epilepsy, brain cancer, schizophrenia, autism, and other diseases and conditions of the brain, and otherwise expanded programs promoting stem cell and other medical research, therapy development and delivery, and student and physician training and fellowships.
According to CIRM′s 2025 Annual Report, to date, these bonds have funded over 1,400 projects in 85 different disease areas, 116 clinical trials, and over 4,600 students and fellows. CIRM has also funded science and medical infrastructure like shared resources laboratories, alpha clinics, and a manufacturing network throughout the state to accelerate the delivery of cell and gene therapies. CIRM′s investments in biotechnology have advanced over 50 startups with roots in CIRM projects, several of which have attracted high-profile investors to help commercialize these therapies. For example, Orchard Therapeutics has licensed a gene-modified cell therapy for severe combined immunodeficiency from UCLA and Gilead has acquired an antibody therapy for cancer from Stanford′s spin-out company, Forty Seven. In 2015, CIRM shifted its funding model from an NIH-style grant system to a more hands-on, milestone-based award structure that links grantees with resources at each phase of a project and provides a predictable, stable funding schedule.
The California Immunology Research and Cures Initiative. The California Immunology Research and Cures Initiative will appear on the ballot in November 2026. This proposition would authorize the issue and sale of $8.4 billion dollars of general obligation bonds to fund a UC-affiliated immunology and immunotherapy research institute as well as individual immunology and immunotherapy research groups via grants. This proposition would be limited to immunology-related research, and only California-based public and nonprofit universities and medical research institutions would be eligible for funding. The proposition attempts to recuperate some of the investment for taxpayers by developing a technology licensing program, requiring a 10% cut of all revenues from the sale, licensing, or commercialization of intellectual property rights, and requiring any products developed with these funds be made available to Californians at a price at least 20% below the national average price. The proposition aims to bring state funding to the UCLA-affiliated California Institute of Immunology and Immunotherapy (CIII), established in 2024 by several philanthropists including Dr. Gary K. Michelson, the proposition′s sponsor. The state allocated $500 million to the CIII in the 2022-2023 budget, to be appropriated over the next several years, but the institute only received $200 million when the remaining $300 million was canceled in the 2024-25 budget.
According to the Author
This bill will place on the next statewide general election ballot a $7.5 billion bond to fund health and science research. This bill will additionally establish the Foundation. The author notes that over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California′s health and economic wellbeing. The author argues that scientific research and innovation have driven California′s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state′s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health (NIH) research there is a return of approximately $2.50 in economic activity. The author concludes that without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, this bill is a critical step.
Arguments in Support
The Union of American Physicians and Dentists (UAPD) and United Auto Workers (UAW) 4811 are cosponsors of this bill and states that this funding will safeguard California′s role as a global leader in innovation, an investment that will dramatically boost long term tax revenue, drive middle class job growth, and provide hope and healing to millions of Californians confronting deadly and debilitating diseases. UAPD and UAW 4811 argue that scientific research and innovation is the engine of California′s economic prosperity and a lifeline to millions of families struggling with health challenges. Recent federal cuts threaten to bulldoze the nation′s top scientific institutions, disrupting innovations critical to California′s future. The NIH, the main funder of biomedical research, awarded about $35 billion in grants to research groups last year, including for the University of California. UAPD and UAW 4811 conclude that federal cuts and suspensions have threatened billions of dollars in scientific research funding, especially targeting California institutions like the UC and the California State University System.
UC is also a cosponsor of this bill and states that it is particularly important at this moment when UC is facing one of the greatest threats in its history. The University currently receives more than $17 billion annually in federal support – for healthcare, research, and student financial aid. Federal funding for research totals $5.7 billion each year. UC argues that the sustained loss of this funding would devastate the UC and cause enormous harm to their students and all Californians. It would mean tens of thousands of jobs lost and an exodus of talent as many of the UC′s world-renowned researchers would be forced to leave the state to pursue their work. UC contends that it is hard to conceive of a more damaging consequence for California. UC and the State face an extraordinary challenge.
Stanford University supports this bill stating that this investment will strengthen California′s position as a global leader in research and innovation, enhance the state′s competitiveness, and accelerate scientific discoveries that can improve outcomes for millions of patients. Stanford University says it has been at the forefront of research innovation, making a profound impact not only within California but also across the U.S. and around the world. Stanford′s commitment to fostering an environment of interdisciplinary collaboration has led to groundbreaking achievements across numerous fields, including technology, medicine, engineering, and the social sciences. Stanford alumni and faculty have created over 39,900 companies since the 1930s, creating over 5.4 million jobs and generating revenues of $2.7 trillion annually. Stanford argues that university research, exemplified by the work conducted at Stanford and other California universities, has been integral to the partnership between academia and the U.S. government. Following World War II, the federal government realized the potential of harnessing universities′ expertise and curiosity-driven culture, opting to fund university research as a strategic model. This government support has provided the foundation for the country′s scientific and innovation ecosystem, fostering advancements across diverse fields. By investing in university research, the government has enabled a continuous flow of discoveries and innovations that fuel economic growth, address societal challenges, and maintain the U.S. leadership in innovation.
Arguments in Opposition
None on file.
FISCAL COMMENTS
According to the Assembly Appropriations Committee:
- Assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale), the total principal and interest costs to pay off the bonds would be approximately $9 billion ($5 billion in principal and $4 billion in interest), with average annual debt service payments of around $300 million (General Fund) when all bonds are sold.
- Administrative costs: GovOps estimates costs between $7.5 million to $15 million to implement this measure. GovOps states this bill requires a new function that GovOps has never done. GovOps estimates it would need between 15 and 23 staff of various classifications and significant funding for operating expenses and equipment to begin implementing the provisions of this bill. GovOps staff would need to support the Foundation and the Council, manage grants and loans made pursuant to this measure, issue reports, conduct bond compliance activities, bond accounting activities, develop the Foundation′s strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc. GovOps would likely need a General Fund loan to establish the Foundation and the Council, and to hire staff prior to the issuance of bonds. The General Fund could be paid back from bond proceeds in the future.
- Ballot costs: The Secretary of State (SOS) estimates this bill will require approximately 12 to 15 additional pages in the State Voter Information Guide and Text of Proposed Laws. Based on current printing rates of $123,359 per page, SOS estimates the cost to add the Bond Act to the ballot between $1.48 million and $1.85 million in fiscal year (FY) 2026-27 (General Fund).
VOTES
SENATE FLOOR: 29-9-2
YES: Allen, Archuleta, Arreguín, Ashby, Becker, Blakespear, Cabaldon, Caballero, Cervantes, Cortese, Durazo, Gonzalez, Grayson, Laird, Limón, McGuire, McNerney, Menjivar, Padilla, Pérez, Reyes, Richardson, Rubio, Smallwood-Cuevas, Stern, Umberg, Wahab, Weber Pierson, Wiener
NO: Alvarado-Gil, Choi, Grove, Jones, Niello, Ochoa Bogh, Seyarto, Strickland, Valladares
ABS, ABST OR NV: Dahle, Hurtado
ASM HEALTH: 11-2-3
YES: Bonta, Addis, Aguiar-Curry, Ahrens, Caloza, Carrillo, Elhawary, Patel, Celeste Rodriguez, Sharp-Collins, Stefani
NO: Johnson, Sanchez
ABS, ABST OR NV: Chen, Patterson, Schiavo
ASM APPROPRIATIONS: 12-1-2
YES: Wicks, Hoover, Arambula, Calderon, Caloza, Fong, Mark González, Krell, Pacheco, Pellerin, Sharp-Collins, Solache
NO: Tangipa
ABS, ABST OR NV: Dixon, Ta
UPDATED
VERSION: August 27, 2026
CONSULTANT: Logan Hess / HEALTH / (916) 319-2097 FN: 0004413
SENATE THIRD READING
STR Bill Id:SB 895
Author:(Wiener, et al.)
As Amended Ver:August 13, 2026
2/3 vote.
SUMMARY
Enacts the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $5 billion pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research. Establishes the California Foundation for Science and Health Research (Foundation) to award such grants and loans to public or private research companies, universities, institutes, and organizations in the fields of biomedical, disease prevention, wildfire prevention, climate, weather, ocean, and coastal and marine ecosystems, among others. Creates the California Foundation for Science and Health Research Fund (Fund) and requires the proceeds from the bonds to be deposited into the Fund. Creates the California Foundation for Science and Health Research Benefit Fund (Benefit Fund), to consist solely of private donations and available for the same purposes as the Fund.
Major Provisions
COMMENTS
Science and California′s economy. The Public Policy Institute of California reports that California′s professional services and information sectors have grown substantially since 1998, due largely to technological innovation. As a result, the state outpaces the nation in technology-driven growth. Technology sectors contribute more than $620 billion to the state economy, the largest output of any state. California is also home to the largest life sciences industry in the U.S. According to Biocom California′s Life Science Economic Impact Report, California-produced goods account for roughly 10% of annual U.S. pharmaceutical exports and more than 15% of U.S. exports of medical equipment and supplies. In 2024, the state′s life sciences industry employed approximately 450,000 workers across 17,220 companies and generated $395.7 billion in total economic output.
According to the U.S. Bureau of Economic Analysis, California accounts for nearly one-third of research and development (R&D) contributions to national gross domestic product (GDP), with research activities generating over $226 billion annually within the state—about 6% of the state′s GDP—and directly employing approximately 688,000 workers. A large share of R&D investment is directed to California universities: the National Center for Science and Engineering Statistics Higher Education Research and Development Survey found that California led the nation in higher education R&D spending, exceeding $14 billion in fiscal year 2024. These investments support a robust innovation ecosystem, enabling California to maintain the largest share of U.S. patent applications—nearly 30% each year. California is a hotspot for emerging technology startups like those in the artificial intelligence industry: two-thirds of Forbes′s 2025 list of the top 50 artificial intelligence companies are headquartered in California.
Impact of federal science funding cuts to California. Federal investment fuels research and development in California. California leads the nation in funding from agencies like the National Institutes of Health (NIH) and National Science Foundation (NSF). California also captures a large share of funding from the National Aeronautics and Space Administration (NASA) and the Department of Energy (DOE), given the concentration of national laboratories and technology industries in the state. In federal fiscal year 2024, California institutions received $5.2 billion from the NIH and over $1 billion from the NSF to support research at the state′s universities, hospitals, and companies. A large share of this funding is funneled to the University of California (UC) system, which receives more NIH and NSF grants than any other institution in the nation. Across all federal agencies, the UCs were awarded $5 billion for nearly 17,000 projects in 2024, accounting for more than half of all UC research awards.
The Trump Administration′s fiscal year 2026 budget proposal included 40% to 55% cuts to scientific funding agencies like the NIH, NSF, and NASA. Additionally, some federal agencies announced policies to cap facilities and administrative (F&A) cost reimbursements, used by the grantee′s institution to support scientific infrastructure, at 15%, a significant cut for many institutions. Although Congress rejected these budget cuts and incorporated language barring the 15% F&A cap in the 2026 budget, science research is still experiencing a challenging federal environment. According to a January 2026 article in Nature, 5,844 NIH grants and 1,996 NSF grants were cancelled or suspended for not aligning with the Trump Administration′s priorities, affecting research on topics like vaccine uptake, infectious diseases, and people from underrepresented groups. Federal agencies are also awarding fewer new grants; for example, the NIH awarded 21% fewer new research project grants in fiscal year 2025. In fiscal year 2026, STAT has reported that the number of competitive NIH awards issued to date is 74% lower than the average recorded by February over fiscal years 2021–2024, and the total value of those awards is 62% below the average at this point over those same years.
Disruptions to the stability and predictability of federal science funding have already impacted California research groups. According to the grant tracking website Grant Witness, 775 California grants were disrupted from the NIH and 467 from the NSF since January 2025. Although many have since been restored due to intervention by the courts, the state is experiencing an estimated loss of $26 million from the NIH, $46 million from the NSF, $835 million from the Environmental Protection Agency (EPA), and $95 million from the Centers for Disease Control and Prevention (CDC). Last July, the federal government froze nearly $600 million in NIH and NSF funding to UC Los Angeles (UCLA) alone over claims of antisemitism on campus. Although these funds were eventually restored by court order, hundreds of research projects were halted for two months with no guarantee of being restored, disrupting experiments, wasting resources, and placing financial strain on graduate and postdoctoral researchers living paycheck to paycheck on federally funded stipends.
Further federal control of research. National Public Radio (NPR) reports that the Trump administration is pursuing a bureaucratic rule change that could allow for greater political influence over billions of dollars in federal research grants. The new rule would have a broad impact on research fields, including housing and transportation. Health and science funding would be most significantly affected. The new proposed rule, published May 29, 2026, would both codify the administration′s strategies to dismantle certain fields of study in the U.S. and lend it new authority to advance the President′s policy priorities, according to NPR. Under the new rule, peer review would not be eliminated, but political appointees would be required to review grants before awards are made. In addition to giving the administration increased authority, the proposed rule officially bans research on diversity, equity and inclusion or gender as grant conditions, and places broad prohibition on international scientific collaborations.
California Institute for Regenerative Medicine (CIRM). California has previously used voter-approved bonds to fund scientific research and infrastructure through CIRM. Following the Bush Administration′s 2001 Executive Order to ban the use of federal funds for embryonic stem cell research, Proposition 71 was placed on the 2004 ballot through the citizen′s initiative process, funded largely by stem-cell research advocate Robert Klein II. Proposition 71 authorized $3 billion in general obligation bonds to establish CIRM in order to fund stem cell research in California over a ten-year period. Proposition 71 also included language requiring that all grants and loan awards be subject to intellectual property agreements that balance the opportunity of the State to benefit from the patents, royalties, and licenses that result from the funded research, with the need to ensure that essential medical research is not unreasonably hindered by the intellectual property agreements. Proposition 71 required, at a minimum, that CIRM grantees share a fraction of the revenue they receive from licensing or self-commercializing an invention or technology that arises from research funded by CIRM pursuant to a specified formula. The Obama Administration rescinded the ban on federal stem cell research in 2009. In 2020, Robert Klein helped to fund another initiative, known as Proposition 14, to authorize an additional $5.5 billion in state general obligation bonds to fund research grants. Proposition 14, which passed with 51% of the vote, dedicated $1.5 billion to research and therapy for Alzheimer′s disease, Parkinson′s disease, stroke, dementia, epilepsy, brain cancer, schizophrenia, autism, and other diseases and conditions of the brain, and otherwise expanded programs promoting stem cell and other medical research, therapy development and delivery, and student and physician training and fellowships.
According to CIRM′s 2025 Annual Report, to date, these bonds have funded over 1,400 projects in 85 different disease areas, 116 clinical trials, and over 4,600 students and fellows. CIRM has also funded science and medical infrastructure like shared resources laboratories, alpha clinics, and a manufacturing network throughout the state to accelerate the delivery of cell and gene therapies. CIRM′s investments in biotechnology have advanced over 50 startups with roots in CIRM projects, several of which have attracted high-profile investors to help commercialize these therapies. For example, Orchard Therapeutics has licensed a gene-modified cell therapy for severe combined immunodeficiency from UCLA and Gilead has acquired an antibody therapy for cancer from Stanford′s spin-out company, Forty Seven. In 2015, CIRM shifted its funding model from an NIH-style grant system to a more hands-on, milestone-based award structure that links grantees with resources at each phase of a project and provides a predictable, stable funding schedule.
The California Immunology Research and Cures Initiative. The California Immunology Research and Cures Initiative will appear on the ballot in November 2026. This proposition would authorize the issue and sale of $8.4 billion dollars of general obligation bonds to fund a UC-affiliated immunology and immunotherapy research institute as well as individual immunology and immunotherapy research groups via grants. This proposition would be limited to immunology-related research, and only California-based public and nonprofit universities and medical research institutions would be eligible for funding. The proposition attempts to recuperate some of the investment for taxpayers by developing a technology licensing program, requiring a 10% cut of all revenues from the sale, licensing, or commercialization of intellectual property rights, and requiring any products developed with these funds be made available to Californians at a price at least 20% below the national average price. The proposition aims to bring state funding to the UCLA-affiliated California Institute of Immunology and Immunotherapy (CIII), established in 2024 by several philanthropists including Dr. Gary K. Michelson, the proposition′s sponsor. The state allocated $500 million to the CIII in the 2022-2023 budget, to be appropriated over the next several years, but the institute only received $200 million when the remaining $300 million was canceled in the 2024-25 budget.
According to the Author
This bill will place on the next statewide general election ballot a $5 billion bond to fund health and science research. This bill will additionally establish the Foundation. The author notes that over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California′s health and economic wellbeing. The author argues that scientific research and innovation have driven California′s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state′s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health (NIH) research there is a return of approximately $2.50 in economic activity. The author concludes that without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, this bill is a critical step.
Arguments in Support
The Union of American Physicians and Dentists (UAPD) and United Auto Workers (UAW) 4811 are cosponsors of this bill and states that this funding will safeguard California′s role as a global leader in innovation, an investment that will dramatically boost long term tax revenue, drive middle class job growth, and provide hope and healing to millions of Californians confronting deadly and debilitating diseases. UAPD and UAW 4811 argue that scientific research and innovation is the engine of California′s economic prosperity and a lifeline to millions of families struggling with health challenges. Recent federal cuts threaten to bulldoze the nation′s top scientific institutions, disrupting innovations critical to California′s future. The NIH, the main funder of biomedical research, awarded about $35 billion in grants to research groups last year, including for the University of California. UAPD and UAW 4811 conclude that federal cuts and suspensions have threatened billions of dollars in scientific research funding, especially targeting California institutions like the UC and the California State University System.
UC is also a cosponsor of this bill and states that it is particularly important at this moment when UC is facing one of the greatest threats in its history. The University currently receives more than $17 billion annually in federal support – for healthcare, research, and student financial aid. Federal funding for research totals $5.7 billion each year. UC argues that the sustained loss of this funding would devastate the UC and cause enormous harm to their students and all Californians. It would mean tens of thousands of jobs lost and an exodus of talent as many of the UC′s world-renowned researchers would be forced to leave the state to pursue their work. UC contends that it is hard to conceive of a more damaging consequence for California. UC and the State face an extraordinary challenge.
Stanford University supports this bill stating that this investment will strengthen California′s position as a global leader in research and innovation, enhance the state′s competitiveness, and accelerate scientific discoveries that can improve outcomes for millions of patients. Stanford University says it has been at the forefront of research innovation, making a profound impact not only within California but also across the U.S. and around the world. Stanford′s commitment to fostering an environment of interdisciplinary collaboration has led to groundbreaking achievements across numerous fields, including technology, medicine, engineering, and the social sciences. Stanford alumni and faculty have created over 39,900 companies since the 1930s, creating over 5.4 million jobs and generating revenues of $2.7 trillion annually. Stanford argues that university research, exemplified by the work conducted at Stanford and other California universities, has been integral to the partnership between academia and the U.S. government. Following World War II, the federal government realized the potential of harnessing universities′ expertise and curiosity-driven culture, opting to fund university research as a strategic model. This government support has provided the foundation for the country′s scientific and innovation ecosystem, fostering advancements across diverse fields. By investing in university research, the government has enabled a continuous flow of discoveries and innovations that fuel economic growth, address societal challenges, and maintain the U.S. leadership in innovation.
Arguments in Opposition
None on file.
FISCAL COMMENTS
According to the Assembly Appropriations Committee:
- Assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale), the total principal and interest costs to pay off the bonds would be approximately $9 billion ($5 billion in principal and $4 billion in interest), with average annual debt service payments of around $300 million (General Fund) when all bonds are sold.
- Administrative costs: GovOps estimates costs between $7.5 million to $15 million to implement this measure. GovOps states this bill requires a new function that GovOps has never done. GovOps estimates it would need between 15 and 23 staff of various classifications and significant funding for operating expenses and equipment to begin implementing the provisions of this bill. GovOps staff would need to support the Foundation and the Council, manage grants and loans made pursuant to this measure, issue reports, conduct bond compliance activities, bond accounting activities, develop the Foundation′s strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc. GovOps would likely need a General Fund loan to establish the Foundation and the Council, and to hire staff prior to the issuance of bonds. The General Fund could be paid back from bond proceeds in the future.
- Ballot costs: The Secretary of State (SOS) estimates this bill will require approximately 12 to 15 additional pages in the State Voter Information Guide and Text of Proposed Laws. Based on current printing rates of $123,359 per page, SOS estimates the cost to add the Bond Act to the ballot between $1.48 million and $1.85 million in fiscal year (FY) 2026-27 (General Fund).
VOTES
SENATE FLOOR: 29-9-2
YES: Allen, Archuleta, Arreguín, Ashby, Becker, Blakespear, Cabaldon, Caballero, Cervantes, Cortese, Durazo, Gonzalez, Grayson, Laird, Limón, McGuire, McNerney, Menjivar, Padilla, Pérez, Reyes, Richardson, Rubio, Smallwood-Cuevas, Stern, Umberg, Wahab, Weber Pierson, Wiener
NO: Alvarado-Gil, Choi, Grove, Jones, Niello, Ochoa Bogh, Seyarto, Strickland, Valladares
ABS, ABST OR NV: Dahle, Hurtado
ASM HEALTH: 11-2-3
YES: Bonta, Addis, Aguiar-Curry, Ahrens, Caloza, Carrillo, Elhawary, Patel, Celeste Rodriguez, Sharp-Collins, Stefani
NO: Johnson, Sanchez
ABS, ABST OR NV: Chen, Patterson, Schiavo
ASM APPROPRIATIONS: 12-1-2
YES: Wicks, Hoover, Arambula, Calderon, Caloza, Fong, Mark González, Krell, Pacheco, Pellerin, Sharp-Collins, Solache
NO: Tangipa
ABS, ABST OR NV: Dixon, Ta
UPDATED
VERSION: August 13, 2026
CONSULTANT: Logan Hess / HEALTH / (916) 319-2097 FN: 0003649
Date of Hearing: June 24, 2026
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
SBPCA Bill Id:SB 895
Author:(Wiener) – As Amended Ver:May 14, 2026
Policy Committee: | Health | Vote: | 11 - 2 |
|
| ||
|
|
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill enacts the California Science and Health Research Bond Act (Bond Act), which authorizes the state to issue general obligation bonds in the amount of $12 billion to finance grants and loans for health and science research.
For a complete enumeration of the provisions of this bill, please refer to the Assembly Health Committee analysis. Major provisions of this bill:
- Establish within the Government Operations Agency (GovOps) the California Foundation for Science and Health Research (Foundation) to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for research and development and to construct facilities for research and development in specified fields, including various health-related fields, wildfire prevention, climate, agriculture, and emerging technologies, among others.
- Establish the Foundation for Science and Health Research Council (Council) to develop the strategic objectives of the Foundation, participate in the overall management of the Foundation, and determine which research projects will be funded by the California Foundation for Science and Health Research Fund (Fund), based on research priorities and the technical merits of the proposals.
- Establish authority for appointments to the Council and define requirements for Council composition and terms, and the conduct of Council business.
- Require the Secretary of GovOps to oversee the appointment and compensation of the director of the Foundation (director) and require the director and personnel to be responsible for implementing the objectives of the established pursuant to this bill.
- Create the Fund and require the proceeds from the bonds to be deposited into the Fund for use by the Foundation to award grants and make loans to public or private research companies, universities, and other organizations for scientific research and development.
- Establish the California Foundation for Science and Health Research Benefit Fund (Benefit Fund), to consist solely of private donations and be continuously appropriated and available for the same purposes as the Fund.
- Require the Foundation to prioritize replacing funding cuts by the federal government.
- Prohibit more than 3% of the moneys in the Fund from being used for administrative costs, as defined.
- State the intent of the Legislature that: (a) the Foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, (b) pharmaceuticals developed through this research be made available to Californians at a discount, and (c) under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx to sell at a discount to Californians and for profit to other states.
- Create the California Foundation for Science and Health Research Finance Committee (Committee) for the purpose of authorizing the issuance and sale of bonds and interim debt authorized by the Bond Act.
- Require the Committee, by resolution, to determine whether it is necessary or desirable to issue and sell bonds, as specified.
- Require the Bond Act to be submitted to the voters at the next statewide election.
- Authorize the issuance of bonds in the amount of $12 billion for the purposes of this bill and to reimburse the General Obligation Bond Expense Revolving Fund,
- Require the State Treasurer to issue and sell bonds in the amount determined by Committee to be necessary or desirable.
- Require proceeds of the bonds issued and sold pursuant to this bill to be deposited into the Fund and all moneys in the fund to be continuously appropriated for purposes of this bill.
- Require moneys in the fund to be made available for a) grants and loans to fund research and operate and maintain facilities for research, and b) administrative costs for the Foundation.
- Require repayment of principal and interest on any loans made by the Foundation to be deposited in the Fund and be used to make additional grants and loans or for paying administrative costs of outstanding bonds.
FISCAL EFFECT:
- Bond costs: The total principal and interest costs to pay off the bonds would be approximately $21.5 billion ($12 billion in principal and $9.5 billion in interest), with average annual debt service payments of $715 million (General Fund) when all bonds are sold, and assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale). If interest rates increase to 5% in the near future, annual debt service would be approximately $781 million and total principal and interest costs over the repayment period would be approximately $23.4 billion.
- Administrative costs: GovOps estimates costs between $7.5 million to $15 million to implement this measure. GovOps states this bill requires a new function that GovOps has never done. GovOps estimates it would need between 15 and 23 staff of various classifications and significant funding for operating expenses and equipment to begin implementing the provisions of this bill. GovOps staff would need to support the Foundation and the Council, manage grants and loans made pursuant to this measure, issue reports, conduct bond compliance activities, bond accounting activities, develop the Foundation's strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc. GovOps would likely need a General Fund loan to establish the Foundation and the Council, and to hire staff prior to the issuance of bonds. The General Fund could be paid back from bond proceeds in the future.
- Ballot costs: The Secretary of State (SOS) estimates this bill will require approximately 12 to 15 additional pages in the State Voter Information Guide and Text of Proposed Laws. Based on current printing rates of $123,359 per page, SOS estimates the cost to add the Bond Act to the ballot between $1.48 million and $1.85 million in fiscal year (FY) 2026-27 (General Fund).
COMMENTS:
- Purpose. This bill is sponsored by United Autoworkers (UAW) Local 4811, UAW Region 6, the University of California (UC), and the Union of American Physicians and Dentists (UAPD). According to the author:
[This bill] will place on the November 2026 ballot a $12 billion bond to fund health and science research…Over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California’s health and economic wellbeing.
Scientific research and innovation have driven California’s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state’s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health research there is a return of approximately $2.50 in economic activity.
Without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, SB 895 is a critical step.
- Background. California leads the nation in funding from agencies like the National Institutes of Health (NIH) and National Science Foundation (NSF). California also receives a large share of funding from the National Aeronautics and Space Administration (NASA) and the Department of Energy (DOE). In federal FY 2024, California institutions received $5.2 billion from the NIH and over $1 billion from the NSF to support research at universities, hospitals, and companies. A large share of federal funding goes to the UC system, which receives more NIH and NSF funds than any other institution in the nation. Federal agencies awarded UCs $5 billion for nearly 17,000 projects in 2024, accounting for more than half of all UC research awards.
The Trump administration’s federal FY 2026 budget proposal included 40% to 55% cuts to scientific funding agencies like the NIH, NSF, and NASA. Although Congress rejected these budget cuts in the 2026 budget, science research is still experiencing a challenging federal environment. According to a January 2026 article in the journal Nature, 5,844 NIH grants and 1,996 NSF grants were cancelled or suspended for not aligning with the Trump Administration’s priorities, affecting research on topics like vaccine uptake, infectious diseases, and underrepresented groups. Federal agencies are awarding fewer new grants; for example, in FY 2026, STAT has reported that the number of competitive NIH awards issued to date is 74% lower than the average recorded by February over FYs 2021 to 2024, and the total value of those awards is 62% below the average at this point over those same years.
According to the grant tracking website Grant Witness, 775 California NIH grants and 467 NSF grants have been disrupted since January 2025. Although many have since been restored due to intervention by the courts, the state is experiencing an estimated loss of $26 million from the NIH, $46 million from the NSF, $835 million from the U.S. Environmental Protection Agency (EPA), and $95 million from the Centers for Disease Control and Prevention (CDC). Last July, the federal government froze nearly $600 million in NIH and NSF funding to UC Los Angeles alone over claims of antisemitism on campus. Although these funds were eventually restored by court order, hundreds of research projects were halted for two months with no guarantee of being restored, disrupting experiments, wasting resources, and placing financial strain on graduate and postdoctoral researchers living paycheck to paycheck on federally funded stipends. Advocates have noted that the uncertainty of funding is extremely harmful to researchers. - Related Legislation. Other bond measures introduced in the current legislative session include:
SB 492 (Menjivar), Youth Housing Bond Act of 2026, which is pending in the Assembly Housing and Community Development Committee.
AB 590 (Lee), Social Housing Bond Act of 2026, which died in the Senate Housing and Community Development Committee.
SB 623 (Archuleta), Veterans’ Bond Act of 2026, which is pending in the Assembly Housing and Community Development Committee.
SB 417 (Cabaldon), The Affordable Housing Bond Act of 2026, which is pending on the Assembly floor.
AB 736 (Wicks), The Affordable Housing Bond Act of 2026, which is pending on the Senate floor.
AB 48 (Alvarez), College Health and Safety Bond Act of 2026, which is pending referral in the Senate Rules Committee.
Analysis Prepared by: Allegra Kim / APPR. / (916) 319-2081
Date of Hearing: June 9, 2026
ASSEMBLY COMMITTEE ON HEALTH
Mia Bonta, Chair
SBPCA Bill Id:SB 895
Author:(Wiener) – As Amended Ver:May 14, 2026
SENATE VOTE: 29-9
SUBJECT: California Science and Health Research Bond Act.
SUMMARY: Enacts the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $12 billion pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research. Establishes the California Foundation for Science and Health Research (Foundation) to award such grants and loans to public or private research companies, universities, institutes, and organizations in the fields of biomedical, disease prevention, wildfire prevention, climate, weather, ocean, and coastal and marine ecosystems, among others. Creates the California Foundation for Science and Health Research Fund (Fund) and requires the proceeds from the bonds to be deposited into the Fund. Creates the California Foundation for Science and Health Research Benefit Fund (Benefit Fund), to consist solely of private donations and available for the same purposes as the Fund. Specifically, this bill:
- Establishes the Foundation within the Government Operations Agency, and specifies that the Foundation’s role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development, including, but not limited to, in the following fields:
- Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, HIV/AIDS, and genetic and chronic diseases that affect children and infants;
- Public health, including, but not limited to, detecting and responding to new and emerging health threats;
- Disease prevention, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS;
- Promoting healthy and safe behaviors, communities, and environment;
- Wildfire prevention;
- Behavioral health, including, but not limited to, addiction and substance use disorders;
- Climate, including climate change and its impact on human health;
- Weather;
- Ocean;
- Coastal and marine ecosystems and resources;
- Agriculture and water;
- Emerging technologies; and,
- Safety, efficacy, and security of drugs, biological products, medical devices, our nation’s food supply, and cosmetics.
- Requires the Secretary of Government Operations to oversee the process of appointing the director of the Foundation and to set the level of salaries, bonuses, and benefits for the director. Permits the Secretary to delegate to the director the hiring and determining of salaries, bonuses, and benefits of additional personnel. Requires the director and personnel to be responsible for implementing the strategic objectives of the Foundation for Science and Health Research Council (Council) established in 13) below, administering the grants and loans awarded by the Council, and all other duties as deemed necessary for the operation of the Foundation.
- Establishes the Fund and requires bond proceeds to be deposited in the Fund.
- Establishes the Benefit Fund to consist solely of private donations and be continuously appropriated for the same purposes as the Fund.
- Requires moneys in the Fund be used by the Foundation to award public and private grants to, and make loans to, public or private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, the fields described above.
- Requires all research and development funded by the Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight.
- Requires all grants or loans provided under the bill be awarded or made available to researchers or projects located within the state, except that funding for research collaboratives between California and out-of-state researchers is permitted.
- Requires all grants or loans to be awarded based on:
- Consistency with research priorities established by the Council; and,
- Scientific merit of the proposed research as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality.
- Requires the Foundation to prioritize funding research that replaces funding cuts by the federal government.
- Prohibits more than 3% of the moneys in the Fund be used for administrative costs, including salaries, legal and accounting fees, and all costs associated with the establishment and operation of the Foundation, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating the Foundation.
- States the intent of the Legislature that the Foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount. States that under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at a discount to Californians and for profit to other states.
- Requires the Foundation to recommend to the Council standards to ensure that if the grantee or loan recipient purchases goods or services using funds authorized for, or made available to, the Foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50% of purchases from California suppliers.
- Establishes the Council to develop the strategic objectives of the Foundation; actively participate in the overall management of the Foundation; and determine which research projects will be funded by the Fund based on research priorities and the technical merits of the proposals.
- Makes the director and personnel of the Foundation responsible for implementing strategic objectives of the Council, administering grants and loans awarded by the Council, and all other duties as deemed necessary for the operation of the Foundation.
- Requires the Council to consist of 11 to 13 members as follows:
- Seven of the members appointed by the Secretary of Government Operations as follows:
- Five members are scientists or hold backgrounds in science or research, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the above-described fields;
- One member with a background in economics; and,
- One member is a patient advocate.
- One member is a health care provider, appointed by the Senate Rules Committee;
- One member is an advocate in climate or environmental fields, appointed by the Speaker of the Assembly;
- One member is the chief executive officer of the California Council on Science and Technology, or their designee;
- One member is a designee of the President of the University of California, if the president chooses to designate a representative, who shall be a scientist or hold a background in science or research;
- One member is a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative, who shall be a scientist or hold a background in science or research; and,
- One member is the President of the Association of Independent California Colleges and Universities, or his or her designee, who shall be a scientist or hold a background in science or research.
- Seven of the members appointed by the Secretary of Government Operations as follows:
- Authorizes individuals and organizations to submit nominations for membership to the Secretary of the Governmental Operations Agency and authorizes the Secretary to solicit nominations from relevant organizations and individuals. Exempts appointees from confirmation by the Senate.
- Requires members of the Council to serve four-year terms, up to a maximum of two terms, and to serve without compensation. Permits members to receive reimbursement for travel and necessary expenses actually incurred in the performance of their duties.
- Requires, if a vacancy occurs within a term, the Secretary of Government Operations to appoint a replacement member within 45 days to serve the remainder of the term. Requires the Secretary, when a term expires, to appoint a member within 30 days. Requires a member to serve until their replacement is appointed.
- Prohibits a grant or loan from being approved if there are more than six vacancies on the Council.
- Provides that a majority of the membership of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the board. Stipulates that, if a vacancy or recusal in the Council occurs, a majority of the remaining members constitutes a quorum.
- Authorizes any member to participate in a decision to approve or award a grant or loan to a person or entity for the purpose of research involving either a disease from which the member or their immediate family member suffers or a disease in which the member has an interest as a representative of a disease advocacy organization, unless prohibited by any other law.
- Authorizes the Council to approve or award a grant or loan in which a member of the Council is financially interested as long as the interested member recuses themselves from making, participating in making, or attempting to use their official position to include a decision on the grant or loan.
- Authorizes the Council to establish one or more scientific peer review panels consisting of experts in the above-described fields for the purposes of reviewing and prioritizing proposals on the basis of scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
- Prohibits an expert on a scientific review panel from having a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing.
- Requires the Foundation to issue an annual report, to be published on its website, that sets forth the Foundation’s activities, grants awarded, loans made available, grants and loans in process, research accomplishments, and future program directions.
- Requires the Foundation to annually commission an independent financial audit of its activities from a certified accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public review of the report.
- Requires the Controller to hold a public meeting with notice and a formal public comment period.
- Requires the Bagley-Keene Open Meeting Act (Bagley-Keene) to apply to all meetings of the Council and scientific peer review panels, except as provided.
- Permits the Council and a scientific peer review panel to conduct closed sessions, as permitted by the Bagley-Keene when it meets to consider or discuss any of the following:
- Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy;
- Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it;
- Matters involving scientific data, analyses, or other research products not yet formally published in academic literature;
- Matters concerning the appointment, employment, performance, compensation, or dismissal of Foundation officers and employees. Requires action on compensation of the Foundation’s officers and employees to only be taken in open session; and,
- Matters believed to pose a security risk to the people of California.
- Requires proceeds of the bonds issued and sold pursuant to this bill be deposited into the Fund and all moneys in the fund be continuously appropriated for purposes of this bill.
- Requires money in the fund be made available for grants and loans to fund research and operate and maintain facilities for research, and administrative costs for the Foundation.
- Requires repayment of principal and interest on any loans made by the Foundation be deposited in the Fund and used to make additional grants and loans or for paying administrative costs of outstanding bonds.
- Creates the California Foundation for Science and Health Research Finance Committee (Committee) for the purpose of authorizing the issuance and sale of bonds and interim debt authorized by the Bond Act. Requires the committee to consist of:
- The Treasurer, who shall also serve as the chairperson;
- The Controller;
- The Director of Finance;
- The Director of the Foundation; and,
- Two members of the Council, chosen by the Secretary of Government Operations, or their designated representatives.
- Requires the Committee to act independently of the Foundation and Council, but permits the Committee to request recommendations and relevant information so as to understand the financial needs of the Foundation to accomplish the strategic objectives and research priorities.
- Requires the Committee, by resolution, to determine whether it is necessary or desirable to issue and sell bonds authorized, as specified.
- Requires the Bond to be submitted to the voters at the next statewide election.
- Permits the provisions of this bill to be amended so long as those amendments are consistent with and further the intent of this act by a statute that is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
- Makes Legislative findings and declarations on the role of the United States and California as leaders in scientific research.
EXISTING LAW:
- Establishes the Government Operations Agency, which includes the Department of Technology, the Department of General Services, and the Office of Data and Innovation, among other departments, offices, and boards. [Government Code (GOV) § 12803.2]
- Establishes the California Taxpayer Access to Publicly Funded Research Act, which requires a grantee that receives funding, in whole or in part, in the form of a research grant from a state agency to provide for free public access to any publication of a peer-reviewed manuscript describing state-agency-funded knowledge, a state-agency-funded invention, or state-agency-funded technology. [GOV § 13989, et seq.]
- Establishes, within the California Constitution, the California Institute for Regenerative Medicine (CIRM) to make grants and loans for stem cell research, for research facilities, and for other vital research opportunities to realize therapies, protocols, and/or medical procedures that will result in, as speedily as possible, the cure for, and/or substantial mitigation of, major diseases, injuries, and orphan diseases. [California Constitution, Article XXXV, § 2]
- Requires every constitutional amendment, bond measure, or other legislative measure submitted to the people by the Legislature to appear on the ballot of the first statewide election occurring at least 131 days after the adoption of the proposal by the Legislature. Permits the Legislature to specify in the text of a measure that it appear the statewide ballot of a different election, provided the specified election is at least 131 days after adoption of the measure by the Legislature. [Elections Code § 9040]
FISCAL EFFECT: According to the Senate Appropriations Committee:
- The total principal and interest costs to pay off the bonds would be approximately $21.5 billion ($12 billion in principal and $9.5 billion in interest), with average annual debt service payments of $715 million (General Fund), when all bonds are sold, and assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale). If interest rates increase to 5% in the near future, annual debt service would be approximately $781 million (General Fund) and total principal and interest costs over the repayment period would be approximately $23.4 billion.
- Unknown costs for the Government Operations Agency, ranging from $10 million to $20 million, to establish and implement the program. State resources would be needed to support the Foundation and the Council in a variety of capacities, manage grants and loans, issue reports, conduct bond compliance activities and bond accounting activities, develop the Foundation's strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc.
- The measure would permit moneys from the proceeds of bonds to be used to pay for administrative costs of the Foundation. The Government Operations Agency notes that the agency would likely need a General Fund loan to start up the Foundation and the Council, and to hire staff prior to the issuance of bonds. The General Fund loan would be paid back from bond proceeds in the future.
- One-time General Fund costs to the Secretary of State (SOS) in the range of $738,000 to $984,000 for printing and mailing costs to place the measure on the ballot in a statewide election. Actual costs may be higher or lower, depending on the length of required elements and the overall size of the ballot.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, this bill will place on the November 2026 ballot a $12 billion bond to fund health and science research. This bill will additionally establish the Foundation. The author notes that over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California’s health and economic wellbeing. The author argues that scientific research and innovation have driven California’s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state’s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health (NIH) research there is a return of approximately $2.50 in economic activity. The author concludes that without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, this bill is a critical step.
- BACKGROUND.
- Science and California’s economy. The Public Policy Institute of California reports that California’s professional services and information sectors have grown substantially since 1998, due largely to technological innovation. As a result, the state outpaces the nation in technology-driven growth. Technology sectors contribute more than $620 billion to the state economy, the largest output of any state. California is also home to the largest life sciences industry in the U.S. According to Biocom California’s Life Science Economic Impact Report, California-produced goods account for roughly 10% of annual U.S. pharmaceutical exports and more than 15% of U.S. exports of medical equipment and supplies. In 2024, the state’s life sciences industry employed approximately 450,000 workers across 17,220 companies and generated $395.7 billion in total economic output.
According to the U.S. Bureau of Economic Analysis, California accounts for nearly one-third of research and development (R&D) contributions to national gross domestic product (GDP), with research activities generating over $226 billion annually within the state—about 6% of the state’s GDP—and directly employing approximately 688,000 workers. A large share of R&D investment is directed to California universities: the National Center for Science and Engineering Statistics Higher Education Research and Development Survey found that California led the nation in higher education R&D spending, exceeding $14 billion in fiscal year 2024. These investments support a robust innovation ecosystem, enabling California to maintain the largest share of U.S. patent applications—nearly 30% each year. California is a hotspot for emerging technology startups like those in the artificial intelligence industry: two-thirds of Forbes’s 2025 list of the top 50 artificial intelligence companies are headquartered in California.
- Impact of federal science funding cuts to California. Federal investment fuels research and development in California. California leads the nation in funding from agencies like the NIH and National Science Foundation (NSF). California also captures a large share of funding from the National Aeronautics and Space Administration (NASA) and the Department of Energy (DOE), given the concentration of national laboratories and technology industries in the state. In federal fiscal year 2024, California institutions received $5.2 billion from the NIH and over $1 billion from the NSF to support research at the state’s universities, hospitals, and companies. A large share of this funding is funneled to the University of California (UC) system, which receives more NIH and NSF grants than any other institution in the nation. Across all federal agencies, the UCs were awarded $5 billion for nearly 17,000 projects in 2024, accounting for more than half of all UC research awards.
The Trump Administration’s fiscal year 2026 budget proposal included 40% to 55% cuts to scientific funding agencies like the NIH, NSF, and NASA. Additionally, some federal agencies announced policies to cap facilities and administrative (F&A) cost reimbursements, used by the grantee’s institution to support scientific infrastructure, at 15%, a significant cut for many institutions. Although Congress rejected these budget cuts and incorporated language barring the 15% F&A cap in the 2026 budget, science research is still experiencing a challenging federal environment. According to a January 2026 article in Nature, 5,844 NIH grants and 1,996 NSF grants were cancelled or suspended for not aligning with the Trump Administration’s priorities, affecting research on topics like vaccine uptake, infectious diseases, and people from underrepresented groups. Federal agencies are also awarding fewer new grants; for example, the NIH awarded 21% fewer new research project grants in fiscal year 2025. In fiscal year 2026, STAT has reported that the number of competitive NIH awards issued to date is 74% lower than the average recorded by February over fiscal years 2021–2024, and the total value of those awards is 62% below the average at this point over those same years.
Disruptions to the stability and predictability of federal science funding have already impacted California research groups. According to the grant tracking website Grant Witness, 775 California grants were disrupted from the NIH and 467 from the NSF since January 2025. Although many have since been restored due to intervention by the courts, the state is experiencing an estimated loss of $26 million from the NIH, $46 million from the NSF, $835 million from the Environmental Protection Agency (EPA), and $95 million from the Centers for Disease Control and Prevention (CDC). Last July, the federal government froze nearly $600 million in NIH and NSF funding to UC Los Angeles (UCLA) alone over claims of antisemitism on campus. Although these funds were eventually restored by court order, hundreds of research projects were halted for two months with no guarantee of being restored, disrupting experiments, wasting resources, and placing financial strain on graduate and postdoctoral researchers living paycheck to paycheck on federally funded stipends.
- Further federal control of research. National Public Radio (NPR) reports that the Trump administration is pursuing a bureaucratic rule change that could allow for greater political influence over billions of dollars in federal research grants. The new rule would have a broad impact on research fields, including housing and transportation. Health and science funding would be most significantly affected. The new proposed rule, published May 29, 2026, would both codify the administration's strategies to dismantle certain fields of study in the U.S. and lend it new authority to advance the President's policy priorities, according to NPR. Under the new rule, peer review would not be eliminated, but political appointees would be required to review grants before awards are made. In addition to giving the administration increased authority, the proposed rule officially bans research on diversity, equity and inclusion or gender as grant conditions, and places broad prohibition on international scientific collaborations.
- CIRM. California has previously used voter-approved bonds to fund scientific research and infrastructure through CIRM. Following the Bush Administration’s 2001 Executive Order to ban the use of federal funds for embryonic stem cell research, Proposition 71 was placed on the 2004 ballot through the citizen’s initiative process, funded largely by stem-cell research advocate Robert Klein II. Proposition 71 authorized $3 billion in general obligation bonds to establish CIRM in order to fund stem cell research in California over a ten-year period. Proposition 71 also included language requiring that all grants and loan awards be subject to intellectual property agreements that balance the opportunity of the State to benefit from the patents, royalties, and licenses that result from the funded research, with the need to ensure that essential medical research is not unreasonably hindered by the intellectual property agreements. Proposition 71 required, at a minimum, that CIRM grantees share a fraction of the revenue they receive from licensing or self-commercializing an invention or technology that arises from research funded by CIRM pursuant to a specified formula. The Obama Administration rescinded the ban on federal stem cell research in 2009. In 2020, Robert Klein helped to fund another initiative, known as Proposition 14, to authorize an additional $5.5 billion in state general obligation bonds to fund research grants. Proposition 14, which passed with 51% of the vote, dedicated $1.5 billion to research and therapy for Alzheimer’s disease, Parkinson’s disease, stroke, dementia, epilepsy, brain cancer, schizophrenia, autism, and other diseases and conditions of the brain, and otherwise expanded programs promoting stem cell and other medical research, therapy development and delivery, and student and physician training and fellowships.
According to CIRM’s 2025 Annual Report, to date, these bonds have funded over 1,400 projects in 85 different disease areas, 116 clinical trials, and over 4,600 students and fellows. CIRM has also funded science and medical infrastructure like shared resources laboratories, alpha clinics, and a manufacturing network throughout the state to accelerate the delivery of cell and gene therapies. CIRM’s investments in biotechnology have advanced over 50 startups with roots in CIRM projects, several of which have attracted high-profile investors to help commercialize these therapies. For example, Orchard Therapeutics has licensed a gene-modified cell therapy for severe combined immunodeficiency from UCLA and Gilead has acquired an antibody therapy for cancer from Stanford’s spin-out company, Forty Seven. In 2015, CIRM shifted its funding model from an NIH-style grant system to a more hands-on, milestone-based award structure that links grantees with resources at each phase of a project and provides a predictable, stable funding schedule.
- The California Immunology Research and Cures Initiative. Signatures were submitted on May 4, 2026 for the California Immunology Research and Cures Initiative, aiming to appear on the ballot in November 2026. This proposition would authorize the issue and sale of $8.4 billion dollars of general obligation bonds to fund a UC-affiliated immunology and immunotherapy research institute as well as individual immunology and immunotherapy research groups via grants. This proposition would be limited to immunology-related research, and only California-based public and nonprofit universities and medical research institutions would be eligible for funding. The proposition attempts to recuperate some of the investment for taxpayers by developing a technology licensing program, requiring a 10% cut of all revenues from the sale, licensing, or commercialization of intellectual property rights, and requiring any products developed with these funds be made available to Californians at a price at least 20% below the national average price. The proposition aims to bring state funding to the UCLA-affiliated California Institute of Immunology and Immunotherapy (CIII), established in 2024 by several philanthropists including Dr. Gary K. Michelson, the proposition’s sponsor. The state allocated $500 million to the CIII in the 2022-2023 budget, to be appropriated over the next several years, but the institute only received $200 million when the remaining $300 million was canceled in the 2024-25 budget.
- SUPPORT. The Union of American Physicians and Dentists (UAPD) and United Auto Workers (UAW) 4811 are cosponsors of this bill and states that this funding will safeguard California’s role as a global leader in innovation, an investment that will dramatically boost long term tax revenue, drive middle class job growth, and provide hope and healing to millions of Californians confronting deadly and debilitating diseases. UAPD and UAW 4811 argue that scientific research and innovation is the engine of California’s economic prosperity and a lifeline to millions of families struggling with health challenges. Recent federal cuts threaten to bulldoze the nation’s top scientific institutions, disrupting innovations critical to California’s future. The NIH, the main funder of biomedical research, awarded about $35 billion in grants to research groups last year, including for the University of California. UAPD and UAW 4811 conclude that federal cuts and suspensions have threatened billions of dollars in scientific research funding, especially targeting California institutions like the UC and the California State University System.
UC is also a cosponsor of this bill and states that it is particularly important at this moment when UC is facing one of the greatest threats in its history. The University currently receives more than $17 billion annually in federal support – for healthcare, research, and student financial aid. Federal funding for research totals $5.7 billion each year. UC argues that the sustained loss of this funding would devastate the UC and cause enormous harm to their students and all Californians. It would mean tens of thousands of jobs lost and an exodus of talent as many of the UC’s world-renowned researchers would be forced to leave the state to pursue their work. UC contends that it is hard to conceive of a more damaging consequence for California. UC and the State face an extraordinary challenge.
Stanford University supports this bill stating that this investment will strengthen California’s position as a global leader in research and innovation, enhance the state's competitiveness, and accelerate scientific discoveries that can improve outcomes for millions of patients. Stanford University says it has been at the forefront of research innovation, making a profound impact not only within California but also across the U.S. and around the world. Stanford's commitment to fostering an environment of interdisciplinary collaboration has led to groundbreaking achievements across numerous fields, including technology, medicine, engineering, and the social sciences. Stanford alumni and faculty have created over 39,900 companies since the 1930s, creating over 5.4 million jobs and generating revenues of $2.7 trillion annually. Stanford argues that university research, exemplified by the work conducted at Stanford and other California universities, has been integral to the partnership between academia and the U.S. government. Following World War II, the federal government realized the potential of harnessing universities' expertise and curiosity-driven culture, opting to fund university research as a strategic model. This government support has provided the foundation for the country’s scientific and innovation ecosystem, fostering advancements across diverse fields. By investing in university research, the government has enabled a continuous flow of discoveries and innovations that fuel economic growth, address societal challenges, and maintain the U.S. leadership in innovation.
- RELATED LEGISLATION. SB 607 (Wiener), as amended September 12, 2025, was substantially similar to this bill. Just prior to this bill’s introduction, SB 607 was amended to address a different subject and is pending referral in the Assembly.
- PREVIOUS LEGISLATION.
- SB 829 (Weiner) of 2025 was similar to this bill but did not contain provisions related to bond issuance. SB 829 was held on the Senate Appropriations suspense file.
- SB 867 (Allen) Chapter 83, Statutes of 2024, enacted the Safe Drinking Water, Wildfire Prevention, and Clean Air Bond Act of 2024, which authorized the issuance of $10 billion in bonds to finance projects for safe drinking water, drought, flood, and water resilience, wildfire and forest resilience, coastal resilience, extreme heat mitigation, biodiversity protection and nature-based climate solutions, climate-smart and sustainable working lands, park creation, and clean air programs. The proposition (Prop 4) was approved by 60% of voters on the 2024 ballot.
- POLICY COMMENTS.
- Recoupment. The current language of this bill states the intent of the Legislature “to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount.” Should this bill pass and ultimately be approved by the voters, the Senate Appropriations Committee estimates annual costs to the General Fund of $715 million to $791 million to service the debt. That is a significant annual investment, which research indicates will provide some economic benefits to the state. This language should be strengthened to require the Foundation to include provisions in the grants, loans, and contracts around recoupment. The author is considering additional substantive language to the intent language around recoupment.
- Appointments to the Council. Other advisory boards, commissions, and councils often stagger terms of their membership to avoid creating vacancies of all members at the same time and creating complete turnover of the body. Should this bill move forward, the author may wish to stagger the initial appointment lengths of some members to address this. The author may also wish to consider adding an appointee to the Council with expertise in community engaged research. According to Yale School of Medicine, community engaged research is a process that incorporates input from people who the research outcomes will impact and involves such people or groups as equal partners throughout the research process. This involvement may include co-designing research questions to solve problems, making decisions, influencing policies, and creating programs and interventions that affect their own lives. Community engagement often involves partnerships and coalitions that help mobilize resources and influence systems, change relationships among partners, and serve as catalysts for changing policies, programs, and practices.
- Public participation in planning. Given the large public investment proposed by this bill, the author may wish to consider the opportunity for public participation in setting research priorities. While it may be challenging to open comment periods on each individual award, public engagement could inform research priorities by allowing a period of public comment on the strategic plans or directions of the Foundation.
REGISTERED SUPPORT / OPPOSITION:
Support
UAW Local 4811 (UNREG) (Co-Sponsor)
Union of American Physicians and Dentists (Co-Sponsor)
University of California (Co-Sponsor)
350 Bay Area Action
Alameda Labor Council
ALS Association
Alzheimer's Greater Los Angeles
Alzheimer's Orange County
Alzheimer's San Diego
American Academy of Neurology
American Anthropological Association
American Brain Coalition
American Parkinson Disease Association
Association of California Caregiver Resource Centers
Association of Independent California Colleges & Universities (AICCU)
Blood Cancer United, Formerly the Leukemia & Lymphoma Society
California Academy of Preventive Medicine
California Academy of Sciences
California Association of Public Hospitals and Health Systems
California Chronic Care Coalition
California Consortium of Addiction Programs and Professionals
California Faculty Association
California Federation of Labor Unions, AFL-CIO
California Psychological Association
California State University, Office of the Chancellor
California Working Families Party
CAPS, UAW Local 1115
Children's Specialty Care Coalition
Cleanearth4kids.org
Council of University of California Faculty Associations
Greater Fresno Parkinson's Support Group
Humane World for Animals
Indivisible CA StateStrong
International Union, United Automobile, Aerospace, and Agricultural Implement Workers of America
Lieutenant Governor Eleni Kounalakis
Michael J. Fox Foundation for Parkinson's Research
National Organization of Legal Services Workers
National Union of Healthcare Workers (NUHW)
Parkinson Association of Northern California
Parkinson Network of Mt. Diablo
Parkinson's Association of San Diego
Parkinson's Community Los Angeles
Parkinson's Foundation
Parkinson's Resource Organization
Point Blue Conservation Science
San Diego Natural History Museum
San Diego; County of
Santa Monica Democratic Club
Silicon Valley Leadership Group (SVLG)
Solano County Democratic Central Committee
Stanford University
Teamsters California
The Los Angeles Trust for Children’s Health
UAW Local 230
UAW Local 509
UAW Local 872
UAW Local 2478
UAW Local 4123
UAW Local 4811
Union of Concerned Scientists
University of California Chicanx Latinx Alumni Association
University of California Student Association
Opposition
None on file
Analysis Prepared by: Logan Hess / HEALTH / (916) 319-2097
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-4171 | SB 895 |
THIRD READING
Bill No: SB 895
Author: Wiener (D), Pérez (D) and Wahab (D), et al.
Amended: 4/6/26
Vote: 27
SENATE HEALTH COMMITTEE: 9-2, 3/25/26
AYES: Weber Pierson, Caballero, Durazo, Gonzalez, Menjivar, Padilla, Pérez, Rubio, Smallwood-Cuevas
NOES: Valladares, Grove
SENATE NATURAL RES. & WATER COMMITTEE: 5-2, 4/14/26
AYES: Becker, Allen, Cabaldon, Cortese, Stern
NOES: Seyarto, Grove
SENATE APPROPRIATIONS COMMITTEE: 5-2, 5/14/26
AYES: Cervantes, Cabaldon, Grayson, Richardson, Wahab
NOES: Seyarto, Dahle
SUBJECT: California Science and Health Research Bond Act
SOURCE: United Auto Workers Region 6 (co-source)
Union of American Physicians and Dentists (co-source)
University of California (co-source)
DIGEST:
This bill creates the California Foundation for Science and Health Research (CFSHR), housed in the Government Operations Agency, to award grants and loans to public or private research companies, universities, institutes, and organizations for scientific research. Establishes the CFSHR Council to determine which projects will be awarded grants and loans. Funds CFSHR through the issuance and sale of $12 billion in bonds, pending voter approval on the 2026 ballot. Establishes the CFSHR Finance Committee to authorize the issuance and sale of bonds.
ANALYSIS:
Existing law:
- Establishes the Government Operations Agency (GovOps), which includes the Department of Technology, the Department of General Services, and the Office of Data and Innovation, among other departments, offices, and boards. [Government Code (GOV) §12803.2]
- Establishes the California Taxpayer Access to Publicly Funded Research Act, which requires a grantee that receives funding, in whole or in part, in the form of a research grant from a state agency to provide for free public access to any publication of a peer-reviewed manuscript describing state-agency-funded knowledge, a state-agency-funded invention, or state-agency-funded technology. [GOV §13989, et seq.]
- Establishes, within the California Constitution, the California Institute for Regenerative Medicine (CIRM) to make grants and loans for stem cell research, for research facilities, and for other vital research opportunities to realize therapies, protocols, and/or medical procedures that will result in, as speedily as possible, the cure for, and/or substantial mitigation of, major diseases, injuries, and orphan diseases. [California Constitution, Article XXXV, §2]
This bill:
CFSHR
- Establishes CFSHR in GovOps, and states that its role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development in various fields, including, but not limited to:
- Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), heart disease, strokes, child and adult leukemia, infectious diseases, HIV/AIDS, and genetic and chronic diseases affecting children and infants;
- Public health, including, but not limited to, detecting and responding to new and emerging health threats;
- Disease prevention, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS;
- Promoting healthy and safe behaviors, communities, and environment;
- Wildfire prevention;
- Behavioral health, including, but not limited to, addiction and substance use disorders;
- Climate, including climate change and its impact on human health and weather;
- Ocean, and coastal and marine ecosystems and resources;
- Agriculture and water;
- Emerging technologies; and,
- Safety, efficacy, and security of drugs, biological products, medical devices, our nation’s food supply, and cosmetics.
CFSHR Fund
- Establishes the CFSHR Fund in the State Treasury, and requires proceeds of bongs issued/sold pursuant to this bill to funds to be deposited. Establishes the CFSHR Benefit Fund in the State Treasury, consisting solely of donations. Requires CFSHR Fund and CFSHR Benefit Fund moneys to be used to award public and private grants and make loans to public or private research companies, universities, institutes, and organizations for scientific research and development, as specified.
- Requires research and development funded to be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to the California Taxpayer Access to Publicly Funded Research Act.
- Requires grants or loans to be awarded or made available to researchers or projects located within this state. Permits funding for research collaboratives between California and out-of-state researchers. Requires grants or loans to be awarded based on:
- Consistency with the research priorities established for CFSHR by the CFSHR Council established under this bill; and,
- The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as specified.
- Requires CFSHR to prioritize funding research that replaces funding cuts by the federal government. Requires research projects, to be eligible for funding, to be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act and the Protection of Human Subjects in Medical Experimentation Act.
CFSHR administration
- Requires the GovOps Secretary to oversee the process of appointing the CFSHR director and to set the level of salaries, bonuses, and benefits. Permits hiring and determining the salaries, bonuses, and benefits of additional personnel to be delegated by the GovOps Secretary to the director, subject to approval and oversight by the GovOps Secretary. Requires the CFSHR director and personnel to be responsible for implementing the strategic objectives of the CFSHR Council, administering the grants and loans awarded by the CFSHR Council, and all other duties as deemed necessary.
- Prohibits more than 3% of CFSHR Fund moneys from being used for administrative costs, as specified.
- Requires all intellectual property assets developed using funds authorized for, or made available to, CFSHR be treated pursuant to state and federal law.
- Requires CFSHR to recommend to the CFSHR Council, and requires the Council to adopt, standards to ensure that if a grantee or loan recipient purchases goods or services using CFSHR funds, they are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50% of purchases from California suppliers.
CFSHR Council
- Establishes the CFSHR Council to:
- Develop the strategic objectives and research priorities;
- Actively participate in the overall management of CFSHR; and,
- Determine which research projects will be funded based on the established research priorities and the technical merits of the proposals, as determined by scientific peer review panels.
- Requires the CFSHR Council to consist of 11 to 13 members as follows:
- Seven members, appointed by the GovOps Secretary, five of whom are scientists, including at least one graduate-level researcher and at least one postdoctoral scholar, with current or past research experience in specified fields, one of whom holds a background in economics, and one of whom is a patient advocate;
- One member who is a health care provider appointed by the Senate Rules Committee;
- One member who is a climate or environmental advocate appointed by the Speaker of the Assembly;
- One member shall be the CEO of the California Council on Science and Technology or their designee;
- One member designated by the President of the University of California (UC) and one member designated by the Chancellor of the California State University (CSU), if the president and/or chancellor chooses to designate a representative, both of whom are required to be scientists or hold a background in science or research; and,
- One member designated by the President of the Association of Independent California Colleges and Universities, or the president’s designee, who is required to be a scientist or hold a background in science or research.
- Permits individuals and organizations to submit nominations for membership to the GovOps Secretary and permits the Secretary to solicit nominations from relevant organizations and individuals. Prohibits appointees from being subject to Senate confirmation.
- Requires CFSHR Council members to serve four-year terms, not to exceed two terms. Stipulates exceptions for graduate-level researchers and postdoctoral scholars.
- Requires the GovOps Secretary, if a vacancy occurs within a term, to appoint a replacement member within 45 days to serve the remainder of the term. Requires the GovOps Secretary, when a term expires, to appoint a member within 30 days. Requires members to serve until their replacement is appointed.
- Requires CFSHR Council members to serve without compensation, but permits reimbursement for travel and necessary expenses actually incurred in the performance of duties.
- Specifies that a majority of the membership of the CFSHR Council (excluding recused or vacant seats) specifies a quorum for the transaction of any business, performance of any duty, or exercise of any power of the board. Requires a vote of a majority of the CFSHR Council members for the approval of funding of any research project or proposal presented for funding. Prohibits a grant or a loan from being approved if there are more than six vacancies on the CFSHR Council.
- Permits the CFSHR Council to establish one or more scientific peer review panels consisting of experts in specified fields for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, potential benefits to the health and well-being of the population, natural resources, environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
- Prohibits an expert on a scientific review panel from having a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing.
- Authorizes a Council member to participate in decisions regarding research into a disease from which the member or their immediate family suffers. Provides that employment or service with specified institutions or organizations is not inimical to the Council member’s duties and provides that the Political Reform Act of 1974 does not apply to the council member if they recuse themselves from the decision to award or approve the grant or loan.
- Applies the Bagley-Keene Open Meeting Act to all meetings of the CFSHR Council and any scientific peer review panels, except when discussing specified matters in closed sessions, including matters involving information relating to medical or scientific research subjects, confidential intellectual property, unpublished research products, personnel issues, and information believed to pose a security risk.
CFSHR annual reporting
- Requires CFSHR to issue an annual report that sets forth its activities, grants awarded, grants in progress, research accomplishments, and future program directions. Requires the report to be published on the CFSHR website.
- Requires CFSHR to annually commission an independent financial audit of its activities from a certified public accounting firm, and provide that audit to the State Controller, who is required to review it annually and issue a public report. Requires the Controller to hold a public meeting with appropriate notice and a formal public comment period. Requires the Controller to evaluate public comments and include appropriate summaries in the annual report.
CFSHR bonds
- Permits $12 billion in bonds to be issued and sold, not including the amount of any refunding bonds issued, as specified. Requires the bonds to be a valid and binding obligation of the State of California, and the full faith and credit of the State of California is pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
- Requires authorized bonds to be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law, and all of the provisions of that law apply to the bonds and to this bill, as specified.
- Requires the proceeds of bonds issued and sold to be deposited into the CFSHR Fund. Makes all moneys in the CFSHR Fund continuously appropriated without respect to fiscal years for the purposes of this bill. Requires the Fund to be available for:
- Grants and loans to fund research and operate and maintain facilities for research under this bill; and,
- Paying general administrative costs of CFSHR, not to exceed 3% of the CFSHR Fund amount;
- Requires repayment of principal and interest on any loans made by CFHSR to be deposited into the CFSHR Fund and used to make additional grants and loans or for paying continuing costs of the annual administration of outstanding bonds.
- Requires proceeds of interim debt and bonds to be deposited into the State Treasury to the credit of the CFSHR Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
CFSHR Finance Committee
- Creates the CFSHR Finance Committee (Finance Committee) solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this bill. Requires the Finance Committee to consist of: the Treasurer; the Controller; the Director of Finance; the CFSHR Director; and, two members of the CFSHR Council, chosen by the GovOps Secretary or their designated representatives. Requires the Treasurer to serve as chairperson of the Finance Committee.
- Requires the Finance Committee, by resolution, to determine whether or not it is necessary or desirable to issue and sell bonds in order to carry out the actions specified in this bill and, if so, the amount of bonds to be issued and sold. Permits successive issues of bonds to be authorized and sold to carry out those actions progressively, and specifies that it is not necessary that all of the bonds authorized to be issued be sold at any one time. Requires the Treasurer to issue and sell bonds in the amount determined by the Finance Committee to be necessary or desirable. Requires the bonds to be issued and sold upon the terms and conditions specified in a resolution adopted by the Finance Committee, as specified.
Revenue and principal/interest payments
- Requires a sum to be collected each year in an amount required to pay the principal of, and interest on, the bonds becoming due each year, and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state. Makes it the duty of all officers charged by law with any duty in regard to the collection of the revenue to perform each and every act that is necessary to collect that additional sum.
- Requires the continuous appropriation from the GF, for the purposes of this bill and without regard to fiscal years, the sum annually necessary to pay the principal of, and interest on, bonds issued and sold, as the principal and interest become due and payable.
- Permits the Director of Finance to authorize the withdrawal from the GF of an amount, not to exceed the amount of the unsold bonds that have been authorized by the Finance Committee, to be sold for the purpose of carrying out this bill, excluding any refunding bonds authorized and any amount withdrawn from the GF pursuant to this section and not yet returned. Requires any amount withdrawn to be deposited into the CFSHR Fund. Requires moneys made available to be returned to the GF, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds.
- Requires moneys in the CFSHR Fund that are derived from premium and accrued interest on bonds sold to be reserved and be available for transfer to the GF as a credit to expenditures for bond interest. Permits those amounts derived from premium to be reserved and used to pay the cost of bond issuance before any transfer to the GF.
Miscellaneous
- Permits bonds issued and sold to be refunded in accordance with the State General Obligation Bond Law. States that approval by the voters of the state for the issuance of the bonds includes the approval of the issuance of any bonds issued to refund any bonds originally issued or any previously issued refunding bonds. Permits any bond refunded with the proceeds of refunding bonds to be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
- Permits the Treasurer, if they sell bonds that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, to maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. Permits the Treasurer to use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
- Requires this bill to be submitted to the voters at the next statewide election in accordance with existing law governing the submission of a statewide measure to the voters. Requires this bill to take effect upon the approval by the voters of the CFSHR Act.
- Makes the provisions of this bill severable
- Makes a legislative finding and declaration that this bill imposes a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution in order toprotect the privacy rights and the intellectual property interests of individuals and the security of the public..
Comments
According to the author of this bill:
This bill will place on the November 2026 ballot a $12 billion bond to fund health and science research. The bill will additionally establish CFSHR. Over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California’s health and economic wellbeing. Scientific research and innovation have driven California’s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state’s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health (NIH) research there is a return of approximately $2.50 in economic activity. Without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, this bill is a critical step.
Background: Please see the Senate Health Committee analysis for background information.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
According to the Senate Appropriations Committee:
- Bond costs: The total principal and interest costs to pay off the bonds would be approximately $21.5 billion ($12 billion in principal and $9.5 billion in interest), with average annual debt service payments of $715 million (GF), when all bonds are sold, and assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale). If interest rates increase to 5% in the near future, annual debt service would be approximately $781 million (GF) and total principal and interest costs over the repayment period would be approximately $23.4 billion.
- Administrative costs: Unknown costs for the GovOps, ranging from $10 million to $20 million, to establish and implement the program. State resources would be needed to support the foundation and the CFSHR Council in a variety of capacities, manage grants and loans, issue reports, conduct bond compliance activities and bond accounting activities, develop the foundation's strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc.
This measure would permit moneys from the proceeds of bonds to be used to pay for administrative costs of the foundation. GovOps notes that the agency would likely need a GFloan to start up the foundation and the council, and to hire staff prior to the issuance of bonds. The GF loan would be paid back from bond proceeds in the future.
- Ballot costs: One-time GF costs to the Secretary of State (SOS) in the range of $738,000 to $984,000, for printing and mailing costs to place the measure on the ballot in a statewide election. Actual costs may be higher or lower, depending on the length of required elements and the overall size of the ballot
SUPPORT: (Verified 5/14/2026)
United Auto Workers Region 6 (co-source)
Union of American Physicians and Dentists (co-source)
University of California (co-source)
350 Bay Area Action
Access Reproductive Justice
ALS Association
ALS Network
American Academy of Neurology
American College of Physicians - California Chapter
American Federation of State, County, and Municipal Employees
Association of Independent California Colleges & Universities
Berkeley Faculty Association
Blood Cancer United
California Academy of Sciences
California Association of Professional Scientists, UAW Local 1115
California Chronic Care Coalition
California Consortium of Addiction Programs and Professionals
California Environmental Voters
California Faculty Association
California Institute of Technology
California Nurses Association
California Physicians Alliance
California Psychological Association
California State University
Chamber San Mateo County
City of Eureka
CleanEarth4Kids.org
Council of University of California Faculty Associations
Courage California
Culver City Democratic Club
Equality California
Greater Fresno Parkinson’s Support Group
Humane World for Animals
Indivisible CA: StateStrong
International Union, United Automobile, Aerospace, and Agricultural Implement
Workers of America
Lieutenant Governor Eleni Kounalakis
Loma Linda University Adventist Health Sciences Center
Michael J. Fox Foundation for Parkinson’s Research
Natera, Inc.
Northeastern University
Palo Alto Chamber of Commerce
Parkinson Network of Mt. Diablo
Parkinson’s Association of Northern California
Parkinson’s Association of San Diego
Parkinson’s Community Los Angeles
Point Blue Conservation Science
Public Health Institute
San Diego Faculty Association
San Diego Natural History Museum
San Francisco Chamber of Commerce
San Mateo County Economic Development Association
Santa Monica Democratic Club
Silicon Valley Leadership Group
Solano County Democratic Central Committee
Stanford University
Teamsters California
The Children's Partnership
U.S. Pain Foundation
The Climate Center
United Auto Workers Local 230
United Auto Workers Local 509
United Auto Workers Local 872
United Auto Workers Local 1115
United Auto Workers Local 4123
United Auto Workers Local 4811
University of California Irvine Faculty Association
University of California Los Angeles Faculty Association
University of California Los Angeles Graduate Students Association
University of California Riverside Faculty Association
University of California San Francisco Faculty Association
University of California Student Association
Western Center on Law & Poverty
Three individuals
OPPOSITION: (Verified 5/14/2026)
None received
ARGUMENTS IN SUPPORT: The United Auto Workers (UAW) Region 6, UAW Local 4811, and the Union of American Physicians and Dentists, co-sponsors of the bill, call for action to counteract federal cuts and suspensions to NIH grants, and state that the CFSHR will safeguard California’s role as a global leader in innovation, boost tax revenue, drive middle class job growth, and provide hope and healing to millions of Californians facing deadly and debilitating diseases. The University of California, another co-sponsor, asserts that they currently receive $5.7 billion annually in federal support for research, and that a sustained loss in federal funding would cause enormous harm to the institution and their students, causing tens of thousands of jobs lost and an exodus of research talent from the state. Other supporters, including groups representing business, labor, patients, physicians, and academics echo that this bill preserves and strengthens California’s global leadership position in science, innovation, and public health, creates hundreds of thousands of high-wage jobs, and ensures that lifesaving and economically vital scientific research continues in the state, even if the federal government cuts or withholds federal funds. University student associations highlight the role of graduate students in driving academic research and the importance of this bill for the scientific and healthcare workforce pipeline in an uncertain federal funding environment. These groups emphasize that reliable funding is important for timely degree completion, access to laboratory resources, and the hands-on experience required for careers in science, medicine, and engineering.
Support if amended. The Association for Frontotemporal Degeneration writes that amending all references of Alzheimer’s disease to “Alzheimer’s and other dementias” would better reflect the full scope of dementias affecting Californians, strengthening the bill’s public health impact by addressing an often-overshadowed need.
Prepared by: Melanie Moreno / HEALTH / (916) 651-4111
5/18/26 15:03:44
**** END ****
SENATE COMMITTEE ON
Senator Sabrina Cervantes, Chair
2025 - 2026 Regular Session
SB 895 (Wiener) - California Science and Health Research Bond Act
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
Bill Summary:
SB 895 would establish the California Foundation for Science and Health Research within the Government Operations Agency; and authorize the sale of $23 billion in general obligation bonds, upon approval by voters at the next statewide election, to finance grants and loans to fund research and construct, operate, and maintain facilities for research.
*********** ANALYSIS ADDENDUM – SUSPENSE FILE ***********
The following information is revised to reflect amendments
adopted by the committee on May 14, 2026
Fiscal Impact:
- Bond costs: The total principal and interest costs to pay off the bonds would be approximately $21.5 billion ($12 billion in principal and $9.5 billion in interest), with average annual debt service payments of $715 million (General Fund), when all bonds are sold, and assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale). If interest rates increase to 5% in the near future, annual debt service would be approximately $781 million (General Fund) and total principal and interest costs over the repayment period would be approximately $23.4 billion.
- Administrative costs: Unknown costs for the Government Operations Agency, ranging from $10 million to $20 million, to establish and implement the program. State resources would be needed to support the foundation and the council in a variety of capacities, manage grants and loans, issue reports, conduct bond compliance activities and bond accounting activities, develop the foundation's strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc.
The measure would permit moneys from the proceeds of bonds to be used to pay for administrative costs of the foundation. The Government Operations Agency notes that the agency would likely need a General Fund loan to start up the foundation and the council, and to hire staff prior to the issuance of bonds. The General Fund loan would be paid back from bond proceeds in the future.
- Ballot costs: One-time General Fund costs to the Secretary of State (SOS) in the range of $738,000 to $984,000, for printing and mailing costs to place the measure on the ballot in a statewide election. Actual costs may be higher or lower, depending on the length of required elements and the overall size of the ballot.
Author Amendments:
Create the California Foundation for Science and Health Research Benefit Fund, add legislative intent language, delete various provisions related to the bond issuance process, and add co-authors.
Committee Amendments:
Reduce the amount of bond authorization from $23 billion to $12 billion.
-- END --
SENATE COMMITTEE ON
Senator Sabrina Cervantes, Chair
2025 - 2026 Regular Session
SB 895 (Wiener) - California Science and Health Research Bond Act
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
Bill Summary:
SB 895 would establish the California Foundation for Science and Health Research within the Government Operations Agency; and authorize the sale of $23 billion in general obligation bonds, upon approval by voters at the next statewide election, to finance grants and loans to fund research and construct, operate, and maintain facilities for research.
Fiscal Impact:
- Bond costs: The total principal and interest costs to pay off the bonds would be approximately $41.1 billion ($23 billion in principal and $18.1 billion in interest), with average annual debt service payments of $1.4 billion (General Fund), when all bonds are sold, and assuming a 30-year maturity and an interest rate of 4.25% (the rate secured by the State Treasurer for a new bond at a recent sale). If interest rates increase to 5% in the near future, annual debt service would be approximately $1.5 billion (General Fund) and total principal and interest costs over the repayment period would be approximately $44.9 billion.
- Administrative costs: The Government Operations Agency estimates costs ranging from $10 million to $20 million to establish and implement the program. State resources would be needed to support the foundation and the council in a variety of capacities, manage grants and loans, issue reports, conduct bond compliance activities and bond accounting activities, develop the foundation's strategic research and financial plans, and handle complex legal issues regarding intellectual property, patents, etc.
The measure would permit moneys from the proceeds of bonds to be used to pay for administrative costs of the foundation. The Government Operations Agency notes that the agency would likely need a General Fund loan to start up the foundation and the council, and to hire staff prior to the issuance of bonds. The General Fund loan would be paid back from bond proceeds in the future.
- Ballot costs: One-time General Fund costs to the Secretary of State (SOS) in the range of $738,000 to $984,000, for printing and mailing costs to place the measure on the ballot in a statewide election. Actual costs may be higher or lower, depending on the length of required elements and the overall size of the ballot.
Background:
Historically, federal science funding has fueled research and development in California. California leads the nation in funding from agencies like the National Institutes of Health (NIH) and National Science Foundation (NSF). California also captures a large share of funding from the National Aeronautics and Space Administration (NASA) and the Department of Energy (DOE), given the concentration of national laboratories and technology industries in the state. In federal fiscal year 2024, California institutions received $5.2 billion from the NIH and over $1 billion from the NSF to support research at the state’s universities, hospitals, and companies. A large share of this funding supports the University of California (UC) system, which receives more NIH and NSF grants than any other institution in the nation. Across all federal agencies, the UCs were awarded $5 billion for nearly 17,000 projects in 2024, accounting for more than half of all UC research awards.
Proposition 71, passed by voters in 2004, authorized $3 billion in general obligation bonds to establish the California Institute for Regenerative Medicine (CIRM) in order to fund stem cell research in California. Proposition 14, passed by voters in 2020, authorized an additional $5.5 billion in general obligation bonds to fund research grants. In addition to supporting stem cell research, Proposition 14 provided dedicated funding to research and therapy for Alzheimer’s disease, Parkinson’s disease, stroke, dementia, epilepsy, brain cancer, schizophrenia, autism, and other diseases and conditions of the brain.
Proposed Law:
Specific provisions of the bill would:
- Establish the California Foundation for Science and Health Research within the Government Operations Agency to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development, as specified.
- Establish the California Foundation for Science and Health Research Council to determine which research projects will be funded; specify requirements for membership of the council; permit the council to establish one or more scientific peer review panels; and apply the Bagley-Keene Open Meeting Act to meetings of the council and scientific peer review panels, except as provided.
- Create the California Foundation for Science and Health Research Fund and require that upon appropriation by the Legislature, funds must be deposited into the fund to be used by the foundation to award public and private grants to, and make loans to, public or private research companies, universities, institutes, and organizations for scientific research and development; specify that the fund may include both private and public funds, including private donations; state the intent of the Legislature that the foundation include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount; and limit the use of funds for administrative costs to 3 percent of the moneys in the fund.
- Authorize the sale of $23 billion in general obligation bonds, upon approval by voters at the next statewide election, to finance grants and loans to fund research and construct, operate, and maintain facilities for research; and create the California Foundation for Science and Health Research Finance Committee for the purpose of authorizing the issuance and sale of the bonds.
Related Legislation:
SB 829 (Wiener, 2025) would have established the California Institute for Scientific Research within the Government Operations Agency. The bill was held on the suspense file in this committee.
Staff Comments:
SOS indicates that printing and mailing costs associated with placing a measure on the statewide ballot are approximately $123,000 per page, depending on the length of the ballot. The fiscal estimates noted above reflect the addition of 6-8 pages in the Voter Information Guide. Actual costs would depend upon the length of the title and summary, analysis by the Legislative Analyst’s Office (LAO), proponent and opponent arguments, and text of the proposal.
-- END --
SENATE COMMITTEE ON NATURAL RESOURCES AND WATER
Senator Josh Becker, Chair
2025 - 2026 Regular
Bill No: SB Hearing Date: April 14, 2026
Author: | |||
Version: | Amended | ||
Urgency: | Fiscal: | ||
Consultant: | |||
Subject: California Science and Health Research Bond Act
SUMMARY
This bill would enact the California Science and Health Research Bond Act, which, if approved by the voters, would authorize the issuance of bonds in the amount of $23 million pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research. The bill would establish the California Foundation for Science and Health Research to award such grants and loans to public or private research companies, universities, institutes, and organizations in the fields of biomedical, disease prevention, wildfire prevention, climate, weather, ocean, and coastal and marine ecosystems, amongst others.
BACKGROUND AND EXISTING LAW
Ongoing threats to federal funding. According to information provided by the author, since early 2025, the federal government has frozen, cut, and cancelled funding for scientific research across the country. California has been especially impacted by these funding cuts as federal investment fuels research and development in California.
Institutions within the state receive funding from agencies such as the National Institutes of Health (NIH), National Science Foundation (NSF), National Aeronautics and Space Administration (NASA) and the US Department of Energy (DOE). In federal fiscal year 2024, California institutions received $5.2 billion from the NIH and over $1 billion from the NSF to support research at the state’s universities, hospitals, and companies. A large share of this funding went towards the University of California (UC) system, which receives more NIH and NSF grants than any other institution in the nation. Across all federal agencies, the UCs were awarded $5 billion for nearly 17,000 projects in 2024, which accounts for more than half of all UC research awards.
The Trump Administration, in its 2027 budget request to Congress released on April 3, 2026, asked for deep cuts to federal research spending, including the following:
- 55% cut to NSF, from $8.8 billion to $4 billion.
- 23% cut to NASA, from $24.4 billion to $18.8 billion. This includes a 47% drop in funding for its science division.
- 15% cut to the DOE’s Office of Science, from $8.4 billion to $7.1 billion.
- 12% cut to the NIH, from $47.2 billion to $41.3 billion.
- 27% cut to the National Oceanic and Atmospheric Administration, from $6.2 billion to $4.5 billion. This includes eliminating the Office of Oceanic and Atmospheric Research.
- 52% cut to the US Environmental Protection Agency (EPA), from $8.8 billion to $4.2 billion. This includes a 32% cut to the EPA’s Science and Technological account.[1]
In 2026, the Trump administration had requested similar cuts, which were largely rejected by lawmakers. This makes the budget proposal unlikely to be supported by Congress, but it is indicative of the administration’s priorities.
Although the 2026 proposed budget cuts were ultimately rejected by Congress, science research continues to experience a challenging federal environment. According to a January 2026 article in Nature, 5,844 NIH grants and 1,996 NSF grants were cancelled or suspended for not aligning with the Trump Administration’s priorities, affecting research on topics like vaccine uptake, infectious diseases, and people from underrepresented groups.
Unstable funding can have significant impacts on the hundreds of research projects that are taking place within California, such as halting projects, disrupting experiments, and financial strain on the researchers.
Existing law establishes the Government Operations Agency, which includes the Department of Technology, the Department of General Services, and the Office of Data and Innovation, among other departments, offices, and boards. (Government Code (GOV) §12803.2)
PROPOSED LAW
This bill would enact the California Science and Health Research Bond Act (Bond Act), which, if approved by the voters, would authorize the issuance of bonds in the amount of $23 million pursuant to the State General Obligation Bond Law, to finance grants and loans to fund research and construct, operate, and maintain facilities for research. Specifically, the Bond Act would:
- Establish the California Foundation for Science and Health Research (Foundation) within the Government Operations Agency, and specifies that the Foundation’s role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development, including, but not limited to, in the following fields:
- Biomedical.
- New and emerging health threats.
- Disease prevention.
- Promoting health and safe behaviors, communities, and environment.
- Wildfire prevention.
- Behavioral health.
- Climate.
- Weather.
- Ocean.
- Coastal and marine ecosystems and resources.
- Agriculture and water.
- Emerging technologies.
- Safety, efficacy, and security of drugs, biological products, medical devices, our nation’s food supply, and cosmetics.
- Require the Secretary of Government Operations to oversee the process of appointing the director of the Foundation and to set the level of salaries, bonuses, and benefits for the director.
- Establish the California Foundation for Science and Health Research Fund (Fund) and require moneys to be deposited in the Fund upon appropriation.
- Require moneys in the Fund be used by the Foundation to award public and private grants to, and make loans to, public or private research companies, universities, institutes, and organizations for scientific research and development, including, but not limited to, the fields described above.
- Require all research and development funded by the Fund to be conducted under established standards of open scientific exchange, peer review, and public oversight.
- Require all grants or loans provided under the bill be awarded or made available to researchers or projects located within the state, except that funding for research collaboratives between California and out-of-state researchers is permitted.
- Require all grants or loans to be awarded based on:
- Consistency with research priorities established by the Council.
- Scientific merit of the proposed research.
- Require the Foundation to prioritize funding research that replaces funding cuts by the federal government.
- Prohibit more than three percent of the moneys in the Fund be used for administrative costs.
- Require the Foundation to recommend to the Council Foundation for Science and Health Research Council (Council), which would be established by the bill (see below), standards to ensure that if the grantee or loan recipient purchases goods or services using funds authorized for, or made available to, the Foundation, the goods or services purchased are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50 percent of purchases from California suppliers.
- Require all grants or loans provided under the bill be awarded or made available to researchers or projects located within the state, except that funding for research collaboratives between California and out-of-state researchers is permitted.
- Establish the Council to develop the strategic objectives of the Foundation; actively participate in the overall management of the Foundation; and determine which research projects will be funded by the Fund based on research priorities and the technical merits of the proposals.
- Make the director and personnel of the Foundation responsible for implementing strategic objectives of the Council, administering grants and loans awarded by the Council, and all other duties as deemed necessary for the operation of the Foundation.
- Require the Council to consist of 11 to 13 members as follows:
- Seven of the members appointed by the Secretary of Government Operations as follows:
- Five members are scientists or hold backgrounds in science or research, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the above-described fields.
- One member with a background in economics.
- One member is a patient advocate.
- Five members are scientists or hold backgrounds in science or research, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in the above-described fields.
- One member is a health care provider, appointed by the Senate Rules Committee.
- One member is an advocate in climate or environmental fields, appointed by the Speaker of the Assembly.
- One member is the chief executive officer of the California Council on Science and Technology, or their designee.
- One member is a designee of the President of the University of California, if the president chooses to designate a representative, who shall be a scientist or hold a background in science or research.
- One member is a designee of the Chancellor of the California State University, if the chancellor chooses to designate a representative, who shall be a scientist or hold a background in science or research,
- One member is the President of the Association of Independent California Colleges and Universities, or his or her designee, who shall be a scientist or hold a background in science or research.
- Seven of the members appointed by the Secretary of Government Operations as follows:
- Authorize individuals and organizations to submit nominations for membership to the Secretary of the Governmental Operations Agency and authorize the Secretary of the Governmental Operations Agency to solicit nominations from relevant organizations and individuals. Appointees are not subject to confirmation by the Senate.
- Require members of the Council to serve four-year terms, and a maximum of two terms.
- Prohibit a grant or loan from being approved if there are more than six vacancies on the Council.
- Prohibit a grant or loan from being approved if there are more than six vacancies on the Council.
- Provide that a majority of the membership of the council constitutes a quorum for the transaction of any business, for the performance of any duty, or for the exercise of any power of the board. If a vacancy or recusal in the Council occurs, a majority of the remaining members constitutes a quorum.
- Authorize any member to participate in a decision to approve or award a grant or loan to a person or entity for the purpose of research involving either a disease from which the member or their immediate family member suffers or a disease in which the member has an interest as a representative of a disease advocacy organization, unless prohibited by any other law.
- Authorize the Council to approve or award a grant or loan in which a member of the Council is financially interested as long as the interested member recuses themselves from making, participating in making, or attempting to use their official position to include a decision on the grant or loan.
- Authorize the Council to establish one or more scientific peer review panels consisting of experts in the above-described fields for the purposes of reviewing and prioritizing proposals on the basis of scientific merit of the proposal, the potential benefits to the health and well-being of the population, natural resources, and environment of the state, and the demonstrated background, training, and expertise of the researchers and investigators to conduct the proposed work.
- Prohibit an expert on a scientific review panel from having a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing.
- Prohibit an expert on a scientific review panel from having a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing.
- Make the director and personnel of the Foundation responsible for implementing strategic objectives of the Council, administering grants and loans awarded by the Council, and all other duties as deemed necessary for the operation of the Foundation.
- Require the Foundation to issue an annual report, to be published on its website, that sets forth the foundation’s activities, grants awarded, loans made available, grants and loans in process, research accomplishments, and future program directions.
- Require the Foundation to annually commission an independent financial audit of its activities from a certified accounting firm, which shall be provided to the Controller, who shall review the audit and annually issue a public review of the report.
- Require the Controller to hold a public meeting with notice and a formal public comment period.
- Require the Controller to hold a public meeting with notice and a formal public comment period.
- Require the Bagley-Keene Open Meeting Act to apply to all meetings of the Council and scientific peer review panels, except as provided, and authorize the Council and scientific peer review panels to conduct closed sessions when they need to consider specified matters including information relating to patients or medical or scientific research subjects; confidential intellectual property or work product; scientific data, analyses, or other research products not yet formally published; amongst others.
- Require proceeds of the bonds issued and sold pursuant to the Bond Act be deposited into the Fund and all moneys in the fund be continuously appropriated for purposes of the Bond Act.
- Require an unspecified amount be made available for grants and loans to fund the construction and acquisition of facilities for research.
- Require an unspecified amount be made available for specific purposes including grants and loans to fund research and operate and maintain facilities for research; administrative costs, as specified; costs of issuing interim debt, as specified; and costs of issuing bonds, as specified.
- Require repayment of principal and interest on any loans made by the Foundation be deposited in the Fund and used to make additional grants and loans or for paying administrative costs of outstanding bonds.
- Create the California Foundation for Science and Health Research Finance Committee (Committee) for the purpose of authorizing the issuance and sale of bonds and interim debt authorized by the Bond Act.
- Require the Committee, by resolution, to determine whether it is necessary or desirable to issue and sell bonds authorized, as specified.
- Require an interest-only floating rate bond structure to be implemented for interim debt and bonds.
- Require the Committee, by resolution, to determine whether it is necessary or desirable to issue and sell bonds authorized, as specified.
ARGUMENTS IN SUPPORT
According to the author, “SB 895 will place on the November 2026 ballot a $23 billion bond to fund health and science research. The bill will additionally establish the California Foundation for Science and Health Research. Over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California’s health and economic wellbeing.”
“Scientific research and innovation have driven California’s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state’s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health research there is a return of approximately $2.50 in economic activity”
“Without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, SB 895 is a critical step.”
ARGUMENTS IN OPPOSITION
None received
COMMENTS
This bill is double referred. This bill is double referred with the Senate Health Committee, with this committee being the committee of second referral. Elements of this bill under the jurisdiction of the Senate Health Committee are included here for context and completeness only. This bill passed out of the Senate Health Committee on March 25, 2026, with a vote of 9 - 2.
You look familiar. Last year, the author had a substantially similar bill, SB 829, which would have established the California Institute for Scientific Research within the Government Operations Agency. The bill was held on the Senate Appropriations suspense file. The main differences between this bill and SN 829 are:
- Slight differences in names. This bill proposes to establish the California Foundation for Science and Health Research, California Foundation for Science and Health Research Fund, and the California Foundation for Science and Health Research Council. SB 829, however, would have created the California Institute for Scientific Research, the California Institute for Scientific Research Fund, and the California Institute for Scientific Research Council.
- Bond provisions. This bill contains provisions related to the issuance of bonds, SB 829 did not.
SUGGESTED AMENDMENTS: none
SUPPORT
Union of American Physicians and Dentists (co-sponsor)
United Auto Workers Region 6 (co-sponsor)
United Auto Workers Region 4811 (co-sponsor)
University of California Office of the President (co-sponsor)
350 Bay Area Action
Access Reproductive Justice
ALS Association
ALS Network
American Academy of Neurology
American College of Physicians - California Chapter
American Federation of State, County and Municipal Employees, ALF-CIO
Association of Independent California Colleges & Universities (AICCU)
Berkeley Faculty Association
Blood Cancer United, Formerly the Leukemia & Lymphoma Society
California Academy of Sciences
California Association of Professional Scientists UAW Local 115
California Chronic Care Coalition
California Consortium of Addiction Programs and Professionals
California Environmental Voters
California Faculty Association
California Institute of Technology
California Nurses Association
California Physicians Alliance
California Psychological Association
California State University, Office of the Chancellor
Chamber San Mateo County
City of Eureka
Clean Earth 4 Kids
Council of University of California Faculty Associations
Courage California
Culver City Democratic Club
Equality California
Greater Fresno Parkinson's Support Group
Humane World for Animals
Imperial Valley Equity and Justice Coalition
Indivisible Ca: StateStrong
International Union, United Automobile, Aerospace, and Agricultural Implement Workers of America
Lieutenant Governor Eleni Kounalakis
Loma Linda University Adventist Health Sciences Center and its Affiliated Entities
Michael J. Fox Foundation for Parkinson's Research
Natera, INC.
Northeastern University
Palo Alto Chamber of Commerce
Parkinson Association of Northern California
Parkinson Network of Mt. Diablo
Parkinson's Association of San Diego
Parkinson's Community Los Angeles
Point Blue Conservation Science
Public Health Institute (PHI)
San Diego Faculty Association
San Diego Natural History Museum
San Francisco Chamber of Commerce
San Mateo County Economic Development Association
Santa Monica Democratic Club
Stanford University
Teamsters California
The Children's Partnership
The Climate Center
U.S. Pain Foundation
UAW Local 230
UAW Local 2478
UAW Local 4123
UAW Local 509
UAW Local 872
University of California
University of California Graduate and Professional Council
University of California Irvine Faculty Association
University of California Los Angeles Faculty Association
University of California Los Angeles Graduate Students Association
University of California Riverside Faculty Association
University of California San Francisco Faculty Association
University of California Student Association
Western Center on Law & Poverty, INC.
OPPOSITION
None Received
-- END --
https://www.science.org/content/article/slasher-sequel-trump-again-proposes-major-cuts-u-s-science-spending, last accessed April 6, 2026; https://www.nature.com/articles/d41586-026-01105-7, last accessed April 6, 2026. ↑
SENATE COMMITTEE ON HEALTH
Senator Dr. Akilah Weber Pierson, Chair
BILL NO: SB 895
AUTHOR: | Wiener, Pérez, Wahab | ||
VERSION: | March 16, 2026 | ||
HEARING DATE: | March 25, 2026 | ||
CONSULTANT: | Melanie Moreno and Natalie Gehred | ||
SUBJECT: California Science and Health Research Bond Act
SUMMARY:
Creates the California Foundation for Science and Health Research (CFSHR), housed in the Government Operations Agency, to award grants and loans to public or private research companies, universities, institutes, and organizations for scientific research. Establishes the CFSHR Council to determine which projects will be awarded grants and loans. Funds CFSHR through the issuance and sale of $23 billion in bonds, pending voter approval on the 2026 ballot. Establishes the CFSHR Finance Committee to authorize the issuance and sale of bonds.
Existing law:
- Establishes the Government Operations Agency (GovOps), which includes the Department of Technology, the Department of General Services, and the Office of Data and Innovation, among other departments, offices, and boards. [GOV §12803.2]
- Establishes the California Taxpayer Access to Publicly Funded Research Act, which requires a grantee that receives funding, in whole or in part, in the form of a research grant from a state agency to provide for free public access to any publication of a peer-reviewed manuscript describing state-agency-funded knowledge, a state-agency-funded invention, or state-agency-funded technology. [GOV §13989 et seq.]
- Establishes, within the California Constitution, the California Institute for Regenerative Medicine (CIRM) to make grants and loans for stem cell research, for research facilities, and for other vital research opportunities to realize therapies, protocols, and/or medical procedures that will result in, as speedily as possible, the cure for, and/or substantial mitigation of, major diseases, injuries, and orphan diseases. [Cal. Const., article XXXV, §2]
This bill:
CFSHR
- Establishes CFSHR in GovOps, and states that its role is to facilitate scientific research by awarding grants and making loans to public or private research companies, universities, institutes, and organizations for scientific research and development and to construct facilities for research and development in various fields, including, but not limited to:
- Biomedical, including finding cures for high mortality diseases, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS;
- Detecting and responding to new and emerging health threats;
- Disease prevention, including, but not limited to, cancer, Alzheimer’s disease, Parkinson’s disease, heart disease, strokes, child and adult leukemia, infectious diseases, and HIV/AIDS;
- Promoting healthy and safe behaviors, communities, and environment;
- Wildfire prevention;
- Behavioral health, including, but not limited to, addiction and substance use disorders;
- Climate, including climate change and its impact on human health and weather;
- Ocean, and coastal and marine ecosystems and resources;
- Agriculture and water;
- Emerging technologies; and,
- Safety, efficacy, and security of drugs, biological products, medical devices, our nation’s food supply, and cosmetics.
CFSHR Fund
- Establishes the CFSHR Fund in the State Treasury, and requires funds to be deposited into it upon appropriation by the Legislature. Permits the CFSHR Fund to be funded by both private and public funds, including private donations. Requires CFSHR Fund moneys to be used to award public and private grants and make loans to public or private research companies, universities, institutes, and organizations for scientific research and development, as specified.
- Requires research and development funded to be conducted under established standards of open scientific exchange, peer review, and public oversight, including, but not limited to the California Taxpayer Access to Publicly Funded Research Act.
- Requires grants or loans to be awarded or made available to researchers or projects located within this state. Permits funding for research collaboratives between California and out-of-state researchers. Requires grants or loans to be awarded based on:
- Consistency with the research priorities established for CFSHR by the CFSHR Council established under this bill; and,
- The scientific merit of the proposed research, as determined by an open, competitive, scientific peer review process that ensures objectivity, consistency, and high quality, as specified.
- Requires CFSHR to prioritize funding research that replaces funding cuts by the federal government. Requires research projects, to be eligible for funding, to be reviewed and approved by an institutional review board that meets the requirements of applicable laws and regulations, including, but not limited to, the California Taxpayer Access to Publicly Funded Research Act and the Protection of Human Subjects in Medical Experimentation Act.
- States legislative intent that:
- CFSHR include provisions in the grants, loans, and contracts to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research, and that pharmaceuticals developed through this research are available to Californians at a discount; and,
- Under certain circumstances, California will be able to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at a discount to Californians and for profit to other states.
CFSHR administration
- Requires the GovOps Secretary to oversee the process of appointing the CFSHR director and to set the level of salaries, bonuses, and benefits. Permits hiring and determining the salaries, bonuses, and benefits of additional personnel to be delegated by the GovOps Secretary to the director, subject to approval and oversight by the GovOps Secretary. Requires the CFSHR director and its personnel to be responsible for implementing the strategic objectives of the CFSHR Council, administering the grants and loans awarded by the CFSHR Council, and all other duties as deemed necessary.
- Prohibits more than 3% of CFSHR Fund moneys from being used for administrative costs, including, but not limited to:
- Salaries, bonuses, and benefits paid or incurred with respect to the hiring or retention of a director and other officers and administrative staff that work on behalf of CFSHR under the supervision of the director;
- Legal and accounting fees and expenses; and,
- All costs associated with the establishment and operation of CFSHR, including, but not limited to, office rent, overhead, information technology and data systems, office supplies and equipment, clerical services, utilities, telephone, travel, repairs and maintenance, program audits, and other general costs of operating.
- Requires all intellectual property assets developed using funds authorized for, or made available to, CFSHR be treated pursuant to state and federal law.
- Requires CFSHR to recommend to the CFSHR Council, and requires the Council to adopt, standards to ensure that if a grantee or loan recipient purchases goods or services using CFSHR funds, they are from California suppliers to the extent reasonably possible, in a good faith effort to achieve a goal of more than 50% of purchases from California suppliers.
CFSHR Council
- Establishes the CFSHR Council to:
- Develop the strategic objectives and research priorities;
- Actively participate in the overall management of CFSHR;
- Determine which research projects will be funded based on the established research priorities and the technical merits of the proposals, as determined by scientific peer review panels; and,
- Determine which state agency will oversee a funded research project, including, but not limited to; the Office of Emergency Services (CalOES); Natural Resources Agency; and, the California Health and Human Services Agency.
- Requires the CFSHR Council to consist of 11 to 13 members as follows:
- Five members, appointed by the GovOps Secretary, who are scientists, including at least one member who is a graduate-level researcher and at least one member who is a postdoctoral scholar, with current or past research experience in specified fields;
- Three members of the public appointed by the GovOps Secretary;
- Two additional members of the public appointed by the Senate Rules Committee and the Speaker of the Assembly;
- One member designated by the President of the University of California (UC) and one member designated by the Chancellor of the California State University (CSU), if the president and/or chancellor chooses to designate a representative, both of whom are required to be a scientist or hold a background in science or research; and,
- One member designated by the President of the Association of Independent California Colleges and Universities, or the president’s designee, who is required to be a scientist or hold a background in science or research.
- Permits individuals and organizations to submit nominations for membership to the GovOps Secretary and permits the Secretary to solicit nominations from relevant organizations and individuals.
- Requires CFSHR Council members to serve four-year terms, not to exceed two terms. Permits a GovOps appointee, if they are a graduate-level researcher or postdoctoral scholar and earns their degree or completes their placement before the conclusion of their four-year term, to serve out the remainder of the academic year on the CFSHR Council. Requires the GovOps Secretary to appoint a current graduate-level researcher or postdoctoral scholar at the conclusion of the academic year.
- Requires the CalOps Secretary, if a vacancy occurs within a term, to appoint a replacement member within 45 days to serve the remainder of the term. Requires the GovOps Secretary, when a term expires, to appoint a member within 30 days. Requires members to serve until their replacement is appointed.
- Requires CFSHR Council members to serve without compensation, but permits reimbursement for travel and necessary expenses actually incurred in the performance of duties.
- Requires a vote of a majority of the CFSHR Council members for the approval of funding of any research project or proposal presented for funding. Prohibits a grant or a loan from being approved if there are more than three vacancies on the CFSHR Council.
- Permits the CFSHR Council to establish one or more scientific peer review panels consisting of experts in specified fields for the purposes of reviewing and prioritizing proposals on the basis of the scientific merit of the proposal, potential benefits to the health and well-being of the population, natural resources, environment of the state, and the demonstrated background, training, and expertise, as appropriate for their career stage, of the researchers and investigators to conduct the proposed work.
- Prohibits an expert on a scientific review panel from having a collaborative or commercial relationship with any applicant of a proposal for funding that the expert is reviewing and prioritizing.
- Applies the Bagley-Keene Open Meeting Act to all meetings of the CFSHR Council. Requires the Council to disclose all awarded grants in public meetings, award all grants, loans, and contracts in public meetings, and to adopt all governance, scientific, medical, and regulatory standards in public meetings.
- Permits the CFSHR Council to conduct closed sessions as permitted by the Bagley-Keene Open Meeting Act or when it meets to consider or discuss:
- Matters involving information relating to patients or medical or scientific research subjects, the disclosure of which would constitute an unwarranted invasion of personal privacy;
- Matters involving confidential intellectual property or a work product, whether patentable or not, including, but not limited to, any formula, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information that is not patented, that is known only to certain individuals who are using it to fabricate, produce, or compound an article of trade or a service having commercial value, and that gives its user an opportunity to obtain a business advantage over competitors who do not know it or use it;
- Matters involving scientific data, analyses, or other research products not yet formally published in academic literature;
- Matters concerning the appointment, employment, performance, compensation, or dismissal of CFSHR officers and employees. Requires action on compensation of CFSHR officers and employees to only be taken in open session; or,
- Matters believed to pose a security risk to the people of California.
CFSHR annual reporting
- Requires CFSHR to issue an annual report that sets forth its activities, grants awarded, grants in progress, research accomplishments, and future program directions. Requires the report to be published on the CFSHR website. Requires the report to include, but not be limited to: the number and dollar amounts of research and facilities grants and loans; the grantees and loan recipients for the prior year; CFSHR administrative expenses; an assessment of the availability of funding for research from sources other than CFSHR; a summary of research findings, including promising new research areas; an assessment of the relationship between grants and loans and the overall strategy of its research program; and a report of strategic research and financial plans.
- Requires CFSHR to annually commission an independent financial audit of its activities from a certified public accounting firm, and provide that audit to the State Controller, who is required to review it annually and issue a public report. Requires the Controller to hold a public meeting with appropriate notice and a formal public comment period. Requires the Controller to evaluate public comments and include appropriate summaries in the annual report.
CFSHR bonds
- Permits $23 billion in bonds to be issued and sold, not including the amount of any refunding bonds issued, as specified. Requires the bonds to be a valid and binding obligation of the State of California, and the full faith and credit of the State of California is pledged for the punctual payment of both the principal of, and interest on, the bonds as the principal and interest become due and payable.
- Requires authorized bonds to be prepared, executed, issued, sold, paid, and redeemed as provided in the State General Obligation Bond Law, and all of the provisions of that law apply to the bonds and to this bill, as specified.
- Requires the proceeds of bonds issued and sold to be deposited into the CFSHR Fund. Makes all moneys in the CFSHR Fund continuously appropriated without respect to fiscal years for the purposes of this bill.
- Requires an unspecified amount of money to be made available for grants and loans to fund the construction and acquisition of facilities for research as provided in this bill. Requires another unspecified amount of money to be available for:
- Grants and loans to fund research and operate and maintain facilities for research under this bill;
- Paying general administrative costs of CFSHR, not to exceed 3% of the CFSHR Fund amount;
- Paying the annual administration costs of the interim debt or bonds after December 31 of the fifth full calendar year after this bill takes effect;
- Paying the costs of issuing interim debt, paying the annual administration costs of the interim debt until and including December 31 of the fifth full calendar year after this bill takes effect, and paying interest on interim debt, if that interim debt is incurred or issued on or before December 31 of the fifth full calendar year after this bill takes effect; and,
- Paying the costs of issuing bonds, paying the annual administration costs of the bonds until and including December 31 of the fifth full calendar year after this bill takes effect, and paying interest on bonds that accrues on or before December 31 of the fifth full calendar year after this bill takes effect, except that this limitation does not apply to premium and accrued interest, as specified.
- Permits moneys in the CFSHR Fund or other proceeds of the sale of bonds to be used to pay principal of or redemption premium on any interim debt issued before the issuance of bonds authorized by this bill. Permits moneys deposited into the CFSHR Fund from the proceeds of interim debt to be used to pay general administrative costs of CFSHR without regard to the 3% limit, so long as the 3% limit is satisfied for each issue of bonds.
- Requires repayment of principal and interest on any loans made by CFHSR to be deposited into the CFSHR Fund and used to make additional grants and loans or for paying continuing costs of the annual administration of outstanding bonds.
- Specifies that allowable costs include costs incidentally but directly related to construction or acquisition, including, but not limited to, planning, engineering, construction management, architectural, and other design work, environmental impact reports and assessments, required mitigation expenses, appraisals, legal expenses, site acquisitions, and necessary easements.
- Requires proceeds of interim debt and bonds to be deposited into the State Treasury to the credit of the CFSHR Fund, except to the extent that proceeds of the issuance of bonds are used directly to repay interim debt.
CFSHR Finance Committee
- Creates the CFSHR Finance Committee (Finance Committee) solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this bill. Requires the Finance Committee to consist of: the Treasurer; the Controller; the Director of Finance; the CFSHR Director; and, two members of the CFSHR Council, chosen by the GovOps Secretary or their designated representatives. Requires the Treasurer to serve as chairperson of the Finance Committee. Permits a majority to act for the Finance Committee.
- Requires the Treasurer to issue and sell bonds in the amount determined by the Finance Committee to be necessary or desirable. Requires the bonds to be issued and sold upon the terms and conditions specified in a resolution adopted by the Finance Committee, as specified.
- Requires the Finance Committee, by resolution, to determine whether or not it is necessary or desirable to issue and sell bonds in order to carry out the actions specified in this bill and, if so, the amount of bonds to be issued and sold. Permits successive issues of bonds to be authorized and sold to carry out those actions progressively, and specifies that it is not necessary that all of the bonds authorized to be issued be sold at any one time. Permits bonds to bear interest, which is includable in gross income for federal income tax purposes if the Finance Committee determines that the treatment is necessary in order to provide funds for the purposes of this bill.
- Requires an interest-only floating rate bond structure to be implemented for interim debt and bonds until at least December 31 of the fifth full calendar year after this bill takes effect, with all interest to be paid from proceeds from the sale of interim debt or bonds, to minimize debt service payable from the General Fund (GF) during the initial period of basic research and development, if the Finance Committee determines, with the advice of the Treasurer, that this structure will result in the lowest achievable borrowing costs for the state during that five-year period considering the objective of avoiding any bond debt service payments, by the GF, during that period. Permits the Finance Committee, upon the initial determination, to delegate to the Treasurer the authority in connection with issuance of bonds as it determines, including, but not limited to, the authority to:
- Implement and continue the bond financing structure established by this article, including during any time following the initial five-year period; and,
- Determine that an alternative financing plan would result in significantly lower borrowing costs for the state consistent with the objectives related to the GF and to implement that alternative financing plan.
Revenue and principal/interest payments
- Requires a sum to be collected each year in an amount required to pay the principal of, and interest on, the bonds becoming due each year, and in the same manner and at the same time as other state revenue is collected, in addition to the ordinary revenues of the state. Makes it the duty of all officers charged by law with any duty in regard to the collection of the revenue to perform each and every act that is necessary to collect that additional sum.
- Requires the continuous appropriation from the GF, for the purposes of this bill and without regard to fiscal years, an amount that equals the total of both of:
- The sum annually necessary to pay the principal of, and interest on, bonds issued and sold, as the principal and interest become due and payable; and,
- The sum necessary to carry out 38) below.
- Permits the CFSHR to request the Pooled Money Investment Board to make a loan from the Pooled Money Investment Account for the purposes of carrying out this bill less any amount withdrawn pursuant to 39) below and not yet returned to the GF. Prohibits the amount of the request from exceeding the amount of the unsold bonds that the Finance Committee has authorized to be sold, excluding any refunding bonds authorized, less any amount loaned and not yet repaid and any amount withdrawn from the GF and not yet returned. Requires the CFSHR to execute any documents required by the Pooled Money Investment Board to obtain and repay the loan. Requires amounts loaned to be deposited into the CFSHR Fund to be allocated by CFSHR in accordance with this bill.
- Permits the Director of Finance to authorize the withdrawal from the GF of an amount, not to exceed the amount of the unsold bonds that have been authorized by the Finance Committee, to be sold for the purpose of carrying out this bill, excluding any refunding bonds authorized, less any amount loaned and not yet repaid, and any amount withdrawn from the GF pursuant to this section and not yet returned. Requires any amount withdrawn to be deposited into the CFSHR Fund. Requires moneys made available to be returned to the GF, with interest at the rate earned by the moneys in the Pooled Money Investment Account, from proceeds received from the sale of bonds.
- Requires moneys in the CFSHR Fund that are derived from premium and accrued interest on bonds sold to be reserved and be available for transfer to the GF as a credit to expenditures for bond interest. Permits those amounts derived from premium to be reserved and used to pay the cost of bond issuance before any transfer to the GF.
Miscellaneous
- Permits bonds issued and sold to be refunded in accordance with the State General Obligation Bond Law. States that approval by the voters of the state for the issuance of the bonds includes the approval of the issuance of any bonds issued to refund any bonds originally issued or any previously issued refunding bonds. Permits any bond refunded with the proceeds of refunding bonds to be legally defeased to the extent permitted by law in the manner and to the extent set forth in the resolution, as amended from time to time, authorizing that refunded bond.
- Permits the Treasurer, if they sells bonds that include a bond counsel opinion to the effect that the interest on the bonds is excluded from gross income for federal tax purposes, under designated conditions, or is otherwise entitled to any federal tax advantage, to maintain separate accounts for the investment of bond proceeds and for the investment of earnings on those proceeds. Permits the Treasurer to use or direct the use of those proceeds or earnings to pay any rebate, penalty, or other payment required under federal law or to take any other action with respect to the investment and use of bond proceeds or earnings required or desirable under federal law to maintain the tax-exempt status of those bonds and to obtain any other advantage under federal law on behalf of the funds of this state.
- States that the proceeds from the sale of bonds authorized by this article are not “proceeds of taxes” as that term is used in Article XIII B of the California Constitution, and the disbursement of these proceeds is not subject to the limitations imposed.
- Requires this bill to be submitted to the voters at the next statewide election in accordance with existing law governing the submission of a statewide measure to the voters. Requires this bill to take effect upon the approval by the voters of the CFSHR Act.
- Requires this bill to be broadly construed to accomplish its purposes. Permits future amendments to statute resulting from this bill, so long as those amendments are consistent with and further its intent, and is passed by a two-thirds vote of the members of each house of the Legislature and signed by the Governor.
- Makes the provisions of this bill severable, so that if any portion, section, subdivision, paragraph, clause, sentence, phrase, word, or application of this act is for any reason held to be invalid by a decision of any court of competent jurisdiction, that decision does not affect the validity of the remaining portions of this act. States that the people of the State of California hereby declare that they would have adopted this act and each and every portion, section, subdivision, paragraph, clause, sentence, phrase, word, and application not declared invalid or unconstitutional without regard to whether any portion of this act or application thereof would be subsequently declared invalid.
- Requires this bill to be liberally construed to effectuate its purposes. States that if this measure is approved by the voters but superseded in whole or in part by a conflicting measure approved by the voters at the same election, and the conflicting measure is later held to be invalid, this measure is self-executing and given full force and effect.
- Makes a legislative finding and declaration that this bill imposes a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. States that the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest: To protect the privacy rights and the intellectual property interests of individuals and the security of the public, it is necessary to restrict the public’s access to this information.
FISCAL EFFECT:
This bill has not been analyzed by a fiscal committee.
COMMENTS:
- Author’s statement. According to the author, this bill will place on the November 2026 ballot a $23 billion bond to fund health and science research. The bill will additionally establish CFSHR. Over the past year we have seen an incredible politicization of what was once considered bipartisan and vital research. With the federal government cutting billions of dollars to scientific research, California is placed in a dire situation. As the state that receives the most federal research dollars and a global leader in research and technology, the cuts risk California’s health and economic wellbeing. Scientific research and innovation have driven California’s economic success for decades. The breakthroughs produced by universities and scientific researchers have sparked new industries and powered the success of the state’s biotech, medical, agricultural, and software industries from startups to global companies. For every dollar invested in National Institutes of Health (NIH) research there is a return of approximately $2.50 in economic activity. Without this investment from the state, Californians and the world will lose out on critical, life-saving discoveries that will treat diseases, uplift public health, and address climate change. For a healthy, prosperous future for all Californians, this bill is a critical step.
- Science and California’s economy. The Public Policy Institute of California reports that California’s professional services and information sectors have grown substantially since 1998, due largely to technological innovation. As a result, the state outpaces the nation in technology-driven growth. Technology sectors contribute more than $620 billion to the state economy, the largest output of any state. California is also home to the largest life sciences industry in the U.S. According to Biocom California’s Life Science Economic Impact Report, California-produced goods account for roughly 10% of annual U.S. pharmaceutical exports and more than 15% of U.S. exports of medical equipment and supplies. In 2024, the state’s life sciences industry employed approximately 450,000 workers across 17,220 companies and generated $395.7 billion in total economic output.
According to the Bureau of Economic Analysis, California accounts for nearly one-third of research and development (R&D) contributions to national gross domestic product (GDP), with research activities generating over $226 billion annually within the state—about 6% of the state’s GDP—and directly employing approximately 688,000 workers. A large share of R&D investment is directed to California universities: the National Center for Science and Engineering Statistics Higher Education Research and Development Survey found that California led the nation in higher education R&D spending, exceeding $14 billion in fiscal year 2024. These investments support a robust innovation ecosystem, enabling California to maintain the largest share of U.S. patent applications—nearly 30% each year. According to Clarivate, three California universities (Stanford, UC Berkeley, and UC San Diego) rank among the top ten worldwide for number of patents filed, and Pitchbook ranks four California universities among the top 20 for number of startup founders. The state has historically ranked highly on the Kauffman Early-Stage Entrepreneurship Index and entrepreneurial components of the Economic Innovation Group’s State Dynamism Index, two measures of entrepreneurial activity nationwide. California is a hotspot for emerging technology startups like those in the artificial intelligence industry: two-thirds of Forbes’s 2025 list of the top 50 artificial intelligence companies are headquartered in California.
- Impact of federal science funding cuts to California. Federal investment fuels research and development in California. California leads the nation in funding from agencies like the National Institutes of Health (NIH) and National Science Foundation (NSF). California also captures a large share of funding from the National Aeronautics and Space Administration (NASA) and the Department of Energy (DOE), given the concentration of national laboratories and technology industries in the state. In federal fiscal year 2024, California institutions received $5.2 billion from the NIH and over $1 billion from the NSF to support research at the state’s universities, hospitals, and companies. A large share of this funding is funneled to the UC system, which receives more NIH and NSF grants than any other institution in the nation. Across all federal agencies, the UCs were awarded $5 billion for nearly 17,000 projects in 2024, accounting for more than half of all UC research awards.
The Trump Administration’s fiscal year 2026 budget proposal included 40% to 55% cuts to scientific funding agencies like the NIH, NSF, and NASA. Additionally, some federal agencies announced policies to cap facilities and administrative (F&A) cost reimbursements, used by the grantee’s institution to support scientific infrastructure, at 15%, a significant cut for many institutions. Although Congress rejected these budget cuts and incorporated language barring the 15% F&A cap in the 2026 budget, science research is still experiencing a challenging federal environment. According to a January 2026 article in Nature, 5,844 NIH grants and 1,996 NSF grants were cancelled or suspended for not aligning with the Trump Administration’s priorities, affecting research on topics like vaccine uptake, infectious diseases, and people from underrepresented groups. Federal agencies are also awarding fewer new grants; for example, the NIH awarded 21% fewer new research project grants in fiscal year 2025. In fiscal year 2026, STAT has reported that the number of competitive NIH awards issued to date is 74% lower than the average recorded by February over fiscal years 2021–2024, and the total value of those awards is 62% below the average at this point over those same years.
Disruptions to the stability and predictability of federal science funding have already impacted California research groups. According to the grant tracking website Grant Witness, 775 California grants were disrupted from the NIH and 467 from the NSF since January 2025. Although many have since been restored due to intervention by the courts, the state is experiencing an estimated loss of $26 million from the NIH, $46 million from the NSF, $835 million from the Environmental Protection Agency (EPA), and $95 million from the Centers for Disease Control and Prevention (CDC). Last July, the federal government froze nearly $600 million in NIH and NSF funding to UCLA alone over claims of antisemitism on campus. Although these funds were eventually restored by court order, hundreds of research projects were halted for two months with no guarantee of being restored, disrupting experiments, wasting resources, and placing financial strain on graduate and postdoctoral researchers living paycheck to paycheck on federally funded stipends.
- CIRM. California has previously used voter-approved bonds to fund scientific research and infrastructure through CIRM. Following the Bush Administration’s 2001 Executive Order to ban the use of federal funds for embryonic stem cell research, Proposition 71 was placed on the 2004 ballot through the citizen’s initiative process, funded largely by stem-cell research advocate Robert Klein II. Proposition 71 authorized $3 billion in general obligation bonds to establish CIRM in order to fund stem cell research in California over a ten-year period. Proposition 71 also included language requiring that all grants and loan awards be subject to intellectual property agreements that balance the opportunity of the State to benefit from the patents, royalties, and licenses that result from the funded research, with the need to ensure that essential medical research is not unreasonably hindered by the intellectual property agreements. Proposition 71 required, at a minimum, that CIRM grantees share a fraction of the revenue they receive from licensing or self-commercializing an invention or technology that arises from research funded by CIRM pursuant to a specified formula. The Obama Administration rescinded the ban on federal stem cell research in 2009. In 2020, Robert Klein helped to fund another initiative, known as Proposition 14, to authorize an additional $5.5 billion in state general obligation bonds to fund research grants. Proposition 14, which passed with 51% of the vote, dedicated $1.5 billion to research and therapy for Alzheimer’s disease, Parkinson’s disease, stroke, dementia, epilepsy, brain cancer, schizophrenia, autism, and other diseases and conditions of the brain, and otherwise expanded programs promoting stem cell and other medical research, therapy development and delivery, and student and physician training and fellowships.
According to CIRM’s 2025 Annual Report, to date, these bonds have funded over 1,400 projects in 85 different disease areas, 116 clinical trials, and over 4,600 students and fellows. CIRM has also funded science and medical infrastructure like shared resources laboratories, alpha clinics, and a manufacturing network throughout the state to accelerate the delivery of cell and gene therapies. CIRM’s investments in biotechnology have advanced over 50 startups with roots in CIRM projects, several of which have attracted high-profile investors to help commercialize these therapies. For example, Orchard Therapeutics has licensed a gene-modified cell therapy for severe combined immunodeficiency from UCLA and Gilead has acquired an antibody therapy for cancer from Stanford’s spin-out company, Forty Seven. In 2015, CIRM shifted its funding model from an NIH-style grant system to a more hands-on, milestone-based award structure that links grantees with resources at each phase of a project and provides a predictable, stable funding schedule.
- The California Immunology Research and Cures Initiative. Signatures are being gathered for the California Immunology Research and Cures Initiative, aiming to appear on the ballot in 2026. This proposition would authorize the issue and sale of $8.4 billion dollars of general obligation bonds to fund a UC-affiliated immunology and immunotherapy research institute as well as individual immunology and immunotherapy research groups via grants. This proposition would be limited to immunology-related research, and only California-based public and nonprofit universities and medical research institutions would be eligible for funding. The proposition attempts to recuperate some of the investment for taxpayers by developing a technology licensing program, requiring a ten percent cut of all revenues from the sale, licensing, or commercialization of intellectual property rights, and requiring any products developed with these funds be made available to Californians at a price at least 20% below the national average price. The proposition aims to bring state funding to the UCLA-affiliated California Institute of Immunology and Immunotherapy (CIII), established in 2024 by several philanthropists including Dr. Gary K. Michelson, the proposition’s sponsor. The state allocated $500 million to the CIII in the 2022-2023 budget, to be appropriated over the next several years, but the institute only received $200 million when the remaining $300 million was canceled in the 2024-2025 budget.
- Double referral. This bill has been double referred. Should it pass out of this committee, it will be referred to the Committee on Natural Resources and Water.
- Prior legislation. SB 829 (Weiner of 2025) was substantially similar to this bill, but did not contain provisions related to a bond issuance. SB 829 was held on the Senate Appropriations suspense file.
SB 867 (Allen, Chapter 83, Statutes of 2024) enacted the Safe Drinking Water, Wildfire Prevention, and Clean Air Bond Act of 2024, which authorized the issuance of $10 billion in bonds to finance projects for safe drinking water, drought, flood, and water resilience, wildfire and forest resilience, coastal resilience, extreme heat mitigation, biodiversity protection and nature-based climate solutions, climate-smart and sustainable working lands, park creation, and clean air programs. The proposition (Prop 4) was approved by 60% of voters on the 2024 ballot.
- Support. The United Auto Workers (UAW) Region 6, UAW Local 4811, and the Union of American Physicians and Dentists, co-sponsors of the bill, call for action to counteract federal cuts and suspensions to NIH grants, and state that the CFSHR will safeguard California’s role as a global leader in innovation, boost tax revenue, drive middle class job growth, and provide hope and healing to millions of Californians facing deadly and debilitating diseases. UAW Region 6 shares that an independent analysis estimates that the $23 billion investment would generate $52.1 billion in economic activity and support between 55,000 and 60,000 jobs per year, not including multipliers like matching private research funds, the economic activity generated through the commercialization of new products, and the savings to the state from the reduced healthcare and energy costs that come from new technologies. The University of California, another co-sponsor, asserts that they currently receive $5.7 billion annually in federal support for research, and that a sustained loss in federal funding would cause enormous harm to the institution and their students, causing tens of thousands of jobs lost and an exodus of research talent from the state. Other supporters, including groups representing business, labor, patients, physicians, and academics echo that this bill preserves and strengthens California’s global leadership position in science, innovation, and public health, creates hundreds of thousands of high-wage jobs, and ensures that lifesaving and economically vital scientific research continues in the state, even if the federal government cuts or withholds federal funds. University student associations highlight the role of graduate students in driving academic research and the importance of this bill for the scientific and healthcare workforce pipeline in an uncertain federal funding environment. These groups emphasize that reliable funding is important for timely degree completion, access to laboratory resources, and the hands-on experience required for careers in science, medicine, and engineering.
- Support if amended. The Association for Frontotemporal Degeneration writes that amending all references of Alzheimer’s disease to “Alzheimer’s and other dementias” would better reflect the full scope of dementias affecting Californians, strengthening the bill’s public health impact by addressing an often-overshadowed need.
SUPPORT AND OPPOSITION:
Support: United Auto Workers Region 6 (co-sponsor)
Union of American Physicians and Dentists (co-sponsor)
University of California (co-sponsor)
350 Bay Area Action
ALS Association
American Academy of Neurology
American Federation of State, County, and Municipal Employees
Association of Independent California Colleges & Universities
Blood Cancer United
California Academy of Sciences
California Association of Professional Scientists, UAW Local 1115
California Consortium of Addiction Programs and Professionals
California Faculty Association
California Institute of Technology
California Physicians Alliance
California State University
Chamber San Mateo County
City of Eureka
Council of University of California Faculty Associations
Courage California
Culver City Democratic Club
Equality California
Greater Fresno Parkinson’s Support Group
Humane World for Animals
Indivisible CA: StateStrong
Lieutenant Governor Eleni Kounalakis
Loma Linda University Adventist Health Sciences Center
Michael J. Fox Foundation for Parkinson’s Research
Natera, Inc.
Palo Alto Chamber of Commerce
Parkinson Network of Mt. Diablo
Parkinson’s Association of Northern California
Parkinson’s Association of San Diego
Parkinson’s Community Los Angeles
Point Blue Conservation Science
Public Health Institute
San Diego Natural History Museum
San Francisco Chamber of Commerce
San Mateo County Economic Development Association
Santa Monica Democratic Club
Stanford University
Teamsters California
The Climate Center
United Auto Workers Local 4811
United Auto Workers Local 872
University of California Los Angeles Faculty Association
University of California Riverside Faculty Association
University of California Student Association
Western Center on Law & Poverty
Two individuals
Oppose: None received.
-- END --
Discussed in Hearing
Senate Floor
Assembly Floor
Assembly Standing Committee on Appropriations
Assembly Standing Committee on Health
Senate Floor
Senate Standing Committee on Natural Resources and Water
Senate Standing Committee on Health
Bill Author
Bill Co-Author(s):